Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific nTPM" "RNA single cell type specificity" "RNA single cell type distribution" "RNA single cell type specificity score" "RNA single cell type specific nTPM" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific nTPM" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific nTPM" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific nTPM" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific nTPM" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific nTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific nTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "CCD Protein" "CCD Transcript" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Blood expression cluster" "Tissue expression cluster" "Cell line expression cluster" "Single cell expression cluster" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [nTPM]" "Tissue RNA - adrenal gland [nTPM]" "Tissue RNA - amygdala [nTPM]" "Tissue RNA - appendix [nTPM]" "Tissue RNA - basal ganglia [nTPM]" "Tissue RNA - bone marrow [nTPM]" "Tissue RNA - breast [nTPM]" "Tissue RNA - cerebellum [nTPM]" "Tissue RNA - cerebral cortex [nTPM]" "Tissue RNA - cervix [nTPM]" "Tissue RNA - choroid plexus [nTPM]" "Tissue RNA - colon [nTPM]" "Tissue RNA - duodenum [nTPM]" "Tissue RNA - endometrium 1 [nTPM]" "Tissue RNA - epididymis [nTPM]" "Tissue RNA - esophagus [nTPM]" "Tissue RNA - fallopian tube [nTPM]" "Tissue RNA - gallbladder [nTPM]" "Tissue RNA - heart muscle [nTPM]" "Tissue RNA - hippocampal formation [nTPM]" "Tissue RNA - hypothalamus [nTPM]" "Tissue RNA - kidney [nTPM]" "Tissue RNA - liver [nTPM]" "Tissue RNA - lung [nTPM]" "Tissue RNA - lymph node [nTPM]" "Tissue RNA - medulla oblongata [nTPM]" "Tissue RNA - midbrain [nTPM]" "Tissue RNA - ovary [nTPM]" "Tissue RNA - pancreas [nTPM]" "Tissue RNA - parathyroid gland [nTPM]" "Tissue RNA - pituitary gland [nTPM]" "Tissue RNA - placenta [nTPM]" "Tissue RNA - pons [nTPM]" "Tissue RNA - prostate [nTPM]" "Tissue RNA - rectum [nTPM]" "Tissue RNA - retina [nTPM]" "Tissue RNA - salivary gland [nTPM]" "Tissue RNA - seminal vesicle [nTPM]" "Tissue RNA - skeletal muscle [nTPM]" "Tissue RNA - skin 1 [nTPM]" "Tissue RNA - small intestine [nTPM]" "Tissue RNA - smooth muscle [nTPM]" "Tissue RNA - spinal cord [nTPM]" "Tissue RNA - spleen [nTPM]" "Tissue RNA - stomach 1 [nTPM]" "Tissue RNA - testis [nTPM]" "Tissue RNA - thalamus [nTPM]" "Tissue RNA - thymus [nTPM]" "Tissue RNA - thyroid gland [nTPM]" "Tissue RNA - tongue [nTPM]" "Tissue RNA - tonsil [nTPM]" "Tissue RNA - urinary bladder [nTPM]" "Tissue RNA - vagina [nTPM]" "Tissue RNA - white matter [nTPM]" "Cell RNA - A-431 [nTPM]" "Cell RNA - A549 [nTPM]" "Cell RNA - AF22 [nTPM]" "Cell RNA - AN3-CA [nTPM]" "Cell RNA - ASC diff [nTPM]" "Cell RNA - ASC TERT1 [nTPM]" "Cell RNA - BEWO [nTPM]" "Cell RNA - BJ [nTPM]" "Cell RNA - BJ hTERT+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]" "Cell RNA - CACO-2 [nTPM]" "Cell RNA - CAPAN-2 [nTPM]" "Cell RNA - Daudi [nTPM]" "Cell RNA - EFO-21 [nTPM]" "Cell RNA - fHDF/TERT166 [nTPM]" "Cell RNA - GAMG [nTPM]" "Cell RNA - HaCaT [nTPM]" "Cell RNA - HAP1 [nTPM]" "Cell RNA - HBEC3-KT [nTPM]" "Cell RNA - HBF TERT88 [nTPM]" "Cell RNA - HDLM-2 [nTPM]" "Cell RNA - HEK 293 [nTPM]" "Cell RNA - HEL [nTPM]" "Cell RNA - HeLa [nTPM]" "Cell RNA - Hep G2 [nTPM]" "Cell RNA - HHSteC [nTPM]" "Cell RNA - HL-60 [nTPM]" "Cell RNA - HMC-1 [nTPM]" "Cell RNA - HSkMC [nTPM]" "Cell RNA - hTCEpi [nTPM]" "Cell RNA - hTEC/SVTERT24-B [nTPM]" "Cell RNA - hTERT-HME1 [nTPM]" "Cell RNA - hTERT-RPE1 [nTPM]" "Cell RNA - HUVEC TERT2 [nTPM]" "Cell RNA - JURKAT [nTPM]" "Cell RNA - K-562 [nTPM]" "Cell RNA - Karpas-707 [nTPM]" "Cell RNA - LHCN-M2 [nTPM]" "Cell RNA - MCF7 [nTPM]" "Cell RNA - MOLT-4 [nTPM]" "Cell RNA - NB-4 [nTPM]" "Cell RNA - NTERA-2 [nTPM]" "Cell RNA - OE19 [nTPM]" "Cell RNA - PC-3 [nTPM]" "Cell RNA - REH [nTPM]" "Cell RNA - RH-30 [nTPM]" "Cell RNA - RPMI-8226 [nTPM]" "Cell RNA - RPTEC TERT1 [nTPM]" "Cell RNA - RT4 [nTPM]" "Cell RNA - SCLC-21H [nTPM]" "Cell RNA - SH-SY5Y [nTPM]" "Cell RNA - SiHa [nTPM]" "Cell RNA - SK-BR-3 [nTPM]" "Cell RNA - SK-MEL-30 [nTPM]" "Cell RNA - SuSa [nTPM]" "Cell RNA - T-47d [nTPM]" "Cell RNA - THP-1 [nTPM]" "Cell RNA - TIME [nTPM]" "Cell RNA - U-138 MG [nTPM]" "Cell RNA - U-2 OS [nTPM]" "Cell RNA - U-2197 [nTPM]" "Cell RNA - U-251 MG [nTPM]" "Cell RNA - U-266/70 [nTPM]" "Cell RNA - U-266/84 [nTPM]" "Cell RNA - U-698 [nTPM]" "Cell RNA - U-87 MG [nTPM]" "Cell RNA - U-937 [nTPM]" "Cell RNA - WM-115 [nTPM]" "Blood RNA - basophil [nTPM]" "Blood RNA - classical monocyte [nTPM]" "Blood RNA - eosinophil [nTPM]" "Blood RNA - gdT-cell [nTPM]" "Blood RNA - intermediate monocyte [nTPM]" "Blood RNA - MAIT T-cell [nTPM]" "Blood RNA - memory B-cell [nTPM]" "Blood RNA - memory CD4 T-cell [nTPM]" "Blood RNA - memory CD8 T-cell [nTPM]" "Blood RNA - myeloid DC [nTPM]" "Blood RNA - naive B-cell [nTPM]" "Blood RNA - naive CD4 T-cell [nTPM]" "Blood RNA - naive CD8 T-cell [nTPM]" "Blood RNA - neutrophil [nTPM]" "Blood RNA - NK-cell [nTPM]" "Blood RNA - non-classical monocyte [nTPM]" "Blood RNA - plasmacytoid DC [nTPM]" "Blood RNA - T-reg [nTPM]" "Blood RNA - total PBMC [nTPM]" "Brain RNA - amygdala [nTPM]" "Brain RNA - basal ganglia [nTPM]" "Brain RNA - cerebellum [nTPM]" "Brain RNA - cerebral cortex [nTPM]" "Brain RNA - hippocampal formation [nTPM]" "Brain RNA - hypothalamus [nTPM]" "Brain RNA - medulla oblongata [nTPM]" "Brain RNA - midbrain [nTPM]" "Brain RNA - pons [nTPM]" "Brain RNA - spinal cord [nTPM]" "Brain RNA - thalamus [nTPM]" "Brain RNA - white matter [nTPM]" "Single Cell Type RNA - Adipocytes [nTPM]" "Single Cell Type RNA - Alveolar cells type 1 [nTPM]" "Single Cell Type RNA - Alveolar cells type 2 [nTPM]" "Single Cell Type RNA - Astrocytes [nTPM]" "Single Cell Type RNA - B-cells [nTPM]" "Single Cell Type RNA - Basal keratinocytes [nTPM]" "Single Cell Type RNA - Basal prostatic cells [nTPM]" "Single Cell Type RNA - Basal respiratory cells [nTPM]" "Single Cell Type RNA - Basal squamous epithelial cells [nTPM]" "Single Cell Type RNA - Bipolar cells [nTPM]" "Single Cell Type RNA - Breast glandular cells [nTPM]" "Single Cell Type RNA - Breast myoepithelial cells [nTPM]" "Single Cell Type RNA - Cardiomyocytes [nTPM]" "Single Cell Type RNA - Cholangiocytes [nTPM]" "Single Cell Type RNA - Club cells [nTPM]" "Single Cell Type RNA - Collecting duct cells [nTPM]" "Single Cell Type RNA - Cone photoreceptor cells [nTPM]" "Single Cell Type RNA - Cytotrophoblasts [nTPM]" "Single Cell Type RNA - dendritic cells [nTPM]" "Single Cell Type RNA - Distal enterocytes [nTPM]" "Single Cell Type RNA - Distal tubular cells [nTPM]" "Single Cell Type RNA - Ductal cells [nTPM]" "Single Cell Type RNA - Early spermatids [nTPM]" "Single Cell Type RNA - Endometrial ciliated cells [nTPM]" "Single Cell Type RNA - Endometrial stromal cells [nTPM]" "Single Cell Type RNA - Endothelial cells [nTPM]" "Single Cell Type RNA - Enteroendocrine cells [nTPM]" "Single Cell Type RNA - Erythroid cells [nTPM]" "Single Cell Type RNA - Excitatory neurons [nTPM]" "Single Cell Type RNA - Exocrine glandular cells [nTPM]" "Single Cell Type RNA - Extravillous trophoblasts [nTPM]" "Single Cell Type RNA - Fibroblasts [nTPM]" "Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]" "Single Cell Type RNA - Glandular and luminal cells [nTPM]" "Single Cell Type RNA - granulocytes [nTPM]" "Single Cell Type RNA - Granulosa cells [nTPM]" "Single Cell Type RNA - Hepatic stellate cells [nTPM]" "Single Cell Type RNA - Hepatocytes [nTPM]" "Single Cell Type RNA - Hofbauer cells [nTPM]" "Single Cell Type RNA - Horizontal cells [nTPM]" "Single Cell Type RNA - Inhibitory neurons [nTPM]" "Single Cell Type RNA - Intestinal goblet cells [nTPM]" "Single Cell Type RNA - Ionocytes [nTPM]" "Single Cell Type RNA - Kupffer cells [nTPM]" "Single Cell Type RNA - Langerhans cells [nTPM]" "Single Cell Type RNA - Late spermatids [nTPM]" "Single Cell Type RNA - Leydig cells [nTPM]" "Single Cell Type RNA - Macrophages [nTPM]" "Single Cell Type RNA - Melanocytes [nTPM]" "Single Cell Type RNA - Microglial cells [nTPM]" "Single Cell Type RNA - monocytes [nTPM]" "Single Cell Type RNA - Muller glia cells [nTPM]" "Single Cell Type RNA - NK-cells [nTPM]" "Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]" "Single Cell Type RNA - Oligodendrocytes [nTPM]" "Single Cell Type RNA - Pancreatic endocrine cells [nTPM]" "Single Cell Type RNA - Paneth cells [nTPM]" "Single Cell Type RNA - Peritubular cells [nTPM]" "Single Cell Type RNA - Plasma cells [nTPM]" "Single Cell Type RNA - Prostatic glandular cells [nTPM]" "Single Cell Type RNA - Proximal enterocytes [nTPM]" "Single Cell Type RNA - Proximal tubular cells [nTPM]" "Single Cell Type RNA - Respiratory ciliated cells [nTPM]" "Single Cell Type RNA - Rod photoreceptor cells [nTPM]" "Single Cell Type RNA - Sertoli cells [nTPM]" "Single Cell Type RNA - Skeletal myocytes [nTPM]" "Single Cell Type RNA - Smooth muscle cells [nTPM]" "Single Cell Type RNA - Spermatocytes [nTPM]" "Single Cell Type RNA - Spermatogonia [nTPM]" "Single Cell Type RNA - Squamous epithelial cells [nTPM]" "Single Cell Type RNA - Suprabasal keratinocytes [nTPM]" "Single Cell Type RNA - Syncytiotrophoblasts [nTPM]" "Single Cell Type RNA - T-cells [nTPM]" "Single Cell Type RNA - Theca cells [nTPM]" "Single Cell Type RNA - Undifferentiated cells [nTPM]" "Single Cell Type RNA - Urothelial cells [nTPM]" A2ML1 "CPAMD9, FLJ25179, p170" ENSG00000166535 "Alpha-2-macroglobulin like 1" A8K2U0 12 8822621-8887001 "Disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "esophagus: 556.3;vagina: 204.8" "Cell type enriched" "Detected in some" 6 "Squamous epithelial cells: 127.6" "Cancer enhanced" "Detected in many" "head and neck cancer: 39.9" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HMC-1: 10.9;hTCEpi: 5.5;SK-BR-3: 13.9" "Low region specificity" "Detected in many" "HPA038847, HPA038848" Enhanced "Secreted in other tissues" NA NA 10000000 "Cluster 84: Esophagus - Epithelial cell function" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 61: Squamous epithelial cells - Keratinization" "HPA038847: AB_2676236, HPA038848: AB_10672654" "unprognostic (1.13e-2)" "unprognostic (7.64e-2)" "unprognostic (1.04e-2)" "unprognostic (9.46e-3)" "unprognostic (2.14e-1)" "unprognostic (5.54e-3)" "unprognostic (4.59e-2)" "unprognostic (7.58e-3)" "unprognostic (2.63e-1)" "unprognostic (1.57e-1)" "unprognostic (1.15e-3)" "unprognostic (2.03e-1)" "unprognostic (1.06e-9)" "unprognostic (2.28e-1)" "unprognostic (3.07e-1)" "unprognostic (5.88e-2)" "unprognostic (2.42e-2)" 0.2 0.1 2.1 0.0 2.1 0.2 4.1 0.8 2.4 116.5 0.6 0.1 0.0 0.5 0.4 556.3 0.7 0.2 0.4 2.0 2.2 0.1 0.3 0.1 0.2 1.8 3.1 0.4 0.2 0.8 1.4 0.7 1.3 0.6 0.0 0.7 99.0 0.0 0.3 72.0 0.1 0.1 1.7 0.1 0.7 5.0 4.3 3.0 0.1 0.0 51.5 1.1 204.8 1.5 0.1 0.0 0.1 0.1 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 1.8 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.1 0.1 0.2 0.1 0.2 0.0 2.5 10.9 0.0 5.5 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 2.1 0.1 0.0 0.1 0.3 0.0 0.0 0.1 0.0 0.0 0.0 13.9 0.0 1.0 0.2 0.1 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.2 0.0 0.3 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 2.1 2.1 0.8 2.4 2.0 2.2 1.8 3.1 1.3 1.7 4.3 1.5 0.0 0.0 0.0 20.2 0.0 0.4 0.5 1.0 1.8 0.7 0.3 0.1 0.7 0.0 2.2 0.0 0.0 0.3 0.0 0.0 1.9 0.0 0.4 4.4 0.9 0.3 0.0 0.0 4.9 0.0 0.5 0.4 0.0 11.9 0.0 0.8 0.0 0.0 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.6 0.3 0.2 0.0 0.0 0.0 1.2 0.0 2.0 0.5 0.0 0.0 0.0 0.0 2.6 0.0 0.1 0.2 0.3 0.0 0.4 0.3 1.0 0.4 127.6 12.6 0.1 0.1 1.9 0.0 8.2 AC010325.1 ENSG00000261341 "Uncharacterized LOC105372440" 19 50776141-50793142 "Predicted membrane proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in some" 24 "testis: 216.1" "Cell type enhanced" "Detected in some" "Breast myoepithelial cells: 1.3;Exocrine glandular cells: 2.0;granulocytes: 1.3" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "AF22: 4.9;HEK 293: 6.5;hTERT-HME1: 4.0;NTERA-2: 3.9" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 12: NES - Nervous system development" "Cluster 60: Granulocytes - Receptor signaling" "unprognostic (1.46e-1)" "unprognostic (1.67e-1)" "unprognostic (2.63e-2)" "unprognostic (2.47e-1)" "unprognostic (9.62e-3)" "unprognostic (9.41e-2)" "unprognostic (1.11e-2)" "unprognostic (5.95e-3)" "unprognostic (1.14e-1)" "unprognostic (1.98e-2)" "unprognostic (1.06e-1)" "unprognostic (1.52e-1)" "unprognostic (5.32e-7)" "unprognostic (3.63e-1)" "unprognostic (2.21e-1)" "unprognostic (3.37e-3)" "unprognostic (3.00e-1)" 0.1 0.3 0.5 0.1 0.2 0.6 0.2 1.3 1.4 0.1 0.0 0.1 0.0 0.6 2.6 0.2 0.2 0.1 0.0 0.4 0.0 0.0 0.1 0.1 0.3 0.4 0.0 0.1 0.9 0.0 0.0 0.2 0.0 0.5 0.3 0.2 0.3 0.1 0.1 8.9 0.1 0.0 0.0 0.5 0.2 216.1 0.0 0.2 0.1 0.0 0.3 0.1 0.0 0.0 0.5 0.0 4.9 1.5 0.0 0.0 0.9 1.3 0.0 2.7 2.0 0.0 0.1 0.1 0.3 0.4 0.4 1.0 0.2 0.0 0.1 0.8 6.5 0.3 0.0 0.5 0.0 0.4 0.5 0.0 0.0 0.9 4.0 0.0 1.3 0.6 1.5 3.0 0.3 0.6 0.5 0.1 3.9 0.0 0.4 0.3 2.5 0.6 0.2 1.0 0.5 0.4 0.3 0.0 0.0 0.3 0.3 0.2 0.0 0.0 1.4 2.2 0.1 0.3 2.2 0.7 1.0 0.7 1.5 0.0 0.4 0.0 0.6 0.0 0.2 0.0 0.3 0.6 0.8 0.4 0.2 0.1 0.1 0.3 0.1 0.8 0.6 0.3 0.5 0.2 1.3 1.4 0.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.3 0.0 0.0 0.6 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.1 0.1 0.1 0.0 0.0 0.0 2.0 0.3 0.6 0.0 0.3 1.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 ACAP1 "CENTB1, KIAA0050" ENSG00000072818 "ArfGAP with coiled-coil, ankyrin repeat and PH domains 1" Q15027 17 7336529-7351477 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "GTPase activation" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 41.0;intestine: 43.3;lymphoid tissue: 96.0" "Cell type enriched" "Detected in many" 6 "Late spermatids: 3430.7" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in some" "Daudi: 23.3;HDLM-2: 31.0;JURKAT: 42.4;Karpas-707: 29.4;NB-4: 37.9;U-937: 24.9" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA075570 Approved Approved "Golgi apparatus" NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 2: Immune cells - Immune response" "Cluster 24: NB-4 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "Golgi apparatus" "HPA075570: AB_2732295" "unprognostic (1.20e-2)" "prognostic favorable (3.66e-4)" "unprognostic (2.49e-1)" "prognostic favorable (2.97e-5)" "unprognostic (4.43e-4)" "prognostic favorable (4.17e-5)" "unprognostic (5.66e-3)" "unprognostic (1.11e-2)" "unprognostic (4.67e-2)" "unprognostic (2.48e-2)" "unprognostic (1.42e-2)" "unprognostic (1.91e-1)" "prognostic unfavorable (1.65e-10)" "unprognostic (1.14e-1)" "unprognostic (5.58e-2)" "unprognostic (2.90e-1)" "unprognostic (8.61e-3)" 5.6 1.1 0.4 18.9 0.5 41.0 2.1 0.5 0.8 2.3 0.5 7.4 4.1 1.5 0.3 4.2 4.0 3.6 2.1 0.3 0.4 4.6 5.2 16.1 39.5 0.6 0.5 0.9 1.2 0.1 1.3 0.5 0.6 3.8 2.1 0.2 3.6 0.4 0.9 2.5 43.3 0.9 0.5 96.0 5.0 0.8 0.8 25.8 5.2 0.8 22.6 4.3 3.7 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.1 0.1 0.0 23.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 31.0 0.0 8.8 0.1 0.0 0.1 11.5 0.3 0.0 0.0 0.0 0.0 0.0 0.0 42.4 0.0 29.4 0.0 0.0 14.5 37.9 0.4 0.0 0.0 15.1 0.2 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 8.9 0.0 0.0 0.1 0.0 0.0 9.1 8.2 10.9 0.1 24.9 0.0 28.8 7.9 30.8 29.6 2.4 33.3 20.2 31.5 32.1 13.7 21.3 26.7 27.5 22.6 32.5 0.4 17.3 39.0 22.3 0.4 0.5 0.5 0.8 0.3 0.4 0.6 0.5 0.6 0.5 0.8 0.6 3.8 9.6 5.5 1.6 150.9 8.3 7.6 25.1 2.8 15.8 7.0 8.1 32.9 7.2 12.3 5.5 18.8 3.9 160.7 2.0 7.9 3.9 498.1 8.3 5.4 5.0 3.6 22.9 0.3 3.7 3.2 8.0 5.6 3.4 40.5 1.8 7.1 5.3 7.5 0.0 1.9 2.7 8.2 26.2 39.5 3430.7 20.2 27.9 24.9 2.8 38.3 11.7 332.7 0.5 1.0 5.5 0.0 15.4 68.0 4.6 1.3 3.8 44.6 20.4 19.7 7.5 8.1 15.6 10.5 1.5 7.4 4.4 268.3 0.9 1.6 3.5 ACP4 ACPT ENSG00000142513 "Acid phosphatase 4" Q9BZG2 19 50790415-50795219 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" Hydrolase "Amelogenesis imperfecta, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 1.2;testis: 3.7" "Not detected" "Not detected" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.5;U-266/84: 2.0" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 16: U-266 - Nucleosome" "unprognostic (9.41e-2)" "unprognostic (1.86e-1)" "unprognostic (4.00e-3)" "unprognostic (3.70e-3)" "unprognostic (7.62e-2)" "unprognostic (3.18e-2)" "unprognostic (3.89e-3)" "unprognostic (5.46e-2)" "unprognostic (2.47e-1)" "unprognostic (5.59e-2)" "unprognostic (3.96e-1)" "unprognostic (1.45e-1)" "unprognostic (2.37e-3)" "unprognostic (2.36e-1)" "unprognostic (4.40e-1)" "unprognostic (1.02e-1)" "unprognostic (1.32e-1)" 0.0 0.0 0.2 0.0 0.1 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.5 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.7 0.0 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.5 1.5 0.0 0.5 0.2 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.9 0.0 0.3 0.2 0.4 0.1 0.2 0.5 0.3 0.1 0.2 0.0 0.5 0.1 0.2 0.1 0.1 0.2 0.0 0.0 0.3 0.0 0.2 0.2 0.2 0.1 0.2 2.0 0.2 0.2 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.8 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 AGPAT2 "BSCL, LPAAT-beta" ENSG00000169692 "1-acylglycerol-3-phosphate O-acyltransferase 2" O15120 9 136673143-136687457 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" "Acyltransferase, Transferase" "Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 369.3;liver: 445.0" "Cell type enhanced" "Detected in many" "Distal enterocytes: 688.9;Late spermatids: 387.3;Paneth cells: 670.7;Proximal enterocytes: 1298.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HDLM-2: 186.9" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019544 Uncertain NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 85: Liver - Metabolism" "Cluster 44: HDLM-2 - Immune response" "Cluster 45: Enterocytes - Digestion" "HPA019544: AB_1844646" "unprognostic (3.20e-2)" "unprognostic (1.27e-1)" "unprognostic (5.01e-3)" "unprognostic (9.26e-2)" "unprognostic (1.50e-1)" "unprognostic (9.30e-3)" "unprognostic (5.06e-3)" "unprognostic (8.98e-2)" "unprognostic (1.42e-1)" "unprognostic (1.27e-1)" "unprognostic (2.17e-1)" "unprognostic (5.61e-2)" "unprognostic (2.60e-1)" "unprognostic (2.19e-2)" "unprognostic (1.92e-1)" "unprognostic (4.58e-2)" "unprognostic (2.93e-1)" 369.3 38.3 11.4 11.8 9.3 34.2 259.9 8.8 15.9 32.1 13.5 83.2 111.4 26.4 9.6 85.6 29.7 15.7 84.9 9.4 12.6 80.2 445.0 60.9 9.2 11.8 12.3 17.7 129.6 18.4 41.5 8.0 11.3 34.3 12.2 0.9 48.1 12.8 37.4 51.1 119.4 6.7 11.4 39.2 52.0 24.1 13.9 5.5 46.9 10.0 5.3 35.5 36.6 9.6 55.0 75.2 8.9 41.4 63.3 19.8 37.3 35.5 28.5 24.1 18.5 86.0 105.7 17.8 77.8 21.0 38.6 145.1 12.7 22.2 2.8 186.9 57.3 26.5 30.3 19.2 42.6 28.1 62.1 19.0 30.9 20.9 11.0 20.9 12.5 23.6 32.7 2.9 10.4 98.5 1.9 87.4 22.5 101.0 135.0 41.0 31.3 100.3 28.5 33.9 19.5 31.4 45.8 47.6 60.3 6.8 30.6 109.3 24.7 31.5 32.1 10.4 23.0 4.4 0.4 11.8 0.4 59.7 32.1 20.1 88.8 111.8 6.8 83.5 6.5 12.8 5.8 7.9 47.8 22.7 4.6 5.5 61.1 7.2 75.7 65.6 8.1 35.2 11.4 9.3 8.8 15.9 9.4 12.6 11.8 12.3 11.3 11.4 13.9 9.6 25.9 16.0 64.4 0.7 20.2 45.2 60.0 64.0 22.8 3.5 23.4 22.4 39.6 87.2 45.3 73.5 0.0 7.3 30.8 688.9 54.8 155.2 136.4 50.4 17.4 27.9 35.8 8.0 1.9 219.5 37.1 30.1 81.6 63.8 13.4 31.4 31.1 228.0 131.2 40.4 2.6 197.3 126.1 53.4 57.4 387.3 26.8 57.6 136.9 4.7 48.8 14.6 23.7 0.0 0.3 169.5 670.7 20.3 13.4 93.5 1298.3 41.9 46.3 3.8 46.0 15.3 29.8 1.8 27.2 47.5 81.3 6.8 26.6 16.4 207.7 196.2 ANKRD31 FLJ40191 ENSG00000145700 "Ankyrin repeat domain 31" Q8N7Z5 5 75068275-75236911 "Predicted intracellular proteins" "DNA recombination, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 7 "testis: 4.9" "Group enriched" "Detected in some" 7 "Spermatocytes: 148.9;Spermatogonia: 37.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "HPA038028, HPA057566" Enhanced Approved Nucleoplasm,Nucleoli,Vesicles,Centrosome NA NA "Cluster 35: T-regs - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Centrosome" "Nucleoli, Vesicles" "HPA038028: AB_10672615, HPA057566: AB_2683470" "unprognostic (1.37e-1)" "unprognostic (4.28e-2)" "unprognostic (5.25e-2)" "unprognostic (5.57e-2)" "unprognostic (1.65e-1)" "unprognostic (5.72e-2)" "unprognostic (4.81e-2)" "unprognostic (2.52e-2)" "unprognostic (3.63e-1)" "unprognostic (1.83e-1)" "unprognostic (1.02e-2)" "unprognostic (1.69e-1)" "unprognostic (3.00e-2)" "unprognostic (4.46e-2)" "unprognostic (5.48e-2)" "unprognostic (1.24e-2)" "unprognostic (1.40e-1)" 0.1 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.1 0.1 0.1 0.7 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.3 0.2 0.1 0.2 0.1 0.0 0.2 0.1 0.0 0.3 0.2 0.1 0.0 0.1 0.1 0.0 0.2 0.0 0.0 4.9 0.1 0.2 0.0 0.0 0.0 0.0 0.4 0.3 0.2 0.1 0.1 0.9 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.1 0.1 0.0 0.3 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.1 0.2 0.0 0.1 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.2 0.3 0.2 0.2 0.1 0.3 0.1 0.0 0.5 5.2 0.4 0.4 0.4 0.5 0.6 3.3 0.8 1.1 1.1 0.0 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.3 3.6 2.8 0.8 0.1 0.0 0.8 5.8 0.2 0.6 0.4 4.1 0.4 12.0 0.5 0.4 0.0 0.1 1.7 5.4 0.0 0.0 0.0 0.0 4.7 1.5 0.1 0.0 1.0 0.1 1.3 0.0 3.0 5.6 0.1 0.1 0.4 1.3 0.0 0.1 0.3 1.2 2.2 13.1 0.6 0.4 148.9 37.7 0.4 0.1 0.3 1.1 0.7 0.1 0.2 ANO5 "GDD1, LGMD2L, TMEM16E" ENSG00000171714 "Anoctamin 5" Q75V66 11 21799934-22283357 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Disease variant, Limb-girdle muscular dystrophy, Osteogenesis imperfecta" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "heart muscle: 24.9;parathyroid gland: 17.0;skeletal muscle: 65.5;tongue: 50.4" "Group enriched" "Detected in many" 7 "Astrocytes: 67.9;Cardiomyocytes: 86.2;Excitatory neurons: 166.6;Inhibitory neurons: 136.4;Oligodendrocyte precursor cells: 81.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A549: 4.9;HAP1: 5.0;HEK 293: 6.6;NTERA-2: 3.5;RPTEC TERT1: 3.2;U-266/84: 3.7" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA058857 Uncertain NA NA "Cluster 8: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA058857: AB_2683835" "unprognostic (5.25e-3)" "unprognostic (1.36e-3)" "unprognostic (2.43e-1)" "unprognostic (7.67e-3)" "unprognostic (3.50e-2)" "unprognostic (5.85e-2)" "unprognostic (8.17e-3)" "unprognostic (2.30e-2)" "unprognostic (1.68e-1)" "unprognostic (3.89e-2)" "unprognostic (2.54e-4)" "unprognostic (8.55e-2)" "prognostic favorable (2.50e-7)" "unprognostic (3.65e-3)" "unprognostic (2.84e-1)" "unprognostic (2.77e-4)" "unprognostic (7.94e-2)" 0.9 4.5 1.9 0.8 3.0 0.0 0.7 0.1 8.9 1.6 3.0 2.6 3.3 1.5 1.3 2.0 0.8 1.7 24.9 4.0 2.2 3.6 2.1 1.2 0.2 2.7 2.1 0.5 3.9 17.0 3.4 0.0 2.2 4.2 3.3 2.1 2.6 4.1 65.5 0.1 2.5 2.7 0.4 0.7 3.0 1.8 2.4 0.2 4.7 50.4 0.3 2.0 0.3 3.4 0.0 4.9 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.0 0.0 0.0 0.0 6.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.3 1.4 2.5 0.0 0.0 0.0 0.0 3.5 2.6 0.0 0.0 0.0 0.0 3.2 0.1 2.7 2.6 0.0 0.0 0.0 2.1 2.1 1.9 0.0 0.0 1.9 0.0 0.0 2.0 3.7 0.0 2.8 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 3.0 0.1 8.9 4.0 2.2 2.7 2.1 2.2 0.4 2.4 3.4 0.4 0.0 5.9 67.9 0.6 0.3 0.3 0.0 0.0 6.7 2.2 0.6 86.2 1.5 0.0 1.8 0.0 0.1 0.0 7.8 1.9 1.3 5.8 0.4 0.2 3.2 5.4 0.4 166.6 2.7 0.0 3.0 1.5 0.3 0.0 3.0 2.5 5.1 0.5 1.7 136.4 7.1 0.0 0.6 1.4 2.9 0.0 1.6 1.8 14.0 1.9 2.8 0.0 81.4 4.2 1.0 4.4 1.2 0.0 1.4 2.7 3.3 0.7 0.8 0.0 8.1 2.4 11.0 0.9 0.1 0.1 0.0 0.2 1.6 4.6 0.2 APOA1 ENSG00000118137 "Apolipoprotein A1" P02647 11 116835751-116837622 "Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Amyloidosis, Atherosclerosis, Cancer-related genes, Disease variant, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "liver: 19248.5" "Group enriched" "Detected in many" 21 "Hepatocytes: 27332.1;Proximal enterocytes: 18348.1" "Cancer enriched" "Detected in many" 48 "liver cancer: 4515.8" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "plasmacytoid DC: 1.2" "Low lineage specificity" "Detected in single" "Cell line enriched" "Detected in many" 17 "Hep G2: 3460.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB016778, HPA046715" Supported Approved Vesicles,Cytosol "Secreted to blood" NA NA 1450000000000 110000000000 "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 85: Liver - Metabolism" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 2: Hepatocytes - Metabolism" Vesicles Cytosol "CAB016778: , HPA046715: AB_2679768" "unprognostic (1.88e-3)" "unprognostic (4.53e-2)" "unprognostic (7.46e-2)" "unprognostic (4.00e-3)" "unprognostic (3.70e-2)" "unprognostic (1.41e-1)" "prognostic favorable (5.05e-4)" "unprognostic (5.40e-2)" "unprognostic (1.89e-1)" "unprognostic (9.60e-3)" "unprognostic (1.59e-3)" "unprognostic (7.02e-2)" "prognostic unfavorable (1.67e-8)" "unprognostic (3.46e-3)" "unprognostic (1.15e-1)" "unprognostic (6.24e-2)" "unprognostic (9.54e-2)" 3.2 1.4 1.2 3.6 1.2 0.0 2.1 1.1 1.4 0.8 0.8 7.4 1709.3 3.5 0.4 1.1 6.1 1.7 67.2 1.0 1.1 3.7 19248.5 2.7 3.2 1.1 1.1 23.1 2.5 0.0 4.2 1.6 1.1 1.1 0.2 0.1 0.7 1.0 0.8 1.0 4053.7 2.1 1.1 9.0 14.6 384.5 1.2 0.9 3.7 0.2 0.1 0.5 1.5 1.2 0.0 0.0 0.6 0.1 0.0 0.0 15.0 0.0 0.0 0.0 0.0 203.4 0.3 3.1 6.0 0.0 0.0 0.6 0.0 0.0 0.0 0.1 0.1 7.3 1.9 3460.4 0.0 16.6 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.3 0.0 0.2 0.3 15.0 1.2 1.2 0.1 0.5 15.0 20.3 0.0 2.6 5.7 20.7 8.9 0.0 0.0 3.9 0.0 0.1 2.6 0.0 0.4 2.1 0.1 1.2 0.2 4.9 0.0 5.5 0.2 0.0 0.0 0.0 0.8 0.2 0.0 0.0 0.0 0.5 0.2 0.1 0.2 0.5 0.0 0.2 0.0 1.2 0.6 0.1 1.2 1.2 1.1 1.4 1.0 1.1 1.1 1.1 1.1 1.1 1.2 1.2 2.0 3.2 3.3 0.3 49.7 0.1 0.5 0.2 0.6 0.5 0.9 0.9 37.0 479.0 1.3 0.0 0.0 0.6 5.1 0.4 0.0 0.1 36.9 15.2 4.3 50.3 1.8 541.9 0.5 1.1 4.2 5.8 17.9 1.7 2.5 419.2 458.7 27332.1 3.3 0.0 0.8 458.8 0.0 681.2 2.0 149.7 22.4 2.1 0.0 0.0 0.0 0.3 3.1 0.0 0.3 0.3 458.2 4.9 1.0 0.1 18348.1 9.0 0.4 0.6 6.6 1.6 13.0 39.8 11.2 0.0 0.6 4.2 35.7 1051.7 175.7 0.3 ARHGAP22 RhoGAP2 ENSG00000128805 "Rho GTPase activating protein 22" Q7Z5H3 10 48446036-48656265 "Predicted intracellular proteins" "Angiogenesis, Differentiation, Transcription, Transcription regulation" "Developmental protein, GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 22.6" "Cell type enhanced" "Detected in many" "Late spermatids: 122.7;Microglial cells: 227.7;Oligodendrocyte precursor cells: 141.8;Oligodendrocytes: 200.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "classical monocyte: 1.1" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 68.8;LHCN-M2: 64.8;TIME: 66.2;U-87 MG: 82.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020696, HPA040391, HPA064439" Uncertain Supported "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 25: Monocytes - Inflammatory response" "Cluster 70: Brain - Nervous system development" "Cluster 10: BJ & FHDF - ECM organization" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Nucleoplasm, Cytosol" "Plasma membrane" "CAB020696: , HPA040391: AB_2676957, HPA064439: AB_2685266" "unprognostic (1.87e-1)" "unprognostic (3.98e-2)" "unprognostic (2.38e-2)" "unprognostic (2.62e-1)" "unprognostic (1.07e-1)" "unprognostic (6.74e-3)" "unprognostic (4.81e-3)" "unprognostic (2.78e-1)" "unprognostic (1.66e-1)" "unprognostic (3.03e-1)" "unprognostic (1.12e-1)" "unprognostic (1.02e-1)" "prognostic unfavorable (2.16e-8)" "unprognostic (7.40e-2)" "unprognostic (1.60e-1)" "unprognostic (9.39e-2)" "unprognostic (3.66e-2)" 2.6 1.9 12.0 3.0 15.7 1.4 1.6 17.6 14.5 1.6 7.7 2.0 0.6 1.1 0.7 1.4 1.8 1.8 4.4 11.9 12.7 1.3 0.8 2.0 2.7 22.6 17.0 4.8 1.7 0.9 2.0 0.8 20.1 3.3 1.0 0.4 2.0 1.1 1.9 2.2 1.6 1.4 16.9 2.8 1.2 4.8 17.0 2.8 6.6 1.6 2.2 2.1 2.2 22.2 6.2 1.4 0.4 0.0 5.1 20.8 4.3 31.9 15.1 3.0 4.1 7.0 0.9 0.0 1.2 13.1 2.1 12.4 0.4 11.2 5.4 0.6 11.5 18.2 0.2 0.1 2.7 2.0 2.0 5.0 11.2 37.1 3.0 68.8 20.6 0.0 17.4 3.0 64.8 0.2 0.2 0.1 7.2 0.0 0.5 0.1 0.0 7.9 6.5 0.7 1.1 6.4 1.5 0.1 0.6 0.6 0.4 0.3 66.2 30.1 0.4 3.8 23.8 0.0 0.0 0.0 82.5 0.3 4.9 0.0 1.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 12.0 15.7 17.6 14.5 11.9 12.7 22.6 17.0 20.1 16.9 17.0 22.2 0.9 0.0 1.7 4.2 2.9 3.4 4.1 6.8 4.6 1.1 0.8 3.0 2.9 1.5 2.9 0.0 2.1 11.6 3.2 0.2 0.0 2.8 53.6 0.7 1.6 2.4 0.0 10.9 51.7 4.4 0.7 6.5 0.5 1.0 0.0 4.4 1.8 0.0 10.3 0.0 29.8 0.3 2.0 7.6 14.2 122.7 2.8 15.6 1.8 227.7 14.8 1.8 0.0 141.8 200.8 2.5 0.0 6.0 0.5 1.9 0.0 0.2 3.8 1.4 0.0 1.6 4.2 1.6 4.3 0.4 0.6 1.0 0.7 10.6 0.1 0.6 ARV1 ENSG00000173409 "ARV1 homolog, fatty acid homeostasis modulator" Q9H2C2 1 230978981-231000733 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport" "Disease variant, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 116.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035709 Approved Uncertain Vesicles NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles "HPA035709: AB_2674744" "unprognostic (2.32e-1)" "unprognostic (4.69e-2)" "prognostic favorable (1.33e-4)" "unprognostic (3.29e-1)" "unprognostic (1.42e-1)" "unprognostic (9.95e-2)" "unprognostic (5.66e-2)" "prognostic favorable (3.27e-5)" "unprognostic (1.37e-1)" "unprognostic (1.12e-2)" "unprognostic (9.57e-2)" "unprognostic (9.82e-2)" "unprognostic (2.31e-1)" "unprognostic (4.82e-1)" "unprognostic (5.63e-2)" "unprognostic (1.39e-1)" "unprognostic (8.12e-3)" 10.6 18.4 23.4 10.2 24.5 13.9 19.0 26.2 32.8 12.2 25.7 24.6 16.4 9.7 22.9 15.7 14.3 16.4 30.1 24.5 25.6 25.2 26.2 15.0 14.8 25.2 24.1 11.2 17.5 33.3 20.1 11.7 25.0 16.2 25.9 29.0 22.0 15.2 21.7 17.8 17.3 13.1 25.7 13.5 17.1 31.3 25.2 15.0 21.9 24.8 15.3 15.2 11.2 27.7 40.8 43.6 20.8 25.1 29.6 26.4 20.1 19.0 34.0 33.5 38.3 16.3 31.4 11.4 22.7 21.3 20.5 32.3 40.6 25.5 39.2 30.4 55.7 36.8 28.9 22.1 30.5 53.6 27.9 28.0 25.8 18.1 20.9 21.9 22.5 34.7 53.7 30.7 22.2 14.3 22.3 16.4 27.1 43.0 27.1 25.2 32.1 33.1 47.1 33.0 21.2 32.6 22.6 26.6 57.9 5.3 46.6 46.6 13.9 13.4 8.7 23.6 45.9 47.4 44.6 28.9 36.8 45.9 36.7 9.1 8.1 8.5 10.0 12.2 13.9 18.1 11.2 12.4 10.1 11.2 13.7 13.0 2.0 12.7 21.2 14.9 15.4 9.0 23.4 24.5 26.2 32.8 24.5 25.6 25.2 24.1 25.0 25.7 25.2 27.7 13.6 16.0 31.7 10.7 12.6 12.9 22.0 75.8 11.4 18.9 14.8 15.6 32.2 21.5 38.9 29.5 2.1 37.9 12.7 15.8 60.7 24.1 52.6 12.7 10.9 12.7 7.7 58.1 20.2 40.8 14.5 14.5 11.7 9.7 17.1 14.4 15.0 17.3 24.9 38.7 25.6 18.5 34.6 13.3 5.5 22.9 9.3 13.5 24.9 8.4 9.8 33.6 7.2 8.5 19.3 21.5 11.5 16.6 14.7 11.6 17.9 32.5 27.3 20.0 0.0 11.4 15.6 116.7 21.0 20.3 15.2 15.6 11.4 22.0 26.4 20.9 BRCA1 "BRCC1, FANCS, PPP1R53, RNF53" ENSG00000012048 "BRCA1 DNA repair associated" P38398 17 43044295-43170245 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA recombination, DNA repair, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Transcription, Transcription regulation, Ubl conjugation pathway" "Activator, DNA-binding, Transferase" "Cancer-related genes, Disease variant, Fanconi anemia, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Erythroid cells: 42.5;Granulosa cells: 38.2;Spermatocytes: 105.8;Spermatogonia: 73.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basophil: 6.8;classical monocyte: 14.7;intermediate monocyte: 4.7;myeloid DC: 10.9;neutrophil: 11.3" "Group enriched" "Detected in all" 6 "dendritic cells: 10.9;granulocytes: 11.3;monocytes: 14.7" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB001946, HPA004840, HPA034966, HPA057371" Approved Supported "Nucleoplasm,Nuclear bodies" NA Yes "Cluster 25: Monocytes - Inflammatory response" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Nucleoplasm, Nuclear bodies" "CAB001946: , HPA004840: , HPA034966: AB_10795287, HPA057371: AB_2732611" "unprognostic (7.87e-3)" "unprognostic (6.97e-2)" "unprognostic (3.53e-3)" "unprognostic (2.39e-1)" "unprognostic (5.42e-2)" "unprognostic (7.07e-3)" "unprognostic (1.56e-3)" "unprognostic (4.14e-3)" "unprognostic (9.62e-3)" "unprognostic (2.47e-1)" "unprognostic (5.53e-3)" "unprognostic (1.28e-1)" "unprognostic (1.08e-4)" "unprognostic (1.08e-3)" "unprognostic (1.48e-1)" "unprognostic (2.12e-1)" "unprognostic (8.31e-2)" 3.1 1.8 4.2 7.5 7.2 13.0 3.6 4.7 5.2 2.7 2.7 6.8 3.2 3.1 2.2 4.0 3.7 1.9 3.0 3.6 4.1 2.0 5.6 3.2 10.3 5.6 5.0 2.8 2.8 5.9 2.8 3.8 6.0 2.4 7.4 8.2 3.2 1.6 4.2 6.0 5.1 3.9 3.7 3.9 3.6 13.0 5.5 14.5 7.8 3.7 11.2 2.8 2.4 10.8 44.1 69.1 37.8 30.1 6.0 13.4 36.6 50.6 21.5 41.9 39.3 42.3 33.4 100.8 9.1 19.0 49.0 49.5 51.9 28.3 69.5 46.9 38.0 48.1 54.0 37.1 1.3 86.0 39.9 3.8 4.5 63.1 20.0 10.6 22.3 46.6 73.7 42.2 39.7 30.0 72.0 27.8 20.5 29.1 18.7 49.0 79.8 40.8 15.4 42.1 25.8 27.4 38.8 12.5 19.4 25.5 33.9 39.6 13.8 37.2 29.6 49.0 53.2 20.1 51.2 75.5 29.6 49.6 39.4 6.8 14.7 2.2 1.5 4.7 1.5 1.2 1.5 1.2 10.9 2.1 1.3 1.5 11.3 1.5 2.0 1.7 0.5 17.5 4.2 7.2 4.7 5.2 3.6 4.1 5.6 5.0 6.0 3.7 5.5 10.8 5.0 0.0 2.8 9.4 5.8 2.9 4.5 1.9 1.2 10.3 4.4 5.2 10.1 5.7 3.5 1.8 22.9 12.8 8.1 6.2 0.0 3.0 11.9 14.0 6.3 4.7 0.0 42.5 3.0 1.1 18.2 7.4 6.1 4.2 8.2 38.2 5.3 18.3 10.1 11.8 4.4 7.5 0.0 3.9 2.8 8.0 2.5 6.4 0.0 4.7 4.9 2.4 5.2 3.0 18.7 1.7 2.4 1.5 16.6 2.3 1.1 1.0 10.0 22.8 6.6 13.7 5.5 105.8 73.5 8.2 2.3 4.0 4.7 9.7 12.7 3.4 BUB1 "BUB1A, BUB1L, hBUB1" ENSG00000169679 "BUB1 mitotic checkpoint serine/threonine kinase" O43683 2 110637528-110678063 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Apoptosis, Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "bone marrow: 11.9;lymphoid tissue: 27.5;testis: 30.3" "Cell type enhanced" "Detected in many" "Erythroid cells: 24.8;Granulosa cells: 66.1;Plasma cells: 35.2;Spermatocytes: 85.6;Spermatogonia: 20.0" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HEL: 221.5" "Region enhanced" "Detected in single" "white matter: 1.7" "Not detected" "Not detected" HPA006123 Supported Nucleoplasm,Cytosol NA Yes "Cluster 46: Basophils - DNA binding" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 36: HEL - Hemostasis" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Cytosol "HPA006123: AB_1845498" "unprognostic (7.74e-2)" "unprognostic (3.45e-2)" "unprognostic (9.72e-3)" "prognostic unfavorable (3.65e-4)" "unprognostic (1.61e-1)" "unprognostic (5.62e-3)" "prognostic unfavorable (1.03e-5)" "prognostic unfavorable (3.94e-4)" "unprognostic (1.26e-3)" "unprognostic (1.15e-1)" "prognostic unfavorable (2.37e-5)" "unprognostic (1.76e-1)" "unprognostic (0.00e+0)" "unprognostic (2.45e-2)" "unprognostic (3.64e-1)" "unprognostic (5.01e-2)" "unprognostic (1.28e-1)" 0.5 0.4 0.1 8.4 0.3 11.9 1.2 0.1 0.1 0.9 0.0 4.3 4.0 1.0 3.5 4.7 0.5 0.9 0.6 0.1 0.1 0.3 0.6 1.2 15.9 0.1 0.6 0.4 0.2 0.7 0.0 3.2 0.3 0.3 5.7 0.1 0.9 0.1 0.1 2.7 3.5 2.2 0.0 5.6 1.9 30.3 0.4 27.5 0.4 0.2 17.0 2.4 1.6 0.3 96.0 29.4 68.5 46.8 3.8 5.3 38.8 50.9 32.9 85.6 62.3 58.3 55.0 64.7 30.9 30.1 80.1 43.2 93.9 35.0 105.7 51.4 45.6 221.5 26.2 50.6 0.8 63.5 57.0 1.7 2.8 65.2 33.1 12.7 49.8 73.2 96.8 126.5 76.8 33.7 126.3 39.0 71.2 39.4 55.3 69.3 64.2 102.7 18.3 27.0 48.3 21.4 34.2 31.4 27.2 44.1 24.0 60.6 19.1 39.7 57.5 28.8 69.0 67.3 65.5 75.4 24.2 48.6 69.8 1.1 0.0 0.2 0.2 0.0 0.3 0.5 0.9 0.5 0.1 0.5 0.6 0.4 0.0 0.5 0.0 0.9 1.5 0.3 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.6 0.3 0.0 0.4 0.3 0.2 0.0 1.5 0.0 5.5 0.5 0.5 2.0 0.6 0.0 0.9 0.8 1.1 0.0 1.6 0.0 0.0 5.8 2.5 2.4 0.0 0.3 13.5 4.5 1.5 1.1 0.0 24.8 0.2 0.0 9.8 2.2 2.0 2.2 0.0 66.1 1.8 0.3 8.1 0.0 0.2 3.1 4.1 1.6 1.4 7.5 0.3 2.0 0.0 0.0 0.6 0.0 0.0 0.5 1.0 0.1 0.0 0.4 35.2 0.5 0.3 0.1 1.8 0.0 6.6 0.2 3.7 85.6 20.0 4.0 0.4 0.7 2.9 0.5 5.9 0.9 C14orf39 SIX6OS1 ENSG00000179008 "Chromosome 14 open reading frame 39" Q8N1H7 14 60396469-60515543 "Plasma proteins, Predicted intracellular proteins" "DNA recombination, Meiosis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "pituitary gland: 4.8;salivary gland: 4.6;testis: 10.8" "Cell type enriched" "Detected in some" 4 "Spermatocytes: 92.5" "Cancer enhanced" "Detected in single" "testis cancer: 0.5" "Group enriched" "Detected in some" 16 "hypothalamus: 2.9;thalamus: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEL: 6.2;JURKAT: 28.3;MOLT-4: 23.9;RH-30: 6.2;U-2 OS: 12.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA059518 Uncertain Approved Nucleoplasm,Nucleoli Yes No "Cluster 77: Retina - Visual perception" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nucleoli" "HPA059518: AB_2684049" "unprognostic (6.17e-2)" "unprognostic (1.73e-3)" "unprognostic (3.00e-6)" "unprognostic (2.78e-1)" "unprognostic (6.97e-2)" "unprognostic (7.55e-4)" "unprognostic (2.12e-1)" "unprognostic (1.71e-1)" "unprognostic (2.17e-1)" "unprognostic (1.78e-1)" "unprognostic (7.46e-2)" "unprognostic (4.35e-1)" "unprognostic (1.50e-1)" "unprognostic (2.09e-1)" 0.3 1.8 0.0 0.1 0.1 0.0 0.1 0.0 0.1 0.2 0.8 0.4 0.2 0.5 0.0 0.1 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.1 0.0 0.1 0.1 1.2 0.0 0.5 4.8 0.0 0.0 1.1 0.0 2.7 4.6 0.1 3.0 0.0 0.1 0.1 0.0 0.0 0.3 10.8 2.4 0.1 0.2 3.7 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.8 6.2 0.0 0.0 0.0 0.0 0.3 4.5 0.0 0.7 0.0 0.1 0.0 28.3 0.0 0.0 2.0 0.0 23.9 0.3 3.0 0.0 1.4 0.0 6.2 0.0 0.4 1.7 0.1 2.6 0.0 0.0 0.0 0.5 0.0 0.1 0.0 0.0 12.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 2.9 0.1 0.1 0.0 0.0 2.4 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.6 0.5 0.0 0.9 0.0 0.1 0.7 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.0 0.0 0.0 0.2 0.0 0.0 2.8 0.0 0.0 0.3 0.0 0.0 1.3 0.0 0.0 0.0 0.0 3.3 0.9 0.0 0.0 0.0 0.0 6.8 0.3 0.0 0.0 1.0 0.0 12.3 0.0 1.0 0.7 0.0 0.0 0.7 0.0 0.8 0.0 0.0 1.2 1.1 0.0 10.0 0.2 92.5 19.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 C19orf84 ENSG00000262874 "Chromosome 19 open reading frame 84" I3L1E1 19 51388289-51390591 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in single" 30 "testis: 22.1" "Cell type enriched" "Detected in some" 10 "Spermatogonia: 31.9" "Group enriched" "Detected in some" 5 "ovarian cancer: 1.3;testis cancer: 3.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 8 "K-562: 6.9" "Not detected" "Not detected" "Low region specificity" "Detected in single" HPA068082 Uncertain Approved Vesicles NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 78: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Vesicles "HPA068082: AB_2685949" "unprognostic (5.94e-2)" "unprognostic (7.72e-2)" "unprognostic (8.51e-2)" "unprognostic (1.43e-3)" "unprognostic (2.08e-1)" "unprognostic (1.47e-1)" "unprognostic (2.13e-3)" "unprognostic (9.28e-4)" "unprognostic (1.31e-1)" "unprognostic (1.87e-1)" "unprognostic (1.29e-1)" "unprognostic (3.84e-1)" "unprognostic (2.61e-7)" "unprognostic (8.30e-3)" "unprognostic (1.86e-1)" "unprognostic (2.92e-2)" "unprognostic (3.99e-3)" 0.0 0.0 0.4 0.2 0.4 0.6 0.0 0.4 0.7 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.4 0.4 0.0 0.0 0.1 0.3 0.4 0.5 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.4 0.0 22.1 0.5 0.1 0.0 0.0 0.1 0.0 0.0 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.8 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.4 0.4 0.7 0.4 0.4 0.4 0.5 0.5 0.3 0.5 0.4 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.6 0.0 2.2 0.3 0.3 0.0 0.0 0.2 0.0 3.1 0.0 0.0 0.0 1.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 31.9 0.0 0.0 0.0 0.1 0.1 0.0 0.0 C20orf141 dJ860F19.4 ENSG00000258713 "Chromosome 20 open reading frame 141" Q9NUB4 20 2814987-2815833 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 79 "testis: 130.2" "Group enriched" "Detected in some" 181 "Early spermatids: 1196.9;Late spermatids: 4648.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "HDLM-2: 21.6" "Not detected" "Not detected" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (4.52e-1)" "unprognostic (1.40e-2)" "unprognostic (1.35e-2)" "unprognostic (7.53e-2)" "unprognostic (1.21e-2)" 0.3 0.0 0.0 0.1 0.0 0.0 0.3 0.0 0.0 0.3 0.0 0.0 0.0 0.7 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 130.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.8 0.0 0.7 0.4 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 21.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 4.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1196.9 0.1 1.3 0.6 0.0 0.0 0.0 0.0 1.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4648.3 12.8 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 13.9 0.0 0.0 0.0 0.0 0.0 0.2 6.6 0.0 0.0 16.1 9.4 0.0 0.0 0.8 0.0 0.1 0.0 0.0 CAMSAP3 "KIAA1543, Nezha, PPP1R80" ENSG00000076826 "Calmodulin regulated spectrin associated protein family member 3" Q9P1Y5 19 7595863-7618304 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 62.7" "Cell type enhanced" "Detected in many" "Distal enterocytes: 40.0;Gastric mucus-secreting cells: 38.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "CACO-2: 26.7;Hep G2: 15.6;MCF7: 13.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA043830, HPA062149" Enhanced Approved Nucleoplasm,Centrosome NA NA "Cluster 31: Skin - Epidermis development" "Cluster 39: CACO-2 - Unknown function" "Cluster 30: Mammary glandular cells - Lactation" "Nucleoplasm, Centrosome" "HPA043830: AB_10795879, HPA062149: AB_2684698" "unprognostic (3.83e-2)" "unprognostic (1.18e-1)" "unprognostic (8.67e-2)" "unprognostic (7.90e-3)" "unprognostic (3.66e-1)" "unprognostic (3.87e-3)" "unprognostic (7.00e-2)" "unprognostic (2.80e-2)" "unprognostic (2.02e-1)" "unprognostic (1.64e-1)" "unprognostic (2.30e-2)" "unprognostic (1.41e-1)" "prognostic favorable (7.55e-7)" "unprognostic (2.16e-2)" "unprognostic (3.88e-2)" "unprognostic (3.72e-2)" "unprognostic (1.59e-3)" 0.4 3.3 3.2 0.8 4.4 0.0 5.3 2.5 9.0 7.7 0.1 10.3 14.9 0.5 2.3 24.8 3.1 1.6 0.4 4.2 0.7 12.0 24.3 4.6 0.2 2.5 0.0 0.5 20.6 2.7 8.2 0.4 0.4 10.2 2.4 3.2 18.1 4.5 0.2 62.7 11.5 0.1 0.0 0.6 15.5 13.0 0.2 0.5 11.1 0.0 1.1 3.6 13.4 2.4 11.2 1.8 0.3 0.9 0.0 0.0 2.0 0.0 0.0 0.0 0.0 26.7 5.8 3.1 4.5 0.0 1.2 9.7 4.3 2.8 0.0 2.0 10.1 0.0 0.5 15.6 0.0 0.0 4.4 0.0 5.5 0.0 0.4 0.4 0.0 4.5 0.9 0.0 0.0 13.0 0.2 0.2 6.6 8.4 4.7 0.7 0.0 3.7 1.9 6.0 8.2 8.7 1.3 12.5 0.0 1.6 10.4 1.7 0.0 0.0 2.0 0.0 0.4 5.0 1.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.2 4.4 2.5 9.0 4.2 0.7 2.5 0.0 0.4 0.0 0.2 2.4 0.2 9.6 19.2 3.3 1.1 9.8 2.7 2.4 3.4 22.7 19.3 12.1 1.5 20.0 5.3 9.2 0.0 0.5 0.2 40.0 3.9 5.7 4.4 9.6 1.4 1.5 13.1 0.0 9.1 11.8 0.7 0.2 38.7 13.5 5.7 8.6 0.4 24.8 0.2 10.1 10.1 22.4 0.0 1.9 1.2 2.9 1.5 1.0 0.0 1.9 0.0 1.5 0.0 4.5 0.6 13.1 28.4 0.0 0.6 6.2 29.2 15.6 2.9 13.4 0.0 0.0 1.1 0.4 2.8 9.8 18.9 0.5 0.9 1.5 18.4 8.0 CARHSP1 "CRHSP-24, CSDC1" ENSG00000153048 "Calcium regulated heat stable protein 1" Q9Y2V2 16 8852942-8869012 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 422.7" "Group enriched" "Detected in all" 7 "Early spermatids: 2062.2;Late spermatids: 6999.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051911 Enhanced NA Yes 280000 "Cluster 10: Basophils - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 14: REH - Unknown function" "Cluster 25: Spermatids - Spermatogenesis" "HPA051911: AB_2681660" "unprognostic (4.08e-1)" "unprognostic (4.99e-2)" "unprognostic (2.46e-1)" "unprognostic (1.33e-1)" "unprognostic (1.15e-1)" "unprognostic (2.08e-3)" "unprognostic (8.57e-2)" "unprognostic (1.88e-3)" "unprognostic (2.03e-1)" "unprognostic (3.29e-1)" "unprognostic (2.61e-1)" "unprognostic (7.19e-3)" "unprognostic (1.76e-3)" "unprognostic (5.94e-2)" "unprognostic (1.10e-1)" "unprognostic (2.61e-1)" "prognostic favorable (7.24e-4)" 101.4 132.5 49.4 33.7 75.0 70.0 67.7 46.8 58.4 101.7 46.5 46.4 31.3 38.2 13.5 193.7 51.0 33.8 48.2 50.1 50.8 109.6 188.2 116.7 46.9 56.1 49.7 68.5 54.8 9.8 33.2 59.2 51.2 35.3 25.6 3.0 110.7 13.9 17.4 34.5 47.1 24.2 47.6 56.7 52.5 422.7 51.0 59.6 35.9 21.3 59.4 45.8 101.7 60.4 84.2 134.8 200.2 40.3 52.1 83.0 98.9 110.7 93.5 92.9 117.8 95.4 224.6 109.1 70.2 83.5 70.9 82.0 79.3 87.9 65.4 87.9 102.1 34.5 108.1 369.8 177.5 59.2 84.6 181.7 40.0 91.8 60.7 87.8 92.6 241.5 94.5 136.1 120.5 152.0 313.5 147.6 124.6 89.0 82.2 367.0 245.9 179.3 75.5 56.0 119.0 153.2 104.9 106.1 104.0 112.4 134.9 60.3 99.9 77.8 144.9 94.6 57.4 67.6 77.4 135.0 173.9 71.9 134.9 81.6 29.6 35.8 25.8 14.3 16.1 17.5 25.0 25.3 25.8 28.6 17.0 23.7 89.2 41.6 19.0 47.4 62.8 20.8 49.4 75.0 46.8 58.4 50.1 50.8 56.1 49.7 51.2 47.6 51.0 60.4 166.3 25.6 9.1 19.6 48.9 42.7 67.2 158.4 22.8 8.0 71.4 38.0 6.0 221.6 86.4 82.8 6.2 141.5 65.1 152.6 54.8 619.1 2062.2 101.9 82.0 145.3 144.9 147.5 4.4 241.8 312.6 86.4 42.8 114.4 39.3 118.0 128.8 323.5 70.5 11.8 5.9 107.7 91.6 62.4 55.3 6999.5 96.3 36.1 58.7 9.4 66.5 7.7 121.5 8.0 25.6 340.0 179.5 73.0 63.9 139.3 174.2 479.0 70.9 11.2 111.7 31.2 95.5 72.7 52.7 84.2 42.1 153.5 65.1 17.0 108.4 169.8 CCDC28B "MGC1203, RP4-622L5.5" ENSG00000160050 "Coiled-coil domain containing 28B" Q9BUN5 1 32200595-32205453 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 7 "skeletal muscle: 225.3;tongue: 75.0" "Cell type enhanced" "Detected in many" "Enteroendocrine cells: 90.1;monocytes: 65.5;NK-cells: 106.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Region enriched" "Detected in all" 4 "cerebellum: 124.9" "Low region specificity" "Detected in all" HPA028589 Uncertain NA NA "Cluster 24: B-cells - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 52: Non-specific - Transcription" "HPA028589: AB_10602175" "prognostic favorable (2.92e-4)" "unprognostic (6.01e-3)" "unprognostic (1.04e-1)" "unprognostic (2.61e-2)" "unprognostic (2.59e-3)" "unprognostic (5.18e-2)" "unprognostic (7.50e-3)" "unprognostic (7.87e-2)" "unprognostic (5.15e-2)" "unprognostic (1.79e-2)" "prognostic favorable (1.10e-5)" "unprognostic (2.61e-2)" "unprognostic (1.22e-2)" "unprognostic (1.44e-2)" "unprognostic (1.67e-1)" "unprognostic (7.83e-2)" "unprognostic (1.07e-2)" 3.8 13.9 14.3 7.1 12.9 6.8 3.3 14.5 18.7 6.6 12.1 7.6 1.7 5.3 1.7 5.5 5.6 4.9 20.8 13.2 13.3 6.5 2.4 3.9 14.1 12.8 13.3 6.0 5.6 19.2 21.1 5.0 12.2 5.3 2.5 5.1 3.6 4.1 225.3 2.7 4.3 6.2 12.6 5.4 3.9 20.8 15.8 12.4 6.3 75.0 9.5 5.0 4.3 13.1 10.6 4.5 20.8 22.7 6.8 8.5 1.2 8.2 11.9 13.2 9.3 9.0 13.2 23.3 14.2 9.3 1.7 0.5 18.7 9.2 2.6 27.0 25.5 29.9 20.7 4.1 10.1 0.2 13.7 10.5 3.5 15.5 0.2 9.2 19.3 40.5 20.5 0.5 9.6 1.3 43.2 8.7 29.4 2.8 5.8 46.5 10.4 19.2 12.2 0.0 45.6 22.9 11.9 3.2 16.3 12.0 12.0 11.5 11.4 7.1 9.5 8.7 7.6 2.1 1.6 0.9 11.7 43.9 10.3 9.7 13.7 3.0 36.3 6.9 17.6 22.0 19.4 34.3 30.6 31.5 28.4 29.3 1.9 46.7 2.1 37.1 26.9 21.8 14.3 12.9 14.5 18.7 13.2 13.3 12.8 13.3 12.2 12.6 15.8 13.1 10.5 0.0 6.1 3.9 11.1 9.1 4.4 17.9 5.7 33.3 9.6 12.7 16.1 11.5 5.3 12.9 22.9 1.9 25.8 1.6 35.2 17.5 13.8 8.1 18.1 15.2 90.1 30.7 3.1 7.6 4.0 19.0 5.6 5.1 3.8 8.0 12.1 0.6 11.7 23.5 3.9 5.7 54.9 4.2 39.2 32.8 20.2 5.7 17.8 0.0 65.5 23.9 106.1 5.5 1.7 7.8 1.7 17.0 1.8 3.4 0.3 4.9 4.2 45.9 0.0 12.5 18.0 3.9 13.3 3.5 7.7 2.2 15.3 48.1 3.4 2.6 CCDC73 NY-SAR-79 ENSG00000186714 "Coiled-coil domain containing 73" Q6ZRK6 11 32602246-32794658 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 3.7" "Group enriched" "Detected in some" 16 "Spermatocytes: 160.3;Spermatogonia: 84.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "MOLT-4: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038668, HPA038669" Uncertain NA NA "Cluster 24: B-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA038668: AB_10673292, HPA038669: AB_2676142" "unprognostic (9.41e-3)" "unprognostic (2.46e-2)" "unprognostic (2.36e-1)" "unprognostic (8.65e-2)" "unprognostic (5.79e-2)" "unprognostic (1.14e-2)" "unprognostic (1.89e-1)" "unprognostic (1.73e-4)" "unprognostic (1.74e-1)" "unprognostic (2.02e-2)" "unprognostic (2.10e-2)" "unprognostic (3.27e-2)" "unprognostic (1.62e-5)" "unprognostic (3.87e-1)" "unprognostic (1.02e-1)" "unprognostic (1.68e-1)" "unprognostic (1.20e-3)" 0.0 0.2 0.1 0.1 0.0 0.3 0.0 0.2 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.2 0.4 0.0 0.2 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.5 0.0 3.7 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.9 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 1.8 0.3 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.4 0.4 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 3.2 0.6 2.3 0.1 0.0 0.3 0.2 0.0 0.1 0.1 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.2 0.0 1.9 0.0 4.8 1.8 0.5 0.6 0.0 0.0 4.5 0.2 0.1 0.2 0.0 0.6 0.0 0.2 0.0 1.1 0.2 0.0 3.9 0.1 0.0 0.0 0.0 4.3 0.6 0.1 0.0 7.5 0.1 0.0 0.0 3.5 1.7 0.3 1.2 0.7 0.3 0.3 0.0 0.9 1.0 0.6 6.6 0.0 0.2 160.3 84.2 0.0 0.0 0.1 0.2 4.3 0.0 0.5 CCDC9 DKFZP586M1019 ENSG00000105321 "Coiled-coil domain containing 9" Q9Y3X0 19 47255980-47273701 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 50.6;Late spermatids: 79.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in all" "NB-4: 116.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045624, HPA072007" Enhanced Approved Cytosol NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 50: Non-specific - Ribosome" "Cluster 24: NB-4 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Cytosol "HPA045624: AB_10961402, HPA072007: AB_2686482" "unprognostic (4.53e-3)" "unprognostic (1.75e-1)" "unprognostic (3.70e-3)" "unprognostic (8.22e-2)" "unprognostic (7.47e-2)" "unprognostic (1.15e-2)" "unprognostic (8.35e-3)" "unprognostic (1.45e-1)" "unprognostic (4.99e-1)" "unprognostic (1.57e-2)" "unprognostic (2.40e-1)" "unprognostic (9.78e-2)" "unprognostic (2.58e-1)" "unprognostic (2.45e-2)" "unprognostic (1.02e-1)" "unprognostic (7.46e-3)" "unprognostic (4.02e-1)" 22.7 21.1 11.7 16.1 12.2 40.7 22.2 10.5 16.1 27.8 17.3 24.8 13.7 24.7 8.8 18.1 24.8 10.3 21.8 12.7 10.0 25.9 22.7 26.6 10.6 15.9 12.0 30.7 49.0 14.0 16.6 13.6 11.3 25.8 8.5 12.6 20.0 12.3 26.2 34.9 18.9 9.8 9.5 23.1 24.8 35.8 12.6 9.3 23.0 11.7 7.7 23.8 23.9 12.3 27.5 27.7 21.2 23.7 6.6 17.9 24.1 37.2 16.4 22.4 24.5 29.5 21.1 12.5 10.0 24.8 18.6 25.5 19.7 16.0 12.1 33.3 12.3 32.3 27.3 22.7 21.1 13.2 31.9 19.2 23.0 21.4 20.0 19.0 15.1 15.6 45.0 61.8 15.0 32.8 15.4 116.9 23.7 45.3 10.8 26.9 20.2 14.4 10.2 19.7 8.3 21.1 50.5 36.4 20.3 17.3 30.2 26.7 20.9 25.8 23.0 15.6 32.2 20.5 38.5 19.0 24.2 17.8 20.3 0.4 1.1 2.0 1.3 1.4 0.7 0.6 1.0 1.0 0.9 0.9 1.0 0.7 3.6 1.1 0.8 1.4 1.9 0.4 11.7 12.2 10.5 16.1 12.7 10.0 15.9 12.0 11.3 9.5 12.6 12.3 13.6 6.4 1.7 1.3 16.4 14.0 15.7 1.8 12.0 3.1 8.9 5.2 3.0 2.8 1.9 1.8 4.2 5.4 9.3 13.1 5.9 7.5 50.6 13.0 10.3 9.7 3.6 8.2 1.4 11.2 9.1 7.6 14.3 16.8 8.2 4.3 3.3 3.6 5.8 0.0 1.0 12.0 2.0 7.8 14.4 79.3 4.4 9.8 7.2 1.9 10.4 1.8 7.2 0.5 0.9 11.1 11.5 3.8 15.2 8.9 7.8 6.7 2.1 7.6 6.6 8.7 10.5 2.8 7.5 12.7 17.8 15.3 12.2 5.3 8.4 13.5 CDK7 "CAK, CAK1, CDKN7, MO15, STK1" ENSG00000134058 "Cyclin dependent kinase 7" P50613 5 69234795-69277430 "Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, DNA damage, DNA repair, Transcription, Transcription regulation" "Kinase, Serine/threonine-protein kinase, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 121.0;Extravillous trophoblasts: 343.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BEWO: 169.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004364, HPA007932, HPA008453, CAB079975" Enhanced Supported "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" NA NA "Cluster 24: B-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 28: BEWO - Transcription regulation" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoplasm "Nucleoli fibrillar center, Plasma membrane, Cytosol" "CAB004364: AB_627243, CAB079975: , HPA007932: AB_1078492, HPA008453: " "unprognostic (3.12e-2)" "unprognostic (1.23e-1)" "unprognostic (4.87e-2)" "unprognostic (4.53e-2)" "unprognostic (3.29e-2)" "unprognostic (4.64e-2)" "unprognostic (2.49e-3)" "unprognostic (1.64e-2)" "unprognostic (7.77e-3)" "unprognostic (1.81e-2)" "prognostic unfavorable (3.09e-4)" "unprognostic (3.40e-2)" "prognostic unfavorable (9.42e-7)" "unprognostic (2.61e-1)" "unprognostic (2.38e-1)" "unprognostic (3.86e-2)" "unprognostic (1.55e-2)" 13.4 19.8 9.4 9.5 10.2 29.1 14.8 10.9 12.9 17.5 11.5 13.7 13.3 12.1 12.9 37.3 12.5 6.4 12.4 9.5 10.5 18.4 13.6 12.7 4.8 9.7 9.7 11.7 14.1 3.2 18.2 16.2 9.8 13.7 7.4 12.8 18.9 4.8 26.8 25.3 12.2 7.7 9.8 12.6 13.5 30.6 10.0 9.3 13.2 15.0 13.3 16.1 19.9 9.4 42.8 5.9 19.4 30.6 6.4 24.4 169.5 30.9 37.5 46.2 42.9 62.2 64.5 3.7 36.4 36.8 34.2 65.3 10.8 31.3 40.6 9.0 3.1 8.6 21.4 25.9 32.8 17.9 33.8 7.1 61.3 1.8 46.0 24.5 32.5 22.3 16.3 16.1 13.3 33.3 9.4 51.7 20.7 2.8 25.4 12.3 0.7 27.1 42.6 25.4 8.6 17.5 11.6 50.4 42.4 28.1 44.9 39.3 7.4 17.1 27.4 33.1 18.2 14.4 30.4 16.5 31.4 10.2 15.5 27.9 7.9 16.2 5.3 8.9 7.9 10.6 7.8 10.6 7.3 14.5 5.9 6.4 8.2 8.6 4.7 8.9 10.5 6.1 9.4 10.2 10.9 12.9 9.5 10.5 9.7 9.7 9.8 9.8 10.0 9.4 12.2 16.0 13.2 10.7 7.8 57.7 21.4 32.9 15.4 6.4 12.3 14.7 11.3 10.0 20.2 5.5 12.5 121.0 11.7 10.2 15.6 27.8 26.8 33.1 10.7 11.6 3.0 9.9 17.6 21.6 343.6 13.0 9.7 27.2 15.8 7.4 7.1 6.7 24.0 1.7 13.7 12.3 20.3 8.5 6.0 7.9 7.5 8.5 7.2 11.2 11.6 10.4 15.5 8.0 11.9 29.3 16.2 7.2 5.8 28.2 12.3 29.3 42.4 8.7 26.3 10.0 12.5 70.1 18.6 15.9 41.9 64.6 11.4 6.8 13.2 29.8 CEP126 KIAA1377 ENSG00000110318 "Centrosomal protein 126" Q9P2H0 11 101915010-102001062 "Predicted intracellular proteins" "Cilium biogenesis/degradation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Endometrial ciliated cells: 143.7;Horizontal cells: 102.6;Respiratory ciliated cells: 138.5;Spermatocytes: 96.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in single" "Low lineage specificity" "Detected in single" "Cell line enhanced" "Detected in many" "ASC diff: 6.1;EFO-21: 5.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038381, HPA038399" Uncertain Nucleoplasm,Cytosol NA NA "Cluster 15: NK-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 49: Ciliated cells - Cilium organization" "Nucleoplasm, Cytosol" "HPA038381: AB_10669780, HPA038399: AB_10670157" "unprognostic (7.61e-2)" "unprognostic (6.75e-2)" "unprognostic (9.07e-2)" "unprognostic (1.02e-2)" "unprognostic (9.31e-2)" "unprognostic (8.87e-2)" "unprognostic (1.55e-4)" "unprognostic (1.52e-2)" "unprognostic (5.77e-2)" "unprognostic (9.55e-2)" "unprognostic (7.72e-3)" "unprognostic (8.87e-2)" "prognostic unfavorable (5.00e-4)" "unprognostic (1.30e-2)" "unprognostic (3.41e-1)" "unprognostic (9.61e-2)" "unprognostic (6.99e-3)" 5.4 4.9 8.2 0.8 9.9 0.9 3.8 9.5 12.3 7.1 16.2 4.2 0.6 4.3 2.6 2.0 9.2 1.9 4.2 9.1 7.1 2.2 0.4 4.4 1.4 9.2 8.9 7.8 2.0 1.4 18.1 0.9 7.4 3.5 1.9 11.1 2.4 3.0 1.0 3.9 2.2 2.1 9.2 1.8 1.9 16.8 8.9 0.8 4.1 1.5 0.8 3.7 5.1 9.0 0.5 1.0 0.6 0.8 6.1 3.3 0.3 0.9 1.1 0.5 0.4 0.3 1.8 0.6 5.7 1.1 2.6 0.5 0.7 1.4 0.4 1.8 0.9 0.1 2.6 0.7 0.7 0.1 0.1 1.0 3.0 0.7 1.5 3.3 1.5 0.8 0.1 0.2 1.3 0.6 0.6 0.1 0.5 0.7 0.9 0.1 0.6 0.0 1.3 0.8 1.7 2.7 0.8 1.2 0.1 1.2 2.2 0.2 1.0 1.7 0.9 0.5 1.4 1.3 0.7 0.1 1.9 0.1 0.5 0.3 0.1 0.3 0.4 0.0 0.3 0.5 0.3 0.4 0.1 0.6 0.4 0.4 0.4 0.9 0.0 1.2 0.1 0.1 8.2 9.9 9.5 12.3 9.1 7.1 9.2 8.9 7.4 9.2 8.9 9.0 6.7 9.6 6.7 0.0 7.2 0.0 5.1 0.0 5.2 29.7 6.4 11.9 6.9 8.6 23.5 18.4 45.9 1.3 20.2 0.5 3.9 2.4 21.7 143.7 45.1 4.0 66.7 2.5 0.0 0.4 0.6 33.4 8.2 3.6 0.0 19.0 3.3 0.0 0.4 102.6 0.0 9.4 0.0 0.3 0.0 12.0 53.7 2.8 0.0 0.0 0.7 25.8 20.6 0.0 0.0 1.1 1.7 51.1 3.5 3.0 0.5 6.0 138.5 53.7 6.6 18.3 11.3 96.3 26.2 1.4 0.0 0.1 6.3 39.3 1.7 2.0 CEP55 "C10orf3, CT111, FLJ10540" ENSG00000138180 "Centrosomal protein 55" Q53EZ4 10 93496612-93529092 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Mitosis" "Developmental protein" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 27.4;testis: 21.7" "Cell type enhanced" "Detected in many" "Early spermatids: 29.4;Extravillous trophoblasts: 17.1;Granulosa cells: 19.8;Spermatocytes: 77.3;Spermatogonia: 17.3" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 8 "T-reg: 1.3" "Lineage enriched" "Detected in single" 14 "T-cells: 1.3" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in single" "Low region specificity" "Detected in single" HPA023430 Approved Approved "Plasma membrane,Midbody,Centriolar satellite" Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "Plasma membrane, Centriolar satellite" Midbody "HPA023430: AB_10960212" "unprognostic (9.85e-2)" "unprognostic (1.12e-2)" "unprognostic (1.04e-1)" "unprognostic (1.29e-1)" "unprognostic (5.15e-2)" "unprognostic (4.26e-2)" "prognostic unfavorable (3.20e-9)" "prognostic unfavorable (1.45e-4)" "unprognostic (1.50e-1)" "unprognostic (1.05e-1)" "prognostic unfavorable (2.66e-5)" "unprognostic (3.99e-2)" "prognostic unfavorable (0.00e+0)" "prognostic favorable (3.15e-4)" "unprognostic (7.86e-2)" "unprognostic (1.49e-1)" "unprognostic (1.63e-1)" 1.3 0.6 0.0 7.6 0.0 5.0 1.4 0.0 0.2 1.7 0.0 7.0 6.7 1.4 0.1 7.3 0.4 1.4 0.3 0.0 0.1 0.3 0.6 1.3 14.7 0.1 0.3 0.2 0.2 0.2 0.3 3.5 0.2 0.3 8.8 0.0 1.2 0.3 0.1 4.5 6.3 5.2 0.0 2.4 4.6 21.7 0.4 27.4 0.5 0.2 15.5 3.1 2.3 0.1 208.5 81.5 53.0 67.7 5.8 12.0 29.6 112.4 78.2 103.5 106.4 87.2 108.6 55.4 48.2 72.8 69.6 115.4 64.8 54.8 123.4 167.2 33.7 21.0 49.2 29.9 0.6 36.3 46.3 2.8 3.8 110.6 133.5 30.7 97.1 89.9 19.3 101.8 118.5 48.3 96.3 54.8 20.9 64.2 58.8 41.3 86.9 30.3 47.1 25.5 21.7 30.7 86.3 26.3 64.9 40.1 68.9 36.4 61.4 65.3 90.6 90.5 186.7 45.1 66.1 66.8 51.0 134.8 59.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.3 0.2 0.0 0.4 0.1 0.2 0.0 1.3 0.0 2.7 3.6 0.9 1.9 0.0 0.0 1.8 2.0 0.4 2.8 0.2 0.0 0.0 7.7 0.9 3.3 0.0 0.6 29.4 1.7 2.0 1.5 0.0 2.5 0.5 0.2 17.1 2.3 8.2 3.6 0.0 19.8 2.2 0.3 12.9 0.0 0.3 4.5 4.1 7.0 5.1 8.2 0.3 5.1 0.0 0.0 0.0 0.0 2.1 0.0 0.1 0.3 0.0 0.4 14.8 1.1 0.4 0.0 0.2 0.0 0.0 0.5 4.5 77.3 17.3 16.1 1.3 1.5 4.3 1.6 7.9 1.7 CERS1 "LAG1, LASS1, UOG1" ENSG00000223802 "Ceramide synthase 1" P27544 19 18868545-18896727 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Lipid biosynthesis, Lipid metabolism" Transferase "Disease variant, Epilepsy, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "brain: 298.6;choroid plexus: 92.2" "Cell type enriched" "Detected in some" 5 "Late spermatids: 126.6" "Group enriched" "Detected in many" 5 "glioma: 13.5;melanoma: 4.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AN3-CA: 32.1;HEK 293: 34.7;NB-4: 39.3;NTERA-2: 25.2" HPA045724 Enhanced Approved "Endoplasmic reticulum" NA NA "Cluster 70: Brain - Nervous system development" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA045724: AB_10969762" "unprognostic (8.25e-2)" "unprognostic (8.91e-2)" "unprognostic (2.12e-2)" "unprognostic (2.14e-1)" "unprognostic (3.59e-2)" "unprognostic (6.47e-2)" "unprognostic (1.15e-2)" "unprognostic (1.13e-1)" "unprognostic (4.02e-1)" "unprognostic (7.04e-3)" "unprognostic (3.52e-3)" "unprognostic (1.92e-1)" "unprognostic (4.59e-2)" "unprognostic (2.99e-2)" "unprognostic (3.15e-2)" "unprognostic (9.15e-2)" "unprognostic (3.49e-1)" 0.9 3.1 206.4 0.8 244.8 0.2 0.6 256.1 216.6 2.1 92.2 3.5 0.1 0.7 0.5 1.0 0.7 2.5 4.3 218.8 200.4 0.8 0.2 0.5 0.0 298.6 233.8 2.8 0.9 2.9 12.8 0.3 240.9 1.4 0.2 4.8 0.9 0.5 21.3 0.6 1.0 1.5 247.7 0.2 1.2 29.3 251.3 0.3 1.0 12.3 0.1 1.7 1.7 248.3 0.2 3.3 19.1 32.1 1.1 0.4 0.8 2.2 0.1 5.4 3.9 15.7 1.2 0.1 22.0 1.4 4.4 0.3 13.8 0.6 2.1 0.0 34.7 0.2 0.7 11.7 2.4 3.4 0.5 1.2 0.2 1.7 0.6 6.0 1.3 0.2 2.2 0.2 3.7 8.4 0.3 39.3 25.2 0.1 0.7 0.2 0.6 0.7 4.1 0.0 17.8 15.8 0.8 0.1 14.1 6.0 5.5 20.5 0.5 0.1 4.3 3.4 4.8 0.7 0.5 0.1 0.2 1.2 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 206.4 244.8 256.1 216.6 218.8 200.4 298.6 233.8 240.9 247.7 251.3 248.3 0.2 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 3.6 0.6 1.3 0.6 0.0 0.0 0.0 2.1 0.0 0.1 0.2 0.0 0.0 21.1 0.3 0.4 0.6 0.0 0.0 0.0 0.2 0.0 1.0 0.0 1.1 0.0 1.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.4 126.6 1.2 0.2 1.8 0.0 0.0 10.1 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.1 0.0 0.1 0.0 1.6 0.0 1.0 0.4 1.4 2.9 0.0 0.4 0.3 0.1 0.4 0.0 0.0 CHPF "CHSY2, CSS2" ENSG00000123989 "Chondroitin polymerizing factor" Q8IZ52 2 219538948-219543809 "Enzymes, Metabolic proteins, Predicted intracellular proteins" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 163.7;Extravillous trophoblasts: 182.7;Syncytiotrophoblasts: 310.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "plasmacytoid DC: 9.5" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035123 Approved Supported Vesicles,Centrosome,Cytosol "Intracellular and membrane" NA NA 570000 "Cluster 52: Eosinophils - Transcription" "Cluster 29: Non-specific - Vesicular transport" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 55: Plasma cells - Humoral immune response" Cytosol "Vesicles, Centrosome" "HPA035123: AB_10602799" "unprognostic (1.13e-3)" "prognostic unfavorable (1.57e-4)" "unprognostic (3.65e-3)" "unprognostic (2.55e-3)" "unprognostic (1.86e-3)" "prognostic unfavorable (1.68e-4)" "unprognostic (1.37e-1)" "unprognostic (6.59e-3)" "unprognostic (7.74e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (6.79e-2)" "unprognostic (1.64e-1)" "unprognostic (6.55e-2)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "prognostic unfavorable (2.96e-4)" 29.9 45.7 26.9 12.5 24.9 1.7 22.3 25.8 34.2 59.1 36.7 21.9 26.7 55.9 13.7 27.3 30.2 24.2 134.8 38.4 31.2 41.1 97.8 42.8 6.5 34.0 30.4 127.4 138.9 24.6 128.3 40.6 32.1 58.6 4.7 8.5 56.1 25.6 16.3 26.2 23.2 12.6 27.4 16.6 40.9 97.5 33.2 3.6 52.8 3.9 4.5 34.3 30.0 34.0 67.5 13.0 9.6 81.0 36.0 55.8 109.7 66.4 55.4 18.5 16.8 36.8 57.5 20.7 139.0 64.6 63.3 84.1 6.3 40.3 2.9 32.3 22.5 7.4 18.0 161.9 49.8 6.6 42.1 75.0 69.2 18.8 17.9 66.7 0.1 7.1 47.2 49.6 17.7 105.5 1.0 17.6 39.8 22.8 50.6 0.1 30.4 41.6 22.4 29.7 23.4 36.0 32.1 30.7 94.3 17.9 10.5 22.6 1.6 67.9 37.1 81.9 35.2 58.9 19.9 9.7 62.1 6.7 70.4 1.7 0.0 6.5 1.9 0.1 2.4 1.0 1.5 1.3 0.0 0.1 1.7 0.6 0.0 1.9 0.0 9.5 1.2 0.7 26.9 24.9 25.8 34.2 38.4 31.2 34.0 30.4 32.1 27.4 33.2 34.0 2.1 0.0 15.2 16.0 16.5 14.5 23.2 52.8 17.1 14.6 40.0 29.6 30.5 22.8 31.2 75.4 10.4 163.7 21.7 15.9 9.8 58.1 4.1 14.0 22.2 2.9 43.0 3.2 4.3 80.4 182.7 56.0 25.5 42.4 10.2 27.4 4.2 64.0 18.5 43.7 9.2 57.8 36.7 2.4 9.1 7.1 24.8 2.3 67.6 5.6 1.8 56.8 9.2 5.5 3.7 65.6 32.7 63.2 123.6 42.3 60.7 20.6 14.6 11.5 26.3 19.3 27.1 11.9 6.3 14.2 11.1 310.3 9.7 46.3 14.3 33.0 CITED1 MSG1 ENSG00000125931 "Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 1" Q99966 X 72301638-72307187 "Predicted intracellular proteins" "Apoptosis, Differentiation, Transcription, Transcription regulation" "Activator, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "epididymis: 1473.6" "Cell type enhanced" "Detected in many" "Breast glandular cells: 87.4;Breast myoepithelial cells: 47.6;Granulosa cells: 31.0;Late spermatids: 58.4;Paneth cells: 33.8" "Cancer enriched" "Detected in many" 6 "thyroid cancer: 134.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in many" 4 "SK-MEL-30: 244.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049051 Supported Supported Nucleoplasm,Cytosol NA NA "Cluster 68: Epididymis - Unknown function" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 35: Glandular cells - Unknown function" Nucleoplasm Cytosol "HPA049051: AB_2680612" "unprognostic (7.04e-2)" "unprognostic (3.39e-2)" "unprognostic (1.34e-1)" "unprognostic (1.79e-3)" "unprognostic (8.81e-2)" "unprognostic (5.67e-4)" "unprognostic (3.40e-1)" "unprognostic (9.55e-2)" "unprognostic (4.60e-3)" "unprognostic (4.38e-2)" "unprognostic (6.33e-3)" "unprognostic (1.18e-1)" "unprognostic (1.38e-1)" "unprognostic (2.62e-1)" "prognostic favorable (6.10e-4)" "prognostic favorable (3.95e-4)" "unprognostic (2.99e-2)" 2.3 5.1 13.0 0.3 6.9 0.2 23.1 5.1 12.2 5.9 3.4 1.0 0.7 3.6 1473.6 0.3 1.5 0.0 0.7 6.7 56.2 5.1 0.4 0.6 0.3 8.5 8.8 1.5 1.5 0.0 209.9 0.0 24.5 11.2 0.2 4.5 0.8 3.0 0.4 0.6 1.0 8.1 4.3 0.4 1.0 199.9 30.6 0.2 8.0 0.4 0.1 0.5 1.0 6.2 0.4 0.3 2.2 57.1 2.5 0.0 2.1 0.0 0.5 0.4 0.3 0.1 0.6 0.0 0.2 0.0 0.6 0.0 20.5 1.4 0.1 6.1 8.0 0.9 0.4 0.0 0.0 0.2 10.4 1.1 0.8 0.5 1.0 0.2 0.2 0.2 2.5 0.0 0.4 0.8 0.2 4.4 3.3 0.0 3.6 0.1 3.6 3.2 0.1 0.4 25.8 12.5 0.4 5.1 244.4 0.2 1.4 1.0 0.0 0.2 1.9 0.4 0.8 0.2 0.5 0.2 0.5 0.4 5.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.0 6.9 5.1 12.2 6.7 56.2 8.5 8.8 24.5 4.3 30.6 6.2 2.2 0.0 0.0 0.0 0.0 0.1 1.0 0.4 0.0 5.6 87.4 47.6 0.4 1.5 0.1 3.7 6.2 0.1 0.3 0.3 0.0 0.1 20.4 0.5 0.8 1.0 1.2 0.0 0.7 0.8 0.1 0.7 0.0 0.3 0.0 31.0 0.4 0.1 0.1 0.0 1.5 0.2 0.0 0.0 0.7 58.4 7.5 0.8 3.6 1.9 0.1 1.7 0.0 0.0 0.1 0.4 33.8 3.0 0.0 19.3 0.7 0.3 0.0 3.8 13.1 1.2 3.2 12.6 6.8 0.0 0.0 0.0 0.1 0.5 0.5 1.0 CLEC12B ENSG00000256660 "C-type lectin domain family 12 member B" Q2HXU8 12 10010627-10018796 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "bone marrow: 5.1;skin 1: 4.2;testis: 13.1" "Cell type enriched" "Detected in some" 5 "Melanocytes: 80.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 11 "GAMG: 2.8;U-937: 6.5" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 27: Brain & Skin - Unknown function" "Cluster 32: U-937 - Innate immune response" "Cluster 48: Smooth muscle cells - ECM organization" "unprognostic (2.08e-2)" "unprognostic (4.81e-2)" "unprognostic (3.60e-1)" "unprognostic (1.81e-1)" "unprognostic (3.76e-1)" "unprognostic (3.36e-3)" "unprognostic (4.14e-4)" "unprognostic (7.69e-2)" "unprognostic (1.59e-1)" "unprognostic (1.04e-2)" "unprognostic (1.29e-1)" "unprognostic (2.02e-5)" "unprognostic (1.41e-2)" "unprognostic (1.99e-1)" "unprognostic (5.48e-1)" "unprognostic (8.95e-4)" 0.4 0.0 0.0 0.5 0.1 5.1 0.2 0.1 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.2 0.8 0.1 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.0 4.2 0.1 0.1 0.0 1.6 0.1 13.1 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 6.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.2 0.1 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 15.4 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.8 0.8 9.5 0.3 2.2 80.0 0.0 2.7 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.4 0.0 0.9 0.0 0.1 0.0 0.0 0.0 CLGN ENSG00000153132 Calmegin O14967 4 140388453-140427661 "Predicted intracellular proteins, Predicted membrane proteins" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 59.5;testis: 113.6" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 313.3;Early spermatids: 162.4;Endometrial ciliated cells: 93.4;Muller glia cells: 176.4;Spermatocytes: 465.5" "Cancer enhanced" "Detected in many" "prostate cancer: 19.1" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 53.0;MOLT-4: 47.8;U-251 MG: 73.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020709, HPA048761, HPA058627" Enhanced Supported "Endoplasmic reticulum" NA NA "Cluster 46: Basophils - DNA binding" "Cluster 43: Testis - Unknown function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 66: Spermatocytes - Spermatogenesis" "Endoplasmic reticulum" "CAB020709: , HPA048761: AB_2680514, HPA058627: AB_2683782" "unprognostic (6.74e-2)" "unprognostic (8.28e-2)" "unprognostic (1.62e-1)" "unprognostic (1.08e-1)" "unprognostic (2.30e-2)" "unprognostic (2.56e-1)" "unprognostic (3.73e-3)" "unprognostic (6.14e-2)" "unprognostic (4.80e-2)" "unprognostic (3.11e-1)" "unprognostic (5.38e-3)" "unprognostic (2.29e-2)" "unprognostic (2.45e-3)" "unprognostic (3.00e-3)" "unprognostic (1.29e-1)" "unprognostic (2.59e-1)" "unprognostic (1.01e-1)" 0.4 6.6 0.9 1.0 0.7 2.4 2.7 3.8 1.6 0.9 2.0 2.6 0.5 1.6 0.6 1.2 13.7 0.4 59.5 0.9 2.6 0.4 3.2 0.5 0.7 2.7 1.9 0.3 2.2 0.6 11.2 0.2 2.6 22.5 1.3 17.2 1.0 0.7 0.4 0.2 1.3 1.5 1.2 0.2 2.0 113.6 2.3 2.4 2.7 1.6 1.2 0.6 0.1 0.9 0.2 10.2 10.3 6.9 4.0 21.1 2.4 0.1 9.4 10.0 18.6 0.3 0.9 0.0 27.8 0.9 8.4 0.2 7.5 0.1 16.2 0.4 9.0 3.0 9.8 7.4 41.4 38.9 0.6 2.2 39.2 1.0 0.9 53.0 0.2 9.6 2.0 0.0 0.0 0.5 47.8 0.5 12.0 0.2 28.1 31.5 0.0 0.4 0.0 0.3 16.8 29.8 6.5 4.1 1.8 3.8 1.9 5.6 0.0 27.4 4.7 9.7 73.6 14.4 31.7 19.9 43.4 1.6 2.9 0.9 0.2 0.4 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.7 3.8 1.6 0.9 2.6 2.7 1.9 2.6 1.2 2.3 0.9 0.8 0.0 2.2 0.3 0.1 0.0 0.9 8.5 1.2 9.2 3.3 1.8 313.3 0.0 6.4 0.0 4.2 0.5 0.0 0.5 0.0 1.2 162.4 93.4 1.3 11.9 5.3 8.6 7.2 4.2 0.1 10.2 0.0 11.3 0.0 10.1 0.7 3.7 0.1 25.2 6.7 0.4 30.5 0.0 0.0 60.2 5.0 0.7 1.8 0.0 0.1 176.4 0.0 6.6 0.6 0.9 3.9 4.5 0.1 33.8 0.2 0.1 24.6 16.3 0.0 0.6 2.0 465.5 23.9 2.8 0.1 0.3 0.7 0.2 0.8 1.3 COBL KIAA0633 ENSG00000106078 "Cordon-bleu WH2 repeat protein" O75128 7 51016212-51316818 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 118.2;skeletal muscle: 131.6;tongue: 107.9" "Cell type enhanced" "Detected in many" "Excitatory neurons: 198.7;Oligodendrocyte precursor cells: 353.9;Oligodendrocytes: 548.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 14 "plasmacytoid DC: 1.4" "Lineage enriched" "Detected in single" 14 "dendritic cells: 1.4" "Cell line enhanced" "Detected in many" "BEWO: 33.7;HeLa: 57.0;OE19: 53.4;RPMI-8226: 45.5;SuSa: 32.6;U-266/84: 34.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019033, HPA019167" Enhanced Approved "Plasma membrane,Cell Junctions" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 80: Striated muscle - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "Plasma membrane, Cell Junctions" "HPA019033: AB_2083648, HPA019167: AB_1847070" "unprognostic (8.09e-2)" "unprognostic (1.08e-2)" "unprognostic (1.43e-1)" "unprognostic (1.62e-3)" "unprognostic (3.13e-1)" "unprognostic (5.33e-3)" "unprognostic (2.90e-1)" "unprognostic (5.29e-2)" "unprognostic (1.70e-1)" "unprognostic (1.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.92e-2)" "prognostic favorable (5.21e-12)" "unprognostic (7.64e-2)" "unprognostic (1.79e-1)" "unprognostic (2.08e-1)" "unprognostic (5.41e-3)" 3.0 1.0 83.8 1.4 96.7 0.0 14.8 62.0 91.1 4.8 41.6 13.3 18.9 2.2 2.1 13.6 19.1 5.8 54.8 81.8 67.9 12.9 19.6 13.8 0.2 76.6 88.3 2.8 18.4 31.5 12.8 4.7 69.2 14.4 10.9 23.3 47.3 4.2 131.6 27.5 21.5 2.7 66.6 0.3 17.6 3.0 89.8 1.3 8.3 107.9 1.0 1.8 5.8 118.2 12.4 8.8 0.2 0.3 0.0 0.0 33.7 0.0 0.0 0.0 0.0 24.1 18.2 0.0 0.9 0.0 1.4 21.1 12.0 0.0 0.0 0.0 9.6 0.0 57.0 4.7 0.0 0.0 0.1 1.5 2.3 0.0 0.0 0.0 0.0 1.6 6.5 0.2 0.2 7.9 0.1 0.1 9.0 53.4 8.0 0.1 0.5 45.5 17.4 0.0 11.0 0.2 3.2 26.2 3.9 32.6 16.6 0.1 0.0 0.0 9.8 0.3 0.9 0.0 34.1 0.1 0.1 0.1 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 83.8 96.7 62.0 91.1 81.8 67.9 76.6 88.3 69.2 66.6 89.8 118.2 1.4 38.5 19.6 48.0 1.0 17.8 3.4 1.2 4.0 2.3 38.0 34.7 76.2 28.6 13.2 9.2 58.4 23.3 4.6 59.4 0.0 21.5 3.8 65.9 3.3 2.2 18.6 0.0 198.7 9.7 9.2 7.7 35.7 74.6 10.1 4.6 0.4 29.7 2.2 0.0 96.6 35.2 4.1 0.8 1.7 3.1 0.6 0.9 16.0 10.3 1.1 94.4 0.0 353.9 548.8 23.2 35.0 0.4 0.2 25.3 76.8 18.6 31.4 73.6 0.0 10.5 1.5 0.7 8.8 6.8 35.7 40.2 1.7 11.2 14.4 7.3 COL9A3 "DJ885L7.4.1, EDM3, FLJ90759, IDD, MED" ENSG00000092758 "Collagen type IX alpha 3 chain" Q14050 20 62816244-62841159 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Disease variant, Dwarfism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 39.7;choroid plexus: 34.4;thyroid gland: 25.4" "Cell type enhanced" "Detected in many" "Early spermatids: 116.6;Late spermatids: 401.9;Muller glia cells: 95.8;Oligodendrocyte precursor cells: 84.9;Oligodendrocytes: 68.9" "Cancer enhanced" "Detected in many" "thyroid cancer: 30.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "BEWO: 143.4;Hep G2: 59.6;SK-MEL-30: 51.1;WM-115: 57.8" "Low region specificity" "Detected in all" "HPA040125, HPA058323" Supported Approved "Nucleoplasm,Intermediate filaments" "Secreted to extracellular matrix" NA NA "Cluster 73: Brain - Neuropeptide signaling" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "Intermediate filaments" "HPA040125: AB_10805604, HPA058323: AB_2683679" "unprognostic (1.14e-3)" "unprognostic (2.14e-2)" "unprognostic (3.93e-1)" "unprognostic (1.21e-3)" "unprognostic (4.25e-2)" "unprognostic (2.39e-2)" "unprognostic (2.33e-1)" "unprognostic (1.24e-2)" "unprognostic (1.27e-1)" "unprognostic (1.25e-1)" "unprognostic (2.39e-1)" "unprognostic (2.13e-1)" "unprognostic (1.64e-2)" "unprognostic (2.94e-1)" "unprognostic (1.51e-1)" "unprognostic (4.79e-2)" "unprognostic (2.67e-1)" 1.6 1.5 17.5 0.7 35.7 0.0 2.8 22.4 21.6 3.3 34.4 12.1 0.7 1.2 0.2 1.3 1.7 0.1 6.3 13.0 16.5 2.9 0.6 0.4 0.2 37.4 31.0 1.7 7.6 0.1 14.0 0.5 24.2 3.2 0.1 1.6 23.6 1.2 0.5 1.9 3.1 0.1 20.5 0.3 2.7 20.7 31.6 0.1 25.4 0.0 0.0 2.8 3.8 39.7 0.2 0.3 0.3 0.2 0.0 0.8 143.4 0.1 0.0 0.1 0.0 1.6 0.2 0.0 13.1 0.0 0.8 0.1 0.2 0.0 0.0 0.0 0.9 0.0 8.2 59.6 0.3 0.0 0.5 2.0 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.3 0.0 0.0 1.0 0.7 6.4 8.2 0.0 2.5 0.0 1.8 0.0 0.1 0.0 1.5 0.2 0.1 51.1 4.6 0.2 5.4 0.0 0.0 0.7 0.1 1.0 0.2 0.1 0.0 0.2 0.0 57.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.5 35.7 22.4 21.6 13.0 16.5 37.4 31.0 24.2 20.5 31.6 39.7 1.6 3.2 0.0 1.0 26.1 3.2 2.2 1.2 1.8 0.9 2.1 2.5 1.6 0.0 0.2 5.5 10.4 5.1 0.4 0.7 1.9 3.6 116.6 2.7 0.4 3.7 4.2 1.3 2.5 0.0 46.4 15.3 6.1 0.7 0.0 0.6 2.5 6.8 2.2 0.0 2.0 3.3 0.0 2.2 0.9 401.9 4.1 1.7 3.6 0.0 0.5 95.8 0.0 84.9 68.9 0.1 7.3 1.5 44.0 1.2 2.3 23.7 2.5 3.7 0.0 0.8 1.0 2.9 7.8 0.9 7.0 4.0 1.4 3.7 2.0 1.0 COMMD8 FLJ20502 ENSG00000169019 "COMM domain containing 8" Q9NX08 4 47450787-47463702 "Predicted intracellular proteins" "Transcription, Transcription regulation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Proximal tubular cells: 231.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA035887 Approved Supported Nucleoplasm,Cytosol NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 7: Kidney - Transmembrane transport" "Cluster 35: RPTEC-TERT1 - Kidney processes" "Cluster 67: Proximal tubular cells - Tubular reabsorption" "Nucleoplasm, Cytosol" "HPA035887: AB_10600702" "unprognostic (9.04e-2)" "unprognostic (1.40e-1)" "unprognostic (8.55e-3)" "unprognostic (5.13e-2)" "unprognostic (2.51e-1)" "unprognostic (1.74e-2)" "prognostic unfavorable (1.40e-4)" "unprognostic (1.07e-2)" "unprognostic (4.24e-2)" "unprognostic (3.47e-2)" "unprognostic (1.78e-1)" "unprognostic (3.78e-2)" "prognostic favorable (2.71e-5)" "unprognostic (1.06e-1)" "unprognostic (2.10e-1)" "unprognostic (7.76e-2)" "unprognostic (7.13e-2)" 13.4 15.5 9.7 20.3 9.8 21.4 13.6 10.0 14.6 11.8 13.0 17.7 18.4 10.4 22.6 24.1 11.3 13.7 27.2 9.5 12.2 45.3 12.7 13.5 30.4 9.9 10.3 10.2 10.4 26.8 13.4 19.0 10.0 10.6 18.1 13.5 8.4 10.0 8.8 17.5 19.0 15.0 10.4 18.1 14.3 24.1 10.3 21.6 21.3 12.6 25.4 16.8 11.8 10.3 32.6 17.6 15.2 7.8 31.6 44.8 21.1 47.8 31.5 30.7 41.5 29.9 37.4 51.7 39.0 45.3 69.4 17.0 49.4 39.1 55.0 30.8 22.1 29.8 17.7 23.2 43.0 73.6 36.8 38.7 51.6 29.2 32.3 28.5 39.5 33.7 22.5 20.6 75.8 18.1 44.1 59.4 10.4 21.8 22.8 21.8 34.7 11.2 88.1 26.3 29.8 15.2 19.9 16.1 39.6 26.5 29.5 48.0 32.7 43.6 41.8 39.2 57.9 21.6 27.6 42.1 47.3 95.2 32.2 114.3 58.2 68.9 44.6 80.4 48.1 48.1 40.5 44.9 74.0 43.4 37.5 43.2 29.0 57.4 89.4 34.3 51.2 71.4 9.7 9.8 10.0 14.6 9.5 12.2 9.9 10.3 10.0 10.4 10.3 10.3 31.3 22.4 16.5 3.3 41.6 22.6 11.4 60.5 21.6 18.2 12.8 16.6 46.1 18.6 32.6 29.5 4.2 86.6 39.1 20.9 107.6 42.8 68.4 43.0 21.6 26.7 21.0 14.5 5.5 46.3 116.3 28.6 16.8 19.2 33.0 11.3 22.5 12.7 90.9 6.7 7.3 19.4 42.7 54.4 42.1 18.9 54.3 50.7 12.4 4.7 82.0 37.2 72.1 2.5 5.3 25.1 23.8 40.6 22.9 8.6 28.0 231.8 57.4 23.8 19.7 16.9 29.9 141.5 59.0 37.3 30.0 105.8 53.9 36.9 28.8 10.2 COPE epsilon-COP ENSG00000105669 "COPI coat complex subunit epsilon" O14579 19 18899514-18919387 "Metabolic proteins, Predicted intracellular proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034345, HPA041605, HPA043576" Supported Enhanced "Golgi apparatus" NA NA 66000 "Cluster 31: Non-specific - Inflammatory response" "Cluster 35: Non-specific - Unknown function" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Golgi apparatus" "CAB034345: AB_2081323, HPA041605: AB_2677578, HPA043576: AB_2678563" "unprognostic (1.48e-1)" "prognostic favorable (2.41e-4)" "unprognostic (1.15e-1)" "unprognostic (5.17e-3)" "unprognostic (1.04e-1)" "unprognostic (7.40e-2)" "unprognostic (3.39e-2)" "unprognostic (2.27e-1)" "unprognostic (1.36e-1)" "unprognostic (1.49e-3)" "unprognostic (1.97e-2)" "unprognostic (8.75e-2)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (2.26e-1)" "unprognostic (3.16e-2)" "unprognostic (6.75e-2)" 102.3 163.7 127.2 85.5 133.4 159.6 100.3 139.4 176.0 101.3 131.3 113.8 90.5 104.1 45.0 160.3 89.8 44.1 135.2 122.4 131.0 141.9 194.3 108.3 91.7 140.6 132.0 80.8 152.0 80.8 160.1 59.3 130.0 127.4 37.7 23.5 144.2 65.4 128.0 120.9 107.8 42.9 137.1 150.0 126.8 171.9 135.9 82.4 123.7 50.0 56.9 99.2 107.1 151.2 186.7 177.4 99.3 177.3 89.0 104.7 287.2 159.2 150.8 174.8 198.7 215.1 148.2 150.8 210.5 134.9 112.9 123.2 82.5 161.0 33.9 94.2 369.9 89.6 150.9 331.1 236.1 180.0 221.1 128.3 149.2 106.2 115.6 92.5 138.9 170.5 140.2 373.6 90.0 443.0 196.9 341.0 188.4 243.0 420.2 222.4 89.6 448.2 115.8 185.4 138.8 222.4 100.0 159.1 181.1 44.9 134.8 291.3 140.9 110.5 81.5 283.3 170.9 357.7 337.5 187.7 189.1 309.9 187.3 656.0 598.5 639.1 337.1 533.1 298.1 391.2 321.9 298.6 528.4 381.9 236.4 270.9 594.9 344.4 468.5 659.3 449.3 930.0 127.2 133.4 139.4 176.0 122.4 131.0 140.6 132.0 130.0 137.1 135.9 151.2 110.5 3.2 16.2 22.2 204.7 159.8 197.9 390.9 54.1 53.2 140.5 111.6 10.4 111.5 205.8 115.8 29.2 386.5 242.8 408.9 463.7 323.7 179.7 134.4 131.8 127.1 168.5 130.5 8.6 368.7 439.1 140.7 166.2 187.8 102.9 176.7 113.6 153.4 447.2 57.2 11.3 445.5 303.2 189.4 286.8 381.0 144.8 217.8 245.5 4.7 373.5 251.9 187.4 8.5 20.8 336.7 421.4 133.2 417.5 255.7 425.6 493.1 152.6 72.1 124.9 92.8 200.5 178.4 202.1 108.6 196.6 542.2 174.9 235.3 297.4 267.2 CORO2A "IR10, WDR2" ENSG00000106789 "Coronin 2A" Q92828 9 98120975-98192637 "Predicted intracellular proteins" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 35.1" "Cell type enhanced" "Detected in many" "Distal enterocytes: 76.2;Proximal enterocytes: 93.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 6 "granulocytes: 11.4;monocytes: 7.8;T-cells: 11.9" "Cell line enhanced" "Detected in many" "BEWO: 66.6;OE19: 56.4;SK-BR-3: 45.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA041161, HPA041302" Enhanced Approved "Plasma membrane,Cytosol" NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 37: Intestine - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" "HPA041161: AB_10795537, HPA041302: AB_10794195" "unprognostic (4.49e-3)" "unprognostic (3.44e-2)" "unprognostic (3.14e-1)" "unprognostic (1.78e-1)" "unprognostic (3.39e-3)" "unprognostic (1.64e-1)" "unprognostic (3.73e-2)" "unprognostic (5.73e-2)" "unprognostic (2.79e-1)" "unprognostic (1.52e-1)" "unprognostic (4.50e-3)" "unprognostic (2.85e-1)" "prognostic unfavorable (6.56e-4)" "unprognostic (4.16e-2)" "unprognostic (1.40e-2)" "unprognostic (1.87e-2)" "unprognostic (6.40e-3)" 1.9 1.7 1.9 4.9 1.5 14.8 4.7 4.9 3.2 6.1 0.0 17.5 34.3 1.6 0.7 15.2 4.7 18.2 0.3 1.2 2.9 1.1 3.3 7.4 2.9 3.7 3.4 0.3 0.4 2.5 4.0 2.1 4.9 14.3 12.9 1.2 6.1 1.4 0.3 9.3 35.1 2.2 0.8 3.0 11.1 9.2 4.5 5.7 1.2 0.3 5.9 12.8 7.7 1.8 8.4 2.9 0.6 2.0 1.2 1.3 66.6 0.6 0.7 2.1 3.2 19.1 1.4 0.1 9.4 1.2 3.2 23.1 7.7 12.7 1.3 6.9 1.8 0.2 11.6 17.1 2.7 7.9 0.7 0.4 15.4 1.0 18.6 0.7 0.7 10.0 6.8 3.8 0.3 6.3 1.5 7.8 8.6 56.4 2.2 6.1 0.1 0.2 1.3 23.5 1.7 2.4 4.4 45.3 1.6 15.0 5.3 12.8 0.6 0.2 9.7 0.2 2.4 0.7 4.0 0.7 0.5 2.5 2.8 11.2 1.4 11.4 2.4 2.9 5.2 0.6 3.9 3.7 0.5 0.5 2.5 3.3 1.0 1.7 7.8 0.7 11.9 1.5 1.9 1.5 4.9 3.2 1.2 2.9 3.7 3.4 4.9 0.8 4.5 1.8 2.8 12.8 27.8 0.7 3.1 6.6 18.9 47.2 14.8 2.1 8.5 4.3 1.9 28.6 46.4 0.0 4.2 10.5 2.1 76.2 0.0 4.5 2.6 15.6 11.6 6.0 7.2 0.8 11.6 5.1 42.2 2.2 36.2 19.9 0.0 38.1 0.7 3.8 6.0 1.7 10.5 15.7 20.3 12.0 2.6 3.9 0.0 10.6 0.0 1.0 1.8 0.7 2.1 0.5 0.8 22.6 19.7 0.4 1.4 15.7 93.0 1.7 35.8 1.7 0.0 1.5 3.7 0.5 3.3 29.4 9.9 15.9 10.7 0.2 36.3 30.4 CRIP2 "CRP2, ESP1" ENSG00000182809 "Cysteine rich protein 2" P52943 14 105472962-105480162 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "heart muscle: 1113.7" "Cell type enhanced" "Detected in many" "Adipocytes: 459.4;Cardiomyocytes: 863.3;Endothelial cells: 510.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "memory B-cell: 52.1;memory CD4 T-cell: 80.4;naive B-cell: 109.9;T-reg: 115.6" "Group enriched" "Detected in all" 30 "B-cells: 109.9;T-cells: 115.6" "Cell line enhanced" "Detected in many" "EFO-21: 321.9;MCF7: 306.5;SK-BR-3: 303.7;T-47d: 266.4;TIME: 259.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042664 Approved Approved "Nucleoplasm,Nucleoli,Plasma membrane" NA NA 160000 "Cluster 26: Non-specific - Mitochondria" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 38: EFO-21 - Unknown function" "Cluster 43: Cardiomyocytes - Nuclear processes" Nucleoli "Nucleoplasm, Plasma membrane" "HPA042664: AB_10797017" "unprognostic (2.68e-1)" "unprognostic (6.53e-3)" "unprognostic (2.11e-3)" "unprognostic (2.19e-1)" "unprognostic (2.39e-1)" "unprognostic (2.14e-1)" "unprognostic (1.63e-2)" "unprognostic (2.56e-1)" "unprognostic (3.20e-3)" "unprognostic (9.68e-2)" "unprognostic (6.96e-2)" "unprognostic (1.14e-1)" "unprognostic (2.04e-2)" "unprognostic (6.25e-2)" "unprognostic (2.35e-2)" "unprognostic (2.39e-2)" "unprognostic (8.26e-3)" 177.6 44.7 160.4 31.3 172.0 1.5 162.5 137.7 259.5 101.6 124.2 101.9 27.0 138.1 36.4 127.3 130.0 47.9 1113.7 172.7 186.4 205.1 52.7 185.7 30.0 157.3 158.7 51.2 46.1 19.2 175.0 49.6 158.6 89.0 8.3 4.1 100.0 72.9 52.5 128.9 82.8 32.0 145.0 104.1 66.1 92.8 191.9 10.4 155.6 42.7 16.5 121.4 100.4 140.8 2.5 201.2 37.9 98.3 4.3 19.9 10.0 17.5 1.9 2.8 1.0 7.1 44.2 0.2 321.9 73.8 4.5 166.8 3.6 50.8 0.1 2.3 1.9 0.2 132.5 73.8 24.3 0.0 25.5 10.5 4.4 5.2 26.2 38.4 192.7 0.2 0.5 1.4 26.8 306.5 0.5 0.6 10.0 45.7 143.4 0.4 7.7 9.9 140.1 0.6 61.6 175.3 30.0 303.7 1.9 4.9 266.4 0.1 259.3 82.7 38.8 2.3 50.5 0.7 0.6 0.9 24.3 0.3 179.3 0.2 1.9 0.0 7.5 0.9 6.8 52.1 80.4 17.2 3.6 109.9 17.8 4.5 1.0 3.7 0.5 0.5 115.6 10.4 160.4 172.0 137.7 259.5 172.7 186.4 157.3 158.7 158.6 145.0 191.9 140.8 459.4 157.0 33.7 17.9 15.0 153.2 96.7 206.4 29.0 2.7 110.0 140.7 863.3 107.2 127.1 189.4 4.2 2.6 8.2 0.9 154.6 106.8 37.9 125.1 28.8 510.4 25.2 9.7 16.4 87.6 30.5 132.9 32.1 126.6 7.6 0.4 346.3 30.4 3.0 94.2 3.0 0.3 81.4 11.8 92.6 84.0 28.0 9.3 156.5 27.2 2.5 57.2 1.0 4.5 3.1 48.9 0.1 14.7 7.0 37.4 0.2 17.0 155.7 4.0 276.1 108.1 339.5 27.8 46.1 20.1 196.8 32.0 32.5 5.9 0.2 103.2 CRYZL1 "4P11, QOH-1" ENSG00000205758 "Crystallin zeta like 1" O95825 21 33589341-33643926 "Predicted intracellular proteins" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 139.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019120, HPA029399, CAB034129" Approved Approved Nucleoplasm,Cytosol NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 21: Non-specific - Transcription" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Cytosol" "CAB034129: AB_2084755, HPA019120: AB_1847264, HPA029399: AB_10600865" "unprognostic (1.54e-1)" "unprognostic (4.69e-2)" "unprognostic (1.53e-1)" "unprognostic (3.18e-2)" "unprognostic (2.55e-1)" "unprognostic (9.19e-2)" "unprognostic (2.73e-1)" "unprognostic (2.57e-3)" "unprognostic (2.90e-2)" "unprognostic (1.08e-1)" "unprognostic (1.76e-1)" "unprognostic (5.86e-2)" "unprognostic (1.59e-2)" "unprognostic (3.59e-2)" "unprognostic (8.16e-3)" "unprognostic (1.59e-1)" "unprognostic (1.28e-3)" 22.4 18.6 23.7 16.4 26.4 22.4 21.1 31.4 33.5 19.2 23.7 28.2 15.0 22.6 19.0 18.8 20.2 16.3 20.0 24.8 25.9 23.5 18.0 16.2 17.7 24.7 26.0 22.0 15.2 22.3 14.2 21.7 25.1 18.3 20.3 29.2 18.0 22.3 19.2 22.9 15.8 21.2 22.5 15.6 17.6 34.0 25.2 18.1 24.5 15.4 14.0 21.0 18.0 34.2 38.0 16.4 45.7 33.8 24.3 35.0 24.0 26.3 37.8 33.0 29.1 24.5 29.0 26.4 23.0 32.5 25.6 20.5 24.6 27.2 30.0 24.6 24.8 49.9 35.5 22.2 38.4 31.0 29.8 32.7 23.4 34.9 27.2 43.1 42.4 42.6 36.8 26.6 31.3 19.3 30.2 31.8 32.3 38.8 21.9 28.5 36.8 36.6 47.1 33.7 19.8 31.2 34.6 17.5 39.7 37.8 34.3 23.1 44.8 26.3 25.3 22.0 20.5 43.4 64.7 29.1 34.4 22.7 30.1 36.1 34.5 36.2 31.7 37.5 34.3 38.2 33.4 29.9 43.3 40.4 43.3 35.3 18.3 47.1 35.6 34.3 29.9 26.8 23.7 26.4 31.4 33.5 24.8 25.9 24.7 26.0 25.1 22.5 25.2 34.2 25.6 32.1 17.3 40.1 25.9 23.6 43.9 58.9 19.9 47.8 22.1 25.1 28.0 31.5 36.0 31.3 31.3 70.4 21.3 20.2 49.0 37.6 90.4 19.6 14.4 29.9 21.0 25.4 42.4 29.1 40.5 28.1 13.3 14.4 65.2 34.5 27.5 15.0 33.5 47.1 47.2 22.5 46.8 26.0 25.7 28.0 44.1 24.6 37.4 26.2 36.1 49.4 41.2 32.2 56.7 28.6 30.3 41.0 11.3 23.3 33.7 44.8 35.0 51.1 19.7 23.7 41.5 139.4 19.4 15.9 21.5 44.6 28.4 27.3 29.4 40.5 DBF4 "ASK, chif, DBF4A, ZDBF1" ENSG00000006634 "DBF4 zinc finger" Q9UBU7 7 87876216-87909553 "Predicted intracellular proteins" "Cell cycle, DNA replication" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 15.1" "Group enriched" "Detected in all" 4 "Early spermatids: 468.6;Spermatocytes: 569.4" "Low cancer specificity" "Detected in all" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA042923 Supported "Nucleoplasm,Nuclear bodies" Yes Yes "Cluster 10: Basophils - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA042923: AB_2678222" "unprognostic (2.48e-1)" "unprognostic (8.32e-2)" "unprognostic (1.15e-2)" "unprognostic (4.86e-3)" "unprognostic (2.81e-2)" "unprognostic (3.63e-1)" "prognostic unfavorable (4.45e-6)" "unprognostic (1.05e-1)" "prognostic unfavorable (6.86e-4)" "unprognostic (1.46e-3)" "unprognostic (1.05e-3)" "unprognostic (2.78e-3)" "prognostic unfavorable (6.42e-7)" "unprognostic (1.98e-2)" "unprognostic (2.40e-1)" "unprognostic (1.47e-1)" "unprognostic (1.30e-1)" 0.1 0.2 0.2 0.2 0.4 0.6 0.2 0.7 0.4 0.2 0.1 0.2 0.2 0.2 0.3 0.1 0.1 0.4 0.1 0.2 0.1 0.2 0.2 0.1 0.5 0.2 0.2 0.2 0.1 0.1 0.0 0.1 0.2 0.2 0.2 0.2 0.1 0.1 0.1 0.2 0.3 0.0 0.1 0.3 0.2 15.1 0.2 0.6 0.3 0.0 0.5 0.1 0.1 0.3 0.9 0.8 2.0 2.5 0.4 0.4 0.5 1.0 0.2 1.0 2.1 1.4 0.6 2.1 0.6 0.6 1.7 0.9 2.2 0.5 1.0 1.6 1.3 1.3 1.0 0.4 0.1 1.7 1.0 0.4 0.6 1.2 1.0 0.3 0.9 1.9 1.2 4.2 1.4 1.7 2.8 2.0 2.0 2.1 1.9 0.7 3.1 2.5 0.8 0.1 3.0 1.8 1.2 2.2 1.0 1.6 0.9 1.6 0.1 1.2 1.4 3.1 2.0 2.3 5.2 2.1 0.8 3.1 2.5 1.0 0.1 0.1 0.3 0.0 0.1 0.2 0.2 0.1 0.0 0.2 0.2 0.3 0.2 0.2 0.0 0.2 0.4 0.1 0.2 0.4 0.7 0.4 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.3 13.3 3.2 12.6 5.5 38.4 15.6 16.4 10.7 12.0 6.6 13.0 16.8 3.7 2.8 7.7 9.2 12.5 19.6 59.2 9.7 3.9 8.3 468.6 12.1 23.6 11.1 14.9 40.8 14.7 14.7 36.4 12.4 14.3 17.7 31.0 19.4 6.4 6.5 16.1 3.3 9.1 20.6 16.2 9.1 15.5 116.0 15.5 20.8 12.4 2.8 11.0 2.1 24.7 6.0 6.7 14.1 8.5 9.4 48.9 18.4 4.2 5.8 10.2 16.6 13.1 9.7 11.4 569.4 74.6 20.5 12.6 9.6 44.4 13.5 22.3 11.7 DESI2 "C1orf121, CGI-146, DESI-2, FAM152A, FLJ21998, PNAS-4, PPPDE1" ENSG00000121644 "Desumoylating isopeptidase 2" Q9BSY9 1 244653103-244709033 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 171.8;Spermatocytes: 192.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA049950 Approved Vesicles NA NA "Cluster 37: B-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Vesicles "HPA049950: AB_2680969" "unprognostic (1.13e-1)" "unprognostic (2.07e-1)" "unprognostic (1.05e-1)" "unprognostic (3.09e-1)" "unprognostic (1.96e-1)" "unprognostic (5.40e-2)" "unprognostic (1.95e-2)" "unprognostic (7.62e-2)" "unprognostic (1.38e-3)" "unprognostic (1.51e-1)" "unprognostic (4.47e-3)" "unprognostic (1.45e-1)" "prognostic unfavorable (4.25e-5)" "unprognostic (4.52e-2)" "unprognostic (8.27e-2)" "unprognostic (2.27e-2)" "unprognostic (9.49e-2)" 17.1 13.6 7.7 13.6 10.7 17.1 14.0 13.0 8.4 18.4 13.1 16.4 16.0 22.7 13.6 16.2 13.3 17.8 16.4 7.4 7.9 11.8 12.8 23.2 17.9 7.7 8.0 13.6 9.3 13.9 7.1 18.6 7.4 14.4 18.2 16.2 11.1 15.6 24.1 15.2 13.3 22.3 8.1 11.7 15.6 54.8 8.3 19.7 23.3 23.6 19.1 18.4 12.0 8.1 68.1 24.3 47.0 40.8 52.8 54.8 61.7 40.8 65.9 36.9 33.9 43.8 31.0 121.8 53.8 47.7 21.5 29.5 58.1 43.1 50.5 43.1 53.6 31.0 17.5 33.0 46.2 52.8 36.1 38.4 57.3 49.3 61.6 35.6 52.8 52.8 48.4 63.7 56.2 11.7 49.6 28.0 109.0 62.7 67.7 36.9 71.9 46.0 28.4 27.6 42.5 57.2 55.4 26.4 47.7 37.7 27.6 39.0 59.7 41.7 45.4 57.4 68.5 69.4 94.1 69.8 33.8 55.7 78.0 2.5 1.7 5.6 2.1 2.1 2.1 5.2 2.2 3.0 2.7 2.7 2.9 2.8 1.4 2.2 2.3 2.4 3.2 0.7 7.7 10.7 13.0 8.4 7.4 7.9 7.7 8.0 7.4 8.1 8.3 8.1 32.7 86.6 60.4 17.9 31.0 55.3 41.3 23.0 38.7 43.2 21.5 26.3 22.1 27.1 25.5 18.4 20.9 29.8 36.1 28.1 21.5 19.8 171.8 32.0 39.6 36.2 15.6 21.7 18.4 33.4 40.0 44.2 28.5 25.0 7.0 28.7 25.7 21.5 23.8 40.4 23.1 19.0 26.4 23.3 27.1 101.5 34.8 27.2 16.0 18.7 25.5 23.8 28.8 35.7 26.9 34.3 28.6 51.9 34.5 69.5 17.0 16.5 17.6 25.1 39.5 41.7 50.2 192.7 105.4 42.4 41.3 43.2 31.2 38.4 25.4 55.5 DHH "HHG-3, MGC35145" ENSG00000139549 "Desert hedgehog signaling molecule" O43323 12 49086656-49094801 "Disease related genes, Human disease related genes, Predicted secreted proteins" "Developmental protein, Hydrolase, Protease" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 20 "testis: 16.7" "Cell type enriched" "Detected in some" 7 "Granulosa cells: 17.1" "Low cancer specificity" "Detected in single" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 10 "AN3-CA: 1.8;EFO-21: 2.3;HUVEC TERT2: 1.5;K-562: 5.6;TIME: 2.7" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "spinal cord: 8.2" "Secreted in male reproductive system" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 40: Granulosa cells - Unknown function" "unprognostic (7.56e-2)" "unprognostic (2.05e-3)" "unprognostic (1.14e-1)" "unprognostic (2.93e-3)" "unprognostic (2.36e-4)" "unprognostic (1.29e-1)" "unprognostic (7.22e-3)" "unprognostic (8.21e-2)" "unprognostic (5.92e-2)" "unprognostic (1.22e-1)" "unprognostic (1.38e-2)" "unprognostic (1.64e-1)" "unprognostic (1.19e-1)" "unprognostic (1.14e-1)" "unprognostic (8.00e-2)" "unprognostic (1.00e-1)" "unprognostic (6.97e-2)" 0.8 0.2 0.2 0.5 0.3 0.0 0.7 0.7 0.5 0.5 0.1 0.4 0.0 0.6 0.2 0.3 0.4 0.3 0.6 0.2 0.1 0.7 0.1 0.5 0.1 0.5 0.4 0.3 0.1 0.0 0.6 0.6 0.4 0.4 0.1 0.0 0.3 0.3 0.1 0.3 0.4 0.4 0.6 0.2 0.3 16.7 0.4 0.0 0.3 0.4 0.0 0.7 0.5 0.8 0.0 0.0 0.1 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 5.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.7 0.5 0.2 0.1 0.5 0.4 0.4 0.6 0.4 0.8 1.6 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 17.1 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.3 1.0 0.7 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.0 0.3 0.0 0.0 0.1 0.1 0.0 0.0 DMC1 LIM15 ENSG00000100206 "DNA meiotic recombinase 1" Q14565 22 38518948-38570204 "Predicted intracellular proteins" "Cell cycle, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 12.3" "Group enriched" "Detected in many" 5 "Spermatocytes: 109.3;Spermatogonia: 36.0" "Cancer enhanced" "Detected in some" "testis cancer: 1.7" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HDLM-2: 25.5;hTEC/SVTERT24-B: 17.4;U-266/84: 21.4" "Not detected" "Not detected" "Low region specificity" "Detected in single" "HPA001232, CAB015397" Enhanced Approved Nucleoplasm NA NA "Cluster 11: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 44: HDLM-2 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Nucleoplasm "CAB015397: AB_629406, HPA001232: AB_1078683" "unprognostic (1.29e-2)" "unprognostic (3.11e-3)" "unprognostic (4.48e-3)" "unprognostic (5.71e-2)" "unprognostic (6.43e-2)" "unprognostic (2.22e-1)" "unprognostic (8.22e-2)" "unprognostic (2.61e-2)" "unprognostic (4.23e-2)" "unprognostic (3.99e-3)" "unprognostic (7.40e-3)" "unprognostic (1.00e-2)" "unprognostic (2.16e-4)" "unprognostic (3.94e-1)" "unprognostic (2.79e-1)" "unprognostic (7.27e-2)" "unprognostic (2.99e-1)" 0.7 0.2 0.4 1.3 0.4 2.3 0.9 1.2 0.7 1.0 0.4 0.9 0.2 2.5 0.9 0.9 0.8 0.4 2.3 0.4 0.2 0.5 0.3 0.4 2.8 0.5 0.2 1.2 0.5 0.3 0.4 0.7 0.5 1.2 1.1 0.8 0.3 0.7 1.3 1.6 0.7 0.7 0.1 0.5 0.6 12.3 0.1 3.4 0.3 0.5 3.1 0.6 0.7 0.5 7.1 2.6 5.0 0.1 0.4 2.1 0.2 7.4 1.0 11.7 8.1 0.2 0.8 3.5 0.3 2.0 0.0 1.2 2.0 0.3 13.1 25.5 0.5 13.6 2.0 0.2 0.2 1.2 2.7 0.5 0.0 17.4 0.0 0.1 0.9 11.2 10.5 3.5 4.1 3.9 2.8 10.3 9.0 3.5 0.2 6.2 0.0 5.2 1.5 0.9 9.7 0.5 12.5 1.1 0.1 1.1 2.1 2.9 0.3 0.1 0.8 0.1 0.1 9.8 21.4 6.4 2.0 2.8 0.9 0.4 0.1 0.1 0.3 0.0 0.0 0.1 0.2 0.1 0.2 0.2 0.2 0.1 0.4 0.5 0.1 0.1 0.1 0.1 0.4 0.4 1.2 0.7 0.4 0.2 0.5 0.2 0.5 0.1 0.1 0.5 0.6 0.0 2.3 3.6 0.7 2.3 1.0 0.4 1.8 0.7 2.7 2.4 2.5 0.0 2.7 3.7 0.0 1.9 0.4 1.3 1.9 0.2 2.9 0.9 0.8 0.8 0.0 11.8 1.1 0.0 1.7 1.4 0.0 1.3 1.3 1.1 0.4 0.1 1.0 0.0 1.4 1.6 0.0 0.0 1.2 3.0 1.5 1.1 0.0 1.9 0.1 4.8 1.0 2.5 0.6 0.1 0.5 1.5 3.8 0.2 0.1 0.4 0.9 0.2 13.1 1.3 0.9 109.3 36.0 0.3 0.6 0.8 0.9 0.3 2.5 0.5 DNMT1 "CXXC9, DNMT, MCMT" ENSG00000130816 "DNA methyltransferase 1" P26358 19 10133342-10231286 "Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, Chromatin regulator, DNA-binding, Methyltransferase, Repressor, Transferase" "Deafness, Disease variant, FDA approved drug targets, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in all" "Cytotrophoblasts: 388.1;Spermatocytes: 229.6;Syncytiotrophoblasts: 323.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA002694, CAB005876" Enhanced Supported Nucleoplasm NA Yes "Cluster 6: Non-specific - Transcription" "Cluster 34: Non-specific - Transcription" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm "CAB005876: AB_731983, HPA002694: AB_1847810" "unprognostic (3.51e-1)" "unprognostic (1.20e-2)" "unprognostic (1.26e-2)" "unprognostic (1.40e-1)" "unprognostic (3.62e-1)" "unprognostic (7.59e-3)" "prognostic unfavorable (1.46e-4)" "unprognostic (2.90e-1)" "unprognostic (4.23e-3)" "unprognostic (1.10e-2)" "unprognostic (1.07e-1)" "unprognostic (1.11e-2)" "unprognostic (1.28e-3)" "unprognostic (7.81e-3)" "unprognostic (1.73e-1)" "unprognostic (8.11e-2)" "unprognostic (1.46e-1)" 7.1 3.9 0.9 16.9 2.9 23.1 7.0 11.7 3.1 9.1 0.0 6.9 6.6 7.3 3.1 7.7 6.5 6.2 4.8 2.1 6.6 3.0 3.9 7.8 26.2 3.8 4.5 5.6 3.6 4.3 4.5 26.0 5.7 4.5 6.8 7.5 5.6 4.6 5.3 7.9 7.9 8.8 0.3 8.1 6.3 12.4 3.3 20.6 6.3 5.0 24.9 7.3 6.4 10.6 77.0 40.6 49.5 45.8 24.6 24.0 138.8 52.4 43.9 77.5 74.9 50.6 40.8 138.3 33.8 30.0 38.6 46.6 68.4 44.2 68.4 57.5 100.9 181.5 39.5 27.1 9.6 91.5 73.4 11.5 9.3 68.5 24.1 18.4 39.9 37.6 75.0 82.8 63.3 37.6 109.2 50.4 87.5 38.3 76.6 117.1 67.9 77.2 21.5 49.3 64.5 41.5 58.2 26.2 16.5 33.6 28.9 42.2 31.8 111.3 42.2 73.0 84.4 49.6 69.5 166.8 35.0 68.5 87.1 20.3 21.2 5.9 29.8 22.0 25.1 14.2 22.8 20.4 19.3 20.0 25.5 20.5 4.6 42.6 13.8 31.9 21.9 12.6 0.9 2.9 11.7 3.1 2.1 6.6 3.8 4.5 5.7 0.3 3.3 10.6 36.4 6.4 26.5 12.7 38.0 29.6 20.7 26.8 21.1 86.7 32.6 29.6 14.6 7.2 28.2 22.0 56.3 388.1 54.4 29.0 13.7 26.0 46.1 48.1 42.0 38.9 15.7 109.6 17.6 14.3 73.2 33.6 33.6 60.3 37.2 43.6 25.0 14.8 76.8 65.6 22.6 25.5 38.7 31.4 47.8 50.8 28.0 57.9 14.2 15.0 52.5 32.2 123.6 14.6 20.1 21.1 11.3 28.6 73.4 16.3 4.5 9.3 42.8 50.2 13.1 22.6 32.8 229.6 145.3 41.6 22.4 323.7 70.4 38.7 43.1 16.6 DTX2 "KIAA1528, RNF58" ENSG00000091073 "Deltex E3 ubiquitin ligase 2" Q86UW9 7 76461676-76505995 "Enzymes, Predicted intracellular proteins" "Notch signaling pathway, Ubl conjugation pathway" Transferase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 54.0" "Cell type enhanced" "Detected in all" "Basal respiratory cells: 87.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "A549: 67.7;CAPAN-2: 110.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042931 Approved Supported "Nucleoplasm,Nuclear membrane" NA Yes "Cluster 8: Neutrophils - Inflammatory response" "Cluster 71: Testis - DNA repair" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 26: Respiratory epithelial cells - Mucosal defense" "Nucleoplasm, Nuclear membrane" "HPA042931: AB_2678227" "unprognostic (1.72e-1)" "unprognostic (1.73e-1)" "unprognostic (1.62e-2)" "unprognostic (1.58e-2)" "prognostic unfavorable (8.47e-4)" "unprognostic (2.85e-2)" "unprognostic (1.28e-3)" "unprognostic (7.54e-2)" "unprognostic (4.76e-2)" "unprognostic (2.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-2)" "prognostic unfavorable (1.13e-8)" "unprognostic (2.87e-2)" "unprognostic (1.53e-1)" "unprognostic (1.50e-1)" "unprognostic (1.19e-2)" 10.0 5.0 5.6 12.3 6.3 5.1 10.3 3.3 10.1 17.4 13.8 15.8 10.2 9.3 1.1 54.0 10.5 9.3 6.8 4.3 5.9 5.4 8.7 10.3 10.9 11.1 8.1 8.1 10.5 8.4 6.7 5.3 8.1 13.7 8.1 4.4 30.4 3.9 12.5 31.0 13.3 4.3 3.8 13.3 14.2 28.1 13.5 9.0 7.9 2.7 10.1 12.1 27.2 12.8 31.8 67.7 9.9 14.7 5.5 5.4 21.2 6.8 5.7 7.2 9.9 19.1 110.9 9.8 4.7 6.8 38.1 23.2 5.3 32.1 4.5 22.1 11.3 5.6 14.4 16.9 7.4 8.2 13.7 9.6 19.1 18.7 10.0 5.6 5.5 17.2 17.3 14.3 8.8 15.3 12.6 28.6 14.4 23.8 10.2 13.8 9.1 17.7 3.4 24.4 3.9 8.2 10.9 18.4 9.3 8.6 18.5 21.6 5.8 40.5 19.0 13.8 27.1 10.7 13.7 11.2 8.8 8.8 21.3 17.7 11.6 17.2 8.6 13.3 6.2 6.6 7.1 8.5 10.1 7.3 7.1 7.9 22.8 4.2 18.8 17.8 11.0 8.4 5.6 6.3 3.3 10.1 4.3 5.9 11.1 8.1 8.1 3.8 13.5 12.8 7.3 6.4 5.0 5.2 13.1 33.9 19.5 87.2 23.3 2.6 7.1 4.8 2.3 4.3 59.2 7.3 8.4 18.5 12.0 39.1 3.9 19.4 33.0 8.1 3.1 5.9 9.1 3.8 5.7 10.8 13.5 6.5 61.2 10.7 3.8 3.2 7.1 4.3 21.6 3.3 5.2 25.6 22.4 11.0 7.7 10.4 5.6 14.5 7.2 19.7 10.0 5.7 8.2 18.1 10.0 23.1 37.9 4.9 13.9 20.0 21.0 3.2 62.8 9.2 6.6 3.0 7.3 11.0 11.0 27.0 35.4 37.6 9.7 1.9 26.1 62.5 DUSP5 HVH3 ENSG00000138166 "Dual specificity phosphatase 5" Q16690 10 110497907-110511533 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "urinary bladder: 175.7" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 409.1;Langerhans cells: 298.4;Plasma cells: 412.2;Urothelial cells: 1063.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "non-classical monocyte: 10.3;plasmacytoid DC: 14.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTERT-HME1: 408.0;Karpas-707: 161.2;U-266/70: 227.8" "Region enhanced" "Detected in all" "cerebellum: 60.7" "Region enriched" "Detected in many" 5 "cerebellum: 45.4" NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 11: Squamous epithelial cells - Epithelial cell function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 22: Epithelial cell types - Mixed function" "unprognostic (1.25e-1)" "unprognostic (3.57e-1)" "unprognostic (5.19e-2)" "unprognostic (1.03e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" "unprognostic (6.35e-2)" "prognostic unfavorable (8.30e-6)" "unprognostic (1.70e-2)" "unprognostic (4.60e-2)" "unprognostic (2.91e-2)" "unprognostic (1.20e-2)" "unprognostic (4.20e-3)" "unprognostic (3.79e-1)" "unprognostic (3.78e-3)" "unprognostic (2.32e-1)" "unprognostic (9.09e-2)" 38.8 37.6 8.5 26.8 8.6 38.5 26.6 26.1 17.3 39.4 13.3 22.3 12.2 19.7 2.0 115.5 12.7 51.4 34.1 17.9 12.4 26.4 25.6 23.2 12.8 7.7 9.3 7.6 8.0 6.7 20.0 48.3 7.4 17.7 26.3 9.8 23.4 12.5 2.7 16.9 19.5 21.1 8.3 28.4 26.5 20.1 10.7 14.9 18.8 3.7 32.5 175.7 37.9 7.9 22.0 14.6 3.0 7.3 11.1 46.5 10.6 50.9 114.6 26.8 32.2 9.4 28.9 2.6 9.4 12.4 56.9 7.0 2.8 26.7 43.2 62.8 1.8 12.1 2.6 5.8 41.8 3.2 15.1 17.9 35.9 85.7 408.0 11.8 17.1 1.2 2.1 161.2 81.4 5.9 0.9 9.2 9.6 2.1 22.2 0.2 6.3 38.8 92.0 42.3 1.6 4.0 3.3 8.0 17.4 25.6 4.5 3.8 26.5 9.0 6.2 21.7 24.7 227.8 44.7 6.2 34.9 16.4 6.4 0.5 0.2 0.0 3.5 2.2 1.3 0.2 1.8 1.0 0.9 0.0 0.1 1.0 0.2 0.0 10.3 14.5 0.1 0.6 8.5 8.6 26.1 17.3 17.9 12.4 7.7 9.3 7.4 8.3 10.7 7.9 150.7 3.2 7.8 0.3 71.2 66.0 409.1 91.4 30.7 9.0 72.7 77.0 33.5 11.5 78.3 35.0 6.2 44.0 97.7 63.5 5.9 29.1 1.5 50.6 32.2 90.8 48.9 0.4 4.4 4.8 11.2 42.7 39.3 196.6 3.8 5.5 158.5 4.1 10.7 0.0 2.2 12.8 22.4 16.6 298.4 3.3 1.5 91.5 158.3 1.0 46.9 2.3 4.1 1.0 0.0 49.1 93.2 0.7 412.2 127.0 44.4 0.6 27.3 12.6 0.0 25.8 37.3 1.2 19.8 61.8 101.9 137.4 122.0 3.3 9.2 1063.2 DYNC2H1 "DHC1b, DHC2, DNCH2, DYH1B, hdhc11" ENSG00000187240 "Dynein cytoplasmic 2 heavy chain 1" Q8NCM8 11 103109410-103479863 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Developmental protein, Motor protein" "Ciliopathy, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 173.7;Cone photoreceptor cells: 112.6;Endometrial ciliated cells: 124.0;Excitatory neurons: 164.7;Inhibitory neurons: 101.8;Respiratory ciliated cells: 171.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "ASC TERT1: 21.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039015, HPA039016" Approved Approved Nucleoplasm,Mitochondria,Cytosol NA NA "Cluster 40: NK-cells - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 30: Epithelial cell lines - Translation" "Cluster 49: Ciliated cells - Cilium organization" Mitochondria "Nucleoplasm, Cytosol" "HPA039015: AB_2676309, HPA039016: AB_10673410" "unprognostic (3.11e-1)" "unprognostic (2.60e-1)" "unprognostic (1.28e-2)" "unprognostic (1.54e-1)" "unprognostic (7.11e-2)" "unprognostic (2.08e-1)" "unprognostic (4.14e-3)" "unprognostic (2.07e-2)" "unprognostic (2.05e-1)" "unprognostic (4.10e-2)" "unprognostic (2.87e-2)" "unprognostic (7.13e-2)" "prognostic favorable (8.49e-5)" "unprognostic (3.75e-3)" "unprognostic (1.62e-1)" "unprognostic (3.88e-2)" "unprognostic (4.11e-3)" 4.2 3.0 5.0 1.2 5.2 0.3 3.5 5.6 10.2 5.1 14.6 3.2 1.6 4.6 3.7 1.6 6.5 3.2 2.0 4.1 6.1 3.7 0.8 2.8 0.9 8.3 8.9 5.6 2.9 6.7 6.8 1.4 6.3 2.6 0.7 10.5 2.6 2.5 0.8 2.8 2.1 2.3 5.5 1.9 2.2 7.9 6.7 1.8 4.6 1.5 0.7 3.3 3.0 5.9 1.3 2.7 7.0 3.3 9.5 21.2 0.4 4.0 6.4 6.5 7.0 1.6 1.5 0.0 5.5 8.0 3.1 5.5 5.5 7.7 5.3 0.0 4.6 1.2 4.8 0.2 9.3 2.2 1.3 13.6 2.8 14.9 16.9 10.3 2.7 1.4 0.2 0.0 8.6 5.4 0.7 0.7 1.9 0.0 7.7 0.0 5.9 0.1 7.5 0.9 4.6 3.6 6.5 1.7 3.1 1.7 6.8 1.5 6.4 7.9 3.3 7.7 3.0 0.0 0.0 0.1 2.3 6.7 2.4 0.0 0.0 0.0 0.1 0.0 0.5 0.0 0.1 0.1 0.0 0.0 0.1 0.1 0.0 0.7 0.0 0.0 0.0 0.0 5.0 5.2 5.6 10.2 4.1 6.1 8.3 8.9 6.3 5.5 6.7 5.9 12.7 0.0 13.1 173.7 2.3 6.6 13.4 17.3 9.6 25.9 8.2 9.7 10.1 4.3 18.0 27.6 112.6 0.3 2.1 0.2 1.9 7.0 26.1 124.0 43.7 11.1 17.3 1.3 164.7 3.4 0.5 32.0 5.6 7.5 3.8 15.4 9.3 0.8 2.5 32.0 101.8 1.0 4.1 0.8 5.8 11.1 20.8 3.1 8.8 45.0 0.9 16.5 1.0 86.0 72.6 10.5 2.9 18.4 3.3 4.9 0.9 16.9 171.0 85.1 19.7 40.8 18.5 90.6 11.6 5.0 5.5 0.5 5.0 23.5 1.7 5.9 DZIP3 "hRUL138, PPP1R66" ENSG00000198919 "DAZ interacting zinc finger protein 3" Q86Y13 3 108589705-108694840 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "RNA-binding, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Cone photoreceptor cells: 327.4;Respiratory ciliated cells: 218.2;Spermatocytes: 351.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA035066, HPA049232" Approved Approved Vesicles No No "Cluster 15: NK-cells - Transcription" "Cluster 77: Retina - Visual perception" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 49: Ciliated cells - Cilium organization" Vesicles "HPA035066: AB_10601549, HPA049232: AB_2680684" "unprognostic (1.14e-1)" "unprognostic (1.90e-1)" "unprognostic (7.68e-2)" "unprognostic (3.12e-2)" "unprognostic (2.15e-1)" "unprognostic (2.37e-2)" "unprognostic (3.33e-1)" "unprognostic (5.16e-2)" "unprognostic (2.74e-1)" "unprognostic (3.76e-2)" "unprognostic (2.59e-3)" "unprognostic (5.38e-2)" "prognostic favorable (3.65e-4)" "unprognostic (6.06e-2)" "unprognostic (2.78e-2)" "unprognostic (5.51e-3)" "unprognostic (3.81e-2)" 5.2 9.7 15.6 4.9 19.4 4.0 5.3 11.8 18.6 5.3 22.6 5.1 3.0 7.9 10.1 3.9 18.7 5.9 11.7 18.8 18.5 10.9 4.3 6.5 10.2 13.3 14.9 10.5 5.3 7.8 24.5 4.9 12.4 9.7 4.7 29.8 3.6 7.0 12.4 3.7 3.9 5.2 10.4 8.3 6.6 34.6 15.5 8.5 12.8 16.2 8.0 5.2 3.4 15.0 9.8 8.2 24.8 14.7 10.7 10.8 8.6 6.1 12.2 10.1 13.9 12.1 6.8 18.0 12.8 6.6 20.9 3.5 13.7 5.3 21.0 6.6 6.1 8.1 3.4 8.5 6.3 3.3 4.5 11.8 2.8 9.4 11.4 10.2 6.4 10.9 8.0 8.7 19.6 8.6 8.2 3.5 15.5 5.0 6.2 10.4 20.5 1.8 8.4 4.7 17.0 16.2 9.8 1.0 11.1 21.6 15.1 2.8 7.6 9.0 13.7 1.8 5.3 9.6 6.0 34.7 6.8 2.7 11.3 6.5 0.5 1.2 4.1 0.8 5.0 6.3 4.2 5.1 0.5 4.6 3.6 4.8 0.1 10.6 1.5 1.5 6.0 1.5 15.6 19.4 11.8 18.6 18.8 18.5 13.3 14.9 12.4 10.4 15.5 15.0 7.3 12.8 12.8 86.8 14.8 7.5 8.6 16.3 9.1 67.8 9.6 8.3 45.0 4.3 26.6 33.1 327.4 21.9 17.1 4.1 13.7 12.9 28.4 106.1 16.0 8.7 52.8 11.1 145.2 9.0 8.8 18.2 9.2 9.2 8.8 30.9 7.5 4.4 9.4 77.4 103.4 6.9 34.6 5.7 7.5 59.9 17.4 5.7 7.2 37.5 10.5 32.9 11.3 79.4 80.6 8.9 4.6 17.7 9.0 6.9 4.5 20.6 218.2 33.7 19.7 16.6 17.7 351.3 112.5 4.4 7.4 14.8 29.4 35.4 7.4 5.6 ESPN DFNB36 ENSG00000187017 Espin B1AK53 1 6424776-6461367 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Hearing Actin-binding "Deafness, Disease variant, Non-syndromic deafness, Retinitis pigmentosa, Usher syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 129.1;retina: 117.8;testis: 145.3" "Cell type enhanced" "Detected in many" "Distal enterocytes: 175.5;Early spermatids: 137.5;Late spermatids: 461.6;Muller glia cells: 272.5;Paneth cells: 186.3;Proximal enterocytes: 512.1" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 13.4;thalamus: 6.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 48.9;Hep G2: 81.5;SK-BR-3: 160.1;T-47d: 53.6" "Low region specificity" "Detected in some" "Region enhanced" "Detected in some" "cerebellum: 2.6" "HPA028674, HPA060220" Enhanced Approved Vesicles NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 45: Intestine - Brush border" "Cluster 8: SK-BR-3 - Unknown function" "Cluster 45: Enterocytes - Digestion" Vesicles "HPA028674: AB_10601316, HPA060220: AB_2684224" "unprognostic (5.06e-2)" "unprognostic (1.18e-2)" "unprognostic (2.69e-1)" "unprognostic (1.28e-1)" "unprognostic (2.19e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (2.28e-1)" "unprognostic (1.16e-1)" "unprognostic (5.71e-2)" "unprognostic (7.48e-3)" "unprognostic (5.53e-2)" "unprognostic (6.26e-3)" "unprognostic (5.51e-2)" "unprognostic (1.16e-1)" "unprognostic (3.04e-2)" "unprognostic (1.17e-2)" 0.6 5.7 0.4 2.6 1.0 28.0 9.2 13.4 1.0 30.3 0.2 28.2 90.4 2.4 39.9 34.3 18.6 0.3 0.9 0.4 1.7 63.4 129.1 3.2 0.3 0.6 1.3 0.4 0.9 26.8 42.1 0.9 1.1 10.0 6.8 117.8 9.4 6.2 0.8 91.7 89.5 0.8 0.3 0.9 2.7 145.3 6.1 1.6 0.4 0.0 1.7 1.3 22.3 0.5 14.1 0.7 0.6 0.1 0.0 0.0 48.9 0.0 0.0 0.2 0.0 29.9 1.5 0.5 6.5 0.0 0.1 32.6 2.3 0.1 0.0 2.0 0.7 0.4 0.7 81.5 0.0 0.6 2.7 0.1 0.6 0.0 0.0 0.0 0.0 1.0 17.6 0.0 0.0 28.2 0.2 1.0 0.6 3.8 12.2 0.0 0.4 10.9 0.2 0.1 21.0 0.7 3.7 160.1 5.0 0.3 53.6 7.4 15.6 0.1 0.8 0.6 0.0 0.0 0.2 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.4 1.0 13.4 1.0 0.4 1.7 0.6 1.3 1.1 0.3 6.1 0.5 0.2 0.0 0.6 0.0 0.8 7.8 2.4 4.5 12.5 5.6 10.7 3.9 1.4 11.5 3.8 9.2 68.8 3.0 0.2 175.5 13.7 0.2 137.5 19.1 0.9 0.8 6.0 8.2 0.2 3.1 0.5 0.3 5.6 12.4 0.0 0.0 3.9 109.4 0.2 0.0 0.2 36.3 8.2 3.2 0.9 461.6 3.7 1.5 0.0 0.0 0.0 272.5 0.0 0.0 0.1 0.1 186.3 2.2 0.0 1.6 512.1 102.2 9.0 72.5 0.0 0.0 0.2 12.3 3.9 17.6 22.7 6.6 1.5 0.0 35.3 2.9 EXOSC8 "bA421P11.3, CIP3, EAP2, OIP2, p9, RRP43, Rrp43p" ENSG00000120699 "Exosome component 8" Q96B26 13 36998816-37009614 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "rRNA processing" RNA-binding "Disease variant, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Spermatocytes: 163.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034240, HPA039702, HPA043942, HPA075230" Uncertain Supported "Nucleoli fibrillar center,Mitotic chromosome,Vesicles" Yes NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 32: U-937 - Innate immune response" "Cluster 66: Spermatocytes - Spermatogenesis" "Nucleoli fibrillar center, Mitotic chromosome, Vesicles" "CAB034240: AB_2101977, HPA039702: AB_2676634, HPA043942: AB_2678742, HPA075230: " "unprognostic (8.67e-2)" "unprognostic (9.39e-2)" "unprognostic (5.77e-2)" "unprognostic (1.03e-1)" "unprognostic (2.58e-2)" "unprognostic (1.24e-2)" "unprognostic (1.02e-1)" "unprognostic (4.01e-2)" "unprognostic (3.24e-3)" "unprognostic (2.45e-2)" "unprognostic (2.35e-2)" "unprognostic (7.32e-3)" "prognostic unfavorable (8.39e-7)" "unprognostic (9.58e-3)" "unprognostic (7.42e-2)" "unprognostic (1.10e-1)" "unprognostic (4.51e-1)" 15.0 14.2 16.6 19.1 17.6 27.5 18.8 17.9 24.3 16.8 16.6 17.0 12.6 14.2 14.4 18.2 16.8 8.4 19.4 16.9 17.8 17.9 19.8 13.5 21.2 17.5 17.1 16.4 13.9 11.6 10.8 15.6 18.1 14.2 19.0 15.3 11.3 13.2 24.2 16.6 14.0 16.6 17.3 17.5 15.3 27.8 17.0 31.5 12.3 24.8 25.1 16.2 14.7 19.7 47.5 33.5 97.7 66.4 28.4 30.1 73.8 68.9 48.8 93.2 74.2 72.7 93.6 65.1 29.8 38.2 91.4 64.7 92.7 67.1 111.5 96.3 73.9 174.8 34.2 87.4 37.0 148.3 58.9 17.4 51.3 62.6 100.2 24.1 72.8 93.6 86.6 41.3 66.4 59.1 78.6 116.6 101.4 113.2 44.0 48.5 98.6 53.5 51.1 30.8 23.8 46.1 38.1 44.5 65.3 51.1 35.4 117.6 37.2 35.5 49.1 42.9 95.5 23.3 29.4 135.7 56.0 104.1 66.8 28.9 29.8 23.5 42.8 39.6 44.8 66.0 54.1 50.5 33.9 57.2 67.1 62.7 6.0 46.2 41.7 54.8 54.6 52.4 16.6 17.6 17.9 24.3 16.9 17.8 17.5 17.1 18.1 17.3 17.0 19.7 43.5 32.1 38.9 15.7 40.1 36.1 51.6 109.6 25.0 20.8 25.0 50.0 50.2 18.6 69.5 11.0 8.4 86.8 46.8 13.1 56.7 58.1 115.7 21.5 31.4 39.4 13.2 57.9 7.0 52.1 92.3 41.8 19.4 20.6 103.6 46.2 18.5 17.4 46.8 28.6 8.6 19.1 79.3 13.6 34.2 54.6 40.7 26.0 26.6 10.3 32.6 27.1 35.0 17.1 22.0 36.1 16.4 36.5 38.8 29.0 18.0 26.6 53.4 32.0 26.3 38.8 52.1 163.3 85.9 29.0 36.2 67.0 38.7 42.7 30.2 37.7 FAM187B "FLJ25660, TMEM162" ENSG00000177558 "Family with sequence similarity 187 member B" Q17R55 19 35224800-35228729 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 241 "testis: 68.7" "Cell type enriched" "Detected in some" 4 "Late spermatids: 2682.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA079535 Enhanced NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "HPA079535: " "unprognostic (3.34e-1)" "unprognostic (4.96e-1)" "unprognostic (2.40e-1)" "unprognostic (2.84e-1)" "unprognostic (2.72e-1)" "unprognostic (2.12e-1)" "unprognostic (1.25e-3)" "unprognostic (2.71e-1)" "unprognostic (2.49e-1)" "unprognostic (1.47e-1)" "unprognostic (1.76e-2)" 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 68.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 548.1 0.0 0.0 0.5 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 2682.3 7.5 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 FAM216A "C12orf24, HSU79274" ENSG00000204856 "Family with sequence similarity 216 member A" Q8WUB2 12 110468415-110490385 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 4 "brain: 15.5;testis: 59.4" "Cell type enhanced" "Detected in many" "Late spermatids: 54.7;Spermatocytes: 215.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038286 Enhanced Approved "Actin filaments" NA NA "Cluster 30: Non-specific - Translation" "Cluster 78: Testis - Spermatogenesis" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 66: Spermatocytes - Spermatogenesis" "Actin filaments" "HPA038286: AB_2675931" "unprognostic (7.91e-2)" "unprognostic (3.73e-2)" "unprognostic (1.56e-1)" "unprognostic (6.02e-3)" "unprognostic (3.04e-1)" "unprognostic (2.76e-1)" "prognostic unfavorable (4.49e-5)" "unprognostic (8.49e-2)" "unprognostic (1.31e-1)" "unprognostic (1.70e-1)" "unprognostic (2.04e-3)" "unprognostic (3.25e-2)" "prognostic unfavorable (4.18e-10)" "unprognostic (7.60e-2)" "unprognostic (4.35e-2)" "unprognostic (6.66e-2)" "unprognostic (1.05e-1)" 3.4 7.5 9.4 6.6 9.6 4.1 3.8 12.9 15.5 4.8 4.7 3.6 1.1 5.8 2.0 3.2 4.5 4.3 9.1 9.7 12.7 3.0 3.2 2.1 7.4 10.4 9.4 7.0 2.0 5.5 5.2 3.6 10.3 3.9 2.2 8.8 1.7 4.4 3.3 1.4 3.2 6.0 8.9 3.9 2.3 59.4 11.1 7.3 3.2 4.3 4.5 4.8 3.2 9.7 31.1 25.8 21.6 28.5 13.7 25.9 3.5 57.3 14.4 63.9 28.3 27.5 8.5 101.2 13.1 24.2 18.1 19.9 38.1 33.3 77.9 30.0 72.8 49.9 17.6 23.4 22.8 68.3 39.1 25.1 7.8 32.5 71.6 47.8 20.5 39.5 63.1 26.7 48.4 11.2 50.4 106.4 64.6 13.6 41.9 24.4 29.6 68.9 24.7 0.9 77.4 27.5 24.4 18.4 14.2 7.8 43.6 49.2 18.9 22.4 7.5 19.9 58.8 41.7 38.9 79.7 31.7 61.0 37.7 0.9 3.6 1.0 1.9 3.1 3.7 7.3 3.7 3.6 4.5 8.2 9.3 5.6 2.9 2.8 2.6 2.4 2.4 3.9 9.4 9.6 12.9 15.5 9.7 12.7 10.4 9.4 10.3 8.9 11.1 9.7 2.4 0.0 1.5 7.8 9.6 1.7 6.0 8.7 7.4 11.6 3.0 7.5 20.1 0.0 3.6 3.7 2.1 0.7 1.4 0.1 0.0 4.1 38.6 3.2 17.5 4.4 1.2 17.2 20.4 0.9 3.0 10.8 1.1 0.7 10.2 6.6 3.9 3.4 8.1 13.5 21.6 0.1 2.0 4.4 2.1 54.7 9.6 3.7 3.6 5.6 4.2 4.2 6.2 14.1 8.9 2.8 0.0 5.7 3.9 8.0 0.1 4.4 5.1 5.1 13.1 8.4 9.3 215.9 21.6 5.1 2.0 0.5 3.6 12.2 0.4 1.5 FBXL19 "CXXC11, DKFZp434K0410, Fbl19, JHDM1C" ENSG00000099364 "F-box and leucine rich repeat protein 19" Q6PCT2 16 30923055-30948783 "Predicted intracellular proteins" "Ubl conjugation pathway" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074250 Approved Nucleoplasm NA No "Cluster 15: NK-cells - Transcription" "Cluster 78: Testis - Spermatogenesis" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "HPA074250: " "unprognostic (1.37e-1)" "prognostic unfavorable (3.27e-4)" "unprognostic (1.03e-1)" "unprognostic (3.80e-2)" "unprognostic (1.40e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (3.54e-4)" "unprognostic (3.61e-2)" "unprognostic (2.52e-1)" "unprognostic (2.89e-1)" "unprognostic (1.48e-1)" "unprognostic (6.95e-3)" "unprognostic (1.37e-3)" "unprognostic (6.02e-2)" "unprognostic (1.60e-1)" "unprognostic (2.45e-2)" "unprognostic (2.38e-2)" 5.4 7.7 16.5 9.8 14.8 8.3 5.5 4.4 27.9 8.7 1.9 8.6 10.4 8.5 4.0 16.5 7.3 8.5 5.6 16.8 10.1 11.5 4.3 5.8 9.7 9.4 8.6 8.4 6.7 7.2 11.4 10.1 9.1 9.9 3.8 8.5 8.9 5.4 4.8 12.7 8.8 4.6 3.1 9.9 8.7 30.0 12.4 10.0 7.9 4.0 5.1 8.5 9.6 14.4 17.5 46.0 44.7 35.6 8.0 8.1 38.6 24.2 12.3 18.3 17.2 24.8 23.9 27.1 27.4 14.4 14.2 24.3 35.9 25.8 14.0 76.3 110.0 30.0 84.0 36.5 9.9 33.5 69.9 8.3 20.4 22.6 16.0 15.9 30.0 37.7 80.0 26.3 10.3 46.9 36.4 46.2 44.4 13.0 15.5 73.1 14.2 27.0 17.7 23.6 29.6 56.3 8.5 53.0 13.7 25.1 32.5 34.8 30.0 20.2 26.1 13.5 17.1 23.1 20.4 16.9 24.7 49.0 29.9 0.0 0.4 0.5 0.3 0.2 0.3 0.5 0.1 0.1 0.2 0.2 0.0 0.3 0.5 0.9 0.0 0.7 0.2 0.1 16.5 14.8 4.4 27.9 16.8 10.1 9.4 8.6 9.1 3.1 12.4 14.4 3.4 0.0 1.1 4.9 1.5 8.3 2.4 2.5 2.8 6.1 6.8 4.1 1.5 4.3 2.9 3.7 12.5 5.7 4.0 8.9 0.0 6.1 5.6 3.8 4.7 5.0 2.4 1.3 4.5 7.1 5.4 3.1 3.6 6.0 0.0 8.9 3.6 2.3 5.2 1.7 5.0 6.5 2.0 2.8 3.9 6.5 1.5 3.4 0.0 3.7 3.3 2.8 4.1 3.0 2.1 8.6 4.1 2.6 1.7 6.4 3.3 5.1 1.8 6.0 6.6 2.2 3.5 4.7 2.9 5.4 8.9 9.3 2.0 4.9 8.5 6.5 FOLR2 FRβ ENSG00000165457 "Folate receptor beta" P14207 11 72216601-72221950 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" Transport Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "placenta: 168.4" "Cell type enriched" "Detected in many" 4 "Hofbauer cells: 1114.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in many" "classical monocyte: 64.2;intermediate monocyte: 50.6" "Group enriched" "Detected in many" 4 "dendritic cells: 18.7;monocytes: 64.2" "Cell line enriched" "Detected in some" 5 "U-698: 18.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "Secreted to blood" NA NA 15000000 "Cluster 25: Monocytes - Inflammatory response" "Cluster 28: Placenta - Pregnancy" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 4: Macrophages - Innate immune response" "unprognostic (2.03e-1)" "unprognostic (6.58e-3)" "prognostic unfavorable (8.42e-4)" "unprognostic (1.47e-1)" "unprognostic (2.76e-1)" "unprognostic (2.83e-1)" "unprognostic (1.39e-1)" "unprognostic (3.36e-1)" "unprognostic (3.38e-1)" "unprognostic (2.51e-1)" "unprognostic (8.11e-2)" "unprognostic (1.16e-1)" "unprognostic (3.91e-3)" "unprognostic (6.16e-3)" "unprognostic (1.14e-1)" "prognostic favorable (8.41e-4)" "unprognostic (7.98e-3)" 119.1 55.0 10.7 28.2 11.0 10.8 31.7 8.2 18.6 27.9 13.8 36.0 19.5 13.5 12.4 31.6 16.8 80.1 38.6 10.9 9.5 10.8 44.8 39.7 78.5 9.3 10.7 16.0 7.1 7.9 6.1 168.4 11.4 6.1 46.7 0.2 12.8 16.7 5.9 9.8 29.6 46.3 9.3 27.7 21.0 13.0 16.2 28.7 9.1 26.3 29.0 81.3 6.3 16.1 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.7 0.2 0.2 0.4 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.2 0.0 0.2 0.0 18.6 0.5 0.8 0.0 0.0 64.2 0.0 0.3 50.6 0.0 9.5 0.0 0.0 18.7 4.0 0.0 0.0 1.1 1.8 13.7 0.2 0.0 20.4 10.7 11.0 8.2 18.6 10.9 9.5 9.3 10.7 11.4 9.3 16.2 16.1 3.4 0.0 0.6 0.0 8.0 7.9 0.1 0.0 1.2 0.0 0.1 1.1 2.2 1.5 0.0 0.0 0.0 7.6 0.6 0.0 0.0 0.0 0.9 0.3 0.1 2.3 0.0 0.0 0.0 0.0 6.0 2.4 0.0 0.5 2.5 0.0 2.2 1.7 1114.8 0.0 0.0 0.0 0.0 229.3 98.8 2.5 1.5 199.4 0.0 15.9 5.1 0.0 0.0 0.0 0.1 0.0 0.0 0.4 2.1 0.1 0.0 0.2 0.0 0.3 0.0 2.5 1.2 0.6 0.7 1.3 5.1 16.0 1.2 0.1 0.0 0.1 GATA5 "bB379O24.1, GATAS" ENSG00000130700 "GATA binding protein 5" Q9BWX5 20 62463497-62475995 "Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" "Activator, DNA-binding" "Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 11.2;testis: 11.5;urinary bladder: 15.4" "Cell type enhanced" "Detected in some" "Gastric mucus-secreting cells: 22.4;Hepatic stellate cells: 7.9;Intestinal goblet cells: 8.7;Proximal enterocytes: 38.8" "Cancer enhanced" "Detected in many" "stomach cancer: 5.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "EFO-21: 1.4;HEL: 2.9;K-562: 4.6;SiHa: 2.0;T-47d: 4.6" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA067583 Approved Nucleoplasm,Cytosol NA NA "Cluster 45: Intestine - Brush border" "Cluster 1: K-562 - Erythropoiesis" "Cluster 45: Enterocytes - Digestion" Nucleoplasm Cytosol "HPA067583: AB_2685867" "unprognostic (2.21e-1)" "unprognostic (2.28e-1)" "unprognostic (1.79e-1)" "unprognostic (2.10e-2)" "unprognostic (2.66e-1)" "unprognostic (2.39e-1)" "unprognostic (2.62e-1)" "unprognostic (8.34e-2)" "unprognostic (1.69e-2)" "unprognostic (5.70e-2)" "unprognostic (1.27e-2)" "unprognostic (7.96e-3)" "unprognostic (2.00e-2)" "unprognostic (1.04e-1)" "unprognostic (2.36e-2)" "unprognostic (5.39e-3)" 2.4 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.1 0.2 0.2 11.2 3.5 0.3 0.1 9.5 1.4 2.8 0.0 0.0 4.0 0.7 1.9 0.0 0.0 0.0 0.7 0.1 3.4 0.4 0.4 0.0 5.4 0.0 0.0 0.3 0.3 0.0 0.2 10.0 0.7 0.0 0.0 10.9 11.5 0.0 0.0 0.6 0.2 0.0 15.4 1.6 0.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 1.4 0.0 0.6 0.0 0.1 0.0 0.0 0.0 0.2 2.9 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 2.0 0.0 0.0 0.8 4.6 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.2 1.7 22.4 0.2 0.0 0.0 7.9 0.0 0.3 0.0 0.0 8.7 0.0 0.0 0.3 2.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 5.0 0.0 0.0 0.0 38.8 0.0 0.0 0.0 0.0 0.0 0.4 0.5 1.1 0.0 0.1 0.0 0.0 0.0 3.4 0.0 GJB1 "CMTX, CMTX1, CX32" ENSG00000169562 "Gap junction protein beta 1" P08034 X 71212811-71225516 "Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 100.9;liver: 335.7" "Cell type enhanced" "Detected in many" "Cholangiocytes: 114.4;Hepatocytes: 286.4;Proximal enterocytes: 118.8;Proximal tubular cells: 68.9;Undifferentiated cells: 66.1" "Cancer enhanced" "Detected in many" "liver cancer: 163.6" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "Hep G2: 143.2;SK-MEL-30: 155.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB012994 Uncertain NA NA "Cluster 15: Liver - Metabolism" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 2: Hepatocytes - Metabolism" "CAB012994: AB_2533228" "unprognostic (2.09e-2)" "unprognostic (1.39e-1)" "unprognostic (8.78e-2)" "unprognostic (2.71e-3)" "unprognostic (2.70e-1)" "unprognostic (4.11e-1)" "unprognostic (2.92e-1)" "unprognostic (3.68e-1)" "unprognostic (2.63e-2)" "unprognostic (2.22e-2)" "unprognostic (7.36e-3)" "unprognostic (1.80e-1)" "prognostic favorable (2.85e-6)" "unprognostic (1.03e-2)" "unprognostic (1.56e-1)" "unprognostic (7.79e-2)" "unprognostic (4.97e-2)" 0.1 0.0 27.1 3.7 63.2 0.0 6.4 76.5 37.6 8.8 12.7 33.9 44.0 1.7 22.5 0.3 27.4 41.5 0.0 27.3 40.9 42.9 335.7 2.4 0.0 90.6 64.4 0.1 83.0 0.0 0.1 0.0 76.0 11.6 23.8 0.0 37.7 7.5 0.0 0.9 34.4 1.8 50.0 0.1 16.4 10.2 56.9 0.0 0.1 0.1 0.0 0.4 0.1 100.9 0.1 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 25.5 0.2 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 143.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.3 0.0 5.1 0.2 0.0 0.2 0.0 0.0 155.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.0 1.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 27.1 63.2 76.5 37.6 27.3 40.9 90.6 64.4 76.0 50.0 56.9 100.9 0.0 0.0 4.8 0.3 0.8 0.6 0.7 0.5 0.0 0.0 7.7 2.4 0.1 114.4 2.7 9.2 0.0 0.0 0.1 50.2 9.8 34.1 0.3 8.2 3.4 0.6 9.6 8.0 0.2 58.9 0.0 0.1 15.8 29.0 4.5 0.0 3.3 286.4 0.0 0.0 0.2 29.4 2.0 4.8 0.4 0.4 0.3 0.8 23.2 0.0 0.6 0.0 0.0 1.0 51.3 32.3 53.4 0.4 0.0 2.6 118.8 68.9 0.1 0.0 0.0 0.0 0.4 0.5 0.0 0.0 0.1 0.0 1.0 0.0 66.1 2.8 GLT8D1 "AD-017, FLJ14611" ENSG00000016864 "Glycosyltransferase 8 domain containing 1" Q68CQ7 3 52694486-52706032 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Spermatocytes: 149.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA010588 Approved Approved Mitochondria NA NA "Cluster 26: Non-specific - Mitochondria" "Cluster 23: Testis - Cell cycle regulation" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "HPA010588: AB_1078098" "unprognostic (1.37e-1)" "unprognostic (2.96e-1)" "unprognostic (1.38e-2)" "prognostic favorable (2.76e-4)" "unprognostic (3.17e-2)" "unprognostic (1.55e-1)" "unprognostic (2.03e-1)" "unprognostic (1.82e-3)" "unprognostic (7.12e-2)" "unprognostic (9.81e-2)" "unprognostic (1.23e-1)" "unprognostic (1.07e-1)" "unprognostic (5.82e-3)" "unprognostic (2.42e-3)" "unprognostic (3.97e-1)" "unprognostic (3.34e-2)" "unprognostic (6.21e-2)" 33.1 39.8 25.4 22.5 26.6 9.3 35.6 25.2 29.3 47.5 35.6 27.7 25.9 35.0 41.3 18.3 54.4 29.8 32.6 26.2 26.7 40.4 69.5 29.6 25.3 24.0 26.9 53.8 35.7 46.0 64.8 48.2 25.5 30.5 32.3 32.2 29.9 32.7 20.8 22.6 23.4 32.2 25.9 24.6 28.9 64.5 26.4 29.2 64.0 24.6 26.8 31.6 28.6 28.6 28.7 33.2 65.7 52.0 142.6 179.8 36.8 70.3 107.8 60.6 69.1 15.5 52.6 24.0 19.7 122.7 73.3 31.9 42.1 72.0 79.5 43.5 30.6 22.8 61.4 71.7 68.3 34.0 68.5 104.1 62.9 52.1 66.8 139.8 91.3 40.6 29.4 53.6 80.6 29.2 23.4 51.8 33.8 49.8 61.5 17.4 37.3 81.9 71.3 30.8 26.9 46.5 58.6 27.9 48.9 61.2 47.7 44.2 67.1 43.7 33.9 63.9 39.6 60.2 73.7 26.4 76.0 53.2 56.2 38.4 13.0 21.8 19.1 8.5 18.3 14.1 22.2 20.0 11.8 9.8 22.3 15.6 6.9 30.3 9.3 23.1 16.8 10.9 25.4 26.6 25.2 29.3 26.2 26.7 24.0 26.9 25.5 25.9 26.4 28.6 25.8 0.0 9.6 16.0 16.0 12.1 16.1 40.3 13.6 41.5 18.1 19.7 15.3 17.2 23.8 18.4 12.5 58.4 26.5 9.4 23.5 34.4 71.4 38.5 38.4 22.7 18.6 8.6 17.9 27.1 63.5 59.2 14.8 15.2 5.7 35.6 34.2 38.2 26.9 21.9 16.8 21.1 30.5 13.6 12.0 23.0 53.7 12.3 24.9 8.4 26.5 37.0 34.0 15.6 14.6 23.3 16.9 48.5 39.1 14.7 22.8 21.5 44.4 21.3 26.3 31.6 25.2 149.5 50.0 10.3 8.0 26.1 21.4 74.2 17.3 10.0 GNG7 FLJ00058 ENSG00000176533 "G protein subunit gamma 7" O60262 19 2511219-2702694 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 14 "brain: 360.9" "Cell type enhanced" "Detected in many" "B-cells: 145.4;Distal tubular cells: 123.3;Horizontal cells: 169.9;Oligodendrocyte precursor cells: 102.5;Oligodendrocytes: 206.1;Plasma cells: 169.7" "Cancer enhanced" "Detected in all" "glioma: 21.9;melanoma: 20.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "memory B-cell: 57.2;naive B-cell: 50.1;plasmacytoid DC: 48.0" "Group enriched" "Detected in many" 4 "B-cells: 57.2;dendritic cells: 48.0" "Cell line enhanced" "Detected in many" "Daudi: 22.3;REH: 66.5;SK-MEL-30: 31.2;U-266/70: 61.0;U-266/84: 30.0" "Region enriched" "Detected in all" 6 "basal ganglia: 1277.2" HPA057790 Supported Supported NA NA 72000 "Cluster 43: B-cells - Humoral immune response" "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 57: B-cells - Immune response" "HPA057790: AB_2683527" "unprognostic (3.97e-3)" "unprognostic (1.16e-4)" "unprognostic (4.92e-2)" "unprognostic (2.72e-1)" "unprognostic (2.79e-1)" "unprognostic (8.42e-4)" "prognostic favorable (3.05e-4)" "prognostic favorable (1.35e-5)" "unprognostic (1.27e-2)" "unprognostic (4.95e-2)" "prognostic favorable (3.71e-4)" "unprognostic (1.27e-1)" "prognostic favorable (0.00e+0)" "unprognostic (6.96e-2)" "unprognostic (1.46e-1)" "unprognostic (6.36e-2)" "unprognostic (4.96e-2)" 3.5 5.7 70.8 5.3 360.9 6.6 4.4 83.9 127.9 5.5 14.0 6.7 5.2 7.2 5.1 12.0 8.2 3.5 26.4 70.1 66.0 10.5 4.2 4.0 9.9 97.2 87.9 12.2 8.0 6.2 17.4 1.4 76.8 9.5 3.1 15.1 26.0 5.7 3.4 2.6 14.2 3.5 76.0 19.4 6.8 8.9 154.1 2.7 5.8 8.1 9.4 7.9 3.3 81.4 0.2 0.0 3.2 7.1 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.0 0.7 22.3 1.0 0.3 0.3 0.2 3.5 0.0 0.1 0.0 3.1 0.6 0.1 2.7 1.6 0.0 12.9 0.4 0.5 0.0 0.2 0.2 0.0 2.7 0.3 14.2 0.0 2.2 0.6 1.4 2.6 0.4 1.4 66.5 0.0 6.2 0.3 0.0 0.1 9.2 0.1 0.1 31.2 2.1 0.4 5.6 0.1 0.1 3.0 0.2 0.2 61.0 30.0 4.7 0.2 7.0 16.5 3.5 1.5 8.0 0.4 0.5 1.1 57.2 0.5 0.4 6.0 50.1 1.2 0.7 11.8 0.2 0.1 48.0 0.0 3.0 70.8 360.9 83.9 127.9 70.1 66.0 97.2 87.9 76.8 76.0 154.1 81.4 14.5 6.4 4.2 40.8 145.4 2.5 13.0 0.3 5.2 10.5 22.9 30.1 55.1 15.7 3.3 9.2 8.4 0.6 56.1 0.9 123.3 17.0 5.4 2.1 2.3 11.7 6.1 8.6 26.5 4.8 1.1 6.6 5.6 3.5 12.7 8.6 19.2 11.4 63.2 169.9 38.8 2.0 0.0 8.5 15.0 11.4 2.5 12.3 51.6 45.9 11.2 84.7 3.1 102.5 206.1 2.7 1.8 2.6 169.7 7.5 0.7 22.6 2.9 11.1 6.6 7.1 5.4 2.7 2.6 1.5 2.0 3.4 6.9 2.1 2.2 7.2 GPI "AMF, NLK" ENSG00000105220 "Glucose-6-phosphate isomerase" P06744 19 34359480-34402413 "Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Gluconeogenesis, Glycolysis" "Cytokine, Growth factor, Isomerase" "Cancer-related genes, Disease variant, Hereditary hemolytic anemia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Early spermatids: 331.0;Late spermatids: 1127.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018655, HPA024305, CAB040563, HPA052171" Enhanced Supported "Nucleoplasm,Plasma membrane,Cytosol" "Secreted to blood" No No 86000000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 8: Non-specific - Mitochondria" "Cluster 25: RPMI-8226 - Immune response" "Cluster 34: Spermatids - Unknown function" "Plasma membrane, Cytosol" Nucleoplasm "CAB018655: AB_2112653, CAB040563: , HPA024305: AB_1849922, HPA052171: AB_2681748" "unprognostic (1.03e-1)" "unprognostic (8.39e-3)" "unprognostic (2.39e-2)" "unprognostic (1.38e-2)" "unprognostic (4.52e-2)" "unprognostic (6.45e-3)" "unprognostic (1.95e-2)" "unprognostic (8.52e-3)" "unprognostic (3.18e-1)" "unprognostic (1.45e-1)" "unprognostic (4.93e-2)" "unprognostic (2.75e-1)" "unprognostic (3.24e-3)" "unprognostic (2.62e-2)" "unprognostic (2.43e-1)" "unprognostic (2.60e-3)" "unprognostic (2.88e-2)" 196.9 283.2 83.4 74.5 101.9 222.8 129.0 67.7 130.5 95.0 84.8 162.9 113.7 92.4 27.2 197.8 88.8 87.1 407.2 108.5 73.6 196.8 222.6 91.2 66.4 73.5 58.5 97.0 84.2 166.3 147.2 47.5 69.3 94.4 84.3 156.1 105.1 61.0 416.6 120.1 126.5 78.4 34.0 102.2 122.5 95.9 83.2 50.1 100.8 374.6 76.0 147.9 121.5 95.8 572.9 596.1 58.7 433.3 167.5 121.9 134.1 183.4 132.4 206.3 253.7 314.9 169.6 303.5 311.4 177.9 149.1 343.7 337.7 437.0 259.4 461.0 105.1 382.1 252.3 310.8 108.4 517.6 259.3 173.7 136.6 289.0 132.7 273.3 209.3 230.5 210.3 261.8 140.2 319.2 245.5 133.5 158.0 421.3 174.6 242.7 149.1 649.4 254.1 275.4 304.9 185.8 331.9 634.3 131.7 100.5 144.4 161.7 171.9 80.8 185.5 256.7 312.8 535.5 383.7 318.4 287.4 372.3 170.6 188.8 93.2 331.3 80.4 141.2 99.1 59.9 73.7 93.1 101.0 50.5 61.8 72.8 7.4 58.0 180.3 31.6 83.4 123.4 83.4 101.9 67.7 130.5 108.5 73.6 73.5 58.5 69.3 34.0 83.2 95.8 34.2 28.9 40.0 98.9 43.8 25.9 30.1 104.5 42.7 98.8 34.1 27.2 232.5 42.9 51.4 57.0 75.0 44.5 41.6 76.7 115.4 101.7 331.0 35.9 41.2 38.0 63.7 46.7 121.8 66.9 69.2 47.1 109.1 58.0 23.4 36.1 42.8 89.5 89.6 237.2 127.2 75.8 50.8 52.9 40.5 1127.2 37.0 58.1 35.6 17.8 44.4 32.6 23.7 43.7 87.7 77.6 39.4 30.5 77.1 31.5 111.8 103.0 33.1 68.3 19.7 44.3 65.0 7.8 22.3 139.1 32.8 39.3 64.3 74.8 126.9 37.2 GTPBP8 HSPC135 ENSG00000163607 "GTP binding protein 8 (putative)" Q8N3Z3 3 112990984-113015060 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Early spermatids: 79.8;Spermatocytes: 79.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034831, HPA058631" Approved Enhanced Mitochondria No No "Cluster 44: Non-specific - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 36: HEL - Hemostasis" "Cluster 66: Spermatocytes - Spermatogenesis" Mitochondria "HPA034831: AB_10671506, HPA058631: AB_2683783" "unprognostic (1.98e-1)" "unprognostic (1.02e-2)" "unprognostic (4.36e-2)" "unprognostic (1.99e-3)" "unprognostic (4.39e-2)" "unprognostic (2.00e-2)" "unprognostic (7.18e-3)" "unprognostic (1.80e-2)" "unprognostic (1.06e-2)" "unprognostic (2.08e-1)" "unprognostic (1.35e-2)" "unprognostic (1.21e-2)" "prognostic favorable (3.07e-5)" "unprognostic (7.10e-2)" "unprognostic (7.21e-2)" "unprognostic (4.57e-1)" "unprognostic (2.69e-1)" 5.3 5.7 3.6 6.1 4.3 8.4 5.6 4.6 4.9 4.6 4.6 6.0 6.6 5.6 3.7 7.4 4.4 5.2 11.9 3.9 3.9 7.3 5.9 4.3 11.2 4.3 3.8 6.7 6.8 8.9 4.5 6.1 4.2 5.7 7.1 4.2 6.5 3.7 20.0 4.8 6.0 5.5 4.4 4.9 7.5 14.4 3.9 9.7 10.1 18.3 8.1 5.9 4.7 6.4 25.5 10.8 15.7 16.5 9.2 15.6 11.5 17.9 14.7 17.0 20.5 18.6 10.4 16.8 9.7 10.0 14.2 17.1 21.0 17.1 23.5 7.0 13.4 46.5 11.4 11.6 8.4 28.9 10.5 11.9 11.9 9.6 7.0 19.2 16.1 19.9 16.4 19.5 18.0 8.8 18.5 14.4 32.8 13.2 20.8 16.1 14.7 10.4 14.4 16.3 17.5 18.2 14.2 11.3 25.7 13.7 12.3 19.6 9.8 12.7 19.4 4.5 16.0 13.1 17.4 24.0 12.7 23.6 14.0 7.9 4.3 2.9 6.4 3.0 5.7 4.2 7.8 6.3 8.1 3.6 9.9 6.5 0.7 8.7 2.7 3.7 5.4 4.5 3.6 4.3 4.6 4.9 3.9 3.9 4.3 3.8 4.2 4.4 3.9 6.4 13.1 16.0 15.4 2.9 16.9 13.5 15.9 28.8 8.0 11.5 12.9 12.4 25.8 10.0 19.5 5.5 6.2 28.3 27.1 10.4 23.5 16.3 79.8 17.7 12.9 11.6 10.2 22.7 5.5 18.3 25.1 13.3 12.8 18.3 19.7 20.0 17.9 7.7 22.7 10.1 6.3 10.3 28.5 16.7 14.8 35.5 11.8 13.6 10.6 4.7 18.3 10.4 13.4 7.1 6.9 16.5 12.2 5.7 17.1 12.8 17.7 29.6 16.0 14.0 0.0 17.4 15.8 79.7 28.1 16.1 12.1 15.2 22.5 34.9 12.0 18.9 HMGA1 HMGIY ENSG00000137309 "High mobility group AT-hook 1" P17096 6 34236873-34246231 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "esophagus: 275.1" "Cell type enhanced" "Detected in many" "Basal prostatic cells: 947.5;Cytotrophoblasts: 894.3;Pancreatic endocrine cells: 1838.5;Prostatic glandular cells: 1483.3;Syncytiotrophoblasts: 822.8;Urothelial cells: 1681.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB032200, HPA065612, HPA068442" Enhanced Supported Nucleoplasm,Nucleoli NA NA 72000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 17: WM-115 - Nervous system development" "Cluster 16: Pancreatic endocrine cells - Mixed function" Nucleoplasm Nucleoli "CAB032200: AB_2117771, HPA065612: , HPA068442: " "unprognostic (1.81e-1)" "unprognostic (1.25e-1)" "unprognostic (1.08e-1)" "prognostic unfavorable (7.13e-4)" "unprognostic (1.57e-1)" "unprognostic (1.20e-3)" "prognostic unfavorable (1.29e-6)" "prognostic unfavorable (3.36e-4)" "unprognostic (8.54e-2)" "unprognostic (1.84e-2)" "prognostic unfavorable (8.71e-4)" "unprognostic (1.55e-1)" "unprognostic (8.22e-2)" "unprognostic (4.52e-3)" "unprognostic (1.19e-1)" "unprognostic (4.37e-1)" "unprognostic (2.65e-2)" 28.1 9.0 22.1 79.6 20.9 184.0 27.4 17.8 27.3 93.3 2.6 59.9 118.7 22.8 16.7 275.1 41.0 39.2 35.8 24.1 23.3 89.2 20.0 46.5 139.3 24.3 19.1 4.7 31.9 15.0 15.4 82.4 21.1 27.7 57.2 32.2 69.7 12.6 119.7 141.6 103.6 9.7 15.4 68.7 73.3 80.1 22.9 156.0 31.5 35.1 154.7 100.1 109.6 25.2 1418.7 547.0 274.2 192.9 124.8 916.6 1193.8 556.0 628.8 421.5 233.4 361.3 960.0 658.9 273.1 229.1 264.0 294.7 326.2 991.8 332.3 146.0 228.2 202.6 177.1 488.2 263.7 732.1 227.3 396.1 109.4 765.1 395.8 1083.8 1290.0 369.3 832.0 32.9 596.0 143.0 650.0 898.8 1340.9 697.5 950.3 947.6 6.2 728.0 286.6 128.4 477.0 202.5 59.3 278.3 533.3 430.2 112.2 775.8 1132.1 218.5 691.2 321.3 528.0 260.5 444.5 867.4 461.2 301.7 1115.0 18.7 26.6 35.5 24.4 26.8 32.2 63.5 45.0 39.0 79.6 39.5 52.0 42.9 6.7 20.1 26.5 86.6 55.8 30.7 22.1 20.9 17.8 27.3 24.1 23.3 24.3 19.1 21.1 15.4 22.9 25.2 11.0 28.9 21.7 2.3 117.8 432.3 947.5 181.3 109.8 29.0 88.8 47.4 30.8 28.6 106.1 40.5 4.2 894.3 70.3 173.5 46.9 755.3 7.2 50.5 14.6 113.9 117.0 268.3 5.4 277.5 799.8 72.0 79.5 115.3 66.7 8.3 18.2 12.3 377.2 11.8 5.7 226.4 97.6 74.0 149.9 24.5 5.6 94.3 90.7 1.0 74.3 44.1 33.0 4.5 2.7 1838.5 249.1 2.6 198.2 1483.3 174.5 15.8 21.7 41.9 0.0 18.6 77.7 40.2 417.6 224.7 361.4 822.8 66.6 0.9 364.3 1681.0 IFT74 "CCDC2, CMG-1, CMG1, FLJ22621" ENSG00000096872 "Intraflagellar transport 74" Q96LB3 9 26947039-27066134 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Bardet-Biedl syndrome, Ciliopathy, Obesity" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Endometrial ciliated cells: 93.2;Respiratory ciliated cells: 97.4;Spermatocytes: 208.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA020247, HPA026684" Approved NA NA "Cluster 15: NK-cells - Transcription" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 30: Epithelial cell lines - Translation" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA020247: AB_1846140, HPA026684: AB_1846141" "unprognostic (3.84e-2)" "unprognostic (1.76e-1)" "unprognostic (1.33e-2)" "unprognostic (1.33e-2)" "unprognostic (2.11e-1)" "unprognostic (1.70e-1)" "unprognostic (1.54e-2)" "unprognostic (1.84e-2)" "unprognostic (1.24e-2)" "unprognostic (1.23e-3)" "unprognostic (1.02e-1)" "unprognostic (1.41e-1)" "unprognostic (1.09e-1)" "unprognostic (2.65e-1)" "unprognostic (3.62e-2)" "unprognostic (2.93e-1)" "unprognostic (2.43e-1)" 7.4 12.8 5.0 6.4 4.9 6.7 14.9 5.8 5.7 13.4 14.8 9.1 4.5 12.4 22.4 8.3 21.8 6.6 8.3 4.8 5.5 13.0 11.8 7.8 6.1 6.3 5.8 12.5 8.3 16.6 12.5 9.7 5.6 11.7 8.9 14.6 7.6 13.3 9.1 7.1 5.9 10.4 5.0 8.1 6.7 49.0 6.1 10.0 20.3 8.9 7.5 8.3 7.7 5.5 15.3 26.2 24.3 18.8 17.5 29.4 6.1 16.8 26.8 20.7 17.8 2.9 10.3 6.7 13.9 17.9 21.8 12.8 18.6 23.6 22.8 17.3 8.6 17.0 10.5 12.0 27.8 10.6 16.3 22.9 32.9 24.8 42.6 25.6 13.4 1.4 12.0 22.8 31.4 6.3 12.4 25.9 15.4 11.7 10.7 7.5 9.8 17.0 31.1 9.3 21.0 21.2 11.0 15.2 9.1 14.8 23.2 14.6 9.1 0.0 20.0 5.1 15.6 7.5 24.5 5.4 9.8 12.6 9.5 2.3 6.2 2.0 5.8 7.3 4.7 12.4 6.1 5.8 9.2 12.6 10.3 7.7 0.4 12.1 7.0 7.8 6.1 3.9 5.0 4.9 5.8 5.7 4.8 5.5 6.3 5.8 5.6 5.0 6.1 5.5 10.1 32.1 27.4 27.4 8.2 7.8 15.8 24.4 10.2 23.9 12.1 16.0 29.1 7.2 28.4 16.5 22.9 23.1 3.4 17.2 21.5 26.5 84.5 93.2 27.6 12.1 13.2 10.7 15.5 22.7 10.6 14.8 7.1 23.1 16.5 19.2 8.9 8.6 15.8 28.6 17.8 13.5 8.2 49.6 4.5 36.1 20.2 9.3 5.4 19.7 8.3 25.2 1.0 23.1 24.2 11.7 10.5 18.0 7.7 6.0 10.2 33.1 97.4 43.5 19.7 18.1 25.4 208.2 29.9 9.7 8.4 10.9 8.3 35.9 17.2 7.3 IQCF2 ENSG00000184345 "IQ motif containing F2" Q8IXL9 3 51861615-51863424 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 89 "testis: 14.0" "Group enriched" "Detected in some" 187 "Early spermatids: 1040.3;Late spermatids: 2718.3" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1040.3 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2718.3 7.2 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 IQCK "FLJ36575, MGC35048" ENSG00000174628 "IQ motif containing K" Q8N0W5 16 19716456-19858467 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 128.3;Cone photoreceptor cells: 114.7;Respiratory ciliated cells: 98.7;Rod photoreceptor cells: 107.4;Spermatocytes: 101.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026792, HPA048786" Approved Approved "Nuclear speckles,Cytosol" NA NA "Cluster 35: T-regs - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 9: Photoreceptor cells - Phototransduction" "Nuclear speckles" Cytosol "HPA026792: AB_1853889, HPA048786: AB_2680520" "unprognostic (4.21e-2)" "unprognostic (3.19e-1)" "unprognostic (6.29e-3)" "unprognostic (2.04e-2)" "unprognostic (3.70e-1)" "unprognostic (4.07e-2)" "unprognostic (1.69e-1)" "unprognostic (8.51e-2)" "unprognostic (1.58e-1)" "unprognostic (9.68e-3)" "unprognostic (1.17e-1)" "unprognostic (5.13e-2)" "unprognostic (4.17e-3)" "unprognostic (2.42e-1)" "unprognostic (8.98e-2)" "unprognostic (6.51e-2)" "unprognostic (1.68e-1)" 3.8 2.7 5.3 1.3 5.7 0.5 5.9 5.2 6.8 7.5 8.7 2.6 3.8 4.6 15.4 1.6 20.2 5.7 3.5 5.1 8.7 8.7 2.1 4.0 1.5 6.2 7.2 6.5 3.6 19.4 6.3 3.2 5.7 3.4 2.9 11.0 6.4 7.6 3.0 2.1 1.6 3.8 6.8 1.8 3.9 18.2 5.6 1.6 16.8 2.9 1.1 4.1 2.0 8.0 2.6 6.8 8.7 5.7 2.6 8.1 0.5 0.0 4.4 4.0 3.1 0.4 4.8 0.3 4.7 2.4 2.5 3.0 1.9 3.3 2.8 1.1 1.8 0.1 1.9 3.4 8.2 1.6 0.0 4.7 2.7 5.4 1.2 4.5 4.4 4.2 2.8 0.8 2.5 8.5 1.6 0.9 2.6 2.8 6.4 5.3 0.8 0.4 10.0 1.8 8.1 3.4 3.9 1.2 5.3 1.6 3.6 0.9 3.1 1.1 0.9 4.6 0.9 0.1 0.6 0.0 5.4 0.2 1.9 0.0 0.3 0.0 0.5 1.3 0.9 0.5 0.5 0.8 0.1 0.2 1.0 0.5 0.0 0.0 1.3 0.3 0.5 0.3 5.3 5.7 5.2 6.8 5.1 8.7 6.2 7.2 5.7 6.8 5.6 8.0 42.4 16.0 5.1 128.3 1.7 6.1 9.7 16.4 9.6 54.1 18.3 16.5 0.7 24.3 17.8 46.0 114.7 4.9 1.3 8.6 46.9 47.2 57.2 76.9 19.0 22.1 5.4 0.8 31.9 29.6 2.8 11.8 12.8 14.9 0.0 6.2 11.7 2.1 6.0 3.3 45.9 4.3 32.6 2.4 3.9 34.8 18.0 3.7 17.8 15.0 1.5 26.3 0.0 37.2 53.4 29.8 2.2 18.0 2.3 7.3 2.0 32.5 98.7 107.4 6.6 7.5 15.6 101.7 35.8 3.9 5.1 4.1 3.0 18.1 6.7 5.1 ISYNA1 "Ino1, INOS, IPS" ENSG00000105655 "Inositol-3-phosphate synthase 1" Q9NPH2 19 18434388-18438167 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Inositol biosynthesis, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism" Isomerase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "choroid plexus: 223.6;testis: 223.8" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 1141.3;Sertoli cells: 315.5;Syncytiotrophoblasts: 1034.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 4.5;NK-cells: 14.4;T-cells: 8.9" "Cell line enriched" "Detected in many" 4 "BEWO: 492.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA007931, HPA008232, CAB020720" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 48: NK-cells - Unknown function" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 47: Cytotrophoblasts - Unknown function" Nucleoplasm Cytosol "CAB020720: , HPA007931: AB_2667940, HPA008232: AB_2668018" "unprognostic (1.87e-2)" "unprognostic (1.86e-1)" "unprognostic (2.98e-2)" "unprognostic (3.16e-2)" "unprognostic (3.88e-1)" "unprognostic (1.81e-2)" "unprognostic (2.49e-1)" "unprognostic (3.12e-1)" "unprognostic (1.74e-1)" "unprognostic (2.28e-2)" "unprognostic (2.73e-2)" "unprognostic (5.08e-2)" "prognostic unfavorable (9.23e-4)" "unprognostic (2.23e-2)" "unprognostic (9.26e-2)" "unprognostic (1.19e-2)" "unprognostic (1.50e-1)" 36.0 32.6 15.2 2.8 13.8 5.8 30.5 12.5 19.5 47.3 223.6 14.2 3.6 44.2 4.4 15.2 78.9 3.7 36.1 19.4 24.5 114.4 13.1 22.2 4.4 16.8 18.8 96.0 40.1 12.8 50.7 46.3 14.2 41.4 0.7 0.9 17.7 26.7 13.2 16.2 16.1 2.8 12.7 35.1 11.3 223.8 25.4 3.0 23.7 3.1 1.8 23.5 31.9 11.3 13.9 42.4 98.6 31.0 0.8 0.2 492.7 6.6 1.0 0.6 0.3 24.5 26.1 0.2 33.5 3.2 0.2 36.6 3.0 0.1 0.0 39.8 116.4 52.0 3.1 80.3 10.2 0.6 1.1 9.4 0.4 2.8 0.4 0.4 6.3 1.1 106.0 2.1 0.0 84.1 4.0 3.4 51.7 14.2 33.7 71.2 0.2 24.6 9.5 0.3 30.4 74.3 1.7 9.9 53.1 20.2 68.2 7.1 18.7 0.5 1.1 0.7 1.6 13.9 7.3 3.2 3.0 1.9 17.7 1.0 0.1 0.0 8.1 0.2 6.2 4.5 8.1 6.9 0.8 2.4 6.2 8.9 0.8 14.4 0.1 2.2 6.2 5.0 15.2 13.8 12.5 19.5 19.4 24.5 16.8 18.8 14.2 12.7 25.4 11.3 38.8 3.2 1.1 2.6 9.0 12.0 82.1 74.9 72.8 0.8 26.1 47.0 4.7 20.0 24.0 47.8 2.1 1141.3 8.4 4.1 52.8 39.4 101.3 33.4 10.9 30.5 64.8 21.5 1.0 8.2 114.0 30.2 7.1 14.8 14.0 36.9 25.7 1.1 84.9 0.0 4.3 4.0 28.5 9.0 7.8 230.1 37.3 4.1 23.2 11.2 5.4 8.6 13.4 0.0 0.3 3.4 1.8 50.4 1.8 21.6 0.7 6.1 23.6 0.7 315.5 5.6 163.6 53.7 21.0 10.6 5.7 1034.6 14.9 14.5 6.2 36.8 KCNG1 "K13, KCNG, kH2, Kv6.1" ENSG00000026559 "Potassium voltage-gated channel modifier subfamily G member 1" Q9UIX4 20 51003656-51023107 "Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 46.8;endometrium 1: 87.4" "Cell type enhanced" "Detected in many" "Cytotrophoblasts: 53.7;Granulosa cells: 34.0;Syncytiotrophoblasts: 97.0" "Cancer enhanced" "Detected in many" "urothelial cancer: 8.9" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 20 "naive B-cell: 7.1" "Lineage enriched" "Detected in single" 71 "B-cells: 7.1" "Cell line enhanced" "Detected in many" "hTCEpi: 53.5;U-138 MG: 40.4;WM-115: 34.6" "Group enriched" "Detected in many" 5 "amygdala: 20.6;basal ganglia: 19.1;cerebral cortex: 14.9;hippocampal formation: 18.1;white matter: 9.1" "Group enriched" "Detected in all" 5 "amygdala: 12.6;basal ganglia: 11.1;cerebral cortex: 22.4;hippocampal formation: 16.8" "HPA039530, HPA040024" Approved Approved Vesicles NA NA "Cluster 21: B-cells - Adaptive immune response" "Cluster 57: Non-specific - Angiogenesis" "Cluster 30: Epithelial cell lines - Translation" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" Vesicles "HPA039530: AB_10795144, HPA040024: AB_10796338" "unprognostic (1.19e-1)" "unprognostic (4.47e-2)" "unprognostic (8.70e-2)" "unprognostic (3.49e-2)" "unprognostic (4.07e-2)" "unprognostic (5.05e-4)" "unprognostic (2.53e-2)" "unprognostic (3.89e-3)" "unprognostic (3.64e-2)" "unprognostic (3.43e-2)" "unprognostic (8.74e-2)" "unprognostic (8.89e-2)" "unprognostic (1.83e-9)" "unprognostic (1.52e-1)" "unprognostic (7.42e-2)" "unprognostic (1.60e-1)" "unprognostic (1.02e-2)" 0.4 3.0 17.3 2.2 26.7 0.0 0.4 0.0 21.7 17.9 0.1 5.0 0.2 87.4 0.8 6.7 19.2 0.9 1.3 14.9 0.6 0.5 0.2 0.3 2.2 28.9 46.8 0.7 2.7 4.1 0.8 7.1 3.2 5.6 0.8 0.1 2.2 12.8 0.0 0.5 5.3 4.1 1.0 2.7 0.7 9.5 1.2 0.2 0.2 0.0 0.9 3.4 6.2 1.1 0.9 3.6 2.7 13.3 1.5 3.4 0.2 11.6 0.1 6.7 5.3 0.2 0.2 0.0 7.1 3.5 18.8 3.4 1.7 3.5 6.9 0.4 4.7 0.0 13.6 0.0 23.2 0.0 0.4 6.8 53.5 25.7 26.1 1.3 1.8 0.1 0.2 0.0 0.6 13.4 0.0 0.4 13.7 0.0 25.0 0.0 0.0 0.0 0.0 4.1 3.9 15.0 25.5 29.3 19.9 4.3 2.1 1.9 0.7 40.4 23.9 0.3 3.4 0.1 0.0 0.0 11.8 1.0 34.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 17.3 26.7 0.0 21.7 14.9 0.6 28.9 46.8 3.2 1.0 1.2 1.1 0.2 3.2 1.1 0.3 10.5 1.1 11.0 0.6 13.6 0.3 1.1 2.3 1.1 7.2 0.9 0.0 0.0 53.7 0.0 7.5 0.0 2.6 18.2 9.3 2.0 1.2 0.0 0.0 2.0 0.0 2.7 1.5 0.5 15.9 0.0 34.0 0.4 0.3 3.3 1.7 2.2 0.6 0.0 0.0 0.3 20.3 1.5 0.3 0.0 1.0 0.0 0.2 1.0 0.0 0.6 0.2 3.4 4.1 0.0 18.1 12.8 0.1 0.9 0.2 0.0 1.1 7.1 12.7 0.7 5.4 0.3 97.0 0.4 0.3 0.4 9.9 KCNH2 "erg1, HERG, Kv11.1, LQT2" ENSG00000055118 "Potassium voltage-gated channel subfamily H member 2" Q12809 7 150944961-150978321 "Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Deafness, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 42.3;pituitary gland: 43.3" "Group enriched" "Detected in many" 4 "Bipolar cells: 217.3;Cardiomyocytes: 83.2;Erythroid cells: 76.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "K-562: 197.7;NB-4: 97.8;SH-SY5Y: 78.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 1: K-562 - Erythropoiesis" "Cluster 56: Bipolar cells - Visual perception" "unprognostic (2.22e-1)" "unprognostic (1.75e-2)" "unprognostic (1.06e-2)" "prognostic unfavorable (6.06e-5)" "unprognostic (9.79e-3)" "unprognostic (1.95e-2)" "unprognostic (3.40e-2)" "unprognostic (3.84e-2)" "unprognostic (3.53e-2)" "unprognostic (3.52e-1)" "prognostic favorable (5.61e-4)" "unprognostic (6.08e-2)" "unprognostic (2.26e-2)" "unprognostic (4.90e-2)" "unprognostic (2.83e-1)" "unprognostic (6.24e-2)" "unprognostic (3.02e-2)" 0.8 3.7 9.8 2.6 8.0 42.3 0.1 13.5 9.0 4.4 4.4 36.1 2.7 16.9 1.7 1.5 7.3 3.2 29.6 5.6 14.8 1.1 0.2 2.0 0.3 23.5 14.7 3.2 3.4 18.1 43.3 1.4 23.0 9.8 1.0 6.7 1.1 8.0 0.2 0.3 8.3 7.8 6.3 1.8 10.9 30.8 17.1 0.4 0.2 0.0 0.1 12.9 2.7 4.1 0.0 0.3 0.9 4.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.5 8.0 2.9 0.0 0.2 0.0 3.1 0.0 0.0 0.8 0.4 18.3 0.0 0.0 0.2 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 4.4 197.7 0.0 0.0 0.9 1.6 97.8 1.3 0.2 0.0 0.1 0.1 10.1 0.0 0.0 3.8 78.2 0.0 0.1 0.0 1.1 0.0 1.8 0.6 0.0 1.5 0.0 0.0 5.3 0.2 2.1 0.0 11.8 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.8 8.0 13.5 9.0 5.6 14.8 23.5 14.7 23.0 6.3 17.1 4.1 0.0 0.0 0.0 1.6 1.6 0.0 0.2 0.1 0.0 217.3 0.4 0.3 83.2 0.0 0.0 0.0 4.2 0.2 0.0 0.0 0.0 2.1 2.0 0.5 0.8 0.9 16.3 76.4 5.2 0.2 0.9 5.0 0.5 0.1 26.1 6.3 1.4 0.1 0.3 16.8 13.9 0.7 12.2 0.0 0.3 4.8 2.5 0.0 0.0 2.8 0.0 4.5 0.0 5.5 1.7 0.3 0.0 13.2 1.4 0.1 0.2 0.1 0.4 10.3 0.0 1.7 2.6 2.5 5.1 0.0 0.0 0.3 0.9 0.7 0.3 0.4 KCTD13 "FKSG86, PDIP1, POLDIP1" ENSG00000174943 "Potassium channel tetramerization domain containing 13" Q8WZ19 16 29905012-29926236 "Disease related genes, Predicted intracellular proteins" "Ubl conjugation pathway" "Autism, Autism spectrum disorder, Disease variant, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 37.5;testis: 36.3" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA043524 Enhanced Supported "Nucleoplasm,Nuclear bodies" No No "Cluster 5: Granulocytes - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 40: Non-specific - Basic cellular processes" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "HPA043524: AB_2678528" "unprognostic (6.97e-2)" "unprognostic (9.06e-3)" "prognostic unfavorable (8.54e-4)" "unprognostic (4.00e-2)" "unprognostic (2.39e-1)" "unprognostic (3.13e-2)" "unprognostic (1.02e-1)" "unprognostic (1.45e-2)" "unprognostic (3.59e-2)" "unprognostic (1.97e-2)" "prognostic favorable (9.05e-4)" "unprognostic (3.92e-3)" "prognostic unfavorable (8.17e-4)" "unprognostic (1.16e-2)" "unprognostic (2.22e-1)" "unprognostic (3.56e-1)" "unprognostic (5.49e-3)" 6.0 7.5 27.3 7.8 28.7 8.5 5.4 17.6 37.5 5.0 17.4 6.3 7.3 5.1 9.9 5.9 8.3 7.8 4.4 36.9 24.5 3.9 3.5 4.5 9.8 19.5 21.3 7.5 7.5 7.9 3.6 4.5 19.6 6.7 6.5 9.4 6.5 8.0 2.7 12.2 7.0 5.2 20.5 7.6 5.8 36.3 23.0 9.6 5.7 2.4 7.1 6.0 2.7 28.8 9.7 12.4 6.2 15.5 10.0 8.1 12.5 5.8 7.2 5.7 8.9 3.5 12.6 17.4 11.3 8.5 9.6 14.4 6.8 5.5 4.4 26.5 17.0 3.7 7.1 6.0 13.7 9.2 15.9 10.2 15.3 11.6 8.7 6.1 4.7 19.9 9.1 14.8 7.9 28.1 18.7 14.2 3.6 5.0 6.0 13.9 4.5 9.0 7.8 9.1 15.5 15.4 2.4 7.0 31.7 5.8 10.1 7.2 10.0 5.0 5.1 15.3 10.6 12.4 5.3 3.9 12.0 10.4 14.4 7.2 3.3 8.0 2.9 2.6 3.0 3.0 5.4 5.0 3.5 2.4 5.0 4.7 11.1 3.1 4.4 3.8 4.4 1.9 27.3 28.7 17.6 37.5 36.9 24.5 19.5 21.3 19.6 20.5 23.0 28.8 7.1 0.0 9.7 20.9 10.6 6.0 5.7 10.4 12.5 9.9 8.5 8.0 3.4 5.7 5.8 0.0 8.4 5.3 7.9 5.2 3.9 6.9 17.9 9.1 6.8 4.7 7.7 3.0 15.4 4.2 5.1 6.5 4.6 8.7 2.5 10.9 6.4 2.4 7.6 5.0 20.5 7.2 10.2 4.4 5.6 9.0 6.2 6.3 8.8 12.2 5.7 5.0 11.3 17.6 28.9 11.0 7.4 6.4 3.6 8.7 6.5 2.9 6.3 6.5 0.0 5.0 7.8 20.6 26.5 12.4 9.1 6.7 10.6 5.8 6.1 7.0 KDM1B "AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2" ENSG00000165097 "Lysine demethylase 1B" Q8NB78 6 18155329-18223854 "Enzymes, Predicted intracellular proteins" "Transcription, Transcription regulation" "Chromatin regulator, Developmental protein, Oxidoreductase, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Group enriched" "Detected in many" 5 "dendritic cells: 3.7;granulocytes: 7.2;monocytes: 8.6" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA031269, HPA055597" Uncertain Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 75: Bone marrow - mRNA splicing & Cell cycle" "Cluster 21: OE19 - Mitochondria" "Cluster 19: Monocytes & Neutrophils - Innate immune response" Nucleoplasm "HPA031269: AB_10601587, HPA055597: " "unprognostic (1.93e-1)" "unprognostic (7.53e-2)" "prognostic favorable (6.94e-4)" "unprognostic (2.57e-2)" "unprognostic (7.25e-2)" "unprognostic (1.08e-1)" "unprognostic (5.57e-3)" "unprognostic (1.32e-2)" "unprognostic (8.41e-2)" "unprognostic (6.84e-2)" "unprognostic (2.16e-1)" "unprognostic (3.17e-2)" "unprognostic (6.68e-2)" "unprognostic (3.02e-2)" "unprognostic (2.90e-1)" "unprognostic (7.36e-2)" "unprognostic (3.53e-1)" 5.9 7.6 5.6 11.4 7.6 27.2 6.3 5.3 7.8 7.6 7.6 14.1 8.0 5.7 3.7 9.1 13.4 6.0 6.8 6.6 5.9 7.8 7.4 8.8 10.4 6.9 6.7 6.7 5.9 3.2 5.8 4.6 6.1 5.2 12.2 12.0 5.7 4.7 17.3 11.2 8.9 6.9 6.2 10.5 5.6 15.7 5.6 10.8 27.2 9.1 9.4 7.7 8.1 9.4 15.1 9.7 11.2 23.0 13.8 20.5 24.5 11.7 12.6 7.5 10.2 16.3 7.4 34.1 31.6 19.2 22.8 15.5 17.8 20.8 16.0 31.6 14.6 17.2 8.6 15.0 6.7 25.5 17.5 10.3 23.4 21.5 17.7 12.1 7.7 15.9 38.3 5.2 12.7 12.6 14.1 10.5 3.8 31.6 12.8 26.8 20.3 24.4 10.7 19.8 34.2 10.6 9.7 23.5 22.9 11.7 22.3 20.3 6.5 16.9 9.5 11.9 15.5 5.2 15.9 20.0 6.4 18.9 37.8 1.2 4.6 7.2 0.5 8.6 0.3 1.2 0.5 0.5 3.7 1.3 0.5 0.2 4.9 0.3 6.9 1.6 0.7 1.3 5.6 7.6 5.3 7.8 6.6 5.9 6.9 6.7 6.1 6.2 5.6 9.4 4.9 0.0 8.2 14.7 8.7 12.7 5.7 3.8 7.4 5.0 7.6 6.6 10.4 11.5 10.4 1.8 10.4 2.7 3.0 23.0 1.9 6.6 0.7 36.2 10.0 4.2 6.7 3.8 19.0 4.3 5.1 5.8 8.2 15.5 2.5 3.3 4.2 7.7 7.5 5.0 10.8 9.6 10.2 36.7 11.7 0.7 3.7 20.6 7.2 22.5 27.7 6.6 8.2 16.1 23.8 7.2 21.2 6.8 3.7 5.4 6.2 11.2 21.0 15.5 0.0 6.9 6.2 0.7 18.2 9.7 15.9 1.4 5.6 3.1 10.6 6.6 KPNA5 "IPOA6, SRP6" ENSG00000196911 "Karyopherin subunit alpha 5" O15131 6 116681187-116741867 "Predicted intracellular proteins, Transporters" "Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 44.1" "Cell type enhanced" "Detected in all" "Alveolar cells type 1: 227.6;Alveolar cells type 2: 240.9;granulocytes: 129.3;Respiratory ciliated cells: 143.6;Spermatocytes: 173.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026464, HPA054037" Enhanced Supported Cytosol NA NA "Cluster 6: Non-specific - Transcription" "Cluster 21: Non-specific - Transcription" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 11: Alveolar cells - Smell perception" Cytosol "CAB026464: , HPA054037: AB_2682351" "unprognostic (9.64e-2)" "unprognostic (1.49e-1)" "unprognostic (1.72e-2)" "unprognostic (3.56e-1)" "unprognostic (6.60e-3)" "unprognostic (6.98e-2)" "unprognostic (1.75e-3)" "unprognostic (5.19e-2)" "unprognostic (1.10e-1)" "unprognostic (6.12e-2)" "unprognostic (1.51e-3)" "unprognostic (3.02e-1)" "unprognostic (6.12e-2)" "unprognostic (8.00e-2)" "unprognostic (4.79e-1)" "unprognostic (7.89e-2)" "unprognostic (1.43e-1)" 4.1 5.4 7.0 5.0 8.2 7.1 6.1 15.9 13.0 6.4 1.9 3.4 3.2 9.4 3.7 5.0 8.1 5.2 4.6 7.6 5.9 5.0 2.5 6.0 8.9 7.7 4.4 19.0 2.5 6.4 4.7 4.4 8.4 6.7 3.2 18.9 4.1 5.3 13.8 3.5 3.6 6.8 3.6 6.5 3.6 44.1 4.8 8.9 10.2 12.7 6.3 4.8 3.6 11.7 2.9 1.7 12.0 7.5 4.4 8.5 4.9 4.2 11.7 7.4 10.5 8.1 3.0 10.8 5.6 4.6 8.4 4.7 6.3 3.7 9.2 6.8 18.1 10.1 5.6 4.5 5.5 7.8 6.0 7.7 2.2 9.0 5.6 8.6 8.3 10.3 15.0 4.6 8.3 3.9 12.5 5.5 5.4 2.0 4.7 10.1 3.9 3.0 5.5 5.5 12.8 11.9 3.2 2.7 4.6 7.7 5.3 7.9 6.8 3.0 6.2 3.2 7.5 11.6 13.4 12.2 3.8 5.6 6.4 27.6 4.7 6.4 13.1 5.1 16.3 25.3 14.8 15.7 2.7 26.6 24.1 17.9 1.3 11.2 6.9 16.7 12.1 4.1 7.0 8.2 15.9 13.0 7.6 5.9 7.7 4.4 8.4 3.6 4.8 11.7 12.5 227.6 240.9 63.0 35.2 13.6 7.1 8.9 13.6 50.9 12.8 13.3 17.1 10.0 118.6 9.2 29.2 4.2 24.2 1.6 9.8 6.1 80.3 22.0 13.0 28.8 33.7 7.6 63.7 5.6 1.8 30.5 6.1 7.9 129.3 18.8 20.3 4.7 4.4 47.1 70.9 7.1 8.2 9.1 9.5 15.2 17.7 21.5 10.6 41.2 7.6 34.7 10.3 64.3 56.7 6.0 1.5 16.6 15.8 8.9 2.4 6.5 143.6 38.8 13.1 16.8 15.4 173.4 10.6 8.8 8.9 3.3 31.9 15.9 4.2 3.8 LAMA1 LAMA ENSG00000101680 "Laminin subunit alpha 1" P25391 18 6941742-7117797 "Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "testis: 5.9" "Cell type enhanced" "Detected in many" "Astrocytes: 90.8;Distal enterocytes: 173.6;Granulosa cells: 77.3;Intestinal goblet cells: 44.2;Paneth cells: 35.8;Proximal enterocytes: 47.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 56.0;ASC diff: 41.0;BEWO: 199.6;hTEC/SVTERT24-B: 41.7;SK-MEL-30: 38.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" CAB010179 Enhanced "Secreted to extracellular matrix" NA NA "Cluster 43: Testis - Unknown function" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "CAB010179: AB_2133741" "unprognostic (2.75e-1)" "unprognostic (3.66e-4)" "unprognostic (2.08e-1)" "unprognostic (3.56e-1)" "unprognostic (4.97e-3)" "unprognostic (3.66e-2)" "unprognostic (1.72e-2)" "unprognostic (7.94e-2)" "unprognostic (2.23e-2)" "unprognostic (3.43e-2)" "unprognostic (3.02e-1)" "unprognostic (6.80e-2)" "unprognostic (1.92e-1)" "unprognostic (1.78e-2)" "unprognostic (4.85e-1)" "unprognostic (3.47e-2)" "unprognostic (7.34e-3)" 0.7 0.0 2.0 0.2 1.5 0.0 1.6 1.9 1.1 0.8 0.5 0.1 0.0 0.9 1.4 0.1 0.2 0.0 0.2 2.0 2.0 2.9 0.1 0.3 0.0 2.0 2.8 1.4 1.1 0.0 1.0 0.1 2.1 0.2 0.0 0.4 1.3 0.6 0.0 0.2 0.0 0.3 2.2 0.1 0.0 5.9 3.0 0.1 2.5 0.0 0.0 0.3 0.2 2.9 0.0 0.0 56.0 0.0 41.0 36.5 199.6 2.0 9.8 9.9 21.5 24.4 0.0 0.0 0.5 3.4 8.0 0.1 0.0 7.3 4.1 0.0 3.2 0.0 11.8 0.0 4.8 0.0 0.0 31.1 1.1 41.7 23.5 0.0 0.0 0.0 0.0 0.0 6.2 0.0 0.0 0.0 19.5 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.3 2.8 0.0 0.0 38.4 11.6 0.0 0.0 0.0 7.5 20.5 4.2 0.1 0.0 0.0 0.0 3.7 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.5 1.9 1.1 2.0 2.0 2.0 2.8 2.1 2.2 3.0 2.9 2.6 6.4 0.0 90.8 0.0 0.0 0.8 0.8 0.6 0.5 2.3 7.2 1.9 4.3 0.0 0.0 0.0 4.1 0.0 173.6 0.0 0.0 1.6 4.1 0.6 0.2 1.2 0.0 1.4 0.5 3.1 4.2 0.0 4.3 0.0 77.3 0.0 0.1 0.9 0.0 1.7 44.2 0.0 0.0 0.0 3.7 0.0 0.2 0.0 15.0 0.0 3.4 0.0 4.0 1.8 0.0 35.8 0.0 0.0 1.0 47.5 1.4 0.1 0.3 0.0 0.6 3.4 0.4 2.5 0.3 0.0 4.8 0.2 4.6 16.5 0.3 LYRM7 "C5orf31, FLJ20796, MZM1L" ENSG00000186687 "LYR motif containing 7" Q5U5X0 5 131170944-131205428 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Chaperone "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "tongue: 33.7" "Cell type enhanced" "Detected in many" "Early spermatids: 161.3;Late spermatids: 209.3;Spermatocytes: 135.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA050053 Approved NA NA "Cluster 24: B-cells - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 16: U-266 - Nucleosome" "Cluster 66: Spermatocytes - Spermatogenesis" "HPA050053: AB_2680999" "unprognostic (1.88e-2)" "unprognostic (2.89e-1)" "unprognostic (3.16e-2)" "unprognostic (1.17e-1)" "unprognostic (1.14e-1)" "unprognostic (5.90e-2)" "unprognostic (1.02e-1)" "unprognostic (9.03e-2)" "unprognostic (2.50e-3)" "unprognostic (1.23e-1)" "unprognostic (1.50e-2)" "unprognostic (3.03e-1)" "prognostic favorable (9.84e-6)" "unprognostic (6.61e-2)" "unprognostic (2.06e-1)" "unprognostic (1.07e-2)" "unprognostic (2.20e-1)" 8.3 5.2 5.3 6.8 6.5 6.1 5.4 5.9 7.9 4.0 3.4 9.4 7.6 5.5 2.9 6.4 3.8 3.6 12.2 5.6 6.6 8.4 8.6 3.7 8.5 5.8 5.8 7.0 2.5 8.0 3.0 3.8 6.2 6.0 6.4 8.9 4.0 3.9 27.2 6.8 6.3 5.2 5.1 6.6 5.3 23.0 7.1 7.7 8.3 33.7 6.6 3.9 3.6 8.6 15.1 5.3 7.7 21.0 17.3 16.1 28.1 20.0 4.2 9.7 9.7 13.5 22.5 37.9 23.4 5.5 27.2 20.4 13.5 17.1 17.4 34.3 13.6 20.4 13.7 7.3 7.8 20.7 10.8 10.1 21.7 9.4 20.8 4.3 7.0 19.3 28.1 17.0 12.3 7.9 23.4 17.0 10.2 18.4 9.6 23.0 28.9 28.9 6.8 13.3 17.2 13.5 13.6 11.5 17.7 12.9 19.8 17.0 7.0 20.1 21.8 15.2 26.0 15.9 51.4 50.9 12.5 37.1 16.0 2.5 8.0 6.4 11.9 10.7 16.0 21.0 16.9 14.8 12.4 22.3 22.5 21.8 4.8 13.5 10.8 17.3 13.3 11.6 5.3 6.5 5.9 7.9 5.6 6.6 5.8 5.8 6.2 5.1 7.1 8.6 15.9 3.2 11.2 15.0 28.6 13.8 10.3 19.8 17.1 40.0 13.4 11.4 82.6 12.8 19.6 16.5 20.9 15.1 19.9 21.9 43.0 9.9 161.3 15.0 18.3 16.7 13.1 30.3 20.6 8.9 30.5 17.6 6.1 9.7 17.7 20.0 22.9 28.2 18.1 30.3 27.7 16.3 14.2 18.1 19.2 209.3 27.1 15.3 8.8 8.4 17.5 32.3 27.8 14.6 27.5 8.0 12.3 27.1 15.5 7.7 31.4 28.8 34.4 34.2 0.0 21.0 16.1 135.6 22.2 22.8 18.6 5.5 21.6 21.4 25.4 7.1 MAGEB2 "CT3.2, DAM6, MAGE-XP-2, MGC26438" ENSG00000099399 "MAGE family member B2" O15479 X 30215563-30220089 "Predicted intracellular proteins" "Ubl conjugation pathway" "Tumor antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 60 "testis: 29.1" "Group enriched" "Detected in some" 4 "Spermatocytes: 24.7;Spermatogonia: 95.8" "Cancer enriched" "Detected in many" 7 "testis cancer: 33.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HL-60: 92.4;K-562: 66.9;Karpas-707: 77.0;U-2 OS: 89.9;U-266/70: 149.7;U-266/84: 168.4" "Not detected" "Not detected" "Not detected" "Not detected" "HPA065224, HPA074544, HPA075519" Enhanced Approved Cytosol NA Yes "Cluster 36: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis" Cytosol "HPA065224: AB_2685437, HPA074544: AB_2732258, HPA075519: AB_2732294" "unprognostic (4.52e-1)" "unprognostic (2.55e-2)" "unprognostic (6.39e-2)" "unprognostic (5.02e-1)" "unprognostic (6.57e-2)" "unprognostic (1.79e-2)" "unprognostic (1.00e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 29.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 6.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 92.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 66.9 77.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.2 0.0 0.5 0.0 14.8 0.2 0.0 89.9 0.3 0.3 149.7 168.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 1.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 2.5 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 13.1 0.0 0.0 24.7 95.8 0.0 0.0 0.0 0.1 0.0 0.3 0.0 MARK4 "FLJ90097, KIAA1860, MARKL1, Nbla00650, PAR-1D" ENSG00000007047 "Microtubule affinity regulating kinase 4" Q96L34 19 45079288-45305284 "Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell cycle, Cell division, Cilium biogenesis/degradation, Mitosis" "Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Horizontal cells: 119.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039186 Approved Supported Cytosol NA NA "Cluster 10: Basophils - Unknown function" "Cluster 23: Testis - Cell cycle regulation" "Cluster 12: NES - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" Cytosol "HPA039186: AB_10796223" "unprognostic (1.64e-1)" "unprognostic (1.95e-1)" "unprognostic (1.57e-3)" "prognostic unfavorable (8.31e-8)" "unprognostic (2.02e-1)" "prognostic unfavorable (3.05e-5)" "unprognostic (1.90e-1)" "unprognostic (2.16e-2)" "unprognostic (6.26e-2)" "unprognostic (5.64e-3)" "unprognostic (1.24e-3)" "unprognostic (7.50e-2)" "unprognostic (3.80e-2)" "unprognostic (6.89e-2)" "unprognostic (7.23e-2)" "unprognostic (4.65e-2)" "unprognostic (3.02e-2)" 13.1 13.5 27.5 7.2 31.4 8.5 13.0 16.1 37.7 17.1 11.3 16.5 5.0 15.5 16.6 16.4 14.8 10.6 17.3 31.6 19.6 13.5 21.8 13.9 8.3 24.0 25.2 21.7 14.0 20.5 16.6 11.6 22.6 16.2 5.8 26.0 12.7 13.0 38.7 26.9 9.1 14.6 14.1 11.4 14.3 40.4 29.9 13.1 12.7 12.0 9.6 19.0 16.7 26.1 20.3 7.7 36.6 23.8 25.3 36.8 8.8 15.3 25.1 21.8 20.8 4.0 10.8 8.5 12.0 28.9 20.6 13.5 26.4 22.5 14.2 15.7 16.0 20.7 8.5 17.0 47.6 4.4 15.1 48.1 31.9 18.7 22.8 43.3 29.5 22.1 22.6 21.8 24.9 14.4 16.7 14.5 12.3 18.6 4.7 61.5 11.4 6.3 23.4 16.0 58.8 27.1 20.5 17.5 12.5 35.9 9.0 29.3 21.6 16.7 12.9 12.2 9.0 22.7 21.8 10.8 17.9 8.4 12.7 1.1 1.0 0.2 1.0 0.7 0.2 0.2 0.3 1.3 0.3 0.2 0.6 0.7 0.9 0.7 0.7 0.9 0.8 0.4 27.5 31.4 16.1 37.7 31.6 19.6 24.0 25.2 22.6 14.1 29.9 26.1 8.7 12.8 3.1 30.7 6.0 25.0 11.3 7.2 15.4 20.9 10.2 7.0 9.1 11.5 4.4 9.2 25.0 4.3 8.1 3.7 11.7 8.4 2.3 6.6 9.5 12.2 6.1 6.1 31.1 6.1 1.5 8.4 10.2 10.5 2.5 18.9 18.5 10.7 7.0 119.5 36.5 4.7 4.1 9.5 11.0 6.3 16.1 8.2 3.6 16.9 5.9 19.6 12.3 23.1 16.4 9.5 3.5 13.9 7.7 13.0 4.7 6.5 2.5 15.6 0.0 7.6 8.4 1.2 8.3 12.5 24.2 11.5 10.3 26.1 3.2 15.5 MDC1 "Em:AB023051.5, KIAA0170, NFBD1" ENSG00000137337 "Mediator of DNA damage checkpoint 1" Q14676 6 30699807-30717447 "Cancer-related genes, Predicted intracellular proteins" "Cell cycle, DNA damage, DNA repair" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enriched" "Detected in all" 4 "Spermatocytes: 74.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 4 "NK-cell: 3.2" "Lineage enriched" "Detected in single" 4 "NK-cells: 3.2" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA006915 Enhanced Supported "Nucleoplasm,Nuclear bodies,Focal adhesion sites" No No "Cluster 48: NK-cells - Unknown function" "Cluster 71: Testis - DNA repair" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Nuclear bodies" "Focal adhesion sites" "HPA006915: AB_1853669" "unprognostic (8.52e-2)" "unprognostic (4.32e-1)" "unprognostic (4.11e-2)" "unprognostic (2.66e-2)" "unprognostic (1.60e-1)" "unprognostic (1.61e-1)" "unprognostic (5.40e-3)" "unprognostic (1.13e-1)" "unprognostic (1.09e-2)" "unprognostic (9.44e-2)" "unprognostic (2.74e-3)" "unprognostic (1.31e-1)" "unprognostic (1.62e-2)" "unprognostic (3.86e-2)" "unprognostic (2.99e-1)" "unprognostic (4.39e-3)" "unprognostic (3.23e-1)" 11.3 7.0 2.7 8.6 3.2 13.0 10.9 4.1 5.2 12.4 3.3 11.0 4.9 13.7 8.5 6.2 12.3 4.6 9.5 2.4 4.1 8.2 9.7 9.5 10.2 4.5 3.3 16.8 10.8 8.6 12.8 7.4 3.5 10.1 6.9 14.1 9.1 8.2 11.0 9.4 10.9 8.9 2.0 11.3 8.4 28.2 3.4 14.5 16.4 5.8 11.3 10.7 9.3 3.6 36.7 11.1 47.4 34.8 6.3 10.0 23.0 14.8 10.0 25.2 21.3 22.7 8.5 37.7 17.5 17.0 23.5 20.2 63.0 28.6 34.9 29.9 65.6 43.4 28.7 12.5 4.1 27.1 16.9 7.9 9.2 48.6 27.3 9.0 11.5 25.7 61.0 36.7 19.1 14.7 14.6 20.0 20.6 8.4 7.8 33.2 24.7 37.4 11.0 10.7 39.9 23.2 11.5 26.2 13.5 29.1 21.8 16.8 13.8 24.8 26.4 19.2 26.3 19.3 21.6 34.5 7.8 63.9 34.3 0.1 0.1 0.1 0.6 0.1 0.3 0.4 0.4 0.5 0.1 0.7 0.5 0.5 0.0 3.2 0.1 0.7 0.0 0.3 2.7 3.2 4.1 5.2 2.4 4.1 4.5 3.3 3.5 2.0 3.4 3.6 9.7 16.0 13.0 10.1 13.4 4.5 5.5 5.6 15.9 11.5 6.8 8.6 7.6 7.2 5.7 5.5 8.4 7.9 11.0 2.5 3.9 5.3 4.7 8.0 8.7 9.7 6.7 14.5 8.3 6.2 11.4 11.2 4.1 13.7 17.1 12.8 6.1 12.0 6.7 5.0 8.1 3.3 12.2 6.0 5.7 3.9 7.8 7.3 1.8 11.2 5.9 10.6 14.4 12.5 9.9 5.2 1.1 6.0 16.9 2.9 1.2 3.0 8.0 17.1 13.1 16.2 8.3 74.5 18.0 8.7 3.7 1.9 12.1 7.7 6.0 1.9 MEIOB "C16orf73, MGC35212" ENSG00000162039 "Meiosis specific with OB-fold" Q8N635 16 1833986-1884294 "Disease related genes, Human disease related genes, Predicted intracellular proteins" Meiosis "DNA-binding, Exonuclease, Hydrolase, Nuclease" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in some" 34 "testis: 37.0" "Cell type enriched" "Detected in some" 6 "Spermatocytes: 499.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "HMC-1: 27.6;K-562: 92.7;THP-1: 76.2" "Not detected" "Not detected" "Low region specificity" "Detected in all" NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 1: K-562 - Erythropoiesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (7.18e-2)" "unprognostic (1.91e-1)" "unprognostic (3.04e-2)" "unprognostic (9.73e-2)" "unprognostic (1.67e-1)" "unprognostic (7.68e-3)" "unprognostic (2.00e-2)" "unprognostic (2.68e-2)" "unprognostic (7.30e-3)" "unprognostic (1.34e-1)" "unprognostic (3.80e-1)" "unprognostic (2.18e-3)" 0.2 0.1 0.3 0.0 0.2 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.0 0.1 0.2 0.3 1.0 0.3 0.0 0.0 0.1 0.1 0.3 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.8 0.0 0.0 0.1 0.7 0.2 0.0 0.1 0.0 0.1 37.0 0.2 0.9 0.2 0.0 0.0 0.0 0.1 0.2 0.0 0.9 0.1 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.2 1.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 27.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 92.7 0.1 0.0 1.5 0.0 0.0 4.2 0.1 0.1 0.0 0.0 0.2 0.0 0.0 0.4 0.6 9.4 0.8 0.0 0.4 1.1 76.2 1.2 0.0 0.0 0.1 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.1 0.3 0.2 0.3 0.1 0.1 0.2 0.1 0.2 0.2 0.0 0.0 0.0 0.7 0.1 0.0 0.2 0.0 0.0 0.5 0.1 0.3 0.8 0.0 0.0 0.0 0.0 0.3 0.1 0.1 0.0 0.5 58.0 0.1 0.3 0.2 0.0 0.0 2.6 0.0 0.2 0.2 0.0 0.2 4.5 2.3 0.0 0.0 0.1 3.3 4.1 0.0 0.0 0.0 0.0 15.9 1.8 0.2 0.0 0.0 0.0 0.1 0.0 1.0 2.1 0.1 0.0 1.5 0.0 0.3 0.0 3.4 0.0 0.3 6.6 0.0 0.3 499.7 75.2 0.6 0.4 0.0 0.0 0.8 0.0 0.4 MEX3D "KIAA2031, OK/SW-cl.4, RKHD1, RNF193, Tino" ENSG00000181588 "Mex-3 RNA binding family member D" Q86XN8 19 1554669-1568058 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "testis: 78.3" "Cell type enriched" "Detected in many" 4 "Late spermatids: 340.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in all" "REH: 67.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065385 Approved NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 14: REH - Unknown function" "Cluster 31: Spermatids - Spermatogenesis" "HPA065385: AB_2685482" "unprognostic (2.71e-1)" "unprognostic (9.01e-2)" "unprognostic (3.90e-1)" "unprognostic (1.61e-2)" "unprognostic (2.04e-1)" "unprognostic (1.80e-2)" "unprognostic (9.35e-3)" "unprognostic (3.58e-2)" "unprognostic (1.89e-1)" "unprognostic (3.85e-1)" "unprognostic (3.74e-1)" "unprognostic (9.37e-3)" "unprognostic (2.75e-3)" "unprognostic (5.13e-2)" "unprognostic (2.67e-2)" "unprognostic (2.57e-1)" "unprognostic (1.36e-2)" 8.2 3.9 11.5 2.6 10.7 0.3 8.1 8.7 10.6 9.2 0.1 8.2 4.6 12.6 5.9 9.6 7.7 2.8 6.5 8.0 5.3 4.8 5.5 7.7 1.2 16.2 10.1 12.3 6.2 2.2 4.9 6.9 9.9 6.9 2.7 0.8 9.2 2.7 1.7 10.8 5.2 3.6 8.9 2.7 6.9 78.3 10.8 1.6 6.1 1.5 2.1 7.7 9.3 18.0 40.6 3.1 17.5 20.3 6.4 6.1 43.2 24.9 5.4 9.6 10.0 9.9 6.9 12.9 27.5 9.3 2.4 20.5 7.7 6.2 11.7 21.2 9.5 3.1 3.3 12.2 5.1 9.4 8.5 4.6 9.0 5.2 4.1 7.6 15.4 6.7 18.7 12.2 11.4 8.1 22.2 10.0 36.5 8.8 11.6 67.4 18.5 10.0 8.7 6.1 26.2 29.6 20.3 11.1 15.2 14.6 14.2 10.4 28.0 19.6 27.4 30.4 32.3 13.6 5.8 13.5 8.3 13.8 16.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 11.5 10.7 8.7 10.6 8.0 5.3 16.2 10.1 9.9 8.9 10.8 18.0 18.1 12.8 8.4 2.0 0.6 14.8 3.5 3.8 6.2 2.4 23.4 13.2 7.3 8.6 4.2 9.2 0.0 5.2 3.4 10.8 0.0 11.9 73.8 15.6 15.6 10.5 18.6 4.0 0.9 9.6 12.8 11.0 2.6 19.9 1.3 8.2 12.5 13.6 2.4 1.7 0.6 7.3 6.1 2.5 8.1 340.7 14.9 3.3 7.2 0.0 1.2 6.0 1.0 3.0 3.5 20.9 6.4 9.4 0.8 8.9 6.2 2.7 1.7 1.7 0.0 5.9 13.6 3.7 4.3 10.1 17.6 16.6 2.5 2.6 9.6 5.1 MICOS13 "C19orf70, MIC13, P117, QIL1" ENSG00000174917 "Mitochondrial contact site and cristae organizing system subunit 13" Q5XKP0 19 5678421-5680516 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Group enriched" "Detected in some" 4 "Cardiomyocytes: 344.8;Cytotrophoblasts: 154.4;Extravillous trophoblasts: 196.7;Hofbauer cells: 242.2;Syncytiotrophoblasts: 125.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042672 Approved Supported Nucleoplasm,Mitochondria "Intracellular and membrane" NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 24: Non-specific - Transcription regulation" Mitochondria Nucleoplasm "HPA042672: AB_10794531" "unprognostic (9.54e-2)" "unprognostic (4.90e-3)" "unprognostic (3.04e-1)" "unprognostic (3.21e-3)" "unprognostic (1.52e-2)" "unprognostic (1.80e-1)" "unprognostic (1.65e-1)" "unprognostic (2.53e-3)" "unprognostic (2.14e-2)" "unprognostic (9.32e-2)" "unprognostic (2.50e-2)" "unprognostic (1.57e-1)" "prognostic favorable (7.60e-5)" "unprognostic (1.08e-1)" "unprognostic (5.94e-2)" "unprognostic (2.27e-1)" "unprognostic (5.47e-2)" 71.0 68.8 139.7 48.4 143.6 54.1 59.3 153.6 180.2 44.4 137.0 76.5 78.6 46.9 44.0 86.9 67.3 53.8 271.2 141.2 154.5 93.5 78.3 44.2 60.4 148.7 143.8 44.7 86.7 97.4 59.8 37.9 147.1 50.1 40.7 18.6 95.3 60.7 279.3 59.7 66.7 43.8 142.0 45.0 61.8 149.2 151.4 38.8 57.9 186.5 35.2 61.3 49.3 146.7 175.7 167.9 43.4 87.6 98.3 117.1 58.7 100.7 121.0 142.6 120.3 132.6 85.2 82.0 157.6 105.2 65.3 124.7 25.8 175.5 34.6 128.9 311.9 76.1 101.2 153.4 162.5 105.8 79.2 133.0 157.9 71.5 92.6 68.0 104.9 112.5 120.5 220.6 101.2 186.3 145.7 129.2 45.1 118.5 474.3 79.5 57.8 286.7 145.3 126.1 111.5 134.8 37.8 198.1 152.2 25.2 128.3 123.8 87.4 121.9 50.5 217.4 169.2 315.8 280.6 66.9 174.5 183.6 126.0 76.8 214.3 77.8 198.9 274.7 237.5 291.6 228.5 225.8 261.4 235.7 222.8 211.3 29.6 192.1 238.8 302.5 211.1 278.1 139.7 143.6 153.6 180.2 141.2 154.5 148.7 143.8 147.1 142.0 151.4 146.7 44.6 0.0 0.0 0.0 8.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 344.8 0.0 0.0 0.0 0.0 154.4 24.5 0.0 0.0 0.0 0.0 0.0 0.0 16.9 0.0 0.0 0.0 0.0 196.7 46.9 0.0 0.0 0.0 0.0 0.0 0.0 242.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 125.9 5.8 0.0 0.0 0.0 MMP15 "MT2-MMP, MTMMP2, SMCP-2" ENSG00000102996 "Matrix metallopeptidase 15" P51511 16 58025754-58046901 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Cholangiocytes: 55.8;Distal enterocytes: 109.3;Proximal enterocytes: 67.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "BEWO: 93.6;Hep G2: 51.1;OE19: 44.6;SK-BR-3: 47.3;WM-115: 78.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002611, HPA040390" Uncertain Approved "Nucleoplasm,Plasma membrane,Cytosol" NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 41: Intestine & Liver - Lipid metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 53: Intestinal epithelial cells - Unknown function" "Plasma membrane, Cytosol" Nucleoplasm "CAB002611: , HPA040390: AB_2676956" "unprognostic (1.76e-2)" "unprognostic (7.32e-2)" "unprognostic (2.69e-1)" "unprognostic (6.85e-2)" "unprognostic (3.09e-1)" "unprognostic (1.68e-1)" "unprognostic (6.88e-3)" "unprognostic (1.40e-1)" "unprognostic (3.02e-2)" "unprognostic (1.24e-2)" "unprognostic (4.81e-2)" "unprognostic (1.81e-1)" "prognostic favorable (8.54e-8)" "unprognostic (3.63e-2)" "unprognostic (1.36e-1)" "unprognostic (1.28e-1)" "prognostic favorable (3.08e-4)" 11.9 3.8 8.9 4.4 6.0 0.4 7.6 7.3 11.2 5.7 5.8 28.0 40.2 3.5 1.1 4.6 6.1 14.3 41.2 6.9 8.7 14.9 50.1 9.9 2.1 15.8 10.6 1.1 18.5 12.7 8.8 28.4 16.8 4.4 14.3 1.5 8.4 9.5 7.0 4.3 33.0 3.7 5.8 9.3 29.6 34.9 18.7 1.0 46.7 5.6 1.3 5.1 2.8 8.6 15.3 11.4 5.8 30.4 6.0 0.3 93.6 1.4 0.8 5.4 1.2 9.1 38.3 0.2 17.7 1.6 4.2 21.0 5.1 4.4 1.6 0.1 10.0 0.1 4.9 51.1 7.7 0.3 19.5 3.1 7.8 0.9 2.3 8.4 3.7 8.5 12.9 0.1 1.8 7.6 0.7 2.6 17.2 44.6 3.2 7.6 0.7 8.3 16.6 5.4 1.6 10.4 20.0 47.3 9.5 13.2 5.2 8.2 3.4 0.4 9.1 3.5 1.3 0.2 0.1 0.3 1.9 2.3 78.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 8.9 6.0 7.3 11.2 6.9 8.7 15.8 10.6 16.8 5.8 18.7 8.6 14.3 19.2 14.4 9.1 0.7 2.5 1.0 4.9 2.8 3.4 5.0 3.0 24.7 55.8 12.6 18.4 16.7 48.2 1.6 109.3 1.9 35.7 5.0 3.6 1.1 17.2 11.4 2.7 1.4 12.0 49.2 4.5 35.2 6.4 0.0 18.6 13.6 39.2 12.9 1.7 1.2 33.3 10.2 3.0 0.3 6.9 0.9 0.9 1.8 1.0 0.0 2.1 0.0 4.5 1.4 13.3 38.5 3.4 0.3 1.3 67.3 7.3 6.0 1.9 0.0 0.7 2.4 0.9 4.6 3.3 2.3 48.4 0.7 23.2 45.0 1.7 MMP28 "EPILYSIN, MM28, MMP-25, MMP-28" ENSG00000271447 "Matrix metallopeptidase 28" Q9H239 17 35756249-35795707 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Astrocytes: 47.7;Basal respiratory cells: 56.8;Distal enterocytes: 82.0;Paneth cells: 46.2;Proximal enterocytes: 47.2;Urothelial cells: 43.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 6.3;naive CD8 T-cell: 3.7" "Lineage enriched" "Detected in single" 7 "T-cells: 6.3" "Cell line enhanced" "Detected in some" "CAPAN-2: 13.8;HaCaT: 86.9;hTCEpi: 38.3;OE19: 41.7;RT4: 15.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA057288, HPA057890" Approved "Nucleoplasm,Focal adhesion sites" "Secreted to extracellular matrix" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 27: Brain & Skin - Unknown function" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 53: Intestinal epithelial cells - Unknown function" Nucleoplasm "Focal adhesion sites" "HPA057288: , HPA057890: " "unprognostic (7.99e-3)" "unprognostic (3.27e-1)" "unprognostic (2.20e-1)" "unprognostic (1.01e-1)" "unprognostic (7.52e-2)" "unprognostic (1.63e-1)" "unprognostic (6.90e-2)" "unprognostic (1.09e-2)" "unprognostic (1.51e-1)" "unprognostic (1.99e-1)" "prognostic unfavorable (6.28e-6)" "unprognostic (9.37e-2)" "unprognostic (1.31e-1)" "unprognostic (8.87e-2)" "unprognostic (1.74e-1)" "unprognostic (1.76e-2)" "unprognostic (3.27e-3)" 14.7 2.0 18.7 0.5 18.1 0.2 8.3 12.1 18.8 4.1 11.9 17.5 1.8 5.2 2.1 13.5 6.1 1.4 3.8 16.2 15.6 1.9 0.3 14.1 0.2 15.2 17.8 1.1 0.8 0.1 1.3 2.0 12.9 5.0 10.5 3.0 2.5 3.5 1.8 23.7 10.2 4.1 14.4 1.1 8.8 22.3 19.3 0.3 5.9 2.4 3.2 16.3 7.6 13.9 0.2 0.8 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 13.8 0.1 1.5 0.0 0.1 86.9 0.0 0.2 0.0 0.0 0.7 0.0 0.2 0.0 4.3 0.0 0.0 1.2 38.3 0.0 3.1 0.7 0.3 0.3 0.0 0.2 0.0 0.3 0.1 0.3 0.0 41.7 0.1 0.8 0.0 0.0 0.0 15.7 0.2 0.7 0.8 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.1 0.6 0.2 1.0 0.0 0.4 6.3 3.7 0.0 0.9 0.2 0.9 0.0 0.4 18.7 18.1 12.1 18.8 16.2 15.6 15.2 17.8 12.9 14.4 19.3 13.9 31.5 28.9 26.5 47.7 0.4 38.5 5.3 56.8 21.1 2.7 1.0 1.5 1.3 7.2 15.2 7.3 0.0 0.0 0.2 82.0 0.0 1.2 6.7 0.1 0.0 16.8 3.6 0.4 2.8 0.4 0.0 4.4 12.2 0.1 0.0 0.0 17.9 0.0 0.1 1.7 4.8 32.9 2.0 0.0 1.8 13.4 1.2 0.5 3.6 10.3 0.4 9.4 1.0 1.0 0.6 16.7 46.2 3.0 0.1 8.6 47.2 0.8 4.5 0.5 6.6 0.7 5.5 1.1 3.7 34.9 33.1 0.0 1.0 0.1 21.5 43.9 MORN3 ENSG00000139714 "MORN repeat containing 3" Q6PF18 12 121648742-121672631 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "choroid plexus: 4.1;fallopian tube: 3.9;testis: 4.5" "Cell type enriched" "Detected in many" 6 "Late spermatids: 2271.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in some" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 9 "BEWO: 13.6;CACO-2: 8.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA038709, HPA038710" Uncertain Approved Nucleoplasm NA NA "Cluster 33: Neutrophils - Chromatin organization" "Cluster 49: Ciliated cells - Cilium organization" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Nucleoplasm "HPA038709: AB_2676164, HPA038710: AB_2676165" "prognostic favorable (1.16e-4)" "unprognostic (2.70e-3)" "unprognostic (5.56e-2)" "unprognostic (5.13e-2)" "unprognostic (7.38e-3)" "unprognostic (3.46e-3)" "unprognostic (7.44e-2)" "unprognostic (3.70e-2)" "unprognostic (4.31e-2)" "unprognostic (3.09e-2)" "unprognostic (3.65e-3)" "unprognostic (3.11e-2)" "unprognostic (1.39e-2)" "unprognostic (3.06e-1)" "unprognostic (2.21e-1)" "unprognostic (8.85e-2)" "unprognostic (1.18e-1)" 0.2 0.3 1.4 0.5 1.6 0.9 0.4 1.3 1.6 0.4 4.1 0.2 0.2 0.3 0.5 0.1 3.9 0.4 0.2 1.5 1.5 0.7 0.1 1.0 1.2 1.7 2.2 0.3 0.3 2.3 1.3 0.8 1.1 0.2 0.2 0.6 0.4 0.3 0.2 2.0 0.4 0.2 1.3 0.7 0.6 4.5 1.6 0.9 0.6 0.0 0.6 0.2 0.2 1.4 0.2 0.1 0.4 0.2 0.0 0.3 13.6 0.2 0.1 0.0 0.1 8.3 0.4 0.2 0.2 0.1 0.2 0.5 0.1 0.2 0.1 0.1 0.1 0.6 0.5 0.5 0.2 0.5 0.9 0.1 0.3 0.4 0.0 0.1 0.3 1.0 0.2 0.3 0.1 0.3 0.9 0.7 0.3 0.0 0.1 0.4 0.0 0.1 0.5 0.2 1.2 1.1 0.1 0.2 0.0 0.6 1.1 0.1 0.2 0.2 0.2 0.4 0.2 0.2 0.1 0.4 1.0 0.4 0.2 1.3 0.3 0.1 0.7 0.1 0.8 0.3 0.8 0.4 0.1 0.5 0.7 0.5 1.2 0.9 0.3 0.5 0.8 0.2 1.4 1.6 1.3 1.6 1.5 1.5 1.7 2.2 1.1 1.3 1.6 1.4 1.1 3.2 1.3 0.0 1.6 3.2 1.2 3.3 0.0 1.3 2.5 1.8 1.4 4.3 8.2 1.8 0.0 0.5 6.6 0.0 7.9 4.4 352.0 34.1 1.2 2.1 0.0 0.0 2.7 1.4 0.7 1.4 0.0 3.0 2.5 2.5 0.7 0.0 0.9 0.0 2.3 0.0 4.1 0.0 0.3 2271.5 9.3 1.7 0.0 0.0 1.8 5.4 5.2 0.0 0.1 2.2 0.0 9.4 3.5 0.7 0.1 1.1 51.7 2.2 0.0 1.5 1.4 8.7 6.7 0.0 4.0 7.3 6.7 3.4 0.2 1.1 MTCL1 "CCDC165, KIAA0802, SOGA2" ENSG00000168502 "Microtubule crosslinking factor 1" Q9Y4B5 18 8705661-8832778 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 90.1;intestine: 28.1;retina: 34.0" "Cell type enhanced" "Detected in many" "Early spermatids: 26.0;Excitatory neurons: 86.4;Granulosa cells: 28.9;Inhibitory neurons: 80.4;Oligodendrocyte precursor cells: 24.1" "Low cancer specificity" "Detected in many" "Region enriched" "Detected in many" 9 "cerebellum: 90.1" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enhanced" "Detected in all" "cerebellum: 32.0" HPA046245 Uncertain NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 21: OE19 - Mitochondria" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA046245: AB_10962580" "unprognostic (2.64e-1)" "prognostic unfavorable (6.45e-4)" "unprognostic (2.35e-1)" "unprognostic (2.27e-2)" "unprognostic (1.70e-1)" "unprognostic (1.01e-1)" "unprognostic (4.41e-4)" "unprognostic (1.30e-2)" "unprognostic (7.19e-2)" "unprognostic (9.95e-2)" "unprognostic (2.51e-1)" "unprognostic (1.79e-2)" "prognostic unfavorable (5.19e-4)" "unprognostic (2.82e-1)" "unprognostic (3.67e-1)" "unprognostic (7.17e-3)" "unprognostic (1.08e-2)" 1.6 0.9 0.0 2.5 0.6 0.5 1.4 90.1 10.1 4.7 0.0 28.1 1.8 2.3 0.7 2.7 1.0 8.1 2.9 0.7 0.5 2.5 1.3 1.2 0.8 4.9 2.6 1.1 3.7 2.8 5.6 2.3 7.3 1.7 1.7 34.0 1.4 3.0 2.1 2.5 4.3 5.2 0.9 0.6 8.9 8.0 0.0 3.7 0.4 1.1 0.5 9.4 4.6 6.3 16.8 35.3 17.4 10.2 7.6 14.1 0.7 22.9 16.9 18.6 13.4 10.4 5.8 10.5 12.8 16.1 13.9 2.5 5.5 9.4 8.5 2.1 4.5 5.1 10.1 9.4 10.9 0.1 7.3 8.3 6.8 10.5 7.2 12.1 14.8 8.8 1.1 17.8 8.7 5.0 0.7 2.5 7.9 40.2 15.2 14.0 12.5 3.8 26.9 29.9 39.3 8.8 10.5 3.0 2.7 14.3 1.0 0.6 28.2 33.8 17.6 27.4 23.8 3.4 2.8 5.1 8.4 0.6 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 90.1 10.1 0.7 0.5 4.9 2.6 7.3 0.9 0.0 6.3 0.4 0.0 1.1 9.4 1.3 0.0 2.8 0.0 4.6 0.0 1.5 1.9 6.5 8.6 0.6 1.8 0.0 5.0 1.8 1.8 1.9 5.6 26.0 2.8 2.3 2.1 1.2 4.6 86.4 3.5 0.4 1.5 5.6 7.8 2.5 28.9 4.6 1.0 0.6 0.0 80.4 1.5 0.0 0.6 0.0 8.8 1.2 0.3 0.0 8.4 0.1 0.0 0.0 24.1 18.3 8.6 0.2 0.4 1.9 4.6 0.2 1.9 0.0 0.0 0.0 0.8 1.9 0.9 5.2 3.0 0.0 1.0 0.4 1.3 1.2 1.3 NAT8L "FLJ37478, Hcml3, Shati" ENSG00000185818 "N-acetyltransferase 8 like" Q8N9F0 4 2059327-2069089 "Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 8 "adipose tissue: 43.5;brain: 99.0" "Cell type enhanced" "Detected in some" "Astrocytes: 126.7;Excitatory neurons: 46.0;Horizontal cells: 80.8;Inhibitory neurons: 37.6;Muller glia cells: 25.0" "Group enriched" "Detected in many" 6 "endometrial cancer: 6.2;glioma: 17.2;melanoma: 14.6;ovarian cancer: 8.0;thyroid cancer: 7.9" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "NB-4: 20.8;SCLC-21H: 25.8;SK-MEL-30: 21.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040677 Approved Mitochondria NA NA "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 65: Brain - Ion transport" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 64: Astrocytes - Nervous system maintenance" Mitochondria "HPA040677: AB_2732486" "unprognostic (1.32e-2)" "unprognostic (8.62e-2)" "unprognostic (3.02e-3)" "prognostic unfavorable (1.01e-5)" "unprognostic (2.56e-1)" "unprognostic (2.63e-4)" "unprognostic (6.58e-2)" "unprognostic (1.79e-1)" "unprognostic (2.90e-2)" "unprognostic (4.54e-1)" "unprognostic (3.70e-2)" "unprognostic (7.06e-2)" "unprognostic (1.78e-3)" "unprognostic (7.24e-3)" "unprognostic (1.14e-2)" "unprognostic (2.10e-2)" "unprognostic (1.35e-2)" 43.5 0.7 56.1 0.1 46.4 0.0 1.6 42.9 99.0 0.0 0.6 0.2 0.1 0.3 1.3 0.1 0.9 0.1 0.8 45.8 29.0 5.3 0.0 0.0 0.2 52.3 46.4 0.2 2.3 0.9 1.8 0.1 57.5 1.0 0.1 3.7 2.3 1.6 5.7 1.0 0.2 0.2 33.0 0.3 0.4 9.0 88.8 0.2 0.3 2.5 0.0 0.0 0.0 38.9 0.1 9.2 4.9 10.0 0.9 0.0 5.7 0.2 0.0 0.2 0.0 4.1 0.3 0.0 1.9 0.0 1.5 0.1 11.1 0.0 0.1 0.0 13.2 0.1 2.1 6.6 1.5 14.5 6.9 0.0 0.2 0.0 0.0 1.8 0.0 3.4 11.5 0.0 0.4 6.2 0.2 20.8 14.1 0.0 4.1 0.7 2.3 0.4 0.2 0.5 25.8 8.6 6.6 0.0 21.4 0.8 0.7 8.3 0.0 0.0 3.3 0.1 5.6 0.0 0.0 0.2 0.0 6.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 56.1 46.4 42.9 99.0 45.8 29.0 52.3 46.4 57.5 33.0 88.8 38.9 0.5 0.0 0.0 126.7 0.0 0.3 0.0 0.0 0.0 14.5 1.4 2.2 2.6 0.0 0.0 1.8 6.2 0.0 5.4 0.0 0.0 4.6 1.1 1.7 0.1 0.4 1.8 0.0 46.0 0.6 0.1 0.2 0.0 1.0 0.0 21.9 0.0 0.0 0.8 80.8 37.6 0.0 0.0 0.0 0.3 3.8 0.0 0.7 10.6 17.8 0.0 25.0 0.0 23.1 15.7 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 5.6 0.0 0.0 0.8 0.5 1.5 0.0 0.1 0.0 0.0 0.1 0.0 0.1 NCAPG "CAP-G, FLJ12450, hCAP-G, YCG1" ENSG00000109805 "Non-SMC condensin I complex subunit G" Q9BPX3 4 17810979-17844865 "Predicted intracellular proteins" "Cell cycle, Cell division, DNA condensation, Mitosis" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 13.9;lymphoid tissue: 15.8" "Cell type enhanced" "Detected in many" "Erythroid cells: 59.3;Extravillous trophoblasts: 26.6;Plasma cells: 20.4;Spermatocytes: 63.7;Spermatogonia: 24.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in many" "Region enhanced" "Detected in single" "white matter: 1.6" "Low region specificity" "Detected in all" HPA039613 Uncertain NA Yes 9500 "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" "HPA039613: AB_10805481" "unprognostic (5.23e-2)" "unprognostic (3.37e-1)" "unprognostic (1.59e-3)" "prognostic unfavorable (8.28e-4)" "unprognostic (4.22e-2)" "unprognostic (1.12e-1)" "prognostic unfavorable (3.13e-6)" "unprognostic (1.18e-3)" "unprognostic (1.63e-2)" "unprognostic (6.70e-2)" "prognostic unfavorable (7.65e-5)" "unprognostic (3.44e-2)" "unprognostic (0.00e+0)" "unprognostic (1.94e-2)" "unprognostic (1.34e-1)" "unprognostic (1.67e-1)" "unprognostic (2.07e-1)" 0.7 0.5 0.1 4.1 0.1 13.9 0.9 0.5 0.1 0.7 0.2 3.0 3.8 0.6 0.0 3.5 0.2 0.9 0.3 0.0 0.2 0.2 0.7 0.6 8.7 0.6 1.2 0.2 0.2 0.1 0.1 3.0 0.7 0.3 2.4 0.3 0.7 0.0 0.2 3.5 3.2 1.0 1.2 2.1 1.9 5.6 0.3 15.8 0.3 0.1 8.7 1.2 1.0 0.2 45.1 28.3 63.8 42.2 4.0 7.8 23.1 56.8 22.2 55.0 55.8 36.3 26.8 66.8 11.3 16.0 47.6 19.9 54.5 22.1 74.8 30.5 27.0 53.6 37.3 29.8 0.2 38.4 20.3 1.5 1.5 40.7 18.6 8.8 27.9 28.9 53.1 74.1 55.0 13.4 44.1 36.9 32.8 26.1 27.9 42.8 57.4 28.0 16.6 13.9 50.0 29.7 51.2 10.9 15.7 27.2 25.6 21.3 23.2 52.5 23.6 30.0 78.9 23.2 23.3 56.1 21.7 39.1 35.8 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.6 0.4 0.1 0.1 0.5 0.1 0.0 0.2 0.6 1.2 0.7 1.2 0.3 0.2 0.3 0.0 1.1 0.0 3.3 2.4 0.6 1.9 1.2 0.2 0.6 0.6 0.2 0.0 0.8 0.0 0.0 11.7 1.6 2.9 0.0 0.1 15.8 0.9 1.9 1.7 1.8 59.3 0.2 0.0 26.6 3.8 7.1 2.3 1.3 14.2 2.2 0.5 9.5 0.0 0.4 3.1 2.0 2.6 2.9 9.5 0.6 3.7 1.8 1.0 0.7 0.3 3.1 0.5 0.5 0.2 0.1 0.0 20.4 0.4 0.2 0.0 0.0 0.2 0.0 0.2 4.3 63.7 24.3 11.0 1.1 2.2 3.7 0.7 5.6 1.3 NDUFA13 "B16.6, CDA016, CGI-39, GRIM-19, GRIM19" ENSG00000186010 "NADH:ubiquinone oxidoreductase subunit A13" Q9P0J0 19 19515736-19529054 "Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins" "Apoptosis, Electron transport, Host-virus interaction, Respiratory chain, Transport" "Disease variant, Primary mitochondrial disease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 2947.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA041213 Supported Supported Mitochondria NA NA "Cluster 12: Non-specific - Basic cellular processes" "Cluster 39: Non-specific - Mitochondria" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" Mitochondria "HPA041213: AB_10794988" "unprognostic (2.87e-1)" "unprognostic (2.88e-3)" "unprognostic (9.98e-2)" "unprognostic (1.11e-1)" "unprognostic (3.36e-2)" "unprognostic (5.78e-2)" "unprognostic (6.00e-2)" "unprognostic (3.30e-2)" "unprognostic (2.81e-1)" "unprognostic (1.83e-3)" "unprognostic (1.26e-2)" "unprognostic (1.13e-1)" "unprognostic (1.45e-2)" "unprognostic (1.33e-1)" "unprognostic (2.37e-1)" "unprognostic (2.15e-2)" "unprognostic (2.15e-2)" 268.1 248.1 586.0 184.1 601.2 318.9 226.6 612.2 726.3 188.2 632.2 324.0 268.5 129.8 414.0 288.3 253.0 165.0 987.1 577.4 609.2 274.5 301.3 154.8 234.9 600.9 585.1 168.3 274.3 541.3 154.7 186.6 588.3 216.1 212.4 100.7 272.8 220.4 1093.2 183.1 245.1 193.5 593.6 160.6 251.2 208.5 624.2 254.5 221.2 1102.9 178.5 250.9 103.5 607.7 371.4 405.5 443.7 531.6 460.2 416.2 606.4 345.8 488.3 500.0 492.2 639.4 584.9 442.6 952.2 495.2 261.4 307.2 313.0 477.6 177.3 276.5 1052.6 308.9 590.9 834.1 448.0 601.1 517.0 546.5 483.7 322.7 335.5 296.3 382.8 533.1 428.6 728.2 400.3 1115.4 811.2 880.9 528.4 846.6 1004.4 536.0 263.0 830.2 711.1 782.6 508.9 633.2 350.0 551.7 481.1 225.2 367.7 1035.9 307.3 538.4 177.5 583.8 541.0 543.6 430.6 510.3 428.4 624.2 390.8 1210.3 1162.6 963.4 758.6 1263.4 678.0 1284.6 874.1 838.9 1165.9 1097.3 831.6 775.7 411.9 779.9 1054.3 979.4 1246.2 2090.8 586.0 601.2 612.2 726.3 577.4 609.2 600.9 585.1 588.3 593.6 624.2 607.7 155.1 131.4 184.8 33.0 194.5 129.0 75.9 346.9 117.8 64.8 211.3 181.2 514.5 224.4 251.2 250.1 25.0 426.6 136.6 951.6 610.5 566.0 411.8 154.5 111.5 131.4 556.3 185.3 22.7 578.5 357.2 173.1 225.3 130.5 259.3 51.3 182.4 422.6 333.6 42.1 27.2 719.7 268.5 307.4 197.9 2947.1 153.4 198.3 263.3 19.7 456.7 186.3 183.4 17.6 41.2 490.5 931.9 129.1 272.0 75.0 1114.7 772.0 236.5 84.2 92.1 91.6 196.2 80.6 111.5 210.0 127.0 498.4 177.5 48.0 683.0 87.4 NKX2-8 "Nkx2-9, NKX2.8, NKX2H" ENSG00000136327 "NK2 homeobox 8" O15522 14 36580004-36582614 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 4.4;esophagus: 2.6;testis: 7.9" "Cell type enhanced" "Detected in some" "Basal prostatic cells: 2.3;Basal squamous epithelial cells: 6.8;Late spermatids: 2.1;Oligodendrocytes: 2.6;Prostatic glandular cells: 2.1;Squamous epithelial cells: 3.4" "Cancer enhanced" "Detected in many" "thyroid cancer: 2.2" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HaCaT: 3.6;PC-3: 2.0" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" HPA062879 Uncertain Approved "Nucleoplasm,Plasma membrane" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 61: Squamous epithelial cells - Keratinization" Nucleoplasm "Plasma membrane" "HPA062879: AB_2684892" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.37e-3)" "unprognostic (2.27e-1)" "unprognostic (3.45e-4)" "unprognostic (2.36e-1)" "unprognostic (8.34e-2)" "unprognostic (7.80e-2)" "unprognostic (3.66e-1)" "unprognostic (3.11e-1)" "unprognostic (8.39e-3)" "unprognostic (4.60e-2)" "unprognostic (2.70e-1)" "unprognostic (6.13e-2)" 0.0 0.0 0.4 0.0 1.1 0.0 0.0 1.2 0.5 0.1 0.2 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.2 2.1 0.0 0.0 0.3 0.0 2.3 1.3 0.0 0.0 0.1 1.1 0.0 2.4 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 2.0 0.0 0.0 7.9 2.1 0.0 1.4 0.0 0.0 0.0 0.0 4.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 3.6 0.0 0.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.2 0.4 0.0 0.8 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 1.2 0.5 0.2 2.1 2.3 1.3 2.4 2.0 2.1 4.4 0.0 0.0 0.0 0.0 0.0 0.5 2.3 0.9 6.8 0.0 1.0 1.1 0.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 2.1 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.1 0.0 0.0 0.0 2.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 3.4 0.4 0.0 0.0 0.0 0.0 0.4 P3R3URF ENSG00000250719 "PIK3R3 upstream reading frame" A0A087WWA1 1 46175486-46176488 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 81 "testis: 141.0" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "cerebellum: 1.7" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in single" 5 "cerebellum: 1.6" NA NA "Cluster 74: Testis - Spermatogenesis" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.7 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 141.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.6 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PABPC1 "PAB1, PABP1, PABPC2, PABPL1" ENSG00000070756 "Poly(A) binding protein cytoplasmic 1" P11940 8 100685816-100722809 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay" RNA-binding "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB011536, HPA045423, HPA067156" Supported Supported Cytosol NA NA 3900000 "Cluster 39: Non-specific - mRNA processing" "Cluster 24: Salivary gland - Salivary secretion" "Cluster 22: JURKAT & MOLT-4 - Adaptive immune response" "Cluster 32: Non-specific - Translation" Cytosol "CAB011536: AB_777008, HPA045423: AB_2679320, HPA067156: AB_2685793" "unprognostic (5.00e-2)" "unprognostic (2.64e-2)" "unprognostic (3.18e-1)" "unprognostic (4.50e-1)" "prognostic favorable (2.51e-4)" "unprognostic (1.93e-2)" "prognostic unfavorable (5.80e-4)" "unprognostic (2.51e-3)" "unprognostic (5.70e-2)" "unprognostic (1.50e-2)" "unprognostic (3.21e-3)" "unprognostic (7.24e-2)" "prognostic unfavorable (5.70e-12)" "unprognostic (6.22e-2)" "unprognostic (2.55e-1)" "unprognostic (6.98e-3)" "unprognostic (1.40e-2)" 627.6 341.5 48.8 490.8 73.4 364.0 575.7 54.9 58.6 700.3 86.2 524.3 450.2 453.5 68.3 1353.3 437.0 227.1 233.8 35.3 80.2 296.4 347.7 490.3 542.4 104.1 58.7 724.0 728.0 126.7 167.7 214.5 92.2 473.9 270.3 80.2 1287.6 172.7 197.7 732.4 502.0 226.5 64.1 483.1 524.7 507.9 92.7 421.0 303.4 75.8 532.3 630.5 853.3 81.6 2069.1 644.4 372.2 842.0 585.0 1050.0 793.4 504.4 593.5 451.8 468.7 791.5 1107.8 3230.4 1609.1 809.5 291.3 792.4 554.6 1092.3 459.5 758.2 555.4 1713.1 302.2 562.6 835.7 673.3 891.0 1338.6 1050.2 554.8 2126.1 950.7 690.8 1071.8 1339.4 1120.1 477.5 857.3 2617.8 949.5 882.3 1487.3 929.6 967.5 541.7 1074.2 301.8 953.1 629.2 650.1 415.8 548.6 1200.7 513.2 1031.7 949.5 1005.1 512.4 809.4 723.9 897.9 753.6 606.1 1523.2 609.7 1378.1 538.8 122.8 401.3 131.2 159.3 405.2 348.9 297.4 333.0 264.3 421.4 263.0 437.4 370.4 112.5 306.9 468.5 277.2 301.5 568.0 48.8 73.4 54.9 58.6 35.3 80.2 104.1 58.7 92.2 64.1 92.7 81.6 348.4 371.8 939.1 28.7 1089.1 787.4 1075.3 735.0 1067.7 66.5 1036.1 641.2 139.7 459.0 1020.8 110.3 50.1 454.2 872.8 457.0 264.1 467.0 1727.8 352.1 628.4 523.0 477.1 999.1 42.4 769.0 860.8 458.8 530.1 436.1 1054.1 357.3 570.8 308.3 615.5 72.3 34.1 853.8 360.1 1520.8 1162.9 306.0 498.9 1144.3 370.0 53.4 1583.7 167.7 679.7 29.7 41.1 626.9 698.0 424.3 674.4 655.3 446.1 388.4 473.5 88.4 499.6 530.4 876.7 1433.1 476.0 929.6 765.3 777.9 1041.1 408.3 1061.2 1296.9 PFKFB4 ENSG00000114268 "6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4" Q16877 3 48517684-48562015 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Hydrolase, Kinase, Multifunctional enzyme, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Extravillous trophoblasts: 40.3;Proximal enterocytes: 43.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 12.5;eosinophil: 21.9;intermediate monocyte: 13.8;neutrophil: 40.4;non-classical monocyte: 25.1" "Group enriched" "Detected in many" 6 "granulocytes: 40.4;monocytes: 25.1" "Cell line enhanced" "Detected in many" "hTERT-RPE1: 52.5;U-87 MG: 83.9;WM-115: 74.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047719, HPA066058" Uncertain Approved Nucleoli NA NA "Cluster 8: Neutrophils - Inflammatory response" "Cluster 58: Brain - Synaptic function" "Cluster 11: RPE1 & U-87MG - Synaptic function" "Cluster 38: Extravillous trophoblasts - Unknown function" Nucleoli "HPA047719: AB_2680129, HPA066058: AB_2685606" "unprognostic (7.60e-2)" "prognostic unfavorable (3.04e-4)" "unprognostic (1.01e-1)" "unprognostic (1.19e-1)" "unprognostic (3.90e-3)" "unprognostic (7.96e-2)" "unprognostic (1.72e-6)" "unprognostic (1.65e-1)" "unprognostic (3.75e-2)" "unprognostic (6.78e-2)" "unprognostic (3.78e-2)" "unprognostic (7.13e-2)" "prognostic unfavorable (3.91e-8)" "unprognostic (2.04e-1)" "unprognostic (6.28e-2)" "unprognostic (2.43e-3)" "unprognostic (3.35e-2)" 1.8 2.5 5.1 4.0 5.5 14.8 1.9 6.1 6.3 3.3 3.4 3.3 18.4 2.0 18.0 7.3 1.6 1.6 1.5 5.1 6.5 3.5 1.7 4.2 1.5 6.8 6.4 3.3 11.2 3.2 5.2 10.2 6.9 3.6 3.4 16.1 2.7 1.3 5.4 3.8 20.8 2.4 5.9 10.3 1.3 24.0 7.7 1.3 1.6 3.4 1.1 2.0 5.8 6.7 12.0 3.9 8.3 8.1 2.8 4.0 16.6 6.1 10.4 11.9 29.3 6.0 4.2 5.5 5.8 4.6 28.4 3.5 3.6 10.6 10.6 3.5 2.9 12.3 9.3 6.7 2.5 2.3 5.1 4.2 15.6 19.4 1.9 52.5 2.9 6.7 4.4 4.5 9.7 2.8 0.8 17.3 5.0 2.3 8.0 0.9 4.1 5.9 4.5 11.4 2.5 5.4 6.6 3.0 23.6 8.2 6.3 5.3 0.9 12.0 4.7 1.6 36.7 21.6 4.4 3.2 83.9 4.3 74.8 0.0 12.5 21.9 0.4 13.8 0.1 0.3 0.6 0.1 5.1 0.2 1.0 0.3 40.4 0.5 25.1 0.6 0.0 4.9 5.1 5.5 6.1 6.3 5.1 6.5 6.8 6.4 6.9 5.9 7.7 6.7 0.1 0.0 1.3 13.1 0.3 3.2 0.3 7.0 1.8 6.3 1.6 1.3 1.0 2.8 2.1 0.0 2.1 13.8 0.2 1.3 0.0 2.9 2.8 1.9 2.4 0.8 4.2 0.4 4.5 1.5 40.3 1.2 0.5 3.3 1.3 2.0 1.1 1.0 6.0 6.7 7.3 13.0 2.0 7.8 0.5 2.6 0.9 7.3 1.8 3.7 3.5 3.3 1.0 6.0 13.9 2.9 1.4 0.7 1.8 0.4 43.6 0.2 2.7 4.4 0.0 0.1 1.5 0.5 0.8 2.5 1.7 5.5 0.9 1.3 3.7 0.1 PHF24 KIAA1045 ENSG00000122733 "PHD finger protein 24" Q9UPV7 9 34957608-34982544 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 5 "brain: 44.8;testis: 16.1" "Cell type enhanced" "Detected in some" "Bipolar cells: 3.7;Cone photoreceptor cells: 8.4;Early spermatids: 3.9;Late spermatids: 7.9;Muller glia cells: 14.2;Spermatocytes: 4.9;Spermatogonia: 4.8" "Cancer enhanced" "Detected in some" "testis cancer: 2.8" "Low region specificity" "Detected in many" "Immune cell enriched" "Detected in single" 20 "neutrophil: 2.0" "Lineage enriched" "Detected in single" 20 "granulocytes: 2.0" "Cell line enhanced" "Detected in single" "WM-115: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA020974 Approved NA NA "Cluster 1: Neutrophils - Mixed function" "Cluster 10: Brain - Neuronal signaling" "Cluster 17: WM-115 - Nervous system development" "Cluster 5: Muller glia cells - Visual perception" "HPA020974: AB_1852364" "unprognostic (5.54e-3)" "unprognostic (1.21e-1)" "unprognostic (9.00e-2)" "unprognostic (2.44e-1)" "unprognostic (1.00e-2)" "unprognostic (6.30e-2)" "unprognostic (3.66e-2)" "unprognostic (1.78e-2)" "unprognostic (7.06e-2)" "unprognostic (2.97e-1)" "unprognostic (4.80e-4)" "unprognostic (1.24e-1)" "unprognostic (4.58e-6)" "unprognostic (1.87e-2)" "unprognostic (1.41e-1)" "unprognostic (9.23e-2)" "unprognostic (2.30e-1)" 0.7 0.2 20.6 0.4 27.8 0.0 0.6 0.0 44.8 0.3 0.0 0.5 0.1 0.5 0.2 0.2 0.4 0.2 0.2 25.5 1.6 0.2 0.1 0.2 1.0 10.5 7.3 0.1 0.0 0.0 0.4 0.0 10.0 0.1 0.2 6.7 0.1 0.0 0.1 0.9 0.5 0.4 0.6 0.2 0.3 16.1 9.4 0.7 0.4 0.0 0.8 0.1 0.3 21.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.0 0.0 20.6 27.8 0.0 44.8 25.5 1.6 10.5 7.3 10.0 0.6 9.4 21.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.7 0.1 0.0 1.1 0.0 0.0 0.0 8.4 0.0 0.0 0.0 0.0 0.0 3.9 0.7 0.3 0.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.9 1.2 0.0 0.0 0.0 0.0 14.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 2.1 0.0 0.1 0.4 4.9 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 PIWIL4 "FLJ36156, HIWI2, Miwi2" ENSG00000134627 "Piwi like RNA-mediated gene silencing 4" Q7Z3Z4 11 94543840-94621421 "Predicted intracellular proteins" "Differentiation, Meiosis, RNA-mediated gene silencing, Spermatogenesis, Translation regulation" "Developmental protein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 24.3" "Cell type enhanced" "Detected in many" "Intestinal goblet cells: 8.7;Spermatogonia: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 4 "NB-4: 93.2" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA036587, HPA036588, HPA057508" Enhanced Supported Nucleoplasm,Mitochondria NA NA "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 24: NB-4 - Immune response" "Cluster 27: Mucus-secreting cells - Mucin production" "Nucleoplasm, Mitochondria" "HPA036587: AB_2732473, HPA036588: AB_10673502, HPA057508: AB_2683452" "unprognostic (1.43e-1)" "unprognostic (9.46e-2)" "unprognostic (2.59e-3)" "unprognostic (2.22e-3)" "unprognostic (3.16e-2)" "unprognostic (1.07e-3)" "unprognostic (1.96e-2)" "unprognostic (5.18e-2)" "unprognostic (1.41e-1)" "unprognostic (1.70e-1)" "unprognostic (6.17e-2)" "unprognostic (2.68e-1)" "unprognostic (1.21e-4)" "unprognostic (6.89e-2)" "unprognostic (1.68e-1)" "unprognostic (2.50e-1)" "unprognostic (2.80e-2)" 3.3 1.1 5.5 2.8 5.3 24.3 3.6 4.9 5.0 4.4 3.4 5.8 5.8 3.7 2.3 1.6 3.6 4.6 2.8 5.6 4.7 3.2 1.3 2.7 3.9 4.5 4.4 3.4 11.3 0.4 2.2 2.0 4.5 2.5 6.0 6.7 8.8 2.6 1.0 1.7 6.3 2.0 4.5 3.7 5.1 13.3 4.9 3.0 2.0 1.0 2.7 3.3 3.0 5.4 0.2 0.1 0.4 0.0 6.6 4.3 0.5 0.5 0.3 0.2 0.9 0.7 0.6 0.0 0.4 2.8 0.2 0.0 0.9 0.0 0.2 2.7 0.3 0.2 0.6 0.0 2.5 6.5 0.1 1.5 0.0 0.5 0.0 0.1 0.1 0.5 0.3 0.0 1.1 0.4 0.3 93.2 0.1 9.2 0.6 0.4 0.0 0.0 2.1 0.0 0.4 0.3 0.4 0.9 0.4 0.3 0.0 20.7 1.2 0.4 0.1 0.1 0.1 0.1 0.0 0.0 0.1 9.9 0.0 0.0 0.4 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.2 5.5 5.3 4.9 5.0 5.6 4.7 4.5 4.4 4.5 4.5 4.9 5.4 1.1 0.0 0.5 3.3 0.2 1.3 0.2 0.4 0.0 0.6 1.3 1.3 3.5 7.2 1.4 0.0 0.0 4.0 0.2 4.1 1.9 6.2 4.7 0.7 0.7 0.6 0.0 0.4 5.4 2.0 0.5 1.6 7.7 1.3 0.0 0.9 0.7 0.0 1.7 0.0 4.9 8.7 0.0 3.0 1.7 2.1 0.3 1.7 0.0 3.7 2.0 0.7 1.0 5.0 6.0 3.0 4.9 1.2 0.1 0.5 4.4 0.6 1.7 3.3 0.0 2.2 1.3 1.2 12.0 0.6 0.1 1.0 0.3 0.3 5.3 0.1 PLPPR5 "LPPR5, PAP2, PAP2D, PRG5" ENSG00000117598 "Phospholipid phosphatase related 5" Q32ZL2 1 98890245-99005032 "Metabolic proteins, Predicted membrane proteins" Hydrolase "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;retina: 1.6;testis: 2.0" "Group enriched" "Detected in some" 4 "Bipolar cells: 8.5;Horizontal cells: 3.3;Spermatogonia: 6.9" "Group enriched" "Detected in some" 13 "glioma: 2.7;renal cancer: 1.5" "Low region specificity" "Detected in many" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "PC-3: 11.9;SH-SY5Y: 21.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018072, HPA059085" Uncertain Approved "Plasma membrane,Cytosol" NA NA "Cluster 65: Brain - Ion transport" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 62: Horizontal cells - Visual perception" "Plasma membrane" Cytosol "HPA018072: AB_1854958, HPA059085: AB_2732631" "unprognostic (2.57e-1)" "unprognostic (1.63e-2)" "unprognostic (1.68e-1)" "unprognostic (1.68e-2)" "unprognostic (2.01e-1)" "unprognostic (2.26e-1)" "unprognostic (1.11e-1)" "unprognostic (3.18e-1)" "unprognostic (1.43e-1)" "unprognostic (2.07e-1)" "prognostic unfavorable (6.22e-4)" "unprognostic (1.81e-2)" "unprognostic (1.28e-1)" "unprognostic (2.33e-1)" 0.0 0.4 5.2 0.0 5.8 0.0 0.0 0.1 6.6 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 4.5 0.0 0.0 0.0 0.0 1.3 3.9 0.0 0.4 0.0 0.2 0.0 2.8 0.0 0.1 1.6 0.0 0.1 0.1 0.0 0.0 0.0 2.0 0.0 0.0 2.0 7.1 0.0 0.0 0.0 0.0 0.2 0.0 3.5 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 11.9 0.0 0.0 0.0 0.5 0.1 0.4 21.6 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 5.8 0.1 6.6 6.1 4.5 1.3 3.9 2.8 2.0 7.1 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.2 1.5 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 0.0 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 0.7 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.5 0.0 0.7 0.0 0.0 0.0 0.6 0.0 1.3 0.0 0.1 0.1 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 POMT2 LGMD2N ENSG00000009830 "Protein O-mannosyltransferase 2" Q9UKY4 14 77274956-77320883 "Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins" "Glycosyltransferase, Transferase" "Congenital muscular dystrophy, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 37.5" "Cell type enhanced" "Detected in many" "Astrocytes: 27.1;Oligodendrocytes: 30.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003663 Uncertain Approved Nucleoplasm,Nucleoli,Cytosol NA NA "Cluster 47: Plasmacytoid DCs - Protein folding" "Cluster 43: Testis - Unknown function" "Cluster 4: Mesenchymal cell lines - Antiviral immune response" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nucleoli, Cytosol" "HPA003663: AB_1079655" "unprognostic (2.15e-1)" "unprognostic (1.07e-2)" "unprognostic (7.92e-2)" "unprognostic (3.37e-2)" "unprognostic (1.48e-1)" "unprognostic (1.31e-1)" "prognostic unfavorable (2.40e-4)" "unprognostic (7.10e-3)" "unprognostic (1.17e-1)" "unprognostic (1.68e-1)" "unprognostic (6.89e-3)" "unprognostic (1.94e-3)" "unprognostic (8.50e-3)" "unprognostic (1.37e-1)" "unprognostic (2.44e-1)" "unprognostic (6.75e-3)" "unprognostic (3.46e-2)" 5.8 12.4 13.2 4.1 14.9 2.5 5.7 13.5 13.4 8.0 12.5 6.7 2.6 6.7 9.8 5.5 5.8 4.0 7.9 12.7 13.1 10.8 9.3 5.6 1.8 14.6 14.6 6.1 8.8 8.6 12.6 7.0 13.4 7.8 3.3 5.6 6.3 6.9 19.1 4.7 4.9 4.6 13.7 5.6 5.9 37.5 14.4 2.9 10.9 8.4 1.9 7.9 5.3 15.4 15.6 19.4 18.6 21.1 13.0 10.3 14.8 13.4 10.8 19.3 16.6 9.6 13.6 4.6 10.6 12.6 27.1 17.1 8.8 13.3 13.5 6.9 12.1 2.8 8.9 7.9 15.8 3.2 8.9 10.5 13.9 18.3 17.8 13.6 11.5 4.5 7.4 10.5 13.0 30.7 5.4 15.0 5.3 21.4 16.2 5.3 18.0 4.1 20.4 11.3 15.6 15.2 8.7 14.6 11.3 12.0 15.1 6.5 9.6 14.6 22.8 17.1 12.0 6.8 14.5 2.1 7.4 4.8 13.2 0.0 0.0 0.0 0.4 0.4 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 0.4 0.0 0.1 13.2 14.9 13.5 13.4 12.7 13.1 14.6 14.6 13.4 13.7 14.4 15.4 3.2 6.4 2.8 27.1 2.0 3.1 2.7 3.4 2.8 7.5 7.2 7.6 4.3 4.3 1.6 1.8 16.7 6.0 1.2 6.5 0.0 7.6 14.3 5.8 6.7 3.1 18.0 0.0 12.9 7.5 10.2 6.1 4.1 7.0 2.5 6.4 2.5 5.7 5.5 8.4 14.5 3.2 2.0 2.2 2.6 17.2 1.8 2.4 1.8 9.4 2.3 5.9 0.0 20.1 30.5 5.5 3.2 4.1 2.1 5.2 2.5 3.6 5.1 15.1 0.0 6.2 5.0 11.3 8.2 5.2 1.8 5.7 1.2 13.9 3.6 1.9 PPP1R14C "CPI17-like, KEPI, NY-BR-81" ENSG00000198729 "Protein phosphatase 1 regulatory inhibitor subunit 14C" Q8TAE6 6 150143044-150250392 "Predicted intracellular proteins" "Protein phosphatase inhibitor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 75.5;skeletal muscle: 66.5;skin 1: 97.2;thyroid gland: 58.7" "Cell type enhanced" "Detected in many" "Basal keratinocytes: 280.2;Cardiomyocytes: 79.5;Skeletal myocytes: 80.9;Suprabasal keratinocytes: 336.6" "Cancer enhanced" "Detected in many" "thyroid cancer: 53.0" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "HaCaT: 40.7;HBEC3-KT: 86.1;HEK 293: 36.2;hTCEpi: 103.0;hTERT-HME1: 41.1;RPTEC TERT1: 35.5;SK-BR-3: 37.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB044667, HPA047907" Approved NA NA "Cluster 31: Skin - Epidermis development" "Cluster 30: Epithelial cell lines - Translation" "Cluster 28: Keratinocytes - Keratinization" "CAB044667: , HPA047907: " "unprognostic (1.81e-3)" "unprognostic (7.65e-2)" "unprognostic (4.25e-3)" "unprognostic (6.92e-2)" "unprognostic (3.96e-3)" "unprognostic (2.20e-2)" "unprognostic (3.81e-3)" "unprognostic (1.55e-1)" "unprognostic (6.63e-2)" "unprognostic (5.13e-2)" "unprognostic (4.50e-2)" "unprognostic (1.18e-1)" "unprognostic (2.86e-2)" "unprognostic (2.14e-1)" "unprognostic (1.98e-1)" "unprognostic (7.49e-3)" "unprognostic (6.77e-2)" 0.4 0.2 5.1 1.4 6.6 0.2 6.0 5.9 8.0 10.2 6.0 12.5 10.4 1.4 0.9 18.4 16.0 0.1 75.5 7.8 5.0 9.5 0.0 12.3 0.3 5.6 5.4 0.1 0.7 5.1 1.7 3.4 5.6 1.3 8.6 0.6 3.2 0.2 66.5 97.2 2.7 0.9 4.4 0.1 0.8 6.7 5.0 0.5 58.7 8.5 5.8 0.5 22.0 5.0 27.9 0.1 11.7 0.1 0.1 0.6 0.0 3.7 0.0 0.0 0.1 1.3 3.8 0.7 8.0 5.3 1.8 40.7 6.1 86.1 0.0 0.0 36.2 0.3 0.0 0.0 0.0 0.0 1.1 0.0 103.0 0.2 41.1 0.0 0.0 0.5 23.6 0.0 0.0 3.8 0.0 0.0 0.4 0.0 0.2 0.7 0.0 0.0 35.5 1.5 6.2 0.0 0.6 37.7 2.2 0.7 0.2 1.9 0.0 0.1 20.4 32.5 9.5 0.0 0.0 0.0 14.2 16.1 2.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.1 6.6 5.9 8.0 7.8 5.0 5.6 5.4 5.6 4.4 5.0 5.0 0.3 19.2 41.1 1.3 0.5 280.2 17.9 19.6 12.0 1.1 6.5 4.3 79.5 0.0 17.1 14.7 0.0 0.1 0.4 24.5 1.9 3.8 0.2 37.9 0.6 3.0 28.2 0.0 28.0 0.2 0.1 6.7 0.0 5.1 1.3 4.1 0.0 0.0 3.0 1.7 13.3 3.1 14.2 0.0 19.7 1.6 0.0 0.6 30.2 2.8 1.1 0.0 0.0 37.2 2.5 12.8 41.5 0.4 0.0 16.6 5.0 38.6 61.5 0.5 0.0 80.9 4.3 0.5 1.8 14.7 336.6 1.9 1.4 0.5 8.7 1.9 PRCP "HUMPCP, PCP" ENSG00000137509 Prolylcarboxypeptidase P42785 11 82822936-82970584 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Carboxypeptidase, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Hepatic stellate cells: 348.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "ASC diff: 463.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA017065, HPA071115" Approved Supported Vesicles "Intracellular and membrane" NA NA 42000000 "Cluster 28: Myeloid DCs - Unknown function" "Cluster 68: Epididymis - Unknown function" "Cluster 34: Mesenchymal cell lines - ECM organization" "Cluster 14: Adipocytes & Endothelial cells - Angiogenesis" Vesicles "HPA017065: AB_1855676, HPA071115: " "unprognostic (3.24e-1)" "unprognostic (2.25e-1)" "unprognostic (1.76e-1)" "unprognostic (1.51e-1)" "unprognostic (2.54e-1)" "unprognostic (1.33e-2)" "unprognostic (9.22e-2)" "unprognostic (1.42e-1)" "unprognostic (7.97e-2)" "unprognostic (2.61e-1)" "unprognostic (2.70e-1)" "unprognostic (1.88e-2)" "prognostic favorable (2.65e-6)" "unprognostic (7.16e-2)" "unprognostic (1.73e-2)" "unprognostic (3.49e-1)" "unprognostic (4.07e-1)" 74.8 87.3 81.1 57.8 82.1 37.7 70.0 84.3 109.1 91.9 95.0 49.3 28.6 62.9 81.4 62.1 57.0 64.3 70.0 76.6 85.6 144.7 151.9 58.1 92.1 84.4 82.1 53.5 37.9 78.4 34.5 152.8 80.9 52.5 46.6 21.9 85.6 55.5 15.9 54.1 31.8 80.8 89.0 54.0 32.0 41.8 86.0 33.7 63.7 28.5 85.0 100.2 57.5 86.7 34.9 41.8 49.6 121.0 463.5 146.7 67.1 67.5 131.9 70.9 97.0 103.5 70.7 55.9 100.7 117.9 72.6 53.2 53.7 45.2 72.0 43.9 38.3 37.7 56.5 76.7 86.2 31.0 124.7 122.0 39.3 72.7 68.6 166.5 224.0 26.3 39.1 69.8 72.7 19.5 4.9 171.7 33.9 90.3 31.1 27.1 97.0 65.1 118.0 71.2 24.0 51.9 101.9 60.2 41.5 80.6 66.6 49.6 65.0 78.8 77.4 71.1 33.5 64.2 113.6 46.3 32.9 41.7 44.5 53.5 76.9 50.9 13.7 79.0 16.1 31.7 14.0 15.9 140.2 34.2 12.0 17.4 89.0 34.7 64.8 27.9 14.8 49.6 81.1 82.1 84.3 109.1 76.6 85.6 84.4 82.1 80.9 89.0 86.0 86.7 86.9 19.2 12.9 58.8 45.5 31.4 41.5 53.4 25.0 11.7 26.2 25.1 26.6 37.1 25.2 62.5 2.1 65.1 29.0 9.8 29.4 32.9 44.9 17.4 37.7 180.4 19.7 13.7 42.2 12.0 120.1 73.6 23.9 29.9 12.7 18.2 348.7 65.4 80.7 16.8 38.5 19.1 14.2 152.9 118.9 47.6 44.1 88.0 71.2 33.7 79.5 53.5 28.8 34.7 10.5 8.2 10.2 46.3 62.2 23.3 3.9 83.8 9.1 5.3 65.7 25.5 25.6 60.8 6.3 54.3 34.9 52.9 22.3 27.7 20.9 39.2 PRM1 CT94.1 ENSG00000175646 "Protamine 1" P04553 16 11280841-11281330 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1099 "testis: 14115.0" "Cell type enriched" "Detected in some" 6 "Late spermatids: 776887.9" "Cancer enriched" "Detected in single" 161 "testis cancer: 11.5" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 2.4;U-2197: 1.7" "Not detected" "Not detected" "HPA055150, HPA059371" Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 24: NB-4 - Immune response" "Cluster 31: Spermatids - Spermatogenesis" Nucleoplasm Cytosol "HPA055150: AB_2682718, HPA059371: " "unprognostic (2.10e-2)" 2.3 2.2 0.0 0.5 0.0 0.0 9.9 0.0 0.0 2.1 0.0 2.1 1.5 1.0 0.0 1.9 1.2 0.0 2.2 0.0 0.2 2.7 4.4 1.3 0.4 0.1 0.0 1.6 3.0 0.0 1.9 0.0 0.1 12.8 0.0 0.0 2.1 1.3 5.8 3.7 4.0 0.0 0.0 1.4 2.4 14115.0 0.0 0.0 4.3 0.0 0.1 1.4 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 126844.3 0.0 0.0 80.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 776887.9 1855.9 161.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1689.6 0.0 0.0 0.0 0.0 0.0 0.0 1157.0 0.0 0.0 2054.0 1211.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRM2 CT94.2 ENSG00000122304 "Protamine 2" P04554 16 11275639-11276480 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1083 "testis: 11696.6" "Cell type enriched" "Detected in some" 7 "Late spermatids: 506606.3" "Cancer enriched" "Detected in single" 187 "testis cancer: 11.0" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 8 "BEWO: 1.1;NB-4: 1.3;U-2197: 1.8" "Not detected" "Not detected" "Not detected" "Not detected" "CAB032738, HPA056386" Enhanced NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 18: U-2197 - ECM organization" "Cluster 31: Spermatids - Spermatogenesis" "CAB032738: AB_2171312, HPA056386: AB_2683111" "unprognostic (3.88e-2)" 1.9 1.9 0.0 0.3 0.0 0.0 8.5 0.0 0.0 1.7 0.0 1.7 0.6 1.0 0.0 1.6 1.1 0.0 1.9 0.0 0.0 2.2 3.6 1.1 0.5 0.0 0.0 1.4 2.6 0.0 1.6 0.0 0.0 10.7 0.0 0.0 1.7 0.8 4.6 3.1 3.2 0.0 0.0 1.1 2.0 11696.6 0.0 0.2 3.6 0.0 0.0 1.3 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 70432.4 0.2 0.0 77.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 506606.3 1538.1 115.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1673.0 0.0 0.0 0.0 0.0 0.0 0.0 913.8 0.0 0.0 1879.2 957.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PRM3 ENSG00000178257 "Protamine 3" Q9NNZ6 16 11273199-11273629 "Predicted intracellular proteins" "Differentiation, DNA condensation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Tissue enriched" "Detected in some" 33 "testis: 88.9" "Cell type enriched" "Detected in some" 4 "Late spermatids: 3440.3" "Not detected" "Not detected" "Region enhanced" "Detected in some" "cerebellum: 2.4" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 6 "TIME: 3.6" "Not detected" "Not detected" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 31: Spermatids - Spermatogenesis" 0.0 0.0 0.4 0.0 0.6 2.6 0.0 2.4 1.2 0.0 0.0 0.0 0.3 0.1 0.0 0.1 0.0 0.0 0.1 0.3 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.2 0.0 0.2 0.6 0.0 0.0 0.1 0.2 0.0 88.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.2 0.0 0.0 0.0 0.1 0.0 3.6 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.6 2.4 1.2 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 854.9 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3440.3 12.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.2 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 8.9 7.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 RABGAP1L "FLJ38519, HHL, KIAA0471, TBC1D18" ENSG00000152061 "RAB GTPase activating protein 1 like" "B7ZAP0, Q5R372" 1 174159410-174995308 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Protein transport, Transport" "GTPase activation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 121.0" "Cell type enhanced" "Detected in all" "Excitatory neurons: 551.4;Inhibitory neurons: 444.0;Microglial cells: 267.0;Oligodendrocyte precursor cells: 362.4;Oligodendrocytes: 342.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in all" "Daudi: 136.9;Karpas-707: 87.6;U-698: 85.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA054695 Uncertain NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 44: Heart - Cardiac muscle contraction" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling" "HPA054695: AB_2682577" "unprognostic (2.57e-2)" "unprognostic (7.77e-2)" "unprognostic (6.78e-2)" "unprognostic (6.89e-3)" "unprognostic (1.54e-2)" "unprognostic (6.96e-3)" "unprognostic (8.55e-2)" "prognostic favorable (1.16e-4)" "unprognostic (2.66e-2)" "unprognostic (3.51e-2)" "unprognostic (2.66e-2)" "unprognostic (1.98e-1)" "unprognostic (9.14e-3)" "unprognostic (6.69e-2)" "unprognostic (2.14e-1)" "unprognostic (5.03e-2)" "unprognostic (2.46e-1)" 12.1 8.6 16.1 22.8 19.1 31.1 15.7 46.1 20.6 15.0 51.2 20.4 22.0 13.1 16.3 18.6 19.0 22.1 121.0 19.4 17.2 16.8 16.3 26.4 41.9 9.6 13.2 28.8 19.9 10.5 20.5 18.3 11.2 10.4 21.2 16.2 23.6 10.5 6.5 16.5 24.3 13.4 10.0 26.3 22.6 31.1 15.9 20.1 10.0 7.4 50.1 19.9 10.3 19.5 15.6 8.0 6.0 6.2 16.4 23.9 13.3 18.1 16.0 7.9 10.6 7.5 56.0 136.9 12.5 14.0 9.3 19.6 5.2 12.1 11.0 37.7 8.5 34.2 11.0 11.5 10.1 15.1 13.2 18.9 8.2 5.7 8.5 13.3 17.7 12.6 20.2 87.6 12.8 5.3 11.9 14.4 37.2 20.9 4.8 41.0 12.0 45.7 15.5 70.9 17.5 10.4 17.2 28.8 12.1 18.4 14.0 18.1 24.5 9.9 8.9 11.0 10.7 75.6 26.3 85.7 10.9 10.1 7.5 16.7 50.0 110.2 25.7 86.5 22.7 34.7 31.5 31.5 40.3 26.4 15.2 23.5 89.6 80.3 180.8 53.6 42.3 32.9 16.1 19.1 46.1 20.6 19.4 17.2 9.6 13.2 11.2 10.0 15.9 19.5 23.1 73.7 106.1 143.7 63.8 12.4 11.4 19.9 39.3 38.7 20.7 13.2 263.0 47.1 38.6 33.1 31.3 39.1 101.2 43.3 13.7 28.8 117.2 59.0 18.6 17.6 49.1 33.8 551.4 36.9 9.5 35.3 46.9 46.8 24.6 8.9 23.9 16.3 38.5 21.9 444.0 37.8 18.3 57.0 16.2 121.3 15.5 63.1 16.0 267.0 100.4 17.3 68.0 362.4 342.8 24.5 36.0 18.8 81.8 11.5 39.8 13.3 100.3 23.8 6.6 15.0 25.1 91.8 18.5 36.9 13.1 28.2 74.6 26.1 27.0 27.5 RAD51AP2 FLJ17540 ENSG00000214842 "RAD51 associated protein 2" Q09MP3 2 17510584-17518439 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 14 "testis: 9.4" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 457.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 78: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "unprognostic (3.87e-2)" "unprognostic (3.31e-2)" "unprognostic (9.98e-2)" "unprognostic (3.12e-2)" "unprognostic (4.61e-1)" "unprognostic (3.51e-1)" "unprognostic (9.80e-2)" "unprognostic (4.84e-3)" "unprognostic (2.64e-1)" "unprognostic (1.92e-1)" "unprognostic (1.71e-1)" "unprognostic (6.26e-3)" "unprognostic (3.82e-2)" "unprognostic (1.62e-3)" "unprognostic (1.15e-1)" 0.0 0.0 0.1 0.0 0.3 0.0 0.1 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.2 0.0 0.2 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.6 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.6 0.2 0.0 0.1 0.2 0.1 0.0 0.0 0.2 0.1 0.0 0.0 0.7 0.2 0.5 1.5 0.9 1.2 0.1 0.7 2.8 0.9 0.0 0.2 0.0 2.1 0.0 0.0 6.0 0.0 0.0 12.8 0.0 0.1 0.2 0.0 0.0 8.0 0.0 0.0 0.2 2.0 0.0 0.0 0.1 0.0 1.7 0.1 0.0 4.1 0.7 0.0 0.0 0.2 5.7 0.9 0.0 0.0 0.0 0.0 0.6 0.0 0.5 0.3 0.1 0.1 0.4 0.1 1.1 0.0 0.1 0.2 0.2 26.3 0.1 0.4 457.6 51.7 0.6 0.6 0.0 0.0 0.5 1.6 0.9 RAD9B FLJ40346 ENSG00000151164 "RAD9 checkpoint clamp component B" Q6WBX8 12 110501655-110533556 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 13 "testis: 11.3" "Group enriched" "Detected in some" 21 "Spermatocytes: 91.5;Spermatogonia: 29.0" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 5 "basophil: 4.7" "Lineage enriched" "Detected in single" 5 "granulocytes: 4.7" "Cell line enhanced" "Detected in some" "JURKAT: 2.7;SiHa: 2.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040643 Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 74: Testis - Spermatogenesis" "Cluster 32: U-937 - Innate immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA040643: AB_10805716" "unprognostic (2.32e-1)" "unprognostic (2.55e-5)" "unprognostic (4.76e-2)" "unprognostic (1.30e-3)" "unprognostic (2.93e-1)" "unprognostic (6.27e-3)" "unprognostic (5.44e-2)" "unprognostic (2.00e-1)" "unprognostic (1.56e-2)" "unprognostic (1.22e-1)" "unprognostic (5.92e-2)" "unprognostic (2.26e-1)" "unprognostic (2.68e-3)" "unprognostic (7.33e-2)" "unprognostic (1.99e-1)" "unprognostic (2.15e-2)" "unprognostic (1.80e-2)" 0.3 0.1 0.3 0.2 0.4 0.3 0.4 0.4 0.4 0.4 0.2 0.3 0.0 0.4 0.4 0.3 0.3 0.1 0.8 0.3 0.3 0.2 0.3 0.3 0.5 0.4 0.3 0.7 0.1 0.1 0.1 0.1 0.4 0.3 0.1 0.4 0.1 0.4 0.8 0.2 0.2 0.5 0.3 0.3 0.2 11.3 0.4 0.4 0.2 0.5 0.3 0.3 0.2 0.7 1.6 0.1 0.1 0.4 0.1 0.3 0.1 0.7 0.2 0.7 0.6 1.6 0.1 1.2 0.3 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.4 1.5 0.2 0.0 0.2 1.9 0.3 0.2 0.2 0.6 0.5 0.2 0.1 2.7 0.3 0.9 0.9 0.2 0.4 0.5 0.1 0.5 0.5 0.1 0.4 0.3 0.3 0.2 0.3 0.1 2.9 0.3 0.4 0.0 0.6 1.0 0.2 0.3 0.0 0.3 0.2 0.6 0.3 0.7 0.3 1.0 1.0 4.7 0.5 0.2 0.2 0.4 0.2 0.4 0.3 0.1 0.9 0.3 0.2 0.1 0.5 0.2 0.9 0.5 0.1 0.3 0.3 0.4 0.4 0.4 0.3 0.3 0.4 0.3 0.4 0.3 0.4 0.7 0.2 0.0 0.0 1.6 0.7 0.5 0.4 0.5 0.0 0.3 0.3 0.3 1.5 0.0 0.1 0.0 0.0 0.0 0.1 0.1 1.9 0.3 2.8 0.2 0.1 0.4 0.0 0.4 0.7 0.0 0.1 0.7 0.0 0.3 0.0 0.9 0.4 0.3 1.3 0.0 0.7 0.0 0.0 1.2 0.3 2.0 1.5 0.5 0.0 1.9 1.9 0.6 1.0 0.5 2.8 0.4 0.0 0.0 0.5 0.2 0.0 0.1 2.4 0.8 0.0 0.5 0.2 91.5 29.0 0.0 0.4 0.1 0.3 0.1 0.1 0.2 RBM44 FLJ40411 ENSG00000177483 "RNA binding motif protein 44" Q6ZP01 2 237798389-237842808 "Predicted intracellular proteins" RNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 31 "testis: 15.7" "Group enriched" "Detected in many" 4 "Spermatocytes: 104.7;Spermatogonia: 59.8" "Not detected" "Not detected" "Not detected" "Not detected" "Immune cell enriched" "Detected in single" 13 "basophil: 1.3" "Lineage enriched" "Detected in single" 13 "granulocytes: 1.3" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA003298 Enhanced NA NA "Cluster 34: Basophils - Unknown function" "Cluster 36: Testis - Spermatogenesis" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA003298: AB_2284846" "unprognostic (1.29e-1)" "unprognostic (2.66e-1)" "unprognostic (5.92e-2)" "unprognostic (1.56e-1)" "unprognostic (8.47e-3)" "unprognostic (3.15e-2)" "unprognostic (2.41e-1)" "unprognostic (2.60e-1)" "unprognostic (1.83e-2)" "unprognostic (8.12e-2)" "unprognostic (4.10e-2)" "unprognostic (4.57e-2)" "unprognostic (5.01e-5)" "unprognostic (1.90e-1)" "unprognostic (4.27e-2)" "unprognostic (6.85e-3)" "unprognostic (7.89e-3)" 0.3 0.0 0.0 0.1 0.0 0.5 0.3 0.0 0.1 0.3 0.0 0.2 0.0 0.2 0.2 0.1 0.1 0.1 0.1 0.0 0.0 0.2 0.1 0.3 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.2 0.1 0.2 0.2 0.0 0.3 0.1 15.7 0.0 0.0 0.1 0.3 0.1 0.2 0.2 0.0 0.0 0.0 0.2 0.1 0.2 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.1 0.3 0.3 0.0 0.1 0.0 0.2 0.3 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 0.2 0.4 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.3 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 1.1 1.6 0.4 0.8 0.7 0.3 0.6 0.0 0.8 0.3 0.7 1.5 1.5 1.8 0.0 0.1 2.2 0.0 0.0 0.1 16.8 2.0 0.5 2.4 0.0 0.0 2.4 0.2 0.3 1.0 0.0 4.6 0.0 0.3 0.0 0.2 0.3 0.0 3.3 0.0 0.0 0.8 2.3 16.1 2.8 1.5 1.8 1.9 1.4 0.0 1.0 3.0 0.4 0.6 0.0 1.5 1.0 2.0 0.1 0.1 1.8 0.0 6.6 2.6 0.7 104.7 59.8 0.2 0.6 0.0 0.8 0.7 0.0 1.6 REEP6 "C19orf32, DP1L1, FLJ25383, Yip2f" ENSG00000115255 "Receptor accessory protein 6" Q96HR9 19 1491166-1497927 "Disease related genes, Human disease related genes, Predicted membrane proteins" "Disease variant, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 217.5;liver: 398.0;testis: 283.9" "Cell type enhanced" "Detected in many" "Early spermatids: 559.1;Late spermatids: 3135.0;Proximal enterocytes: 898.7" "Cancer enhanced" "Detected in all" "liver cancer: 114.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CACO-2: 57.9;Hep G2: 56.2;K-562: 155.7;T-47d: 121.4" "HPA003895, HPA048015" Enhanced Supported "Endoplasmic reticulum" NA NA "Cluster 27: Non-specific - Gene expression" "Cluster 45: Intestine - Brush border" "Cluster 1: K-562 - Erythropoiesis" "Cluster 25: Spermatids - Spermatogenesis" "Endoplasmic reticulum" "HPA003895: AB_1845723, HPA048015: AB_2680233" "unprognostic (1.21e-1)" "unprognostic (1.56e-1)" "unprognostic (7.76e-2)" "unprognostic (1.63e-3)" "unprognostic (3.24e-1)" "unprognostic (2.43e-2)" "unprognostic (1.92e-1)" "unprognostic (6.85e-2)" "unprognostic (7.38e-2)" "unprognostic (4.56e-1)" "unprognostic (1.49e-1)" "unprognostic (1.93e-1)" "unprognostic (1.40e-2)" "unprognostic (2.17e-1)" "unprognostic (8.08e-2)" "unprognostic (2.83e-1)" "unprognostic (5.38e-2)" 8.4 86.5 11.1 1.3 12.4 1.2 17.5 10.1 18.0 5.6 7.7 3.0 217.5 3.5 14.6 14.3 4.6 7.0 3.9 12.7 8.8 22.1 398.0 1.6 1.3 9.7 10.1 7.7 28.5 2.0 9.8 1.6 9.9 20.1 1.7 94.0 17.9 6.8 2.0 9.3 199.6 0.9 8.4 1.7 4.2 283.9 12.1 0.7 6.0 0.7 1.0 9.2 7.0 10.9 7.3 9.2 2.6 34.3 5.6 2.0 39.5 1.8 0.7 1.9 1.9 57.9 22.5 3.9 12.2 1.1 2.3 7.3 9.8 0.6 1.0 1.9 4.1 21.3 1.3 56.2 4.2 1.6 6.6 4.7 4.1 0.4 1.4 3.2 1.1 4.9 155.7 5.0 0.3 29.6 1.8 4.7 12.8 21.1 19.5 4.9 1.1 10.0 10.9 2.7 0.7 17.2 9.8 14.2 6.3 1.9 121.4 5.7 3.4 2.8 5.4 8.7 1.2 16.4 5.3 0.8 11.2 9.4 8.2 0.0 1.1 0.0 5.5 1.2 2.8 0.1 1.4 1.2 1.9 0.6 2.0 2.2 0.0 4.9 4.3 3.3 1.6 1.6 11.1 12.4 10.1 18.0 12.7 8.8 9.7 10.1 9.9 8.4 12.1 10.9 1.5 3.2 3.2 2.6 2.7 6.8 7.9 6.8 10.8 30.4 47.4 20.3 1.8 91.5 10.5 5.5 33.3 69.4 2.5 7.8 7.9 34.5 559.1 4.5 7.1 4.2 6.0 10.1 1.5 69.2 12.8 4.7 2.6 3.0 10.2 132.9 5.0 267.4 9.6 23.5 1.2 51.9 4.1 6.3 4.3 3135.0 34.2 4.1 30.2 0.0 1.7 44.2 2.1 0.0 1.5 25.0 53.6 16.6 1.9 13.1 898.7 52.0 8.3 292.8 19.7 0.8 3.3 29.9 36.5 17.5 6.7 36.0 4.3 50.1 70.7 14.7 RNF43 "DKFZp781H0392, FLJ20315, URCC" ENSG00000108375 "Ring finger protein 43" Q68DV7 17 58353676-58417595 "Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" "Ubl conjugation pathway, Wnt signaling pathway" "Developmental protein, Transferase" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 22.7" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 67.7;Intestinal goblet cells: 41.6;Undifferentiated cells: 63.6" "Cancer enriched" "Detected in many" 4 "colorectal cancer: 41.7" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "A549: 17.0;CACO-2: 24.7;Hep G2: 49.4;OE19: 54.7" HPA008079 Uncertain NA NA "Cluster 15: NK-cells - Transcription" "Cluster 87: Intestine & Kidney - Transmembrane transport" "Cluster 21: OE19 - Mitochondria" "Cluster 53: Intestinal epithelial cells - Unknown function" "HPA008079: AB_1856371" "unprognostic (2.53e-1)" "unprognostic (1.09e-1)" "unprognostic (7.46e-2)" "unprognostic (2.56e-1)" "unprognostic (1.10e-1)" "unprognostic (4.33e-2)" "unprognostic (1.39e-1)" "unprognostic (3.62e-1)" "unprognostic (2.93e-1)" "unprognostic (1.05e-1)" "unprognostic (5.69e-2)" "unprognostic (3.79e-1)" "prognostic favorable (6.04e-9)" "unprognostic (3.61e-3)" "unprognostic (2.56e-1)" "unprognostic (3.58e-1)" "unprognostic (1.04e-2)" 0.2 10.9 1.7 2.0 3.1 0.7 5.5 9.6 2.7 2.6 1.5 13.4 22.7 1.7 4.4 10.4 4.8 2.7 2.7 2.0 1.3 6.1 9.1 3.6 0.4 1.8 3.4 0.9 8.2 5.2 4.3 4.8 1.9 9.4 19.3 1.2 9.3 4.8 0.3 11.3 16.9 0.6 1.4 0.5 5.8 3.4 2.3 3.7 1.9 0.0 1.5 2.1 5.2 1.4 1.1 17.0 2.7 0.0 0.0 0.0 9.3 0.0 0.0 0.0 0.0 24.7 8.2 0.0 8.5 0.0 1.9 4.6 0.6 6.8 0.0 8.6 11.3 1.9 0.8 49.4 0.0 0.2 0.1 0.0 13.4 0.0 2.1 0.0 0.0 0.2 0.2 0.4 0.0 0.2 0.1 0.2 0.4 54.7 1.0 0.3 0.0 2.2 5.9 9.0 1.6 0.1 1.6 0.7 0.5 5.4 2.0 0.1 0.0 0.0 1.8 0.0 0.0 0.6 1.4 0.1 0.3 0.0 3.8 0.1 0.0 0.0 0.2 0.0 0.3 0.2 0.1 0.3 0.0 0.1 0.2 0.1 0.1 0.3 0.0 0.0 0.2 0.0 1.7 3.1 9.6 2.7 2.0 1.3 1.8 3.4 1.9 1.4 2.3 1.4 0.3 3.2 8.9 29.0 2.5 9.6 17.5 14.1 67.7 2.5 17.3 13.6 4.0 17.2 5.8 18.4 2.1 26.0 2.2 33.0 15.6 5.3 1.2 14.6 1.1 1.8 15.5 0.8 1.8 2.7 3.1 0.7 9.7 12.7 0.0 7.2 0.7 11.9 2.6 5.0 1.3 41.6 12.2 0.8 0.9 1.5 0.3 1.3 14.2 4.7 2.8 12.0 10.3 0.0 0.7 6.2 21.1 0.4 1.0 9.9 28.7 2.9 5.6 2.8 0.0 0.5 1.1 1.0 0.8 28.4 6.1 5.9 3.1 0.4 63.6 6.3 RORC "NR1F3, RORG, RZRG, TOR" ENSG00000143365 "RAR related orphan receptor C" P51449 1 151806071-151831845 "Disease related genes, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors" "Biological rhythms, Transcription, Transcription regulation" "Activator, Developmental protein, DNA-binding, Receptor" "Disease variant" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 86.2;skeletal muscle: 128.0" "Cell type enhanced" "Detected in many" "Distal tubular cells: 35.2;Hepatocytes: 47.8;Proximal enterocytes: 32.9" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in some" "cerebellum: 4.1" "Immune cell enriched" "Detected in many" 6 "MAIT T-cell: 50.3" "Lineage enriched" "Detected in many" 44 "T-cells: 50.3" "Cell line enhanced" "Detected in some" "HDLM-2: 23.8;Karpas-707: 11.5;MOLT-4: 6.3;RPMI-8226: 6.0;SK-BR-3: 5.7;T-47d: 9.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA065620 Supported "Nuclear bodies" NA NA "Cluster 16: MAIT-cells - Unknown function" "Cluster 59: Non-specific - Translation" "Cluster 44: HDLM-2 - Immune response" "Cluster 30: Mammary glandular cells - Lactation" "Nuclear bodies" "HPA065620: AB_2685521" "unprognostic (6.51e-2)" "unprognostic (7.78e-2)" "prognostic favorable (1.83e-4)" "unprognostic (9.20e-2)" "unprognostic (3.05e-4)" "unprognostic (6.29e-5)" "unprognostic (1.13e-3)" "unprognostic (8.94e-2)" "unprognostic (1.67e-1)" "unprognostic (7.88e-2)" "unprognostic (3.78e-2)" "unprognostic (2.42e-1)" "prognostic favorable (2.94e-5)" "unprognostic (2.13e-1)" "unprognostic (3.22e-1)" "unprognostic (1.82e-2)" "unprognostic (1.80e-2)" 2.9 4.9 0.2 1.8 0.1 0.4 7.5 4.1 0.3 6.5 5.2 9.3 11.6 1.9 4.6 5.4 21.2 3.7 11.6 0.2 0.4 18.8 86.2 12.7 0.9 0.9 1.6 0.3 59.2 33.5 18.3 0.0 0.7 15.8 9.2 0.0 41.0 11.0 128.0 24.7 13.9 0.3 0.8 1.3 19.8 10.7 0.4 52.7 26.4 58.8 2.4 3.0 3.4 0.4 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.3 0.1 0.0 0.0 0.0 23.8 0.0 0.0 2.5 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 11.5 0.0 0.3 6.3 0.0 0.0 0.0 0.0 0.0 0.1 6.0 0.1 0.0 0.0 0.2 0.1 5.7 0.0 0.0 9.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 3.4 0.0 50.3 0.0 8.0 7.5 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.4 5.8 1.2 0.2 0.1 4.1 0.3 0.2 0.4 0.9 1.6 0.7 0.8 0.4 0.4 0.1 6.4 6.0 0.3 0.8 2.0 4.4 3.1 3.4 0.0 18.4 9.8 5.9 21.5 5.3 16.5 0.0 0.0 1.8 12.0 35.2 8.3 0.4 15.3 2.6 0.7 9.6 5.3 0.1 7.0 0.0 0.3 17.3 18.9 0.0 0.3 1.8 47.8 0.1 0.0 0.0 20.0 16.2 2.7 0.3 0.9 0.6 0.6 3.6 0.0 0.2 0.0 0.0 0.0 0.0 3.2 16.0 0.4 0.3 5.0 32.9 17.1 10.5 0.0 0.0 4.2 0.5 0.2 0.0 5.0 3.0 0.0 6.8 0.1 15.3 3.5 RSPO2 MGC35555 ENSG00000147655 "R-spondin 2" Q6UXX9 8 107899316-108083642 "Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins" "Sensory transduction, Wnt signaling pathway" "Developmental protein, Heparin-binding" "Cancer-related genes, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0;intestine: 13.9;placenta: 17.3" "Group enriched" "Detected in some" 8 "Excitatory neurons: 75.3;Inhibitory neurons: 86.7" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HEK 293: 1.2;U-266/70: 4.2" "Group enriched" "Detected in many" 7 "amygdala: 7.9;cerebral cortex: 17.9;hippocampal formation: 21.3;white matter: 13.2" "Group enriched" "Detected in many" 4 "amygdala: 8.3;cerebral cortex: 7.7;hippocampal formation: 8.5;midbrain: 12.9;spinal cord: 7.7" "HPA024764, CAB025900, HPA053068" Uncertain "Secreted in other tissues" NA NA "Cluster 65: Brain - Ion transport" "Cluster 29: U-266 - Adaptive immune response" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" "CAB025900: , HPA024764: AB_10603236, HPA053068: AB_2682031" "unprognostic (1.10e-2)" "unprognostic (2.18e-1)" "unprognostic (3.97e-2)" "unprognostic (1.52e-1)" "unprognostic (2.04e-1)" "unprognostic (1.19e-1)" "unprognostic (8.33e-3)" "unprognostic (1.82e-1)" "unprognostic (9.48e-2)" "unprognostic (1.31e-1)" "unprognostic (1.40e-1)" "unprognostic (8.45e-2)" "unprognostic (1.95e-2)" "unprognostic (1.17e-2)" 0.2 0.0 2.8 0.7 4.4 0.1 0.0 1.3 16.2 3.4 2.6 13.9 3.4 0.0 1.7 5.9 0.0 3.2 0.2 6.6 13.2 0.0 0.4 7.1 0.0 2.6 23.0 0.3 0.0 0.0 2.9 17.3 2.0 8.7 7.8 0.3 0.0 2.3 0.0 0.0 4.6 0.3 2.1 0.0 7.6 0.7 3.5 0.0 0.0 0.0 0.0 1.7 0.8 6.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 4.2 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 4.4 1.3 16.2 6.6 13.2 2.6 23.0 2.0 2.1 3.5 6.6 0.0 0.0 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.8 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 75.3 0.0 0.3 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 86.7 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 4.7 0.0 0.0 0.0 4.0 4.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.4 0.0 0.1 0.6 0.0 1.7 0.0 0.0 1.0 0.0 0.2 0.0 0.0 SEC14L4 "dJ130H16.5, TAP3" ENSG00000133488 "SEC14 like lipid binding 4" Q9UDX3 22 30488902-30505711 "Predicted intracellular proteins" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "bone marrow: 8.2;liver: 19.3" "Cell type enhanced" "Detected in some" "Alveolar cells type 1: 22.4;Alveolar cells type 2: 6.9;Cholangiocytes: 11.5;Erythroid cells: 26.5;Hepatocytes: 22.8" "Cancer enhanced" "Detected in many" "liver cancer: 4.3" "Not detected" "Not detected" "Immune cell enhanced" "Detected in single" "basophil: 1.0" "Lineage enriched" "Detected in single" 7 "granulocytes: 1.0" "Cell line enriched" "Detected in some" 4 "BEWO: 37.7" "Region enhanced" "Detected in single" "thalamus: 1.2" HPA069748 Approved Centrosome NA NA 82000 "Cluster 6: Non-specific - Transcription" "Cluster 60: Liver - Hemostasis & Lipid metabolism" "Cluster 28: BEWO - Transcription regulation" "Cluster 6: Erythroid cells - Oxygen transport" Centrosome "HPA069748: AB_2686187" "unprognostic (6.98e-4)" "unprognostic (2.72e-2)" "unprognostic (2.40e-2)" "unprognostic (1.03e-3)" "unprognostic (6.78e-2)" "unprognostic (2.07e-2)" "unprognostic (9.88e-2)" "unprognostic (4.93e-2)" "unprognostic (3.34e-2)" "unprognostic (1.56e-2)" "unprognostic (1.88e-2)" "unprognostic (8.87e-2)" "unprognostic (4.06e-8)" "unprognostic (1.69e-1)" "unprognostic (1.64e-1)" "unprognostic (2.28e-1)" "unprognostic (5.98e-2)" 0.1 0.9 0.5 0.1 0.5 8.2 0.2 0.5 0.5 0.5 0.5 0.0 0.1 0.1 0.0 0.0 0.2 0.1 0.0 0.3 0.3 0.2 19.3 4.4 0.1 0.5 0.5 0.2 0.2 3.3 0.1 0.2 0.5 0.1 0.0 0.4 0.1 0.0 0.0 0.7 0.1 0.1 0.4 0.2 0.5 4.4 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.8 2.3 7.1 0.0 0.0 0.0 0.0 37.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.0 0.1 0.0 0.1 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.1 0.0 0.1 0.1 0.3 2.5 0.0 0.1 0.0 0.1 0.1 0.2 0.1 9.2 0.4 0.1 0.0 0.0 0.0 0.2 0.1 0.1 2.4 0.1 0.0 0.1 0.0 0.1 0.1 0.1 1.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.1 0.0 0.0 0.5 0.5 0.5 0.5 0.3 0.3 0.5 0.5 0.5 0.4 0.6 0.8 0.3 22.4 6.9 0.7 0.1 0.1 0.5 0.3 0.0 0.4 0.2 0.3 0.7 11.5 1.4 1.8 0.0 0.1 1.3 0.0 0.0 0.5 0.7 1.8 0.2 0.2 0.0 26.5 0.4 0.0 0.4 0.3 0.0 0.2 1.3 0.2 0.4 22.8 0.1 1.7 0.4 0.2 0.0 0.3 0.3 0.1 0.6 0.4 0.0 0.0 0.1 5.3 0.0 0.5 0.1 0.1 0.0 0.0 0.0 0.5 0.0 0.0 4.3 0.9 0.0 0.9 0.1 0.3 0.3 0.0 0.0 0.0 0.3 0.0 0.0 0.6 SEMA6C KIAA1869 ENSG00000143434 "Semaphorin 6C" Q9H3T2 1 151131685-151146664 "Predicted intracellular proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "skeletal muscle: 322.9;tongue: 96.9" "Cell type enhanced" "Detected in many" "Adipocytes: 12.9;Cardiomyocytes: 19.1;Cone photoreceptor cells: 20.9;Inhibitory neurons: 13.7;Skeletal myocytes: 12.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in many" "AF22: 14.1;HUVEC TERT2: 24.8;TIME: 11.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA076150, HPA077625" Approved "Nucleoplasm,Nucleoli fibrillar center,Plasma membrane,Cytosol" "Intracellular and membrane" NA NA 1500000 "Cluster 33: Striated muscle - Muscle contraction" "Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function" "Cluster 37: Myocytes - Muscle contraction" "Nucleoplasm, Plasma membrane" "Nucleoli fibrillar center, Cytosol" "HPA076150: , HPA077625: " "unprognostic (6.97e-2)" "unprognostic (8.40e-2)" "unprognostic (1.56e-3)" "prognostic unfavorable (3.27e-4)" "unprognostic (2.79e-1)" "unprognostic (2.88e-2)" "unprognostic (3.00e-2)" "unprognostic (1.24e-2)" "unprognostic (5.66e-3)" "unprognostic (4.25e-2)" "prognostic favorable (3.06e-5)" "unprognostic (3.72e-2)" "unprognostic (1.67e-2)" "unprognostic (6.12e-2)" "unprognostic (9.49e-2)" "unprognostic (1.10e-1)" "unprognostic (1.85e-1)" 8.8 2.8 7.7 1.8 6.7 1.2 7.9 21.9 9.4 12.0 1.0 7.6 13.7 10.5 1.4 5.5 10.7 3.7 38.8 7.9 5.4 12.1 12.4 5.1 1.7 5.0 5.0 14.8 3.6 2.1 13.4 1.9 4.9 8.3 1.8 5.2 8.5 2.3 322.9 8.9 10.8 6.2 2.2 3.0 5.4 32.2 7.3 2.2 4.7 96.9 0.9 8.4 8.8 5.3 0.9 1.0 14.1 5.4 5.8 1.9 1.3 1.0 0.5 0.9 1.3 0.3 0.6 0.7 4.0 3.3 2.0 1.4 1.3 0.5 0.8 1.3 4.2 7.7 0.7 1.2 0.8 0.1 2.7 3.3 1.7 1.2 0.6 2.8 24.8 4.1 0.7 0.7 2.3 0.5 1.3 1.0 6.3 0.2 1.7 9.0 3.1 0.3 0.5 0.4 7.1 9.3 1.3 0.6 1.2 3.5 1.6 1.3 11.8 2.3 3.3 3.5 0.6 5.9 1.2 6.1 0.6 0.3 0.8 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.7 6.7 21.9 9.4 7.9 5.4 5.0 5.0 4.9 2.2 7.3 5.3 12.9 0.0 2.8 3.9 1.0 1.7 0.8 0.3 0.6 5.7 1.9 3.0 19.1 1.5 0.8 0.0 20.9 0.2 0.6 0.1 0.0 0.3 0.6 0.4 2.8 10.2 0.0 0.8 6.7 0.4 0.6 4.4 0.5 0.4 0.0 9.9 6.8 5.3 0.4 6.7 13.7 0.3 0.0 2.5 0.7 3.1 5.6 0.5 1.8 4.7 0.4 1.9 1.0 5.5 1.5 0.4 0.0 2.6 1.9 0.5 3.3 2.9 0.3 7.5 0.0 12.0 2.9 3.3 1.2 0.5 1.0 0.1 0.8 0.5 0.8 0.5 SLC1A6 EAAT4 ENSG00000105143 "Solute carrier family 1 member 6" P48664 19 14950034-15022990 "Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Group enriched" "Detected in some" 7 "brain: 88.2;testis: 28.0" "Cell type enhanced" "Detected in some" "Bipolar cells: 17.1;Early spermatids: 35.3;Horizontal cells: 23.5;Late spermatids: 31.8;Syncytiotrophoblasts: 40.0" "Cancer enriched" "Detected in some" 7 "urothelial cancer: 5.2" "Region enriched" "Detected in all" 6 "cerebellum: 88.2" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "HAP1: 7.4;NTERA-2: 6.1;U-698: 28.3" "Region enriched" "Detected in all" 6 "cerebellum: 136.3" "Region enhanced" "Detected in all" "cerebellum: 53.8" "HPA041505, HPA044066" Enhanced Supported Supported "Plasma membrane,Intermediate filaments" NA NA "Cluster 69: Cerebellum - Gene expression regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "Plasma membrane" "Intermediate filaments" "HPA041505: AB_2677520, HPA044066: AB_2678796" "unprognostic (3.62e-2)" "unprognostic (1.35e-1)" "unprognostic (4.41e-2)" "unprognostic (1.52e-1)" "unprognostic (1.12e-1)" "unprognostic (5.94e-3)" "unprognostic (8.90e-2)" "unprognostic (6.52e-4)" "unprognostic (1.55e-1)" "unprognostic (5.40e-3)" "unprognostic (1.11e-2)" "unprognostic (9.92e-2)" "unprognostic (1.35e-1)" "unprognostic (5.57e-2)" "prognostic unfavorable (6.88e-6)" 0.1 0.2 9.1 0.2 10.8 0.9 0.4 88.2 14.4 0.1 0.5 0.2 0.3 0.4 1.7 0.1 0.2 0.2 0.2 14.5 5.0 0.1 0.2 0.2 0.3 3.7 7.5 0.3 0.6 0.9 0.3 0.7 8.1 0.5 0.3 2.3 0.4 0.5 0.3 8.6 0.3 0.2 3.2 0.4 0.2 28.0 6.6 0.2 0.3 0.1 0.3 0.1 0.1 5.1 0.1 0.1 0.3 0.4 0.2 0.2 0.9 0.1 0.1 0.1 0.1 0.2 0.2 0.1 0.1 0.2 0.1 1.4 7.4 0.2 0.1 0.2 0.1 0.2 0.4 0.3 0.0 0.2 0.1 0.1 0.2 0.1 0.1 0.2 0.1 0.2 0.1 0.6 0.1 0.6 0.0 0.5 6.1 0.0 0.1 0.1 0.1 0.1 0.1 0.3 0.5 0.2 0.2 2.8 0.0 1.1 0.3 0.1 0.0 0.3 1.1 0.3 0.1 0.5 0.1 28.3 0.1 0.3 0.1 0.3 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 0.1 0.1 0.3 0.0 0.0 0.1 0.0 0.0 9.1 10.8 88.2 14.4 14.5 5.0 3.7 7.5 8.1 3.2 6.6 5.1 0.0 0.0 0.0 0.7 0.0 3.2 0.7 0.0 0.0 17.1 0.0 0.1 2.1 0.0 0.0 1.8 0.0 1.9 0.0 0.0 0.0 0.0 35.3 0.0 0.1 0.1 0.0 0.0 8.2 0.4 9.9 0.4 0.0 0.0 0.0 5.8 0.0 0.0 0.5 23.5 8.6 0.0 0.0 0.0 0.7 31.8 0.6 0.0 0.0 1.0 0.0 0.7 0.0 4.5 0.9 0.0 0.0 0.7 0.0 0.2 0.0 0.2 0.0 0.8 0.0 0.0 0.4 2.2 6.3 0.0 6.8 40.0 0.0 0.0 0.0 0.1 SLC41A1 MgtE ENSG00000133065 "Solute carrier family 41 member 1" Q8IVJ1 1 205789094-205813748 "Metabolic proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "heart muscle: 99.3;tongue: 75.9" "Cell type enhanced" "Detected in many" "Cardiomyocytes: 175.0;Theca cells: 100.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in single" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014721, HPA015138" Uncertain Approved Mitochondria NA NA "Cluster 39: Non-specific - mRNA processing" "Cluster 38: Heart - Muscle contraction" "Cluster 44: HDLM-2 - Immune response" "Cluster 54: Cardiomyocytes - Muscle contraction" Mitochondria "HPA014721: , HPA015138: AB_1857160" "unprognostic (1.18e-1)" "prognostic unfavorable (1.48e-4)" "unprognostic (2.77e-2)" "unprognostic (1.30e-2)" "unprognostic (2.30e-1)" "unprognostic (1.38e-2)" "unprognostic (2.37e-3)" "unprognostic (5.23e-2)" "unprognostic (5.53e-3)" "unprognostic (1.11e-1)" "unprognostic (1.87e-2)" "unprognostic (4.46e-2)" "unprognostic (3.09e-3)" "unprognostic (2.60e-1)" "unprognostic (1.67e-1)" "unprognostic (1.95e-1)" "unprognostic (1.65e-1)" 9.7 10.8 10.1 6.4 10.4 5.8 4.7 11.0 8.2 4.8 36.7 5.8 2.1 6.5 5.1 5.6 11.0 7.1 99.3 8.6 6.4 9.2 1.4 8.4 7.4 11.1 10.2 11.3 61.6 9.3 4.6 3.7 9.5 7.5 1.8 6.1 3.7 6.7 48.8 3.8 3.8 6.0 8.9 5.3 9.8 18.5 13.7 5.7 17.8 75.9 5.1 6.2 3.9 9.5 18.2 16.1 9.6 15.6 11.7 11.6 13.2 17.9 17.8 18.2 15.9 8.0 10.1 25.9 11.3 16.5 14.9 18.5 9.5 13.4 6.2 48.6 14.8 6.4 16.5 1.2 11.2 0.0 17.4 14.9 10.8 20.8 14.7 14.9 11.3 20.5 11.9 10.5 14.7 11.2 11.8 1.8 11.5 4.8 7.1 13.8 29.0 6.4 4.1 22.0 8.1 10.4 14.0 12.3 11.0 8.0 8.8 6.7 14.3 21.5 13.8 19.9 19.2 34.7 24.9 8.5 16.6 8.3 13.6 0.0 0.1 0.0 1.6 0.1 2.0 0.6 1.5 1.5 0.0 0.7 1.4 1.5 0.0 0.4 0.0 0.0 1.5 1.0 10.1 10.4 11.0 8.2 8.6 6.4 11.1 10.2 9.5 8.9 13.7 9.5 18.2 3.2 23.0 20.5 11.2 20.8 24.3 4.6 10.8 14.6 14.4 10.2 175.0 5.7 8.5 0.0 50.1 1.8 11.5 1.6 1.9 9.6 2.4 6.8 9.8 24.1 6.0 6.5 5.3 11.0 14.5 15.7 11.7 6.2 7.0 13.9 8.6 2.2 3.4 18.5 6.6 2.7 4.1 2.4 6.5 2.7 9.9 3.5 8.8 15.9 0.8 17.0 8.2 7.1 8.3 9.3 1.3 9.4 8.3 24.9 0.0 15.7 7.9 20.3 0.0 29.7 16.1 8.1 12.9 7.5 18.2 3.1 14.5 100.2 1.5 22.0 SLC45A4 KIAA1126 ENSG00000022567 "Solute carrier family 45 member 4" Q5BKX6 8 141207166-141308305 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell type enhanced" "Detected in many" "Collecting duct cells: 49.7;Cone photoreceptor cells: 54.2;Endometrial ciliated cells: 57.6;Glandular and luminal cells: 97.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 7 "eosinophil: 8.3;neutrophil: 7.0" "Lineage enriched" "Detected in single" 22 "granulocytes: 8.3" "Cell line enhanced" "Detected in many" "HMC-1: 18.3;OE19: 30.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023154 Uncertain Approved "Plasma membrane" NA NA "Cluster 45: Eosinophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 21: OE19 - Mitochondria" "Cluster 44: Endometrium - Transcription" "Plasma membrane" "HPA023154: AB_2191204" "unprognostic (7.79e-3)" "unprognostic (1.06e-1)" "unprognostic (4.30e-2)" "unprognostic (1.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.96e-2)" "unprognostic (1.26e-1)" "unprognostic (4.49e-3)" "unprognostic (1.02e-1)" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "prognostic favorable (1.73e-6)" "unprognostic (8.79e-3)" "unprognostic (1.13e-1)" "unprognostic (1.77e-2)" "unprognostic (2.40e-2)" 3.5 2.5 3.8 3.7 4.8 5.8 2.9 1.2 16.6 7.1 14.7 4.4 2.3 4.3 1.5 3.3 7.1 2.7 6.6 5.1 1.5 10.2 0.9 6.7 2.7 6.6 1.0 3.1 7.9 2.5 14.9 5.0 6.6 6.6 1.6 5.4 7.8 5.3 4.6 5.7 4.1 1.7 0.7 4.8 12.5 13.7 2.2 2.3 5.8 1.4 2.0 3.4 2.8 6.1 4.6 9.8 3.7 5.9 0.3 0.3 16.1 2.5 1.5 2.2 1.7 6.4 12.2 0.9 11.8 1.0 3.1 3.7 2.1 1.2 1.0 7.2 3.3 2.7 3.1 0.0 1.7 1.1 18.3 0.8 1.9 1.6 0.9 0.5 1.5 5.0 5.6 0.7 0.8 11.9 11.0 2.5 4.7 30.8 4.1 3.3 0.2 3.1 8.9 7.9 5.5 4.6 2.7 0.8 4.5 2.6 1.9 7.2 0.8 0.0 2.4 3.8 4.9 3.9 12.7 1.3 2.1 4.3 4.0 1.1 0.1 8.3 0.1 0.1 0.1 0.0 0.1 0.3 0.1 0.0 0.1 0.1 7.0 0.2 0.1 0.3 0.2 0.1 3.8 4.8 1.2 16.6 5.1 1.5 6.6 1.0 6.6 0.7 2.2 6.1 3.3 9.6 12.7 6.5 3.0 2.7 6.6 3.6 5.2 33.1 6.4 5.8 13.5 15.7 8.9 49.7 54.2 8.7 7.5 14.7 0.0 9.3 12.5 57.6 10.8 3.4 2.4 0.0 29.0 2.7 0.8 2.9 37.2 97.1 1.3 1.8 1.1 0.0 6.7 3.3 21.7 7.7 8.2 2.5 3.3 5.9 2.1 8.6 3.6 7.5 1.8 4.3 5.2 6.6 0.9 7.8 4.5 2.2 5.3 6.0 3.7 3.2 22.3 9.2 0.0 1.5 3.2 5.7 2.6 4.4 2.4 16.3 4.6 4.0 5.1 11.3 SLC52A3 "bA371L19.1, C20orf54, hRFT2, RFVT3" ENSG00000101276 "Solute carrier family 52 member 3" Q9NQ40 20 760080-776015 "Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Deafness, Disease variant" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 19.2;testis: 40.1" "Cell type enhanced" "Detected in many" "Collecting duct cells: 23.9;Cytotrophoblasts: 32.8;Distal enterocytes: 18.8;Glandular and luminal cells: 21.3;Paneth cells: 21.7;Proximal enterocytes: 35.5;Syncytiotrophoblasts: 52.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "basophil: 2.1" "Lineage enriched" "Detected in single" 4 "granulocytes: 2.1" "Cell line enhanced" "Detected in some" "CAPAN-2: 42.1;OE19: 31.8;RT4: 12.3;SK-BR-3: 15.4;T-47d: 20.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049391, HPA059078" Approved NA NA "Cluster 11: Basophils - Unknown function" "Cluster 78: Testis - Spermatogenesis" "Cluster 42: Epithelial cell lines - Epithelial cell function" "Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling" "HPA049391: AB_2680743, HPA059078: AB_2732630" "unprognostic (4.53e-2)" "unprognostic (1.11e-1)" "unprognostic (8.60e-2)" "unprognostic (7.84e-2)" "unprognostic (1.29e-1)" "unprognostic (9.03e-3)" "unprognostic (2.12e-3)" "unprognostic (1.43e-3)" "unprognostic (1.15e-2)" "unprognostic (4.36e-2)" "unprognostic (4.39e-3)" "unprognostic (4.82e-2)" "unprognostic (2.04e-3)" "prognostic favorable (5.51e-6)" "unprognostic (3.04e-1)" "unprognostic (2.21e-1)" "unprognostic (1.44e-1)" 2.1 0.2 11.0 1.5 8.9 0.4 2.6 9.5 11.4 2.3 5.5 11.5 14.4 2.0 2.0 4.9 1.8 2.6 5.7 9.0 11.1 9.4 0.1 1.2 0.4 12.9 9.8 0.9 1.6 0.2 0.3 4.3 12.3 8.0 7.1 0.6 6.1 4.0 0.6 1.8 19.2 1.7 9.8 0.2 5.6 40.1 12.5 0.1 0.5 0.9 0.8 4.9 2.5 9.7 6.6 2.2 0.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.1 4.6 42.1 0.0 7.0 0.0 0.6 6.9 0.0 6.0 0.0 0.0 0.0 0.8 0.7 0.3 0.0 0.0 0.3 0.0 1.8 0.0 0.0 0.1 0.0 0.0 0.2 0.3 0.0 0.1 0.0 0.1 0.6 31.8 4.5 0.0 0.0 1.1 0.0 12.3 0.1 0.2 7.2 15.4 0.1 0.8 20.1 0.0 0.0 0.2 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.1 2.1 0.2 0.3 0.2 0.0 0.2 0.2 0.2 0.1 0.0 0.4 0.2 0.3 0.8 0.5 0.1 0.3 0.1 0.2 11.0 8.9 9.5 11.4 9.0 11.1 12.9 9.8 12.3 9.8 12.5 9.7 3.8 9.6 3.1 0.0 0.1 0.6 2.2 5.3 1.8 0.4 3.2 2.4 0.7 4.3 5.3 23.9 2.1 32.8 0.0 18.8 1.9 6.6 1.1 8.9 1.1 10.8 0.0 0.0 0.1 2.0 0.9 0.4 4.6 21.3 0.0 5.9 0.0 0.0 2.6 0.0 0.0 6.0 6.1 0.0 1.3 3.2 0.9 0.2 1.8 2.8 0.0 0.0 0.0 0.0 0.0 5.2 21.7 0.4 0.1 4.3 35.5 0.1 2.4 0.1 0.0 0.4 0.6 0.6 0.8 2.3 1.1 52.1 0.2 1.3 10.8 5.8 SLC7A5 "CD98, D16S469E, E16, LAT1, MPE16" ENSG00000103257 "Solute carrier family 7 member 5" Q01650 16 87830023-87869507 "Metabolic proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 110.7;brain: 121.9" "Cell type enhanced" "Detected in many" "Basal squamous epithelial cells: 178.7;Microglial cells: 109.6;Plasma cells: 135.1;Syncytiotrophoblasts: 107.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in some" 10 "plasmacytoid DC: 17.2" "Lineage enriched" "Detected in many" 10 "dendritic cells: 17.2" "Cell line enhanced" "Detected in all" "HBEC3-KT: 1326.5;hTCEpi: 2229.0;MCF7: 1264.6;SiHa: 1873.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052673, HPA056077" Approved Supported "Vesicles,Plasma membrane,Cytosol" NA NA 51000 "Cluster 3: Plasmacytoid DCs - Unknown function" "Cluster 76: Brain & Bone marrow - Chromatin organization" "Cluster 30: Epithelial cell lines - Translation" "Cluster 65: Plasmacytoid DCs - Unknown function" "Plasma membrane, Cytosol" Vesicles "HPA052673: AB_2681909, HPA056077: AB_2683031" "unprognostic (2.71e-3)" "unprognostic (1.10e-2)" "unprognostic (1.02e-1)" "unprognostic (2.64e-1)" "unprognostic (3.22e-2)" "unprognostic (2.99e-3)" "unprognostic (1.64e-1)" "prognostic unfavorable (2.43e-4)" "unprognostic (6.86e-2)" "unprognostic (4.46e-2)" "unprognostic (1.27e-1)" "unprognostic (3.17e-1)" "prognostic unfavorable (0.00e+0)" "unprognostic (5.93e-2)" "unprognostic (5.52e-3)" "unprognostic (1.64e-2)" "unprognostic (7.19e-3)" 10.6 3.9 121.9 18.3 87.8 110.7 6.0 89.5 119.4 11.0 64.5 11.4 6.6 5.2 35.7 100.2 6.4 6.6 21.1 96.0 91.0 18.0 26.6 9.8 14.1 111.3 104.3 8.1 14.0 1.8 22.8 17.0 104.9 9.8 2.7 42.5 28.6 10.4 30.1 25.1 8.9 3.2 93.0 16.7 34.4 65.6 117.1 6.9 3.9 2.8 11.5 24.6 22.6 88.1 187.4 693.5 13.2 192.1 5.1 10.6 487.3 147.1 52.8 87.4 56.3 456.3 260.4 170.1 126.7 187.6 30.5 818.3 142.5 1326.5 61.0 179.9 71.9 140.3 618.0 331.2 199.5 131.2 246.0 35.9 2229.0 107.8 791.4 28.5 18.0 588.8 212.6 185.1 71.1 1264.6 159.2 192.7 63.3 116.7 166.0 152.0 52.4 264.1 98.3 15.7 109.2 43.5 1873.1 368.9 406.9 123.0 170.0 171.8 14.3 30.9 201.3 127.8 114.5 237.9 213.2 728.2 120.1 322.1 296.4 1.0 0.0 0.0 1.0 0.0 1.3 0.5 0.5 0.9 0.4 0.0 0.1 0.4 0.2 0.2 0.0 17.2 1.6 0.5 121.9 87.8 89.5 119.4 96.0 91.0 111.3 104.3 104.9 93.0 117.1 88.1 3.7 0.0 0.6 8.1 23.0 73.3 17.9 27.0 178.7 15.2 12.0 8.9 2.9 2.8 6.3 1.8 16.7 15.4 80.0 3.4 0.0 18.1 1.0 20.5 7.6 29.1 86.3 86.3 12.0 9.6 35.4 9.5 43.3 51.0 66.9 4.5 1.8 17.3 9.2 10.1 13.2 6.3 8.2 3.0 50.5 5.0 1.8 51.0 39.2 109.6 2.6 14.8 2.1 15.1 1.6 25.7 2.3 1.5 135.1 18.2 1.0 0.4 3.2 52.7 0.0 33.6 31.5 1.6 4.5 58.8 37.5 107.4 65.8 2.7 4.2 42.8 SLC9C2 "MGC43026, SLC9A11" ENSG00000162753 "Solute carrier family 9 member C2 (putative)" Q5TAH2 1 173500460-173603072 "Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 1.3;choroid plexus: 1.9;testis: 6.0" "Cell type enriched" "Detected in some" 4 "Astrocytes: 27.1" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA059122, HPA079529" Enhanced Approved "Nuclear speckles,Plasma membrane" NA NA "Cluster 49: Ciliated cells - Cilium organization" "Cluster 64: Astrocytes - Nervous system maintenance" "Plasma membrane" "Nuclear speckles" "HPA059122: , HPA079529: " "unprognostic (2.10e-1)" "unprognostic (2.69e-1)" "unprognostic (8.52e-2)" "unprognostic (5.88e-3)" "unprognostic (3.24e-2)" "unprognostic (2.21e-1)" "unprognostic (1.29e-3)" "unprognostic (1.19e-1)" "unprognostic (4.21e-2)" "unprognostic (4.92e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-6)" "unprognostic (1.66e-1)" "unprognostic (1.01e-2)" "unprognostic (2.98e-1)" "unprognostic (1.81e-1)" 0.0 0.0 0.4 0.0 0.5 0.0 0.0 0.2 0.2 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.0 1.3 1.2 0.2 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.2 0.1 6.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.4 0.5 0.2 0.2 0.5 0.3 1.3 1.2 0.8 0.8 0.4 0.6 0.0 0.0 0.0 27.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 1.6 0.0 1.3 0.0 6.2 0.1 1.3 0.1 0.0 0.1 6.2 1.7 0.1 0.4 0.0 0.0 5.0 0.0 0.5 0.3 0.0 0.1 0.0 0.5 0.4 1.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 4.0 0.0 0.0 0.0 4.7 0.0 0.7 0.0 1.5 0.7 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.1 0.0 0.1 0.1 5.4 0.4 0.0 0.0 0.1 0.0 1.3 0.0 0.0 SMC1B "bK268H5, SMC1L2" ENSG00000077935 "Structural maintenance of chromosomes 1B" Q8NDV3 22 45344063-45413619 "Predicted intracellular proteins" "Cell cycle, Meiosis" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 98 "testis: 31.1" "Group enriched" "Detected in some" 6 "Spermatocytes: 897.6;Spermatogonia: 448.5" "Cancer enriched" "Detected in many" 6 "cervical cancer: 4.9" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "A-431: 8.9;EFO-21: 4.0;SiHa: 18.0;U-266/70: 3.9" "Not detected" "Not detected" "Not detected" "Not detected" HPA001500 Enhanced Supported Nucleoplasm,Cytosol NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 20: HeLa - Mitochondria" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nucleoplasm, Cytosol" "HPA001500: AB_1080030" "unprognostic (1.18e-2)" "unprognostic (6.16e-3)" "unprognostic (2.22e-1)" "unprognostic (3.38e-3)" "unprognostic (1.77e-1)" "unprognostic (3.21e-2)" "unprognostic (6.18e-2)" "unprognostic (1.87e-3)" "unprognostic (3.41e-2)" "unprognostic (3.65e-1)" "unprognostic (4.49e-2)" "unprognostic (3.79e-1)" "unprognostic (3.83e-9)" "unprognostic (2.10e-1)" "unprognostic (1.11e-2)" "unprognostic (1.78e-1)" "unprognostic (1.98e-3)" 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 31.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 8.9 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.7 0.1 0.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.0 0.2 0.2 0.2 0.1 0.0 0.1 0.1 0.0 0.0 0.4 0.2 0.1 0.0 18.0 0.0 0.0 0.0 0.1 1.5 0.1 0.0 0.0 0.4 0.0 3.9 0.0 0.0 0.0 0.3 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.3 0.1 0.0 0.2 0.1 0.0 0.0 0.3 0.6 0.8 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.1 75.6 0.5 0.2 0.8 0.0 0.0 1.4 0.0 0.9 0.3 0.0 0.2 0.0 0.7 0.4 0.1 0.1 0.0 1.1 0.0 0.0 0.3 0.0 36.9 5.6 0.5 0.0 1.0 0.0 0.3 0.0 1.0 1.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.2 1.0 98.6 0.4 0.2 897.6 448.5 0.0 0.0 0.8 0.1 0.0 0.0 0.2 SMIM1 Vel ENSG00000235169 "Small integral membrane protein 1 (Vel blood group)" B2RUZ4 1 3772749-3775982 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 40.3;testis: 42.2" "Cell type enhanced" "Detected in many" "Distal tubular cells: 84.1;Erythroid cells: 404.4;Granulosa cells: 81.5;Proximal tubular cells: 247.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in many" 11 "eosinophil: 48.5" "Lineage enriched" "Detected in many" 12 "granulocytes: 48.5" "Group enriched" "Detected in many" 4 "HEL: 68.0;Hep G2: 32.5;K-562: 33.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" HPA069088 Enhanced NA NA 340000 "Cluster 45: Eosinophils - Innate immune response" "Cluster 43: Testis - Unknown function" "Cluster 36: HEL - Hemostasis" "Cluster 6: Erythroid cells - Oxygen transport" "HPA069088: AB_2686080" "unprognostic (9.50e-3)" "unprognostic (7.19e-4)" "unprognostic (5.40e-2)" "unprognostic (2.10e-2)" "unprognostic (2.50e-3)" "unprognostic (3.25e-1)" "unprognostic (2.63e-3)" "unprognostic (2.13e-2)" "unprognostic (2.31e-2)" "unprognostic (9.85e-2)" "unprognostic (2.90e-1)" "unprognostic (1.87e-1)" "unprognostic (2.25e-2)" "unprognostic (7.10e-2)" "unprognostic (2.91e-2)" "unprognostic (5.56e-2)" "unprognostic (1.32e-2)" 2.6 2.7 1.8 0.4 2.6 32.1 3.2 3.8 3.0 5.8 6.2 2.9 0.7 2.8 1.1 1.4 3.4 1.3 40.3 1.4 3.9 16.9 13.1 3.7 1.0 8.7 5.3 8.7 9.4 4.3 16.0 2.1 9.0 6.9 0.1 0.4 17.3 5.5 1.1 2.1 2.1 0.2 5.5 4.0 6.6 42.2 3.6 0.4 9.3 0.2 0.5 3.4 3.6 6.2 0.3 1.4 1.4 3.0 0.0 0.0 5.0 0.9 1.2 0.0 0.0 3.5 3.9 0.1 6.3 0.0 0.2 1.3 0.4 1.5 0.0 6.1 3.6 68.0 0.0 32.5 2.4 0.0 1.2 2.1 0.8 0.3 0.5 2.9 0.0 0.3 33.9 1.2 0.0 7.8 0.0 2.1 0.3 3.4 6.0 0.0 0.0 9.9 3.8 1.0 1.6 6.3 0.2 6.8 4.8 0.5 7.0 3.7 0.4 0.0 0.8 0.0 0.0 2.8 0.8 0.2 0.0 0.0 0.2 4.4 2.0 48.5 1.1 1.0 0.4 2.5 1.6 0.6 0.6 3.7 4.0 1.9 3.2 0.2 0.4 0.6 1.2 2.2 1.8 2.6 3.8 3.0 1.4 3.9 8.7 5.3 9.0 5.5 3.6 6.2 1.1 6.4 20.1 0.7 5.9 1.7 13.1 4.4 10.2 0.4 31.1 35.9 57.0 8.6 8.1 16.5 0.0 23.4 1.4 1.6 84.1 17.2 10.8 3.7 1.2 3.9 5.4 404.4 0.1 14.5 18.8 10.1 6.6 3.5 1.3 81.5 3.9 50.2 10.4 1.7 0.1 3.9 8.2 8.9 1.0 27.8 9.9 8.5 42.7 0.0 4.3 47.0 2.1 0.0 1.6 13.7 1.7 9.8 11.1 10.2 1.9 247.9 2.2 1.5 0.0 3.6 4.3 8.7 20.4 1.7 1.1 6.7 4.6 3.0 4.3 9.1 SNRPA1 "Lea1, U2A'" ENSG00000131876 "Small nuclear ribonucleoprotein polypeptide A'" P09661 15 101281510-101295282 "Plasma proteins, Predicted intracellular proteins" "mRNA processing, mRNA splicing" "Ribonucleoprotein, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA045622, HPA048499" Supported Supported "Nucleoplasm,Nuclear speckles,Nuclear bodies" NA NA 48000 "Cluster 39: Non-specific - mRNA processing" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 19: HEK293 & PC-3 - Transcription regulation" "Cluster 66: Spermatocytes - Spermatogenesis" Nucleoplasm "Nuclear speckles, Nuclear bodies" "HPA045622: AB_2679394, HPA048499: AB_2680421" "unprognostic (2.73e-1)" "unprognostic (1.48e-1)" "unprognostic (8.09e-2)" "unprognostic (2.20e-1)" "unprognostic (8.08e-2)" "unprognostic (1.07e-1)" "prognostic unfavorable (8.56e-5)" "unprognostic (5.80e-2)" "unprognostic (1.66e-3)" "prognostic favorable (8.83e-5)" "unprognostic (4.74e-2)" "unprognostic (6.77e-3)" "prognostic unfavorable (0.00e+0)" "unprognostic (3.06e-2)" "unprognostic (2.84e-1)" "unprognostic (2.43e-1)" "unprognostic (1.37e-2)" 19.0 18.2 11.0 35.5 11.4 68.1 20.8 13.2 15.4 14.7 14.7 30.6 24.3 15.5 33.0 33.8 18.6 12.7 25.8 12.0 11.6 25.2 25.5 19.5 43.3 11.5 11.3 13.6 22.2 18.3 13.9 30.4 11.7 16.3 30.8 15.5 23.1 12.6 19.7 18.5 30.1 19.3 10.9 25.2 23.2 37.8 12.4 37.4 18.3 12.4 51.9 26.3 18.2 12.6 175.5 119.5 112.7 57.4 31.3 25.6 111.3 158.2 72.8 139.2 105.1 255.8 150.7 192.9 89.2 107.8 109.0 101.7 170.2 113.1 148.1 98.0 262.5 151.4 196.7 137.3 24.0 175.1 103.7 21.0 83.0 89.0 111.3 30.9 90.9 147.1 216.1 175.8 86.5 194.6 177.6 185.7 144.5 232.0 100.1 174.5 121.7 194.8 103.3 450.2 88.6 92.7 97.2 109.0 125.1 117.1 105.2 136.4 66.2 74.1 141.0 86.8 160.3 143.5 464.8 378.9 59.9 162.9 89.3 3.8 36.6 21.5 55.7 47.2 55.3 53.0 57.7 56.1 58.0 47.4 46.6 59.0 6.8 48.5 44.0 54.7 68.9 39.0 11.0 11.4 13.2 15.4 12.0 11.6 11.5 11.3 11.7 10.9 12.4 12.6 41.5 19.2 54.6 16.3 71.6 65.6 73.4 141.6 70.6 37.8 41.8 52.6 30.5 18.6 80.3 36.8 12.5 124.3 69.6 37.4 68.4 94.6 96.2 52.7 42.5 47.2 27.0 61.4 30.9 109.0 154.1 51.5 27.0 55.6 65.8 37.7 21.4 35.5 67.0 37.0 29.2 44.2 126.1 24.1 39.2 22.4 34.8 36.4 42.7 13.1 76.4 39.6 47.4 16.6 28.6 95.3 41.8 28.6 76.1 142.3 78.7 87.1 89.2 34.9 13.1 37.9 67.1 192.9 65.9 68.3 50.6 112.3 68.1 42.3 52.4 101.6 SOWAHD ANKRD58 ENSG00000187808 "Sosondowah ankyrin repeat domain family member D" A6NJG2 X 119758588-119760202 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 4.1;lymphoid tissue: 7.1;testis: 5.0" "Cell type enhanced" "Detected in some" "B-cells: 12.2;Extravillous trophoblasts: 38.3;Hofbauer cells: 17.5;Proximal enterocytes: 9.1;Rod photoreceptor cells: 8.2;Syncytiotrophoblasts: 9.4" "Cancer enriched" "Detected in many" 6 "testis cancer: 8.5" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in many" "naive B-cell: 11.7" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in some" "BEWO: 4.3;NB-4: 2.9;SK-BR-3: 3.2;THP-1: 8.3;U-937: 7.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA065955 Uncertain NA NA "Cluster 24: B-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 43: THP-1 - Innate immune response" "Cluster 38: Extravillous trophoblasts - Unknown function" "HPA065955: AB_2685586" "unprognostic (1.78e-2)" "unprognostic (9.37e-2)" "unprognostic (3.10e-2)" "unprognostic (8.88e-2)" "unprognostic (1.67e-1)" "unprognostic (4.38e-2)" "unprognostic (2.03e-1)" "unprognostic (7.20e-2)" "unprognostic (3.45e-2)" "unprognostic (6.07e-2)" "unprognostic (5.80e-2)" "unprognostic (2.41e-2)" "unprognostic (1.04e-5)" "unprognostic (5.82e-2)" "unprognostic (3.14e-2)" "unprognostic (9.22e-2)" "unprognostic (3.74e-3)" 0.3 0.4 0.7 1.8 0.6 2.1 0.2 0.6 0.9 0.2 0.3 1.2 2.1 0.1 0.0 0.2 0.3 0.2 0.2 0.6 0.6 1.1 0.3 1.6 2.5 1.1 0.6 0.3 0.3 0.7 0.1 1.1 0.9 0.2 0.5 0.7 1.7 0.1 0.0 0.3 4.1 0.1 1.0 7.1 1.2 5.0 1.1 0.6 0.1 0.2 1.5 0.3 0.1 1.5 0.4 0.0 0.1 0.1 0.0 0.0 4.3 0.0 0.0 0.4 0.6 0.8 0.1 0.2 0.6 0.0 0.5 0.0 0.0 0.0 0.1 0.7 0.5 0.0 0.0 1.2 0.2 0.8 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.1 0.4 0.0 2.9 0.9 0.8 0.3 2.5 0.1 0.1 0.0 0.1 0.2 0.1 0.9 3.2 0.1 0.3 0.5 8.3 0.1 0.1 0.1 0.1 0.0 0.4 0.0 0.1 0.0 7.4 0.0 0.0 3.1 1.9 0.0 3.3 0.0 9.1 0.4 0.3 2.0 11.7 1.7 0.9 3.3 0.3 2.9 1.0 0.0 0.7 0.7 0.6 0.6 0.9 0.6 0.6 1.1 0.6 0.9 1.0 1.1 1.5 0.2 0.0 0.0 0.0 12.2 0.0 0.1 0.0 0.0 0.8 0.3 0.5 0.5 1.5 0.0 3.7 0.0 6.1 2.7 3.7 0.0 0.4 0.6 0.1 0.0 0.4 0.0 0.0 0.0 0.4 38.3 0.1 0.5 0.2 0.0 0.2 0.0 0.0 17.5 1.7 0.0 0.9 0.0 5.4 0.6 1.2 0.0 6.5 0.0 0.0 3.4 0.6 1.0 0.0 0.0 0.0 0.5 0.0 1.1 0.0 9.1 0.2 0.0 8.2 0.0 0.0 0.2 0.1 0.9 0.1 0.1 9.4 0.5 0.1 2.3 0.0 SPEM1 "C17orf83, FLJ40081" ENSG00000181323 "Spermatid maturation 1" Q8N4L4 17 7420324-7421632 "Predicted membrane proteins" "Differentiation, Spermatogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 333 "testis: 68.7" "Cell type enriched" "Detected in some" 6 "Late spermatids: 5248.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 31: Spermatids - Spermatogenesis" "unprognostic (1.28e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 68.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 808.7 0.0 0.1 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5248.6 11.8 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 13.8 7.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPEM2 C17orf74 ENSG00000184560 "SPEM family member 2" Q0P670 17 7425616-7427568 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 571 "testis: 128.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA023649 Uncertain Approved "Golgi apparatus" NA NA "Cluster 36: Testis - Spermatogenesis" "Golgi apparatus" "HPA023649: AB_1845606" "unprognostic (3.00e-1)" "unprognostic (3.88e-1)" "unprognostic (1.12e-4)" "unprognostic (1.25e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 128.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SPPL2C IMP5 ENSG00000185294 "Signal peptide peptidase like 2C" Q8IUH8 17 45844881-45847067 "Enzymes, Predicted membrane proteins" "Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 73 "testis: 36.8" "Group enriched" "Detected in some" 146 "Early spermatids: 202.7;Late spermatids: 615.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA077339 Supported NA NA "Cluster 74: Testis - Spermatogenesis" "Cluster 34: Spermatids - Unknown function" "HPA077339: " "unprognostic (6.70e-4)" "unprognostic (1.34e-1)" 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 36.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 202.7 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 615.6 2.8 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SRC "ASV, c-src, SRC1" ENSG00000197122 "SRC proto-oncogene, non-receptor tyrosine kinase" P12931 20 37344685-37406050 "Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters" "Cell adhesion, Cell cycle, Host-virus interaction, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Distal enterocytes: 42.0;Gastric mucus-secreting cells: 43.8;Langerhans cells: 46.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in some" "intermediate monocyte: 2.4;non-classical monocyte: 2.3" "Group enriched" "Detected in many" 6 "dendritic cells: 1.4;monocytes: 2.4" "Cell line enhanced" "Detected in many" "A549: 110.8;HBEC3-KT: 102.6;RT4: 106.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004023, HPA030875" Approved Supported "Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol" NA NA 3200000 "Cluster 51: Monocytes - Innate immune response" "Cluster 71: Testis - DNA repair" "Cluster 15: RT4 - Unknown function" "Cluster 27: Mucus-secreting cells - Mucin production" "Plasma membrane, Cell Junctions" "Nucleoplasm, Cytosol" "CAB004023: AB_2106059, HPA030875: AB_2673640" "unprognostic (5.58e-2)" "unprognostic (9.83e-2)" "unprognostic (3.56e-1)" "unprognostic (4.54e-3)" "unprognostic (1.52e-1)" "unprognostic (1.54e-2)" "prognostic unfavorable (4.90e-5)" "unprognostic (3.89e-2)" "unprognostic (7.04e-2)" "unprognostic (8.13e-2)" "unprognostic (1.54e-2)" "prognostic unfavorable (1.63e-4)" "prognostic unfavorable (1.22e-4)" "unprognostic (2.33e-2)" "unprognostic (4.72e-2)" "unprognostic (3.65e-2)" "prognostic favorable (5.22e-5)" 9.7 25.3 5.7 13.3 5.2 8.4 10.1 0.4 6.2 25.1 1.5 30.3 39.8 31.9 3.2 26.1 23.8 27.9 8.8 6.4 5.5 21.4 4.3 16.1 6.3 2.6 3.4 23.6 30.8 11.1 15.9 8.1 2.2 30.8 17.1 5.5 11.8 27.4 2.4 13.0 38.8 17.2 1.7 14.2 39.9 25.2 5.0 6.1 9.8 1.5 8.1 35.6 24.6 3.0 24.6 110.8 24.9 22.6 9.3 14.7 51.6 22.0 18.9 26.3 16.6 41.9 21.5 0.7 13.4 40.2 29.9 43.5 15.1 102.6 10.3 0.1 13.7 6.2 3.9 65.9 22.0 0.3 9.3 15.7 34.2 17.3 22.8 29.4 24.3 14.2 0.6 0.2 4.4 16.7 6.0 0.8 11.7 67.3 98.8 26.5 6.6 0.7 11.0 106.3 23.1 83.6 25.0 34.5 27.2 19.1 31.1 9.0 35.8 31.4 20.9 11.7 20.1 0.3 0.8 0.3 22.1 0.1 24.0 0.0 1.6 0.0 0.0 2.4 0.0 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.3 2.3 1.4 0.0 1.0 5.7 5.2 0.4 6.2 6.4 5.5 2.6 3.4 2.2 1.7 5.0 3.0 1.0 3.2 1.7 3.3 4.1 8.2 12.5 9.5 10.8 6.5 6.2 7.5 2.2 18.6 4.7 12.9 2.1 2.3 4.9 42.0 1.9 12.2 1.8 6.4 10.7 1.4 16.8 0.4 9.5 18.7 8.3 7.2 43.8 12.4 0.0 14.8 1.1 1.6 5.7 3.3 9.1 29.2 8.2 9.4 46.3 3.3 10.8 22.8 1.8 9.4 9.7 4.4 1.0 9.0 0.6 39.1 19.2 17.3 4.3 18.0 36.7 9.3 5.6 5.2 13.1 1.8 6.7 0.3 1.1 11.2 9.1 2.3 1.0 2.9 16.9 36.6 SSTR3 ENSG00000278195 "Somatostatin receptor 3" P32745 22 37204237-37212477 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.6;lymphoid tissue: 11.1;testis: 7.8" "Cell type enhanced" "Detected in some" "Excitatory neurons: 2.3;Late spermatids: 2.0;Microglial cells: 1.9" "Cancer enhanced" "Detected in some" "pancreatic cancer: 1.9" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in single" "naive CD4 T-cell: 1.1" "Lineage enriched" "Detected in single" 10 "T-cells: 1.1" "Group enriched" "Detected in some" 11 "RPMI-8226: 23.3;SCLC-21H: 8.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB022647 Approved NA NA "Cluster 32: T-cells - Unknown function" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 25: RPMI-8226 - Immune response" "Cluster 63: NK-cells & T-cells - Immune response" "CAB022647: " "unprognostic (1.63e-2)" "unprognostic (5.58e-3)" "unprognostic (1.32e-2)" "unprognostic (3.18e-2)" "unprognostic (7.03e-2)" "unprognostic (6.26e-5)" "unprognostic (1.11e-1)" "unprognostic (1.72e-2)" "unprognostic (1.90e-2)" "unprognostic (8.95e-2)" "unprognostic (3.88e-3)" "unprognostic (2.93e-1)" "unprognostic (1.51e-7)" "unprognostic (1.55e-1)" "unprognostic (1.24e-2)" "unprognostic (5.61e-3)" "unprognostic (1.06e-2)" 0.1 0.3 2.2 1.0 2.2 0.4 0.0 1.2 6.4 0.0 0.0 0.2 1.3 1.1 0.0 0.0 0.1 0.0 0.0 1.9 2.2 0.1 0.0 0.0 1.8 6.8 3.5 3.3 1.8 0.0 2.6 0.0 6.7 0.0 0.2 0.3 0.2 0.0 0.0 0.0 0.5 1.0 1.2 0.6 0.2 7.8 7.6 11.1 0.0 0.0 0.9 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 23.3 0.0 0.0 8.3 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.1 1.1 0.9 0.0 0.0 0.0 0.0 0.1 0.2 2.2 2.2 1.2 6.4 1.9 2.2 6.8 3.5 6.7 1.2 7.6 2.3 0.0 0.0 0.0 0.3 0.7 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.3 0.1 0.0 0.0 0.0 0.6 0.4 0.0 0.0 SUSD3 MGC26847 ENSG00000157303 "Sushi domain containing 3" Q96L08 9 93058688-93085133 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 57.3;testis: 77.2" "Cell type enhanced" "Detected in many" "B-cells: 32.4;Granulosa cells: 30.8;Hepatocytes: 66.6;Hofbauer cells: 49.4;Proximal tubular cells: 59.4;T-cells: 37.5;Theca cells: 34.7" "Cancer enhanced" "Detected in all" "breast cancer: 50.0" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 150.7;Karpas-707: 32.6;MCF7: 36.8;NB-4: 78.0;RPMI-8226: 82.5;THP-1: 34.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042310 Uncertain NA NA "Cluster 20: T-cells - T-cell receptor" "Cluster 66: Lymphoid tissue - Immune response regulation" "Cluster 27: U-698-M & Daudi - Adaptive immune response" "Cluster 32: Non-specific - Translation" "HPA042310: AB_10796902" "prognostic favorable (5.13e-4)" "unprognostic (5.42e-2)" "unprognostic (3.65e-1)" "unprognostic (8.34e-3)" "unprognostic (9.06e-2)" "unprognostic (2.84e-2)" "unprognostic (2.94e-2)" "unprognostic (7.41e-3)" "unprognostic (5.06e-2)" "unprognostic (1.23e-2)" "unprognostic (5.63e-2)" "unprognostic (3.55e-1)" "unprognostic (3.54e-3)" "unprognostic (2.57e-1)" "unprognostic (2.11e-1)" "unprognostic (3.39e-3)" "unprognostic (5.33e-2)" 6.1 1.8 4.5 17.6 3.9 41.3 15.4 4.6 4.3 16.7 4.4 3.8 4.9 19.8 10.0 4.2 35.4 4.2 1.3 4.3 5.6 21.2 27.8 4.1 57.3 6.4 5.7 40.1 1.0 1.3 5.4 2.0 6.5 2.4 2.2 6.4 11.4 3.2 1.2 3.6 18.7 6.1 6.6 36.3 4.5 77.2 5.9 31.8 4.2 0.6 30.5 4.4 6.1 8.0 7.3 0.0 0.0 0.0 0.0 0.0 0.1 0.8 1.5 0.6 0.3 3.4 1.3 150.7 0.6 0.6 0.1 0.3 2.4 0.1 0.0 13.4 0.1 20.7 0.1 2.4 9.5 0.1 4.6 9.9 0.7 0.0 0.0 0.0 0.0 0.0 6.2 32.6 0.0 36.8 0.2 78.0 1.8 1.1 4.6 6.5 0.0 82.5 0.0 0.0 0.2 0.2 0.1 1.1 0.0 1.7 19.4 34.6 0.5 0.0 0.0 0.0 0.0 6.6 3.8 9.7 0.0 0.0 0.2 0.6 16.7 79.1 24.0 15.5 27.4 88.7 124.8 43.4 41.1 70.1 214.8 87.7 5.8 11.2 3.0 3.6 182.9 68.3 4.5 3.9 4.6 4.3 4.3 5.6 6.4 5.7 6.5 6.6 5.9 8.0 2.6 0.0 6.7 0.0 32.4 0.6 0.2 0.3 0.0 0.5 24.2 11.0 0.8 17.2 0.2 0.0 4.2 1.0 2.4 0.4 9.8 0.7 3.0 0.4 2.9 3.4 0.0 2.5 0.1 0.2 2.1 9.0 1.1 0.3 3.8 30.8 1.4 66.6 49.4 0.0 0.1 0.4 8.2 10.5 9.2 11.2 5.6 29.1 1.8 17.8 8.3 1.7 2.1 0.5 0.1 0.6 0.1 5.3 17.9 1.4 0.2 59.4 0.7 9.2 0.0 0.1 1.6 3.4 3.9 0.1 0.3 1.4 37.5 34.7 0.7 0.2 SYCP1 "CT8, HOM-TES-14, SCP1" ENSG00000198765 "Synaptonemal complex protein 1" Q15431 1 114854863-114995370 "Plasma proteins, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 70 "testis: 40.2" "Cell type enriched" "Detected in some" 8 "Spermatocytes: 1162.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in single" 98 "THP-1: 17.2" "Region enriched" "Detected in single" 51 "cerebellum: 14.7" "Not detected" "Not detected" HPA021083 Enhanced Approved "Nuclear bodies,Cytosol" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 43: THP-1 - Innate immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "Nuclear bodies, Cytosol" "HPA021083: AB_1857685" "unprognostic (2.91e-1)" "unprognostic (6.89e-3)" "unprognostic (4.87e-1)" "unprognostic (8.74e-3)" 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 40.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 139.5 0.3 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 16.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 56.7 5.3 0.4 0.0 1.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.0 0.0 1162.6 32.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 SYCP3 ENSG00000139351 "Synaptonemal complex protein 3" Q8IZU3 12 101728648-101739472 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cell cycle, Cell division, Meiosis" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 146 "testis: 82.9" "Group enriched" "Detected in many" 8 "Spermatocytes: 825.7;Spermatogonia: 346.9" "Cancer enriched" "Detected in single" 16 "testis cancer: 5.7" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in single" "Karpas-707: 1.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB032978, HPA039635, HPA043938" Enhanced NA NA "Cluster 46: Basophils - DNA binding" "Cluster 74: Testis - Spermatogenesis" "Cluster 2: Karpas-707 - Immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "CAB032978: AB_656732, HPA039635: AB_2676607, HPA043938: AB_2678740" "unprognostic (2.86e-3)" "unprognostic (3.91e-1)" "unprognostic (3.18e-1)" "unprognostic (9.61e-3)" "unprognostic (1.40e-1)" "unprognostic (1.22e-2)" "unprognostic (7.49e-2)" "unprognostic (1.65e-1)" "unprognostic (1.82e-1)" "unprognostic (2.86e-2)" "unprognostic (7.15e-3)" "unprognostic (7.81e-3)" "unprognostic (4.85e-2)" "unprognostic (1.93e-2)" "unprognostic (2.24e-1)" "unprognostic (4.07e-2)" "unprognostic (5.86e-4)" 0.0 0.1 0.3 0.3 0.4 0.2 0.0 0.5 0.3 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.0 0.0 0.0 0.2 0.0 0.0 0.2 0.1 82.9 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 1.3 0.2 0.0 0.3 0.2 0.0 0.1 0.0 0.0 0.2 0.6 0.4 0.2 0.0 0.1 0.0 0.0 0.5 0.1 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.5 0.3 0.1 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.4 0.0 2.0 9.1 4.5 0.0 0.7 0.4 1.2 2.2 0.9 0.6 1.3 1.5 0.3 1.8 0.0 0.4 3.1 0.6 0.0 0.1 24.1 0.3 1.3 0.9 1.2 0.4 10.1 0.4 0.2 0.7 0.0 0.7 3.8 0.3 0.7 0.2 0.6 0.0 10.7 0.7 0.0 1.0 0.3 31.2 9.0 1.7 0.0 0.0 0.4 0.3 1.0 9.5 1.8 0.3 1.9 1.9 2.0 0.9 1.0 0.3 0.8 1.7 65.7 2.0 0.4 825.7 346.9 0.7 0.3 0.1 2.0 0.2 1.3 0.5 TDRD15 ENSG00000218819 "Tudor domain containing 15" B5MCY1 2 21123968-21144368 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enriched" "Detected in single" 6 "testis: 5.4" "Cell type enhanced" "Detected in some" "Early spermatids: 5.0;Late spermatids: 12.1;Sertoli cells: 6.6;Spermatocytes: 34.5;Spermatogonia: 8.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "NB-4: 1.5;U-266/70: 7.5;U-266/84: 3.0" "HPA051770, HPA054675" Uncertain NA NA "Cluster 83: Testis - Spermatogenesis" "Cluster 29: U-266 - Adaptive immune response" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" "HPA051770: AB_2681601, HPA054675: AB_2682569" "unprognostic (4.20e-3)" "unprognostic (1.46e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 7.5 3.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 5.0 0.0 0.3 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.7 2.0 0.4 0.0 0.1 0.0 0.0 0.0 0.0 12.1 0.6 0.2 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 6.6 0.1 0.0 34.5 8.5 0.0 0.0 0.0 0.2 0.0 0.1 0.0 TIMM9 TIM9A ENSG00000100575 "Translocase of inner mitochondrial membrane 9" Q9Y5J7 14 58408495-58427531 "Predicted intracellular proteins" "Protein transport, Translocation, Transport" Chaperone "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" HPA002932 Approved Supported Mitochondria NA NA 78000 "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" Mitochondria "HPA002932: AB_1080287" "prognostic favorable (8.04e-4)" "unprognostic (8.05e-2)" "unprognostic (3.08e-1)" "unprognostic (1.02e-1)" "unprognostic (2.54e-1)" "unprognostic (3.11e-2)" "prognostic unfavorable (9.89e-5)" "unprognostic (1.51e-1)" "unprognostic (1.84e-1)" "prognostic favorable (6.39e-5)" "unprognostic (3.41e-1)" "unprognostic (7.32e-2)" "unprognostic (7.16e-2)" "unprognostic (4.13e-2)" "unprognostic (1.54e-1)" "unprognostic (1.20e-1)" "unprognostic (5.77e-2)" 42.4 35.8 22.6 18.1 25.1 21.3 40.5 26.9 39.7 37.1 25.7 45.1 23.0 33.6 35.6 29.9 36.1 24.0 34.9 24.0 24.7 46.4 31.8 24.0 28.4 23.8 24.6 48.3 75.7 21.2 27.7 22.3 24.3 32.2 18.0 28.2 35.8 20.5 66.1 33.2 26.8 26.8 24.2 26.1 37.1 22.4 23.3 18.8 30.2 23.6 25.1 39.2 31.4 28.0 71.0 56.7 45.8 46.6 53.0 99.6 63.0 67.6 38.3 55.0 48.7 60.3 74.3 100.4 73.1 38.8 45.2 48.0 63.9 67.0 76.3 68.0 38.5 53.0 36.2 68.8 129.1 78.5 45.6 77.1 86.5 51.4 100.4 80.2 54.4 47.2 82.0 57.8 53.9 120.3 75.5 101.0 38.2 106.2 98.8 63.3 73.8 58.9 70.3 63.1 60.3 34.3 44.6 109.7 126.7 55.2 78.0 45.1 57.4 63.0 87.0 41.4 73.8 40.4 43.1 91.8 50.0 79.1 76.8 8.8 14.8 4.0 14.3 17.0 26.3 28.5 22.5 21.4 21.4 22.3 28.5 27.3 1.6 27.8 19.2 23.2 25.2 12.5 22.6 25.1 26.9 39.7 24.0 24.7 23.8 24.6 24.3 24.2 23.3 28.0 26.8 32.1 20.0 12.7 40.5 35.3 46.4 47.6 38.7 15.9 44.2 55.2 20.7 32.9 26.0 14.7 22.9 80.1 30.7 12.2 72.4 39.1 36.7 21.4 38.5 33.6 25.2 35.3 14.2 54.1 92.9 32.2 25.5 21.9 36.8 36.6 39.7 33.0 61.2 5.0 15.4 43.2 24.4 47.9 29.9 32.7 74.3 30.0 33.8 3.7 47.6 31.6 39.1 8.5 12.2 38.2 30.5 51.6 33.8 57.3 35.3 117.7 15.0 24.0 19.7 49.7 32.3 78.8 22.1 39.2 39.6 73.5 29.9 56.9 53.4 42.8 TMEM130 "DKFZp761L1417, FLJ42643" ENSG00000166448 "Transmembrane protein 130" Q8N3G9 7 98846488-98870771 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "adrenal gland: 37.1;brain: 141.0;pituitary gland: 100.3;testis: 37.4" "Group enriched" "Detected in some" 4 "Bipolar cells: 51.2;Excitatory neurons: 43.8;Inhibitory neurons: 53.9" "Cancer enhanced" "Detected in many" "renal cancer: 9.1" "Low region specificity" "Detected in many" "Immune cell enhanced" "Detected in single" "neutrophil: 1.6" "Lineage enriched" "Detected in single" 5 "granulocytes: 1.6" "Cell line enhanced" "Detected in some" "BJ hTERT+: 6.7;EFO-21: 6.4;GAMG: 6.9;hTERT-RPE1: 11.0;NTERA-2: 3.8;SH-SY5Y: 7.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA012928 Uncertain Supported "Golgi apparatus" NA NA 9400 "Cluster 33: Neutrophils - Chromatin organization" "Cluster 10: Brain - Neuronal signaling" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 56: Bipolar cells - Visual perception" "Golgi apparatus" "HPA012928: AB_1858085" "unprognostic (1.36e-2)" "unprognostic (1.33e-3)" "unprognostic (3.85e-2)" "unprognostic (1.56e-2)" "unprognostic (3.61e-3)" "unprognostic (3.23e-2)" "unprognostic (2.97e-1)" "prognostic favorable (7.84e-4)" "unprognostic (1.07e-2)" "unprognostic (1.17e-2)" "unprognostic (4.69e-2)" "unprognostic (5.65e-2)" "unprognostic (1.86e-3)" "unprognostic (7.90e-3)" "unprognostic (1.22e-1)" "unprognostic (1.17e-2)" "unprognostic (1.73e-1)" 0.5 37.1 63.7 1.5 64.2 0.6 1.2 0.0 116.6 3.2 0.0 3.9 0.8 1.1 9.4 1.6 1.0 1.8 0.6 67.3 141.0 3.4 0.1 6.2 2.3 11.6 8.2 0.9 0.8 2.7 100.3 0.5 17.0 2.4 1.2 17.9 0.4 6.7 2.0 0.4 1.5 0.8 7.2 0.7 1.4 37.4 55.7 1.8 0.5 0.1 0.3 0.9 4.9 42.4 0.0 0.6 0.0 0.0 0.2 0.0 0.3 2.9 6.7 0.5 0.4 0.1 0.1 0.1 6.4 1.7 6.9 0.1 0.0 0.0 0.1 0.2 0.3 0.1 0.3 0.1 0.0 0.0 0.6 0.1 0.0 0.0 0.0 11.0 0.3 0.2 0.1 0.4 0.3 0.5 0.1 0.2 3.8 0.0 0.2 0.1 0.0 0.6 0.0 0.1 0.4 7.8 0.1 0.1 0.0 2.5 0.0 0.0 0.0 0.0 0.5 0.0 0.2 0.3 0.2 0.1 0.4 0.4 0.2 0.8 0.2 0.2 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.2 0.2 0.2 1.6 0.3 0.2 0.2 0.1 0.1 63.7 64.2 0.0 116.6 67.3 141.0 11.6 8.2 17.0 7.2 55.7 42.4 0.1 0.0 0.0 2.6 0.0 0.4 0.4 0.1 0.0 51.2 0.3 0.4 1.0 1.5 2.0 1.8 2.1 0.1 1.5 0.1 0.0 0.0 1.6 0.1 0.2 0.5 0.0 0.0 43.8 0.2 0.1 2.1 0.0 0.2 0.0 0.5 0.7 0.0 0.1 0.0 53.9 0.0 2.0 0.0 1.2 2.7 0.9 0.3 0.0 3.7 0.0 1.7 0.0 11.6 4.2 0.0 0.0 6.8 0.0 0.3 0.2 0.1 0.3 4.3 0.0 0.6 0.8 0.6 0.6 0.0 0.3 0.3 0.2 0.0 0.1 0.2 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030921-124033067 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 12.6;intestine: 8.4;testis: 5.3" "Cell type enhanced" "Detected in some" "Astrocytes: 9.4;Bipolar cells: 3.7;Oligodendrocytes: 11.4;Proximal enterocytes: 10.0" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 130.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA056391 Uncertain Approved "Plasma membrane" NA NA "Cluster 45: Intestine - Brush border" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 45: Enterocytes - Digestion" "Plasma membrane" "HPA056391: AB_2683114" "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.0 1.0 7.5 0.0 11.0 0.0 0.0 9.8 9.0 0.1 2.5 0.1 8.4 0.1 0.4 0.0 0.6 0.0 0.2 7.7 9.6 0.0 0.0 0.0 0.0 9.1 12.6 0.2 0.0 0.8 0.9 0.1 9.0 0.2 0.1 0.1 0.4 0.0 0.0 0.0 3.9 0.1 7.9 0.1 1.8 5.3 10.2 0.0 0.0 0.0 0.0 0.3 0.0 11.7 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 130.7 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.5 11.0 9.8 9.0 7.7 9.6 9.1 12.6 9.0 7.9 10.2 11.7 0.0 0.0 0.0 9.4 0.0 0.0 0.1 0.0 0.0 3.7 0.0 0.0 0.7 0.0 0.0 0.0 0.0 2.7 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.9 0.2 0.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.1 0.0 1.1 0.3 0.0 0.0 0.0 0.3 0.6 0.0 0.0 0.0 0.0 1.2 0.0 2.0 11.4 0.0 2.5 0.0 0.0 0.1 10.0 0.1 0.0 0.2 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.3 0.0 1.2 0.7 0.2 TMEM239 ENSG00000198326 "Transmembrane protein 239" Q8WW34 20 2816302-2820284 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 115 "testis: 106.3" "Cell type enriched" "Detected in some" 5 "Late spermatids: 127.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enriched" "Detected in some" 9 "HDLM-2: 9.2" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 44: HDLM-2 - Immune response" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (5.12e-3)" "unprognostic (2.95e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 106.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 127.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 TNP1 ENSG00000118245 "Transition protein 1" P09430 2 216859458-216860064 "Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, DNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 1160 "testis: 5953.3" "Group enriched" "Detected in some" 205 "Early spermatids: 41424.6;Late spermatids: 136509.6" "Group enriched" "Detected in some" 58 "liver cancer: 6.0;testis cancer: 4.8" "Region enhanced" "Detected in many" "basal ganglia: 4.9" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "Hep G2: 2.5;U-2197: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" HPA044387 Enhanced NA NA "Cluster 36: Testis - Spermatogenesis" "Cluster 37: Hep G2 - Hepatocyte cell processes" "Cluster 34: Spermatids - Unknown function" "HPA044387: AB_2678923" "unprognostic (1.67e-1)" 0.9 0.8 1.4 0.4 4.9 0.0 4.0 1.4 1.4 1.0 0.0 0.9 0.8 0.6 0.0 0.8 0.6 0.0 0.8 1.6 0.0 1.1 2.0 0.6 0.1 0.0 0.0 0.8 1.3 0.0 0.8 0.0 0.0 5.1 0.0 0.0 0.8 0.0 2.3 1.4 1.6 0.0 0.0 0.6 1.0 5953.3 1.0 0.0 2.4 0.0 0.0 0.6 0.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 4.9 1.4 1.4 1.6 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 41424.6 0.0 0.0 15.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 136509.6 410.1 26.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 246.7 0.0 0.0 0.0 0.0 0.0 0.0 249.8 0.0 0.1 433.2 234.5 0.0 0.0 0.0 0.0 0.5 0.0 0.0 TOP2A TOP2 ENSG00000131747 "DNA topoisomerase II alpha" P11388 17 40388525-40417896 "Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" "Biological rhythms" "DNA-binding, Isomerase, Topoisomerase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 127.8;testis: 65.7" "Cell type enhanced" "Detected in many" "Erythroid cells: 216.8;Granulosa cells: 117.5;Spermatocytes: 621.2;Spermatogonia: 269.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Immune cell enhanced" "Detected in some" "T-reg: 2.4" "Low lineage specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Group enriched" "Detected in many" 4 "basal ganglia: 4.2;white matter: 8.0" "Low region specificity" "Detected in some" "CAB002448, HPA006458, HPA026773" Enhanced Approved Supported Nucleoplasm,Nucleoli Yes Yes "Cluster 4: T-regs - Cell cycle regulation" "Cluster 53: Non-specific - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 12: Non-specific - Cell cycle regulation" Nucleoplasm Nucleoli "CAB002448: AB_564035, HPA006458: AB_1858189, HPA026773: AB_1858190" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "unprognostic (2.28e-3)" "unprognostic (9.42e-3)" "unprognostic (1.80e-1)" "unprognostic (1.52e-1)" "prognostic unfavorable (5.92e-6)" "prognostic unfavorable (4.99e-4)" "unprognostic (6.21e-3)" "unprognostic (2.09e-1)" "prognostic unfavorable (3.83e-5)" "unprognostic (5.03e-2)" "prognostic unfavorable (0.00e+0)" "unprognostic (7.46e-2)" "unprognostic (1.07e-1)" "unprognostic (2.18e-1)" "unprognostic (2.29e-1)" 2.2 2.5 0.2 20.0 0.2 42.0 5.4 0.1 0.7 5.0 1.1 17.8 18.1 3.9 0.3 29.0 1.5 2.6 1.2 0.2 0.2 1.2 2.8 4.1 40.3 0.2 0.8 1.0 0.9 0.3 0.3 15.9 0.5 1.4 19.8 0.1 4.3 0.5 0.3 15.3 17.0 7.6 0.2 9.9 8.9 65.7 1.1 127.8 1.9 0.2 42.5 6.0 9.6 0.4 212.6 275.6 343.1 158.0 16.8 33.9 76.3 283.3 151.5 255.0 224.2 130.5 157.6 339.4 140.1 96.7 152.7 326.5 266.8 113.5 339.5 182.7 177.8 224.8 167.9 216.7 1.6 318.4 228.6 7.4 9.2 179.8 181.4 55.1 136.3 216.5 247.5 225.8 279.2 72.6 372.3 209.6 143.0 152.4 108.3 310.7 531.9 141.3 61.6 133.3 201.6 144.6 229.3 281.4 89.4 198.2 236.9 143.2 90.3 167.0 233.2 195.5 276.7 128.4 154.9 290.7 94.3 214.9 285.0 0.2 0.0 0.0 0.2 0.0 0.0 0.6 0.3 0.3 0.1 0.1 0.0 0.0 0.1 1.4 0.1 0.0 2.4 0.4 0.2 0.2 0.1 0.7 0.2 0.2 0.2 0.8 0.5 0.2 1.1 0.4 1.0 0.0 2.0 0.3 17.4 11.7 3.7 15.0 2.2 0.0 18.7 17.1 1.3 2.8 5.8 0.0 0.0 72.9 6.1 19.8 0.0 0.8 20.3 12.7 15.8 9.3 0.0 216.8 0.2 0.0 92.4 23.3 23.0 10.0 0.0 117.5 20.7 5.4 83.5 0.0 0.1 34.2 18.3 33.9 13.2 19.1 4.7 14.1 1.8 0.0 2.6 0.0 3.1 0.0 0.1 0.3 3.5 1.9 31.3 3.1 3.4 0.1 1.8 0.0 72.3 0.5 19.5 621.2 269.6 45.1 6.1 8.9 14.8 4.3 61.0 6.9 TOX2 "C20orf100, dJ1108D11.2, GCX-1" ENSG00000124191 "TOX high mobility group box family member 2" Q96NM4 20 43914852-44069616 "Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 50.2" "Cell type enhanced" "Detected in many" "Early spermatids: 22.3;Excitatory neurons: 20.5;Hepatic stellate cells: 34.2;Inhibitory neurons: 76.9;Oligodendrocyte precursor cells: 45.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enhanced" "Detected in some" "eosinophil: 6.5" "Low lineage specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HHSteC: 92.0;U-266/70: 57.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA049900, HPA058396" Approved Supported Nucleoplasm NA NA "Cluster 52: Eosinophils - Transcription" "Cluster 32: Brain & Lymphoid tissue - Unknown function" "Cluster 30: Epithelial cell lines - Translation" "Cluster 8: Neurons & Oligodendrocytes - Synaptic function" Nucleoplasm "HPA049900: AB_2680942, HPA058396: AB_2683704" "unprognostic (2.15e-2)" "unprognostic (1.82e-2)" "unprognostic (8.97e-3)" "prognostic unfavorable (2.60e-4)" "unprognostic (1.33e-1)" "unprognostic (1.01e-1)" "unprognostic (7.53e-3)" "unprognostic (6.29e-2)" "unprognostic (1.66e-1)" "unprognostic (1.86e-1)" "unprognostic (1.75e-2)" "unprognostic (2.78e-2)" "prognostic unfavorable (7.45e-8)" "unprognostic (1.60e-1)" "unprognostic (2.00e-1)" "unprognostic (7.60e-2)" "unprognostic (3.12e-1)" 10.0 4.0 11.2 6.2 8.2 1.8 6.8 4.9 18.4 10.2 2.3 7.6 1.3 6.2 1.1 12.8 3.6 2.9 3.6 8.3 35.7 5.1 5.2 36.4 13.3 12.3 18.8 3.1 2.0 10.1 24.6 2.6 15.9 16.7 2.4 1.9 3.8 2.7 1.5 5.1 10.2 1.6 5.8 5.7 9.7 20.8 25.9 50.2 7.4 6.4 8.1 17.6 8.9 10.6 9.9 12.5 4.9 0.9 4.7 13.3 0.1 11.5 5.3 8.1 8.9 0.0 4.0 0.0 16.8 16.6 35.2 5.1 3.2 0.3 8.4 15.5 2.7 0.0 1.1 0.0 92.0 0.1 19.4 31.0 14.0 27.0 1.6 25.8 9.4 9.5 0.0 14.5 4.6 11.3 3.2 4.5 3.0 0.3 42.2 0.0 10.1 15.4 0.0 1.2 4.3 35.8 2.4 0.0 18.0 0.5 0.0 9.2 11.3 0.0 7.5 0.3 0.1 57.4 13.5 9.0 16.9 0.1 27.0 0.0 0.2 6.5 0.0 0.1 0.0 0.1 0.3 0.1 0.0 0.0 0.1 0.0 0.7 1.1 0.0 2.6 1.2 0.1 11.2 8.2 4.9 18.4 8.3 35.7 12.3 18.8 15.9 5.8 25.9 10.6 8.0 0.0 0.6 3.9 3.4 1.0 1.0 0.7 0.0 0.8 0.2 0.1 0.8 1.5 0.1 0.0 0.0 0.0 7.3 0.3 0.0 0.1 22.3 0.3 8.9 8.9 0.0 0.0 20.5 0.2 0.1 6.7 1.5 0.3 0.0 10.7 34.2 0.5 1.5 3.3 76.9 0.6 0.0 2.9 3.6 17.3 1.8 1.2 1.8 3.7 0.2 4.6 1.0 45.2 0.5 0.1 2.2 0.7 12.1 0.5 0.0 0.1 0.0 0.1 0.0 0.4 8.7 1.3 1.8 0.2 1.3 0.3 10.5 0.1 1.8 0.3 TRAFD1 FLN29 ENSG00000135148 "TRAF-type zinc finger domain containing 1" O14545 12 112125538-112153604 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "monocytes: 117.6;Spermatocytes: 75.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039254, HPA039266" Enhanced Approved Nucleoplasm,Cytosol NA NA "Cluster 2: Granulocytes - Unknown function" "Cluster 84: Esophagus - Epithelial cell function" "Cluster 15: RT4 - Unknown function" "Cluster 3: Monocytes - Immune response regulation" Nucleoplasm Cytosol "HPA039254: AB_10805358, HPA039266: AB_10795142" "unprognostic (7.80e-2)" "prognostic favorable (5.73e-4)" "unprognostic (6.12e-2)" "unprognostic (1.44e-1)" "unprognostic (9.46e-2)" "unprognostic (2.51e-2)" "prognostic unfavorable (4.87e-4)" "unprognostic (1.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.78e-1)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "prognostic unfavorable (9.26e-6)" "unprognostic (1.07e-1)" "unprognostic (6.15e-2)" "unprognostic (3.33e-3)" "prognostic favorable (3.92e-5)" 17.1 14.6 15.9 30.4 21.5 30.1 20.3 21.2 18.9 21.2 24.7 40.6 16.7 16.8 15.6 32.0 15.4 17.7 22.3 15.1 17.3 15.7 13.5 26.3 37.1 22.4 20.0 18.7 11.8 15.7 11.7 19.0 23.0 22.0 20.6 18.7 19.0 19.8 12.9 35.9 20.3 25.9 20.5 31.3 17.2 29.1 20.1 32.6 13.8 11.4 40.4 29.9 21.7 30.2 23.8 26.2 41.8 40.8 28.8 27.3 22.1 27.2 38.8 36.5 29.4 29.5 21.9 27.4 22.6 28.9 15.7 49.0 42.0 26.3 24.2 47.3 40.1 44.4 37.7 16.3 50.0 27.1 67.7 34.4 43.5 27.1 35.7 37.2 32.6 16.6 50.1 16.9 23.6 41.2 31.5 39.0 35.4 27.8 31.8 43.8 25.6 46.8 24.3 89.5 36.4 27.3 57.4 55.7 15.1 30.8 35.8 38.7 22.1 17.2 12.2 17.1 14.3 40.3 36.2 29.3 18.5 21.6 19.1 323.7 96.1 226.1 45.1 86.8 30.1 56.7 43.1 40.3 50.1 60.2 39.4 36.6 188.2 70.8 93.1 33.5 63.7 101.2 15.9 21.5 21.2 18.9 15.1 17.3 22.4 20.0 23.0 20.5 20.1 30.2 10.7 19.2 13.1 6.8 12.4 12.2 7.4 18.5 30.7 7.0 14.7 11.8 10.9 5.7 18.9 12.9 25.0 20.1 8.5 15.4 5.9 21.3 1.7 9.0 14.3 11.3 15.6 9.0 8.4 20.8 15.6 15.1 15.3 7.5 12.0 10.0 7.9 5.7 14.8 15.2 12.2 10.3 30.5 11.9 9.9 3.7 11.8 14.0 7.2 7.5 117.6 9.9 19.6 10.6 28.6 25.8 15.5 12.8 8.7 22.7 13.0 6.3 10.2 10.9 0.0 5.6 8.8 75.6 36.0 22.0 15.2 26.4 14.0 10.0 9.4 14.4 TSSK6 "CT72, FLJ24002, SSTK" ENSG00000178093 "Testis specific serine kinase 6" Q9BXA6 19 19512418-19515548 "Enzymes, Metabolic proteins, Predicted intracellular proteins" "Differentiation, Spermatogenesis" "Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 102 "testis: 167.6" "Cell type enriched" "Detected in some" 5 "Late spermatids: 8709.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "BEWO: 3.4;CACO-2: 1.7" "Not detected" "Not detected" "Not detected" "Not detected" NA NA "Cluster 32: T-cells - Unknown function" "Cluster 83: Testis - Spermatogenesis" "Cluster 28: BEWO - Transcription regulation" "Cluster 25: Spermatids - Spermatogenesis" "unprognostic (2.12e-1)" "unprognostic (7.89e-2)" "unprognostic (7.26e-2)" "unprognostic (6.64e-2)" "unprognostic (3.39e-1)" "unprognostic (7.20e-5)" "unprognostic (3.38e-1)" "unprognostic (5.51e-3)" "unprognostic (5.17e-2)" "unprognostic (1.46e-1)" "unprognostic (3.98e-4)" "unprognostic (2.28e-2)" "unprognostic (5.34e-3)" "unprognostic (2.74e-3)" "unprognostic (2.78e-2)" "unprognostic (1.52e-3)" "unprognostic (9.89e-2)" 0.6 0.7 0.4 0.0 0.6 0.1 0.7 0.5 0.5 0.4 0.1 0.7 0.5 0.8 0.0 0.7 0.6 0.0 0.3 0.3 0.2 0.9 1.2 0.4 0.3 0.7 0.6 0.5 1.0 0.0 0.7 0.0 0.7 0.9 0.0 0.0 0.6 0.0 0.3 1.6 1.0 0.0 0.6 1.2 0.9 167.6 0.5 0.1 0.9 0.0 0.1 0.6 0.6 1.0 0.0 0.6 0.0 0.0 0.0 0.1 3.4 0.1 0.2 0.0 0.1 1.7 0.0 0.7 0.1 0.0 0.0 0.4 0.1 0.6 0.0 0.5 0.0 0.4 0.4 0.0 0.4 0.4 0.7 0.3 0.1 0.2 0.5 0.0 0.1 0.0 0.2 0.0 0.0 0.2 0.3 0.7 0.3 0.0 0.0 0.6 0.0 0.5 0.0 0.2 0.2 0.4 0.0 0.0 0.0 0.0 0.6 0.5 0.0 0.5 0.2 0.9 0.2 0.8 0.6 0.0 0.7 0.4 0.9 0.0 0.1 0.3 0.1 0.0 0.1 0.7 0.0 0.2 0.0 0.1 0.8 0.4 0.1 0.0 0.0 0.2 0.1 0.2 0.4 0.6 0.5 0.5 0.3 0.2 0.7 0.6 0.7 0.6 0.5 1.0 0.2 0.0 0.0 0.0 0.0 0.4 0.2 0.1 0.0 0.0 0.3 0.1 1.7 1.5 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.2 1462.5 0.5 0.4 2.7 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.8 0.0 0.1 0.7 0.5 0.1 0.0 0.0 0.0 2.0 0.8 0.5 8709.8 47.8 2.2 1.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 57.2 0.1 0.1 0.5 0.2 0.3 0.0 19.7 1.1 0.3 57.7 25.7 0.0 0.1 0.1 0.2 0.0 0.1 0.1 TTYH2 C17orf29 ENSG00000141540 "Tweety family member 2" Q9BSA4 17 74213571-74262020 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "brain: 214.5" "Cell type enhanced" "Detected in many" "Astrocytes: 46.0;Bipolar cells: 59.2;Langerhans cells: 52.1;Oligodendrocytes: 206.9" "Group enriched" "Detected in all" 6 "glioma: 16.7;melanoma: 20.3" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "classical monocyte: 13.3;intermediate monocyte: 22.3;myeloid DC: 14.6;non-classical monocyte: 28.6;plasmacytoid DC: 18.2" "Group enriched" "Detected in many" 5 "dendritic cells: 18.2;monocytes: 28.6" "Cell line enhanced" "Detected in many" "HSkMC: 22.2;SK-MEL-30: 81.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" NA NA "Cluster 51: Monocytes - Innate immune response" "Cluster 70: Brain - Nervous system development" "Cluster 33: SK-MEL-30 - Melanocyte processes" "Cluster 42: Oligodendrocytes - Myelin sheath organization" "unprognostic (1.19e-1)" "unprognostic (5.08e-1)" "unprognostic (1.58e-3)" "unprognostic (3.51e-4)" "unprognostic (1.59e-1)" "unprognostic (2.44e-1)" "unprognostic (1.67e-2)" "unprognostic (5.90e-2)" "unprognostic (8.71e-2)" "unprognostic (2.85e-1)" "unprognostic (1.81e-2)" "unprognostic (2.87e-1)" "prognostic unfavorable (9.74e-5)" "unprognostic (8.98e-3)" "unprognostic (5.70e-3)" "unprognostic (2.50e-3)" "unprognostic (3.51e-3)" 5.5 4.7 75.4 7.3 132.2 3.3 4.4 101.4 103.2 7.1 34.7 8.2 2.6 4.9 3.5 3.2 6.3 5.1 18.1 83.7 91.3 2.0 1.6 5.5 7.7 129.0 115.2 17.2 8.3 4.0 7.0 10.3 123.3 4.6 2.5 19.8 6.9 4.0 14.8 5.2 4.8 3.9 88.2 11.7 3.9 15.2 113.6 5.1 10.1 9.4 5.7 5.3 4.7 214.5 0.2 1.9 9.0 8.7 1.1 1.3 0.2 0.5 0.1 0.5 0.1 5.9 0.1 5.3 1.3 0.2 1.0 14.5 8.9 0.3 0.3 12.5 5.0 5.7 0.3 0.5 6.2 0.6 3.8 22.2 4.6 0.1 1.6 0.6 0.3 3.8 1.0 2.6 0.2 1.0 2.7 0.4 1.7 8.7 15.7 8.8 16.1 10.1 0.2 0.7 3.1 11.0 0.0 5.5 81.3 4.6 2.9 1.2 0.2 0.0 4.4 0.1 0.3 0.5 0.3 0.1 0.3 1.7 4.9 1.0 13.3 1.2 2.4 22.3 0.3 0.3 4.6 3.8 14.6 0.3 0.7 1.7 1.2 0.1 28.6 18.2 4.5 7.0 75.4 132.2 101.4 103.2 83.7 91.3 129.0 115.2 123.3 88.2 113.6 214.5 8.0 0.0 4.1 46.0 1.3 2.3 0.6 0.2 1.2 59.2 1.5 2.4 1.9 2.8 0.1 0.0 6.2 0.3 7.9 0.0 0.0 0.2 27.7 0.4 0.7 6.9 1.8 0.0 1.0 0.2 0.4 4.1 0.5 0.9 21.6 0.5 1.8 0.5 5.0 3.3 0.9 0.2 0.0 12.3 52.1 11.5 9.6 13.7 23.2 15.0 16.5 18.4 0.0 10.6 206.9 0.1 0.1 2.6 1.3 0.8 0.0 0.2 0.3 10.8 19.7 3.2 2.7 2.4 1.5 0.4 2.6 0.3 2.3 4.3 0.0 0.4 UBA52 "CEP52, HUBCEP52, L40, MGC126879, MGC126881, MGC57125, RPL40" ENSG00000221983 "Ubiquitin A-52 residue ribosomal protein fusion product 1" P62987 19 18571730-18577550 "Predicted intracellular proteins, Ribosomal proteins" "Ribonucleoprotein, Ribosomal protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in all" "Late spermatids: 11928.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA041344, HPA049132, HPA056624" Supported Approved "Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol" NA NA "Cluster 30: Non-specific - Translation" "Cluster 50: Non-specific - Ribosome" "Cluster 30: Epithelial cell lines - Translation" "Cluster 32: Non-specific - Translation" "Endoplasmic reticulum, Cytosol" "Nucleoplasm, Plasma membrane" "HPA041344: AB_2677422, HPA049132: AB_2680646, HPA056624: AB_2683196" "unprognostic (1.98e-2)" "unprognostic (9.35e-2)" "unprognostic (1.46e-1)" "unprognostic (4.72e-2)" "unprognostic (5.36e-3)" "unprognostic (9.35e-2)" "unprognostic (1.74e-3)" "unprognostic (4.00e-2)" "unprognostic (7.44e-2)" "unprognostic (1.72e-1)" "unprognostic (1.27e-1)" "unprognostic (2.87e-1)" "unprognostic (2.52e-3)" "unprognostic (1.87e-1)" "unprognostic (5.61e-2)" "unprognostic (2.43e-1)" "unprognostic (2.23e-1)" 1161.5 955.0 823.8 793.2 845.7 2181.5 1115.4 815.0 1021.1 1262.7 808.6 984.4 531.1 938.2 966.2 1196.8 984.5 610.9 989.3 803.8 848.5 931.1 927.4 888.7 1469.5 861.9 825.6 1622.0 1664.8 844.0 758.0 720.8 858.2 917.0 789.6 235.6 1061.1 615.4 1629.9 1444.0 916.6 712.9 883.0 1239.2 989.5 755.3 853.4 1487.1 748.6 1196.7 1674.0 995.3 1107.5 875.5 1680.6 1304.1 961.2 1612.8 2437.7 2298.9 2376.3 1260.7 1738.5 2044.2 1618.9 2381.2 1521.6 2403.4 1268.0 2092.8 803.0 1103.3 1881.9 2242.7 1918.7 650.0 2938.0 1320.1 1942.1 2733.4 1770.8 2898.3 1616.2 2684.2 3008.4 1406.4 2024.7 1778.7 2083.2 1508.8 2131.5 3231.7 1769.8 2786.9 2336.4 2584.2 2162.6 3166.1 2800.9 1899.3 958.6 2769.6 2001.7 2497.0 1246.1 1505.9 914.3 2187.0 2300.9 1424.6 970.6 3681.4 1562.7 1017.6 850.0 2172.8 2271.9 1973.0 2863.7 2412.2 1386.0 3245.8 1412.8 962.6 2155.2 1163.1 1761.2 1764.2 2401.7 3126.7 2616.4 2119.8 2320.3 3025.4 2946.4 2445.0 1168.8 1864.5 1629.2 2469.2 2250.9 4829.5 823.8 845.7 815.0 1021.1 803.8 848.5 861.9 825.6 858.2 883.0 853.4 875.5 831.5 464.8 673.1 15.0 2198.0 1898.4 2027.9 1544.8 1365.8 117.9 1444.5 1279.9 332.3 1109.5 886.1 654.7 68.8 2020.5 1806.7 1264.6 1571.0 1437.7 3146.5 772.1 1337.9 1108.6 1106.6 2241.7 10.8 2271.5 2803.3 1060.1 672.2 1194.9 805.8 1061.9 1385.3 1919.9 2574.7 104.3 12.4 1812.7 710.1 3200.4 2894.6 11928.8 1875.2 2003.3 1250.4 8.4 3379.8 599.1 2276.1 11.1 23.1 1799.4 1853.6 1034.7 1202.4 2110.3 1645.1 2688.2 510.4 219.1 696.8 1483.1 2041.1 629.9 674.5 1939.2 2239.4 2282.9 1892.0 1285.6 1783.6 2426.6 WDR35 "FAP118, IFT121, IFTA1, KIAA1336, MGC33196" ENSG00000118965 "WD repeat domain 35" Q9P2L0 2 19910263-19990105 "Disease related genes, Human disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" "Ciliopathy, Disease variant, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in many" "Astrocytes: 36.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Immune cell enriched" "Detected in single" 5 "basophil: 2.9" "Lineage enriched" "Detected in single" 5 "granulocytes: 2.9" "Low cell line specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044147 Approved NA NA "Cluster 34: Basophils - Unknown function" "Cluster 42: Ciliated cells - Cilium & Cell projection" "Cluster 13: SH-SY5Y - Nervous system development" "Cluster 49: Ciliated cells - Cilium organization" "HPA044147: AB_10970242" "unprognostic (2.51e-1)" "unprognostic (4.93e-2)" "unprognostic (9.13e-2)" "unprognostic (4.01e-2)" "unprognostic (3.66e-2)" "unprognostic (2.79e-1)" "unprognostic (2.94e-3)" "unprognostic (3.08e-2)" "unprognostic (3.23e-1)" "unprognostic (2.91e-1)" "unprognostic (3.01e-2)" "unprognostic (3.68e-2)" "unprognostic (6.98e-2)" "unprognostic (2.17e-2)" "unprognostic (5.03e-2)" "unprognostic (1.02e-1)" "unprognostic (2.71e-1)" 3.6 5.1 4.3 2.7 4.4 2.0 7.8 4.1 4.7 6.6 10.0 4.9 1.7 9.3 7.2 2.9 11.3 3.5 3.3 4.1 5.5 7.9 2.0 4.5 2.7 5.5 5.5 9.6 3.8 14.4 9.0 2.7 5.1 5.5 3.0 12.6 3.0 6.3 2.5 3.4 3.0 6.2 4.9 2.0 3.7 10.6 6.0 4.8 8.8 2.6 2.6 4.4 3.7 5.7 8.3 10.4 9.9 9.5 7.6 7.4 0.5 4.2 7.4 6.0 4.3 3.2 3.6 0.0 1.8 4.7 5.0 2.6 10.6 10.3 9.9 1.6 8.2 8.1 6.6 10.0 6.6 15.8 3.1 9.0 7.2 10.7 15.2 10.8 7.4 3.3 13.1 2.3 6.1 3.0 2.3 11.4 11.9 1.5 10.0 0.0 7.1 3.5 12.8 4.7 18.6 21.9 6.9 4.6 12.3 4.7 4.9 3.4 7.7 6.8 3.3 9.4 12.4 4.7 8.3 0.0 12.7 1.1 6.8 2.9 0.1 0.3 0.5 0.0 0.1 0.4 0.3 0.3 0.2 0.6 0.3 0.4 0.2 0.4 0.0 0.1 0.4 0.2 4.3 4.4 4.1 4.7 4.1 5.5 5.5 5.5 5.1 4.9 6.0 5.7 2.9 3.2 9.0 36.6 5.7 3.3 3.5 5.0 2.2 6.5 5.8 7.2 10.8 11.5 7.2 11.0 2.1 0.2 2.9 0.3 0.0 3.3 1.9 16.1 13.1 3.1 6.0 7.8 30.0 4.0 1.0 9.7 5.1 4.0 9.5 9.4 3.6 2.4 1.3 6.7 21.9 1.5 4.1 0.9 2.8 3.5 10.2 2.0 3.6 18.7 1.1 10.0 2.1 25.1 27.6 6.3 0.7 10.9 2.4 2.0 0.7 5.6 28.6 15.2 6.6 14.6 7.4 28.8 9.0 2.2 2.6 0.3 5.4 9.0 1.5 1.1 XKR9 ENSG00000221947 "XK related 9" Q5GH70 8 70669339-70790371 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "intestine: 5.3;testis: 7.7" "Cell type enhanced" "Detected in many" "Excitatory neurons: 42.0;Inhibitory neurons: 17.9;Oligodendrocytes: 23.0;Spermatocytes: 82.3;Spermatogonia: 19.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Not detected in immune cells" "Not detected" "Not detected" "Not detected" "Cell line enhanced" "Detected in some" "CACO-2: 3.3;hTCEpi: 6.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA044430 Enhanced Approved Mitochondria NA NA "Cluster 4: T-regs - Cell cycle regulation" "Cluster 45: Intestine - Brush border" "Cluster 30: Epithelial cell lines - Translation" "Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis" Mitochondria "HPA044430: AB_10961283" "unprognostic (1.79e-2)" "unprognostic (7.31e-2)" "unprognostic (1.42e-1)" "unprognostic (1.40e-3)" "unprognostic (1.85e-1)" "unprognostic (1.22e-1)" "unprognostic (2.23e-2)" "unprognostic (9.33e-2)" "unprognostic (1.63e-1)" "unprognostic (2.63e-2)" "prognostic unfavorable (7.20e-4)" "unprognostic (2.29e-1)" "unprognostic (6.96e-6)" "unprognostic (3.65e-1)" "unprognostic (3.26e-1)" "unprognostic (4.04e-3)" "unprognostic (3.71e-2)" 0.2 1.1 0.5 0.4 0.5 0.5 0.4 0.0 1.6 0.2 0.0 0.9 2.6 0.2 1.3 0.5 0.1 2.2 0.2 0.5 0.3 0.5 3.3 0.6 0.5 0.6 0.2 0.2 0.3 0.1 0.6 0.4 1.1 0.6 0.5 2.4 0.5 0.0 0.2 0.9 5.3 0.3 0.0 0.5 1.8 7.7 0.3 0.5 0.4 0.3 0.5 1.0 0.2 1.5 2.3 0.1 0.5 0.2 0.0 0.5 0.3 0.9 0.4 0.3 0.9 3.3 0.2 0.3 1.5 0.0 1.1 0.1 0.0 0.5 1.1 0.4 0.3 0.2 0.2 0.2 0.0 0.7 1.2 0.6 6.4 0.1 0.0 0.2 0.0 1.6 0.1 2.3 0.1 0.3 0.4 0.3 1.3 0.1 0.4 0.3 0.6 0.1 0.1 1.7 1.4 0.2 0.4 1.0 0.3 0.1 0.3 0.1 0.2 0.3 0.6 0.4 0.3 2.0 0.5 1.5 0.1 0.2 0.2 0.2 0.0 0.0 0.2 0.0 0.4 0.2 0.4 0.2 0.0 0.2 0.6 0.4 0.1 0.2 0.0 0.0 0.8 0.0 0.5 0.5 0.0 1.6 0.5 0.3 0.6 0.2 1.1 0.0 0.3 1.5 0.1 6.4 2.2 14.4 1.1 2.7 3.5 3.9 4.6 2.2 0.7 1.0 0.4 1.5 3.3 0.0 8.4 1.0 0.3 1.4 0.0 1.6 5.3 0.5 0.3 0.6 0.0 0.0 42.0 4.6 0.6 0.8 6.1 0.6 0.0 0.3 0.0 2.3 0.3 1.7 17.9 3.4 0.0 0.3 0.4 4.9 0.9 0.2 0.0 1.9 0.0 1.5 2.1 1.5 23.0 6.0 1.3 0.4 0.8 1.7 11.7 0.5 3.2 5.3 0.0 0.1 0.2 82.3 19.7 0.5 0.9 1.0 1.0 0.1 0.4 2.3 YAE1 "C7orf36, CIAB2, GK003, YAE1D1" ENSG00000241127 "YAE1 maturation factor of ABCE1" Q9NRH1 7 39566385-39610320 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell type enhanced" "Detected in some" "Cardiomyocytes: 17.2;Cytotrophoblasts: 15.1;Extravillous trophoblasts: 12.0;Fibroblasts: 6.2;Hofbauer cells: 10.0;Syncytiotrophoblasts: 5.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA019226, HPA031249" Uncertain Approved Cytosol NA NA "Cluster 30: Non-specific - Translation" "Cluster 21: Non-specific - Transcription" "Cluster 17: WM-115 - Nervous system development" "Cluster 24: Non-specific - Transcription regulation" Cytosol "HPA019226: AB_1845759, HPA031249: AB_2673807" "unprognostic (1.19e-1)" "unprognostic (2.41e-1)" "unprognostic (8.73e-3)" "unprognostic (1.57e-1)" "unprognostic (8.75e-2)" "unprognostic (4.30e-1)" "prognostic unfavorable (1.64e-4)" "unprognostic (1.27e-1)" "unprognostic (3.69e-2)" "unprognostic (3.04e-3)" "unprognostic (1.17e-2)" "unprognostic (1.45e-2)" "unprognostic (2.39e-2)" "unprognostic (1.67e-2)" "unprognostic (6.54e-3)" "unprognostic (1.94e-1)" "unprognostic (8.02e-3)" 11.2 13.9 14.6 9.7 15.6 2.3 17.4 17.4 20.3 14.7 15.4 18.9 14.4 17.0 21.9 15.2 15.4 11.0 16.4 14.8 15.0 15.3 12.0 11.1 10.0 14.5 14.8 21.0 11.1 21.1 14.4 10.9 14.8 13.5 20.0 18.3 13.4 12.3 13.9 11.0 19.3 15.9 14.9 9.4 14.1 19.8 14.4 11.0 14.9 16.6 9.1 12.4 11.6 16.4 29.3 18.5 35.5 40.2 28.5 28.5 21.3 43.8 33.6 35.4 39.7 14.9 17.1 15.1 19.9 33.4 62.4 27.9 35.2 26.3 33.1 15.4 28.7 13.7 20.9 28.7 26.6 14.6 10.5 26.9 21.0 39.3 42.4 21.1 29.6 13.7 46.8 6.9 29.7 18.5 11.8 29.2 81.0 34.6 21.8 16.5 24.9 17.4 33.0 24.4 48.1 52.3 32.7 46.6 44.1 38.9 41.3 27.6 21.3 17.7 34.3 23.8 35.5 22.1 50.3 34.9 22.1 34.6 56.2 21.6 6.4 8.6 9.9 6.8 11.0 16.1 12.8 15.2 7.1 16.2 22.7 16.6 0.7 10.7 5.1 10.6 15.5 7.9 14.6 15.6 17.4 20.3 14.8 15.0 14.5 14.8 14.8 14.9 14.4 16.4 2.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 17.2 0.0 0.0 0.0 0.0 15.1 0.7 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 12.0 6.2 0.0 0.0 0.0 0.0 0.0 0.0 10.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 5.1 0.1 0.0 0.0 0.0 ZC3H8 "Fliz1, ZC3HDC8" ENSG00000144161 "Zinc finger CCCH-type containing 8" Q8N5P1 2 112211529-112255136 "Predicted intracellular proteins, Transcription factors" "Apoptosis, Transcription, Transcription regulation" "Repressor, RNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low immune cell specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034803, HPA034804" Approved Supported "Nucleoplasm,Nuclear bodies" NA NA "Cluster 15: NK-cells - Transcription" "Cluster 23: Testis - Cell cycle regulation" "Cluster 26: Non-specific - Cell cycle regulation" "Cluster 52: Non-specific - Transcription" Nucleoplasm "Nuclear bodies" "HPA034803: AB_2674338, HPA034804: AB_10670284" "unprognostic (2.45e-1)" "unprognostic (1.64e-1)" "unprognostic (1.03e-1)" "prognostic unfavorable (1.12e-6)" "unprognostic (4.93e-2)" "unprognostic (1.01e-1)" "unprognostic (4.29e-3)" "unprognostic (8.76e-2)" "unprognostic (1.20e-2)" "unprognostic (5.04e-2)" "unprognostic (7.22e-2)" "unprognostic (2.89e-2)" "prognostic unfavorable (1.89e-4)" "unprognostic (2.74e-2)" "unprognostic (3.49e-2)" "unprognostic (8.02e-3)" "unprognostic (4.88e-3)" 3.6 3.9 4.7 5.7 4.8 6.2 8.0 6.5 6.2 5.4 3.1 4.6 5.2 4.6 4.4 8.6 5.1 2.6 8.6 5.0 4.7 5.7 5.9 2.9 8.5 4.5 4.1 6.0 9.0 11.2 6.6 3.7 4.5 5.6 6.0 5.9 7.1 3.9 11.0 7.6 4.6 4.4 4.0 6.1 4.4 9.0 4.1 9.1 7.2 11.0 8.6 4.9 6.1 4.8 22.1 10.5 13.2 13.7 7.4 8.0 20.6 6.8 5.8 9.5 7.9 25.3 8.3 45.6 12.4 4.8 13.3 13.1 19.4 13.7 12.5 16.2 9.0 30.3 11.8 12.9 11.7 28.6 13.4 10.0 27.0 18.4 28.4 7.0 7.2 27.3 39.2 12.2 7.5 14.6 31.0 25.7 12.2 23.1 29.2 21.2 22.5 18.8 8.7 9.7 19.8 15.4 12.9 13.7 29.9 11.5 10.9 15.1 9.6 12.3 15.9 8.8 17.4 21.9 27.9 44.4 8.8 23.4 4.9 2.7 2.5 0.8 4.0 2.0 8.4 5.9 4.2 4.3 2.5 6.1 7.1 5.9 1.4 7.2 2.6 4.1 4.7 2.4 4.7 4.8 6.5 6.2 5.0 4.7 4.5 4.1 4.5 4.0 4.1 4.8 15.5 9.6 15.2 17.0 35.6 12.6 18.2 16.6 30.7 50.2 28.7 28.6 35.4 12.8 22.8 7.3 41.7 18.1 38.7 13.4 27.4 15.2 30.9 25.5 28.0 15.4 14.9 19.8 35.8 18.6 16.8 16.4 12.2 15.1 35.4 20.2 13.6 11.3 11.4 38.7 46.2 27.4 22.4 15.7 7.8 40.6 22.1 13.7 1.8 12.2 18.1 16.1 43.3 41.2 27.8 19.5 11.3 20.3 14.3 21.2 12.7 24.3 17.4 53.5 13.1 20.9 16.2 60.9 39.0 34.3 17.8 14.2 31.6 24.4 24.0 12.5